SAJ 10-Q: SBIC merger unlocks undistributed capital; CLO details disclosed

Q: What is Saratoga Investment Corp.'s (SAJ) exposure to the Saratoga CLO?

The Company holds $57.8M of subordinated notes in the Saratoga CLO and has received cumulative distributions of $92.2M to date.

Q: What SOFR rates are disclosed in the filing that affect portfolio yields?

The filing discloses the 1M TERM SOFR at 4.27% and the 3M TERM SOFR at 4.17% as of August 31, 2025 .

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

10-Q

Rhea-AI Filing Summary

Saratoga Investment Corp. (SAJ) reports consolidated quarterly disclosures describing its single reportable segment, portfolio composition and valuation practices. The company holds $57.8M of subordinated notes in the Saratoga CLO and has received cumulative distributions of $92.2M, management fees of $39.6M and incentive fees of $1.2M from that vehicle. The present value of projected future cash flows of those subordinated notes was approximately $0.1M using a 70.0% discount rate as of August 31, 2025.

The filing notes the SBIC subsidiary repaid SBA debentures and merged into the Company, unlocking undistributed capital and referencing the SBIC regulatory cap of $350.0M in outstanding debentures with at least $175.0M combined regulatory capital. SOFR reference rates are disclosed: 1M TERM SOFR 4.27% and 3M TERM SOFR 4.17%. The company details valuation hierarchy, level classifications, and use of an independent valuation firm and audit committee review for Level 3 assets.

Positive

Access to undistributed capital after SBIC LP repaid SBA debentures and merged into the Company
$92.2M of cumulative distributions received from Saratoga CLO and $39.6M of management fees earned to date
Use of independent valuation firm and audit committee review for Level 3 investment valuations

Negative

Present value of projected cash flows for subordinated notes is approximately $0.1M using a 70.0% discount rate
Significant reliance on model assumptions with discount rates ranging up to 70.0% and wide valuation input ranges
U.S. federal excise tax accrual increased to $2.4M for the year ended fiscal period noted

Insights

CLO exposure is concentrated in subordinated positions with minimal present value of projected cash flows.

The company holds $57.8M in Saratoga CLO subordinated notes and reported the present value of projected future cash flows at approximately $0.1M using a 70.0% discount as of August 31, 2025, indicating the subordinated tranche currently carries deep discounting.

This structure depends on the Saratoga CLO earning a spread (reported weighted average spread over SOFR of 3.6%) and on future cash distributions; monitor quarterly cash distributions and CLO leverage levels over the next 12 months for recovery of subordinated cashflows.

Valuations rely on models and third‑party review for Level 3 assets, with pronounced subjective inputs.

Valuation techniques include market comparables, discounted cash flows and enterprise value waterfalls and use discount rates and recovery/prepayment assumptions (default 2.0%, recovery 70.0%, prepayment 20.0%) disclosed in the filing. An independent valuation firm reviews selected valuations quarterly and the audit committee approves fair values.

Because inputs span wide ranges (discount rates up to 70.0%), investors should watch for changes in key model inputs and independent valuation firm conclusions at each quarter-end to assess mark volatility within the next 3 quarters.

10/07/2025 - 04:02 PM

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended August 31, 2025

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File No. 814-00732

SARATOGA INVESTMENT CORP.

(Exact name of registrant as specified in its charter)

Maryland		20-8700615
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification Number)

535 Madison Avenue

New York, New York 10022

(Address of principal executive offices)

(212) 906-7800

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.001 per share	SAR	The New York Stock Exchange
6.00% Notes due 2027	SAT	The New York Stock Exchange
8.00% Notes due 2027	SAJ	The New York Stock Exchange
8.125% Notes due 2027	SAY	The New York Stock Exchange
8.50% Notes due 2027	SAZ	The New York Stock Exchange

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days: Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☒
Non-accelerated filer	☐	Smaller reporting company	☐
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

The number of outstanding common shares of the registrant as of October 7, 2025 was 16,103,948.

TABLE OF CONTENTS

		Page
PART I.	FINANCIAL INFORMATION	1

Item 1.	Consolidated Financial Statements	1

	Consolidated Statements of Assets and Liabilities as of August 31, 2025 (unaudited) and February 28, 2025	1

	Consolidated Statements of Operations for the three and six months ended August 31, 2025 (unaudited) and August 31, 2024 (unaudited)	2

	Consolidated Statements of Changes in Net Assets for three and six months ended August 31, 2025 (unaudited) and August 31, 2024 (unaudited)	3

	Consolidated Statements of Cash Flows for the six months ended August 31, 2025 (unaudited) and August 31, 2024 (unaudited)	4

	Consolidated Schedules of Investments as of August 31, 2025 (unaudited) and February 28, 2025	5

	Notes to Consolidated Financial Statements as of August 31, 2025 (unaudited)	27

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	109

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	148

Item 4.	Controls and Procedures	150

PART II.	OTHER INFORMATION	151

Item 1.	Legal Proceedings	151

Item 1A.	Risk Factors	151

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	151

Item 3.	Defaults Upon Senior Securities	151

Item 4.	Mine Safety Disclosures	151

Item 5.	Other Information	151

Item 6.	Exhibits	152

Signatures		154

PART I. FINANCIAL INFORMATION

Item 1. Consolidated Financial Statements

Saratoga Investment Corp.

Consolidated Statements of Assets and Liabilities

	August 31, 2025			February 28, 2025
	(unaudited)
ASSETS
Investments at fair value
Non-control/Non-affiliate investments (amortized cost of $886,285,227 and $886,071,934, respectively)	$	898,724,347		$	897,660,110
Affiliate investments (amortized cost of $50,318,387 and $38,203,811, respectively)		52,755,641			40,547,432
Control investments (amortized cost of $76,035,288 and $75,817,587, respectively)		43,815,022			39,870,208
Total investments at fair value (amortized cost of $1,012,638,902 and $1,000,093,332, respectively)		995,295,010			978,077,750
Cash and cash equivalents		105,660,178			148,218,491
Cash and cash equivalents, reserve accounts		95,144,529			56,505,433
Interest receivable (net of reserve of $244,970 and $210,319, respectively)		8,617,063			7,477,468
Management fee receivable		278,769			314,193
Other assets		1,215,885			950,522
Total assets	$	1,206,211,434		$	1,191,543,857

LIABILITIES
Revolving credit facilities	$	70,000,000		$	52,500,000
Deferred debt financing costs, revolving credit facilities		(833,266	)		(1,254,516	)
SBA debentures payable		170,000,000			170,000,000
Deferred debt financing costs, SBA debentures payable		(3,621,941	)		(4,041,026	)
8.75% Notes Payable 2025		-			20,000,000
Discount on 8.75% notes payable 2025		-			(9,055	)
Deferred debt financing costs, 8.75% notes payable 2025		-			(374	)
7.00% Notes Payable 2025		12,000,000			12,000,000
Discount on 7.00% notes payable 2025		(2,622	)		(68,589	)
Deferred debt financing costs, 7.00% notes payable 2025		(348	)		(8,345	)
7.75% Notes Payable 2025		-			5,000,000
Deferred debt financing costs, 7.75% notes payable 2025		-			(19,685	)
4.375% Notes Payable 2026		175,000,000			175,000,000
Premium on 4.375% notes payable 2026		164,326			287,848
Deferred debt financing costs, 4.375% notes payable 2026		(440,876	)		(865,593	)
4.35% Notes Payable 2027		75,000,000			75,000,000
Discount on 4.35% notes payable 2027		(147,988	)		(213,424	)
Deferred debt financing costs, 4.35% notes payable 2027		(515,174	)		(688,786	)
6.25% Notes Payable 2027		15,000,000			15,000,000
Deferred debt financing costs, 6.25% notes payable 2027		(166,199	)		(202,144	)
6.00% Notes Payable 2027		105,500,000			105,500,000
Discount on 6.00% notes payable 2027		(68,143	)		(87,295	)
Deferred debt financing costs, 6.00% notes payable 2027		(1,171,054	)		(1,524,089	)
8.00% Notes Payable 2027		46,000,000			46,000,000
Deferred debt financing costs, 8.00% notes payable 2027		(752,573	)		(927,484	)
8.125% Notes Payable 2027		60,375,000			60,375,000
Deferred debt financing costs, 8.125% notes payable 2027		(950,880	)		(1,156,234	)
8.50% Notes Payable 2028		57,500,000			57,500,000
Deferred debt financing costs, 8.50% notes payable 2028		(1,068,010	)		(1,273,134	)
Base management and incentive fees payable		6,645,499			6,230,944
Deferred tax liability		4,559,105			4,889,329
Payable from open trades		2,000,000			-
Accounts payable and accrued expenses		1,915,770			1,676,335
Interest and debt fees payable		3,160,274			3,909,517
Due to Manager		630,966			349,189
Total liabilities		795,711,866			798,878,389
Commitments and contingencies (See Note 9)

NET ASSETS
Common stock, par value $0.001, 100,000,000 common shares authorized, 16,027,312 and 15,183,078 common shares issued and outstanding, respectively		16,027			15,183
Capital in excess of par value		434,306,847			412,913,597
Total distributable deficit		(23,823,306	)		(20,263,312	)
Total net assets		410,499,568			392,665,468
Total liabilities and net assets	$	1,206,211,434		$	1,191,543,857
NET ASSET VALUE PER SHARE	$	25.61		$	25.86

See accompanying notes to consolidated financial statements.

Saratoga Investment Corp.

Consolidated Statements of Operations

(unaudited)

	For the three months ended						For the six months ended
	August 31, 2025			August 31, 2024			August 31, 2025		August 31, 2024
INVESTMENT INCOME
Interest from investments
Interest income:
Non-control/Non-affiliate investments	$	23,697,449		$	35,721,214		$	49,162,112	$	66,945,491
Affiliate investments		684,587			491,015			1,280,211		987,855
Control investments		1,191,555			1,247,256			2,382,216		3,244,368
Payment in kind interest income:
Non-control/Non-affiliate investments		121,084			1,654,044			289,313		1,717,874
Affiliate investments		604,880			250,346			1,189,629		491,450
Control investments		77,880			1,277			77,880		284,590
Total interest from investments		26,377,435			39,365,152			54,381,361		73,671,628
Interest from cash and cash equivalents		2,360,397			1,671,031			4,387,608		2,295,662
Management fee income		663,632			792,323			1,368,807		1,596,779
Dividend income:
Non-control/Non-affiliate investments		127,689			162,779			689,872		412,270
Control investments		903,439			915,590			1,339,857		2,212,640
Total dividend from investments		1,031,128			1,078,369			2,029,729		2,624,910
Structuring and advisory fee income		221,600			35,000			485,975		445,843
Other income		(28,436	)		61,500			290,893		1,046,703
Total investment income		30,625,756			43,003,375			62,944,373		81,681,525

OPERATING EXPENSES
Interest and debt financing expenses		12,372,030			13,128,941			24,823,895		26,091,022
Base management fees		4,374,324			4,766,445			8,707,656		9,749,025
Incentive management fees expense (benefit)		2,271,173			4,550,270			4,807,686		8,135,004
Professional fees		649,899			125,886			1,349,099		1,125,196
Administrator expenses		1,283,333			1,133,333			2,533,333		2,208,333
Insurance		74,310			77,597			148,620		155,193
Directors fees and expenses		118,500			80,000			250,000		193,000
General and administrative		412,769			821,584			1,058,180		1,430,711
Income tax expense (benefit)		(11,315	)		121,921			43,139		61,638
Total operating expenses		21,545,023			24,805,977			43,721,608		49,149,122
NET INVESTMENT INCOME		9,080,733			18,197,398			19,222,765		32,532,403

REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS
Net realized gain (loss) from investments:
Non-control/Non-affiliate investments		52,691			558,701			2,315,675		558,701
Control investments		-			(34,007,428	)		638,355		(55,202,425	)
Net realized gain (loss) from investments		52,691			(33,448,727	)		2,954,030		(54,643,724	)
Net change in unrealized appreciation (depreciation) on investments:
Non-control/Non-affiliate investments		478,796			32,524,852			850,944		46,681,677
Affiliate investments		139,577			353,445			93,633		954,668
Control investments		3,109,340			(4,150,142	)		3,727,113		(4,976,759	)
Net change in unrealized appreciation (depreciation) on investments		3,727,713			28,728,155			4,671,690		42,659,586
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments		423,998			(159,187	)		368,913		(620,188	)
Net realized and unrealized gain (loss) on investments		4,204,402			(4,879,759	)		7,994,633		(12,604,326	)
NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS	$	13,285,135		$	13,317,639		$	27,217,398	$	19,928,077

WEIGHTED AVERAGE - BASIC AND DILUTED EARNINGS (LOSS) PER COMMON SHARE	$	0.84		$	0.97		$	1.75	$	1.45
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING - BASIC AND DILUTED		15,775,387			13,726,142			15,560,114		13,704,759

*	Certain prior period amounts have been reclassified to conform to current period presentation.

See accompanying notes to consolidated financial statements.

Saratoga Investment Corp.

Consolidated Statements of Changes in Net Assets

(unaudited)

	For the six months ended
	August 31, 2025			August 31, 2024
INCREASE (DECREASE) FROM OPERATIONS:
Net investment income	$	19,222,765		$	32,532,403
Net realized gain (loss) from investments		2,954,030			(54,643,724	)
Net change in unrealized appreciation (depreciation) on investments		4,671,690			42,659,586
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments		368,913			(620,188	)
Net increase in net assets resulting from operations		27,217,398			19,928,077

DECREASE FROM SHAREHOLDER DISTRIBUTIONS:
Total distributions to shareholders		(30,777,392	)		(20,104,269	)
Net decrease in net assets from shareholder distributions		(30,777,392	)		(20,104,269	)

CAPITAL SHARE TRANSACTIONS:
Proceeds from issuance of common stock⁽¹⁾		17,245,664			-
Capital contribution from Manager		569,322			-
Stock dividend distribution		3,601,941			2,005,926
Offering costs		(22,833	)		-
Net increase (decrease) in net assets from capital share transactions		21,394,094			2,005,926
Total increase (decrease) in net assets		17,834,100			1,829,734
Net assets at beginning of period		392,665,468			370,224,108
Net assets at end of period	$	410,499,568		$	372,053,842

(1)	See Note 11 to the Consolidated Financial Statements contained herein for more information on share issuance.

See accompanying notes to consolidated financial statements.

Saratoga Investment Corp.

Consolidated Statements of Cash Flows

(unaudited)

	For the six months ended
	August 31, 2025			August 31, 2024
Operating activities
NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS	$	27,217,398		$	19,928,077
ADJUSTMENTS TO RECONCILE NET INCREASE (DECREASE) IN NET ASSETS RESULTING
FROM OPERATIONS TO NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES:
Distributions from CLO, payment-in-kind and other adjustments to cost		(1,061,847	)		(6,573,881	)
Net accretion of discount on investments		(1,164,246	)		(1,285,027	)
Amortization of deferred debt financing costs		2,502,178			2,522,568
Income tax expense (benefit)		38,689			61,638
Net realized (gain) loss from investments		(2,954,030	)		54,643,724
Net change in unrealized (appreciation) depreciation on investments		(4,671,690	)		(42,659,586	)
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments		(368,913	)		620,188
Proceeds from sales and repayments of investments		94,942,515			135,842,533
Purchases of investments		(102,307,963	)		(41,885,424	)
(Increase) decrease in operating assets:
Interest receivable		(1,139,595	)		213,732
Management fee receivable		35,424			9,197
Other assets		(265,363	)		(403,782	)
Current income tax receivable		-			97,745
Increase (decrease) in operating liabilities:
Base management and incentive fees payable		414,555			1,169,499
Payable from open trades		2,000,000			-
Accounts payable and accrued expenses		239,435			159,498
Interest and debt fees payable		(749,243	)		418,839
Directors fees payable		-			80,000
Due to Manager		281,777			334,693
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES		12,989,081			123,294,231

Financing activities
Borrowings on debt		17,500,000			30,000,000
Paydowns on debt		-			(12,500,000	)
Repayments of notes		(25,000,000	)		-
Payments of deferred debt financing costs		(25,000	)		(1,198,831	)
Proceeds from issuance of common stock		17,245,664			-
Capital contribution from Manager		569,322			-
Payments of cash dividends		(27,175,451	)		(18,098,343	)
Payments of offering costs		(22,833	)		-
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES		(16,908,298	)		(1,797,174	)
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS AND CASH AND CASH EQUIVALENTS, RESERVE ACCOUNTS		(3,919,217	)		121,497,057
CASH AND CASH EQUIVALENTS AND CASH AND CASH EQUIVALENTS, RESERVE ACCOUNTS, BEGINNING OF PERIOD		204,723,924			40,507,124
CASH AND CASH EQUIVALENTS AND CASH AND CASH EQUIVALENTS, RESERVE ACCOUNTS, END OF PERIOD (See note 2)	$	200,804,707		$	162,004,181

Supplemental information:
Interest paid during the period	$	23,070,960		$	23,149,615
Cash paid for taxes		286,573			88,955
Supplemental non-cash information:
Payment-in-kind interest income and other adjustments to cost		1,061,847			6,573,881
Net accretion of discount on investments		1,164,246			1,285,027
Amortization of deferred debt financing costs		2,502,178			2,522,568
Stock dividend distribution		3,601,941			2,005,926

See accompanying notes to consolidated financial statements.

Saratoga Investment Corp.

Consolidated Schedule of Investments

August 31, 2025
(unaudited)

Company(1)	Industry	Investment Interest Rate/ Maturity	Original Acquisition Date	Principal/ Number of Shares		Cost		Fair Value (c)		% of Net Assets
Non-control/Non-affiliate investments - 219.0% (b)
Altvia MidCo, LLC.	Alternative Investment Management Software	First Lien Term Loan (6M USD TERM SOFR+8.08%), 12.46% Cash, 7/18/2027	7/18/2022	$	11,313,400	$	11,244,393	$	11,338,289		2.8	%
Altvia MidCo, LLC. (h)	Alternative Investment Management Software	Series A-1 Preferred Shares	7/18/2022		2,083,939		2,083,939		2,984,758		0.7	%
		Total Alternative Investment Management Software					13,328,332		14,323,047		3.5	%
BQE Software, Inc. (d)	Architecture & Engineering Software	First Lien Term Loan (3M USD TERM SOFR+5.50%), 9.67% Cash, 4/13/2028	4/13/2023	$	24,500,000		24,344,273		24,747,450		6.0	%
BQE Software, Inc. (j)	Architecture & Engineering Software	Delayed Draw Term Loan (3M USD TERM SOFR+5.50%), 9.67% Cash, 4/13/2028	4/13/2023	$	500,000		499,327		505,050		0.1	%
		Total Architecture & Engineering Software					24,843,600		25,252,500		6.1	%
Golden TopCo LP (h)	Association Management Software	Class A-2 Common Units	5/10/2023		1,072,394		1,072,394		1,762,266		0.4	%
		Total Association Management Software					1,072,394		1,762,266		0.4	%
Artemis Wax Corp. (d)(j)	Consumer Services	Delayed Draw Term Loan (1M USD TERM SOFR+6.75%), 11.02% Cash, 5/20/2026	5/20/2021	$	57,500,000		57,411,505		57,264,250		14.0	%
Artemis Wax Corp. (h)	Consumer Services	Series B-1 Preferred Stock	5/20/2021		934,463		1,500,000		-		0.0	%
Artemis Wax Corp. (h)	Consumer Services	Series D Preferred Stock	12/22/2022		331,640		1,711,866		1,992,262		0.5	%
		Total Consumer Services					60,623,371		59,256,512		14.5	%
Schoox, Inc. (h)(i)	Corporate Education Software	Series 1 Membership Interest	12/8/2020		1,050		548,298		4,029,606		1.0	%
		Total Corporate Education Software					548,298		4,029,606		1.0	%
Innergy, Inc.	Custom Millwork Software	First Lien Term Loan (3M USD TERM SOFR+5.50%), 9.67% Cash, 2/20/2030	2/20/2025	$	32,000,000		31,744,246		31,897,600		7.8	%
Innergy, Inc. (j)	Custom Millwork Software	Delayed Draw Term Loan (3M USD TERM SOFR+5.50%), 9.67% Cash, 2/20/2030	2/20/2025	$	-		-		-		0.0	%
		Total Custom Millwork Software					31,744,246		31,897,600		7.8	%
GreyHeller LLC (h)	Cyber Security	Common Stock	11/10/2021		7,857,689		1,906,275		3,857,402		0.9	%
		Total Cyber Security					1,906,275		3,857,402		0.9	%

Saratoga Investment Corp.

Consolidated Schedule of Investments

August 31, 2025
(unaudited)

Company(1)	Industry	Investment Interest Rate/ Maturity	Original Acquisition Date	Principal/ Number of Shares		Cost		Fair Value (c)			% of Net Assets
Gen4 Dental Partners Holdings, LLC	Dental Practice Management	First Lien Term Loan (1M USD TERM SOFR+5.75%), 10.02% Cash, 5/13/2030	5/13/2024	$	7,071,429		7,013,683		7,142,143			1.7	%
Gen4 Dental Partners Holdings, LLC (j)	Dental Practice Management	Delayed Draw Term Loan (1M USD TERM SOFR+5.75%), 10.02% Cash, 5/13/2030	5/13/2024	$	-		-		-			0.0	%
Gen4 Dental Partners Holdings, LLC (j)	Dental Practice Management	Revolving Credit Facility (1M USD TERM SOFR+5.75%), 10.02% Cash, 5/13/2030	5/13/2024	$	-		-		-			0.0	%
Gen4 Dental Partners Holdings, LLC (h)(i)	Dental Practice Management	Series A Preferred Units	2/8/2023		493,999		1,027,519		1,141,138			0.3	%
Modis Dental Partners OpCo, LLC	Dental Practice Management	First Lien Term Loan (1M USD TERM SOFR+9.42%), 13.69% Cash, 4/18/2028	4/18/2023	$	7,000,000		6,934,194		7,089,600			1.7	%
Modis Dental Partners OpCo, LLC (j)	Dental Practice Management	Delayed Draw Term Loan (1M USD TERM SOFR+9.42%), 13.69% Cash, 4/18/2028	4/18/2023	$	13,000,000		12,851,297		13,166,400			3.2	%
Modis Dental Partners OpCo, LLC (h)	Dental Practice Management	Class A Preferred Units	4/18/2023		3,200,000		3,200,000		2,656,768			0.6	%
		Total Dental Practice Management					31,026,693		31,196,049			7.5	%
Exigo, LLC (d)	Direct Selling Software	First Lien Term Loan (1M USD TERM SOFR+6.25%), 10.62% Cash, 3/16/2027	3/16/2022	$	23,940,038		23,858,946		23,147,623			5.6	%
Exigo, LLC (j)	Direct Selling Software	Revolving Credit Facility (1M USD TERM SOFR+6.25%), 10.62% Cash, 3/16/2027	3/16/2022	$	-		-		(20,688	)		0.0	%
Exigo, LLC (h), (i)	Direct Selling Software	Common Units	3/16/2022		1,041,667		1,041,667		725,378			0.2	%
		Total Direct Selling Software					24,900,613		23,852,313			5.8	%
C2 Educational Systems, Inc. (d)	Education Services	First Lien Term Loan (3M USD TERM SOFR+8.50%), 12.67% Cash, 11/30/2026	5/31/2017	$	23,000,000		22,999,951		22,958,600			5.6	%
C2 Educational Systems, Inc. (h)	Education Services	Series A-1 Preferred Stock	5/18/2021		3,127		499,904		620,869			0.2	%
Ready Education (d)	Education Software	First Lien Term Loan (3M USD TERM SOFR+7.00%), 11.17% Cash, 8/5/2027	8/5/2022	$	32,000,000		31,841,271		32,000,000			7.8	%
		Total Education Software					55,341,126		55,579,469			13.6	%
TG Pressure Washing Holdings, LLC (h)	Facilities Maintenance	Preferred Equity	8/12/2019		488,148		488,148		-			0.0	%
		Total Facilities Maintenance					488,148		-			0.0	%
GDS Software Holdings, LLC	Financial Services	First Lien Term Loan (3M USD TERM SOFR+7.00%), 11.17% Cash, 12/30/2026	12/30/2021	$	22,713,926		22,667,206		22,713,926			5.5	%
GDS Software Holdings, LLC (d)	Financial Services	Delayed Draw Term Loan (3M USD TERM SOFR+7.00%), 11.17% Cash, 12/30/2026	12/30/2021	$	3,286,074		3,269,333		3,286,074			0.8	%
GDS Software Holdings, LLC (h)	Financial Services	Common Stock Class A Units	8/23/2018		250,000		250,000		294,505			0.1	%
		Total Financial Services					26,186,539		26,294,505			6.4	%
Inspect Point Holdings, LLC	Fire Inspection Business Software	First Lien Term Loan (1M USD TERM SOFR+5.50%), 9.77% Cash, 07/19/2029	7/19/2023	$	18,000,000		17,864,134		18,046,800			4.4	%
Inspect Point Holdings, LLC (j)	Fire Inspection Business Software	Delayed Draw Term Loan (1M USD TERM SOFR+5.50%), 9.77% Cash, 07/19/2029	7/19/2023	$	-		-		-			0.0	%
		Total Fire Inspection Business Software					17,864,134		18,046,800			4.4	%

Saratoga Investment Corp.

Consolidated Schedule of Investments

August 31, 2025
(unaudited)

Company(1)	Industry	Investment Interest Rate/ Maturity	Original Acquisition Date	Principal/ Number of Shares		Cost		Fair Value (c)		% of Net Assets
Stretch Zone Franchising, LLC (d)	Health/Fitness Franchisor	First Lien Term Loan (3M USD TERM SOFR+7.00%), 11.17% Cash, 3/31/2028	3/31/2023	$	16,228,726		16,130,962		15,539,005		3.8	%
Stretch Zone Franchising, LLC (j)	Health/Fitness Franchisor	First Lien Term Loan (3M USD TERM SOFR+7.00%), 11.17% Cash, 3/31/2028	3/31/2023	$	8,738,545		8,685,975		8,367,157		2.0	%
Stretch Zone Franchising, LLC (h)	Health/Fitness Franchisor	Class A Units	3/31/2023		20,000		2,000,000		1,050,559		0.3	%
		Total Health/Fitness Franchisor					26,816,937		24,956,721		6.1	%
Alpha Aesthetics Partners OpCo, LLC	Healthcare Services	First Lien Term Loan (1M USD TERM SOFR+9.88%), 14.15% Cash, 3/20/2028	3/20/2023	$	3,900,000		3,863,476		3,952,260		1.0	%
Alpha Aesthetics Partners OpCo, LLC	Healthcare Services	Delayed Draw Term Loan (1M USD TERM SOFR+9.88%), 14.15% Cash, 3/20/2028	3/20/2023	$	15,100,000		14,940,178		15,302,340		3.7	%
Alpha Aesthetics Partners OpCo, LLC (h)	Healthcare Services	Class A Preferred Units	3/20/2023		3,675,000		3,675,000		3,395,002		0.8	%
Axiom Medical Consulting, LLC	Healthcare Services	First Lien Term Loan (3M USD TERM SOFR+6.00%), 10.17% Cash, 9/11/2028	9/11/2023	$	2,500,000		2,483,683		2,500,000		0.6	%
Axiom Medical Consulting, LLC (j)	Healthcare Services	Delayed Draw Term Loan (3M USD TERM SOFR+6.00%), 10.17% Cash, 9/11/2028	9/11/2023	$	-		-		-		0.0	%
Axiom Parent Holdings, LLC (h)	Healthcare Services	Class A Preferred Units	6/19/2018		400,000		258,389		1,381,276		0.3	%
ComForCare Health Care (d)	Healthcare Services	First Lien Term Loan (3M USD TERM SOFR+6.25%), 10.42% Cash, 12/31/2028	1/31/2017	$	70,000,000		69,685,324		70,140,000		17.1	%
		Total Healthcare Services					94,906,050		96,670,878		23.5	%
Procurement Partners, LLC	Healthcare Software	First Lien Term Loan (3M USD TERM SOFR+6.50%), 10.67% Cash, 5/12/2026	11/12/2020	$	35,125,000		35,063,719		35,125,000		8.6	%
Procurement Partners, LLC	Healthcare Software	First Lien Term Loan (3M USD TERM SOFR+6.50%), 10.67% Cash, 5/12/2026	11/12/2020	$	10,300,000		10,300,566		10,300,000		2.5	%
Procurement Partners Holdings LLC (h)	Healthcare Software	Class A Units	11/12/2020		571,219		571,219		362,559		0.1	%
Procurement Partners Holdings LLC (h)	Healthcare Software	Class AA Units	11/12/2020		220,385		30,994		96,142		0.0	%
		Total Healthcare Software					45,966,498		45,883,701		11.2	%
Roscoe Medical, Inc. (h)	Healthcare Supply	Common Stock	3/26/2014		5,081		508,077		-		0.0	%
		Total Healthcare Supply					508,077		-		0.0	%
Granite Comfort, LP (d)	HVAC Services and Sales	First Lien Term Loan (3M USD TERM SOFR+7.40%), 11.57% Cash, 5/16/2027	11/16/2020	$	43,000,000		42,872,582		42,359,300		10.3	%
Granite Comfort, LP (j)(d)	HVAC Services and Sales	Delayed Draw Term Loan (3M USD TERM SOFR+7.40%), 11.57% Cash, 5/16/2027	11/16/2020	$	11,131,745		11,072,756		10,965,882		2.7	%
		Total HVAC Services and Sales					53,945,338		53,325,182		13.0	%
Vector Controls Holding Co., LLC (h)	Industrial Products	Warrants to Purchase Limited Liability Company Interests, Expires 11/30/2027	5/31/2015		329		-		9,564,438		2.3	%
		Total Industrial Products					-		9,564,438		2.3	%
AgencyBloc, LLC	Insurance Software	First Lien Term Loan (1M USD TERM SOFR+7.76%), 12.03% Cash, 10/1/2026	10/1/2021	$	15,495,852		15,449,440		15,495,852		3.8	%
Panther ParentCo LLC (h)	Insurance Software	Class A Units	10/1/2021		2,500,000		2,500,000		5,487,117		1.3	%
		Total Insurance Software					17,949,440		20,982,969		5.1	%

Saratoga Investment Corp.

Consolidated Schedule of Investments

August 31, 2025
(unaudited)

Company(1)	Industry	Investment Interest Rate/ Maturity	Original Acquisition Date	Principal/ Number of Shares		Cost		Fair Value (c)		% of Net Assets
Avantra	IT Services	First Lien Term Loan (3M USD TERM SOFR+7.97%), 12.14% Cash, 9/20/2029	9/19/2024	$	17,000,000		16,835,833		17,010,200		4.1	%
Maple Holdings Midco Limited (h)	IT Services	Class A Common Units	9/19/2024		2,000,000		2,000,000		2,354,573		0.6	%
		Total IT Services					18,835,833		19,364,773		4.7	%
ActiveProspect, Inc. (d)	Lead Management Software	First Lien Term Loan (3M USD TERM SOFR+6.00%), 10.37% Cash, 8/8/2027	8/8/2022	$	11,525,624		11,478,085		11,525,624		2.8	%
ActiveProspect, Inc. (j)	Lead Management Software	Delayed Draw Term Loan (3M USD TERM SOFR+6.00%), 10.37% Cash, 8/8/2027	8/8/2022	$	-		-		-		0.0	%
		Total Lead Management Software					11,478,085		11,525,624		2.8	%
Madison Logic, Inc. (d)(m)	Marketing Orchestration Software	First Lien Term Loan (1M USD TERM SOFR+7.00%), 11.37% Cash, 12/30/2028	12/30/2022	$	18,969,360		18,795,385		18,311,123		4.5	%
		Total Marketing Orchestration Software					18,795,385		18,311,123		4.5	%
ARC Health OpCo LLC (d)	Mental Healthcare Services	First Lien Term Loan (3M USD TERM SOFR+8.33%), 12.52% Cash, 8/5/2027	8/5/2022	$	6,500,000		6,478,716		6,267,300		1.5	%
ARC Health OpCo LLC (d)	Mental Healthcare Services	Delayed Draw Term Loan (3M USD TERM SOFR+8.33%), 12.52% Cash, 8/5/2027	8/5/2022	$	26,914,577		26,909,246		25,951,035		6.3	%
ARC Health OpCo LLC (h)	Mental Healthcare Services	Class A Preferred Units	8/5/2022		3,818,400		4,169,599		343,771		0.1	%
		Total Mental Healthcare Services					37,557,561		32,562,106		7.9	%
Chronus LLC	Mentoring Software	First Lien Term Loan (3M USD TERM SOFR+5.25%), 9.57% Cash, 8/26/2026	8/26/2021	$	15,000,000		14,964,299		14,719,500		3.6	%
Chronus LLC (d)	Mentoring Software	First Lien Term Loan (3M USD TERM SOFR+6.00%), 10.32% Cash, 8/26/2026	8/26/2021	$	5,000,000		4,982,509		4,906,500		1.2	%
Chronus LLC (h)	Mentoring Software	Series A Preferred Stock	8/26/2021		3,000		3,000,000		1,434,555		0.3	%
		Total Mentoring Software					22,946,808		21,060,555		5.1	%
Cloudpermit	Municipal Government Software	First Lien Term Loan (3M USD TERM SOFR+5.75%), 9.92% Cash, 9/5/2029	9/5/2024	$	28,000,000		27,765,444		28,056,000		6.8	%
Cloudpermit (j)	Municipal Government Software	Delayed Draw Term Loan (3M USD TERM SOFR+5.75%), 9.92% Cash, 9/5/2029	9/5/2024	$	-		-		-		0.0	%
Cloudpermit (h)	Municipal Government Software	Limited Partner Interests	9/5/2024		2,000		2,000,000		2,284,334		0.6	%
		Total Municipal Government Software					29,765,444		30,340,334		7.4	%
Emily Street Enterprises, L.L.C. (d)	Office Supplies	Senior Secured Note (3M USD TERM SOFR+6.75%), 11.00% Cash, 12/31/2028	12/28/2012	$	5,300,000		5,285,696		5,339,220		1.3	%
		Total Office Supplies					5,285,696		5,339,220		1.3	%
Buildout, Inc. (d)	Real Estate Services	First Lien Term Loan (3M USD TERM SOFR+7.00%), 11.27% Cash, 9/30/2025	7/9/2020	$	14,000,000		13,998,661		13,630,400		3.3	%
Buildout, Inc.	Real Estate Services	Delayed Draw Term Loan (3M USD TERM SOFR+7.00%), 11.27% Cash, 9/30/2025	2/12/2021	$	38,500,000		38,499,680		37,483,600		9.1	%
Buildout, Inc. (h)(i)	Real Estate Services	Limited Partner Interests	7/9/2020		1,250		1,372,557		761,294		0.2	%
		Total Real Estate Services					53,870,898		51,875,294		12.6	%

Saratoga Investment Corp.

Consolidated Schedule of Investments

August 31, 2025
(unaudited)

Company(1)	Industry	Investment Interest Rate/ Maturity	Original Acquisition Date	Principal/ Number of Shares		Cost		Fair Value (c)		% of Net Assets
Wellspring Worldwide Inc.	Research Software	First Lien Term Loan (3M USD TERM SOFR+8.42%), 12.59% Cash, 2/28/2029	6/27/2022	$	9,372,000		9,315,608		9,372,000		2.3	%
Wellspring Worldwide Inc.	Research Software	Delayed DrawTerm Loan (3M USD TERM SOFR+8.42%), 12.59% Cash, 2/28/2029	6/27/2022	$	25,310,000		25,057,736		25,310,000		6.3	%
Archimedes Parent LLC (h)	Research Software	Class A Common Units	6/27/2022		2,475,160		2,475,160		2,258,449		0.6	%
		Total Research Software					36,848,504		36,940,449		9.2	%
LFR Chicken LLC	Restaurant	First Lien Term Loan (1M USD TERM SOFR+7.00%), 11.27% Cash, 11/19/2026	11/19/2021	$	12,000,000		11,966,521		12,000,000		2.9	%
LFR Chicken LLC (j)	Restaurant	Delayed Draw Term Loan (1M USD TERM SOFR+7.00%), 11.27% Cash, 11/19/2026	11/19/2021	$	18,000,000		17,941,846		18,000,000		4.4	%
LFR Chicken LLC (h)	Restaurant	Series B Preferred Units	11/19/2021		497,183		1,000,000		1,739,873		0.4	%
		Total Restaurant					30,908,367		31,739,873		7.7	%
Avionte Holdings, LLC (h)	Staffing Services	Class A Units	1/8/2014		100,000		100,000		2,402,643		0.6	%
		Total Staffing Services					100,000		2,402,643		0.6	%
AIMCO 2025-24A E (a)	Structured Finance Securities	First Lien Term Loan (3M USD TERM SOFR+6.10%), 10.27% Cash, 4/19/2038	4/30/2025	$	1,500,000		1,500,000		1,537,010		0.4	%
APID 2023-45A ER (a)	Structured Finance Securities	First Lien Term Loan (3M USD TERM SOFR+5.15%), 9.32% Cash, 7/26/2038	6/5/2025	$	2,800,000		2,800,000		2,822,996		0.7	%
APID 2017-28A DR (a)	Structured Finance Securities	First Lien Term Loan (3M USD TERM SOFR+5.00%), 9.17% Cash, 10/20/2038	7/25/2025	$	2,500,000		2,500,000		2,509,375		0.6	%
BGCLO 2025-13A D2 (a)	Structured Finance Securities	First Lien Term Loan (3M USD TERM SOFR+4.05%), 8.22% Cash, 10/23/2038	8/7/2025	$	2,000,000		2,000,000		2,007,500		0.5	%
BSP 2025-40A E (a)	Structured Finance Securities	First Lien Term Loan (3M USD TERM SOFR+5.25%), 9.42% Cash, 7/25/2038	5/22/2025	$	3,000,000		3,000,000		3,047,520		0.7	%
BSP 2016-10A C2R3 (a)	Structured Finance Securities	First Lien Term Loan (3M USD TERM SOFR+4.10%), 8.27% Cash, 7/20/2038	7/10/2025	$	2,000,000		2,000,000		2,018,538		0.5	%
HLM 2025-26A D2 (a)	Structured Finance Securities	First Lien Term Loan (3M USD TERM SOFR+4.10%), 8.27% Cash, 7/20/2038	7/18/2025	$	2,000,000		2,000,000		2,003,098		0.5	%
NMC CLO-4A ER (a)	Structured Finance Securities	First Lien Term Loan (3M USD TERM SOFR+6.91%), 11.08% Cash, 3/20/2038	4/17/2025	$	1,000,000		980,000		1,030,730		0.3	%
NMC CLO-7A E (a)	Structured Finance Securities	First Lien Term Loan (3M USD TERM SOFR+5.00%), 9.17% Cash, 3/31/2038	3/13/2025	$	1,000,000		1,000,000		1,007,315		0.2	%
NMC CLO-5A ER (a)	Structured Finance Securities	First Lien Term Loan (3M USD TERM SOFR+5.85%), 10.02% Cash, 7/20/2036	6/30/2025	$	3,000,000		3,000,000		3,010,914		0.7	%
NMC CLO-3A D2R (a)	Structured Finance Securities	First Lien Term Loan (3M USD TERM SOFR+4.10%), 8.27% Cash, 10/20/2038	8/4/2025	$	2,250,000		2,250,000		2,254,462		0.5	%
OAKC 2016-13A ER2 (a)	Structured Finance Securities	First Lien Term Loan (3M USD TERM SOFR+5.75%), 9.92% Cash, 10/21/2037	4/10/2025	$	1,000,000		976,250		1,008,666		0.2	%
OAKC 2025-22A E (a)	Structured Finance Securities	First Lien Term Loan (3M USD TERM SOFR+5.55%), 9.72% Cash, 7/20/2038	5/9/2025	$	1,250,000		1,250,000		1,272,248		0.3	%
OAKC 2020-7A D2R2 (a)	Structured Finance Securities	First Lien Term Loan (3M USD TERM SOFR+4.05%), 8.22% Cash, 7/19/2038	6/18/2025	$	3,250,000		3,250,000		3,273,689		0.9	%

Saratoga Investment Corp.

Consolidated Schedule of Investments

August 31, 2025
(unaudited)

Company(1)	Industry	Investment Interest Rate/ Maturity	Original Acquisition Date	Principal/ Number of Shares		Cost		Fair Value (c)		% of Net Assets
OCP 2025-43A E (a)	Structured Finance Securities	First Lien Term Loan (3M USD TERM SOFR+6.50%), 10.67% Cash, 7/20/2038	4/23/2025	$	1,000,000		1,000,000		1,029,623		0.3	%
OCP 2023-28A (a)	Structured Finance Securities	First Lien Term Loan (3M USD TERM SOFR+5.25%), 9.42% Cash, 7/16/2038	6/18/2025	$	3,000,000		3,000,000		3,024,711		0.7	%
OCP 2016-11A D2R3 (a)	Structured Finance Securities	First Lien Term Loan (3M USD TERM SOFR+4.10%), 8.27% Cash, 7/26/2038	6/26/2025	$	1,500,000		1,500,000		1,512,831		0.4	%
TREST 2017-1A ERR (a)	Structured Finance Securities	First Lien Term Loan (3M USD TERM SOFR+5.95%), 10.12% Cash, 7/25/2037	3/7/2025	$	1,250,000		1,257,125		1,263,751		0.3	%
WBOX 2023-4A ER (a)	Structured Finance Securities	First Lien Term Loan (3M USD TERM SOFR+6.48%), 10.65% Cash, 4/20/2036	4/10/2025	$	2,000,000		1,970,000		2,026,294		0.5	%
WBOX 2025-5A D2 (a)	Structured Finance Securities	First Lien Term Loan (3M USD TERM SOFR+4.10%), 8.27% Cash, 7/20/2038	6/24/2025	$	2,000,000		2,000,000		2,005,686		0.5	%
		Total Structured Finance Securities					39,233,375		39,666,957		9.7	%
StockIQ Technologies, LLC	Supply Chain Planning Software	First Lien Term Loan (3M USD TERM SOFR+5.25%), 9.42% Cash, 3/26/2030	3/25/2025	$	10,000,000		9,916,132		9,913,000		2.4	%
StockIQ Technologies, LLC (j)	Supply Chain Planning Software	Delayed Draw Term Loan (3M USD TERM SOFR+5.25%), 9.42% Cash, 3/26/2030	3/25/2025	$	-		-		-		0.0	%
StockIQ Technologies, LLC (h)	Supply Chain Planning Software	Class A Units	3/25/2025		200,000		200,000		200,000		0.0	%
		Total Supply Chain Planning Software					10,116,132		10,113,000		2.4	%
JDXpert	Talent Acquisition Software	First Lien Term Loan (3M USD TERM SOFR+8.50%), 12.93% Cash, 5/2/2027	5/2/2022	$	6,000,000		5,973,214		6,000,000		1.6	%
JDXpert	Talent Acquisition Software	Delayed Draw Term Loan (3M USD TERM SOFR+8.50%), 12.93% Cash, 5/2/2027	5/2/2022	$	1,000,000		994,682		1,000,000		0.2	%
JDXpert (j)	Talent Acquisition Software	Delayed Draw Term Loan (3M USD TERM SOFR+8.50%), 12.93% Cash, 5/2/2027	3/31/2023	$	500,000		496,840		500,000		0.1	%
Jobvite, Inc. (d)	Talent Acquisition Software	First Lien Term Loan (3M USD TERM SOFR+7.50%), 11.67% Cash, 8/5/2028	8/5/2022	$	20,000,000		19,916,732		19,892,000		4.8	%
		Total Talent Acquisition Software					27,381,468		27,392,000		6.7	%
VetnCare MSO, LLC (j)	Veterinary Services	Delayed Draw Term Loan (3M USD TERM SOFR+5.75%), 9.92% Cash, 5/12/2028	5/12/2023	$	13,290,655		13,195,562		13,358,438		3.3	%
		Total Veterinary Services					13,195,562		13,358,438		3.3	%
Sub Total Non-control/Non-affiliate investments							886,285,227		898,724,347		219.0	%

Saratoga Investment Corp.

Consolidated Schedule of Investments

August 31, 2025
(unaudited)

Company(1)	Industry	Investment Interest Rate/ Maturity	Original Acquisition Date	Principal/ Number of Shares		Cost		Fair Value (c)		% of Net Assets
Affiliate investments - 12.9% (b)
ETU Holdings, Inc. (f)	Corporate Education Software	First Lien Term Loan (3M USD TERM SOFR+9.00%), 13.32% Cash, 2/18/2028	8/18/2022	$	7,000,000		6,966,488		6,907,600		1.7	%
ETU Holdings, Inc. (f)	Corporate Education Software	Second Lien Term Loan 15.00% PIK, 2/18/2028	8/18/2022	$	7,673,478		7,647,727		6,825,558		1.7	%
ETU Holdings, Inc. (f)(h)	Corporate Education Software	Series A Preferred Units	8/18/2022		3,000,000		3,000,000		-		0.0	%
		Total Corporate Education Software					17,614,215		13,733,158		3.4	%
Axero Holdings, LLC (f)	Employee Collaboration Software	First Lien Term Loan 4.50% Cash, (3M USD TERM SOFR + 2.50%) PIK, 12/31/2027	6/30/2021	$	16,501,550		16,484,512		16,577,459		4.1	%
Axero Holdings, LLC (f)	Employee Collaboration Software	Delayed Draw Term Loan 4.50% Cash, (3M USD TERM SOFR + 2.50%) PIK, 12/31/2027	6/30/2021	$	1,171,078		1,167,045		1,176,464		0.3	%
Axero Holdings, LLC (f)(j)	Employee Collaboration Software	Revolving Credit Facility 4.50% Cash, (3M USD TERM SOFR + 2.50%) PIK, 12/31/2027	2/3/2022	$	-		-		-		0.0	%
Axero Holdings, LLC (f)(h)	Employee Collaboration Software	Series A Preferred Units	6/30/2021		2,055,609		2,055,609		3,843,989		0.9	%
Axero Holdings, LLC (f)(h)	Employee Collaboration Software	Series B Preferred Units	6/30/2021		2,055,609		2,055,609		6,484,572		1.6	%
		Total Employee Collaboration Software					21,762,775		28,082,484		6.9	%
SmartAC.com, LLC (f)	HVAC Monitoring Devices	First Lien Term Loan (3M USD TERM SOFR+7.50%), 11.67% Cash, 4/7/2030	4/7/2025	$	8,000,000		7,941,398		7,940,000		1.9	%
SmartAC.com, LLC (f)	HVAC Monitoring Devices	Delayed Draw Term Loan (3M USD TERM SOFR+7.50%), 11.67% Cash, 4/7/2030	4/7/2025	$	-		-		-		0.0	%
SmartAC.com, LLC (f)(j)	HVAC Monitoring Devices	Series A Preferred Units	4/7/2025		1,262,201		2,999,999		2,999,999		0.7	%
		Total HVAC Monitoring Devices					10,941,397		10,939,999		2.6	%
Sub Total Affiliate investments							50,318,387		52,755,641		12.9	%

Saratoga Investment Corp.

Consolidated Schedule of Investments

August 31, 2025
(unaudited)

Company(1)	Industry	Investment Interest Rate/ Maturity	Original Acquisition Date	Principal/ Number of Shares		Cost		Fair Value (c)		% of Net Assets
Control investments - 10.6% (b)
Zollege PBC (g)	Education Services	First Lien Term Loan 4.84% PIK, 8/9/2027	5/11/2021	$	1,539,130		1,539,130		1,158,965		0.3	%
Zollege PBC (h)(g)	Education Services	Common Stock	5/11/2021		7,731,294		558,799		7,450,808		1.8	%
		Total Education Services					2,097,929		8,609,773		2.1	%
Pepper Palace, Inc. (k)(g)	Specialty Food Retailer	First Lien Term Loan 4.42% PIK, 12/31/2028	6/30/2021	$	2,400,000		2,400,000		1,303,440		0.3	%
Pepper Palace, Inc. (j)(k)(g)	Specialty Food Retailer	Delayed Draw Term Loan 4.42% PIK, 12/31/2028	6/30/2021	$	-		-		-		0.0	%
Pepper Palace, Inc. (j)(k)(g)	Specialty Food Retailer	Revolving Credit Facility 4.42% PIK, 12/31/2028	6/30/2021	$	1,000,000		1,000,000		543,100		0.1	%
Pepper Palace, Inc. (h)(g)	Specialty Food Retailer	Class A Units	6/30/2021		100,000		138,561		-		0.0	%
		Total Specialty Food Retailer					3,538,561		1,846,540		0.4	%
Saratoga Investment Corp. CLO 2013-1, Ltd. (a)(e)(g)	Structured Finance Securities	Other/Structured Finance Securities 0.00%, 4/20/2033	1/22/2008	$	111,000,000		14,428,858		131,085		0.0	%
Saratoga Investment Corp. CLO 2013-1, Ltd. Class F-2-R-3 Note (a)(g)	Structured Finance Securities	Other/Structured Finance Securities (3M USD TERM SOFR+10.00%), 14.43%, 4/20/2033	8/9/2021	$	9,375,000		9,375,000		1,303,125		0.3	%
Saratoga Investment Corp. Senior Loan Fund 2022-1, Ltd. Class E Note (a)(g)	Structured Finance Securities	Other/Structured Finance Securities (3M USD TERM SOFR+8.55%), 12.72%, 10/20/2033	10/28/2022	$	12,250,000		11,392,500		12,250,000		3.0	%
		Total Structured Finance Securities					35,196,358		13,684,210		3.3	%
Saratoga Senior Loan Fund I JV, LLC (a)(g)(j)	Investment Fund	Unsecured Loan 10.00%, 10/20/2033	12/17/2021	$	17,618,954		17,618,954		16,790,863		4.1	%
Saratoga Senior Loan Fund I JV, LLC (a)(g)	Investment Fund	Membership Interest	12/17/2021		17,583,486		17,583,486		2,883,636		0.7	%
		Total Investment Fund					35,202,440		19,674,498		4.8	%
Sub Total Control investments							76,035,288		43,815,022		10.6	%
TOTAL INVESTMENTS - 242.5% (b)						$	1,012,638,902	$	995,295,010		242.5	%

Saratoga Investment Corp.

Consolidated Schedule of Investments

August 31, 2025
(unaudited)

	Number of Shares		Cost		Fair Value		% of Net Assets
Cash and cash equivalents and cash and cash equivalents, reserve accounts - 25.7% (b)
U.S. Bank Money Market (l)		200,804,707	$	200,804,707	$	200,804,707		48.9	%
Total cash and cash equivalents and cash and cash equivalents, reserve accounts		200,804,707	$	200,804,707	$	200,804,707		48.9	%

(1)	Securities are exempt from registration under Rule 144A of the Securities Act of 1933, as amended, and are restricted securities. Money market funds are valued at net asset value and are considered level 1 investments within the fair value hierarchy.

(a)

Represents an investment that is not a “qualifying asset” under Section 55(a) of the Investment Company Act of 1940, as amended (the 1940 Act”). As of August 31, 2025, non-qualifying assets represent 7.8% of the Company’s portfolio at fair value. As a BDC, the Company generally has to invest at least 70% of its total assets in qualifying assets.

(b)	Percentages are based on net assets of $410,499,568 as of August 31, 2025.

(c)

Because there is no “readily available market quotations” (as defined in the 1940 Act) for these investments, the fair values of these investments were determined using significant unobservable inputs and approved in good faith by our board of directors. These investments have been included as Level 3 in the Fair Value Hierarchy, except for the CLO BB and BBB debt which are level 2 investments (see Note 3 to the consolidated financial statements).

(d)	These securities are either fully or partially pledged as collateral under the Company’s senior secured revolving credit facility (see Note 8 to the consolidated financial statements).

(e)

This investment does not have a stated interest rate that is payable thereon. As a result, the 0.00% interest rate in the table above represents the effective interest rate currently earned on the investment cost and is based on the current cash interest and other income generated by the investment.

(f)	As defined in the 1940 Act, this portfolio company is an “affiliate” as we own between 5.0% and 25.0% of the outstanding voting securities. Transactions during the six months ended August 31, 2025 in which the issuer was an affiliate are as follows:

Company	Fair Value at the Beginning of Year		Purchases		Sales		Total Interest from Investments		Management Fee Income		Net Realized Gain (Loss) from Investments		Net Change in Unrealized Appreciation (Depreciation)			Fair Value at End of Period
Axero Holdings, LLC	$	27,179,347	$	-	$	-	$	1,017,002	$	-	$	-	$	291,349		$	28,082,484
ETU Holdings, Inc.		13,368,085		-		-		1,065,990		-		-		(196,317	)		13,733,158
SmartAC.com,LLC		-		10,939,999		-		386,849		-		-		(1,398	)		10,939,999
Total	$	40,547,432	$	10,939,999	$	-	$	2,469,841	$	-	$	-	$	93,634		$	52,755,641

Saratoga Investment Corp.

Consolidated Schedule of Investments

August 31, 2025
(unaudited)

(g)

As defined in the 1940 Act, we “control” this portfolio company because we own more than 25% of the portfolio company’s outstanding voting securities. Transactions during the six months ended August 31, 2025 in which the issuer was both an affiliate and a portfolio company that we control are as follows:

Company	Fair Value at the Beginning of Year		Purchases		Sales		Total Interest from Investments		Total Dividends from Investments		Management Fee Income		Net Realized Gain (Loss) from Investments		Net Change in Unrealized Appreciation (Depreciation)			Fair Value at End of Period
Pepper Palace, Inc.		1,547,000		600,000		-		-		-		-		-		(300,460	)		1,846,540
Zollege PBC		3,937,150		-		-		78,087		-		-		-		4,594,743			8,609,773
Saratoga Investment Corp. CLO 2013-1, Ltd.		240,578		-		-		-		-		1,368,807		-		350,686			131,085
Saratoga Investment Corp. Senior Loan Fund 2022-1, Ltd. Class E Note		12,250,000		-		-		803,853		-		-		-		-			12,250,000
Saratoga Investment Corp. CLO 2013-1, Ltd. Class F-2-R-3 Note		2,280,938		-		-		697,208		-		-		-		(977,813	)		1,303,125
Saratoga Senior Loan Fund I JV, LLC		16,533,626		-		-		880,948		-		-		-		257,237			16,790,863
Saratoga Senior Loan Fund I JV, LLC		3,080,916		-		-		-		1,339,857		-		-		(197,280	)		2,883,636
Total	$	39,870,208	$	600,000	$	-	$	2,460,096	$	1,339,857	$	1,368,807	$	-	$	3,727,113		$	43,815,022

(h)	Non-income producing at August 31, 2025

(i)	Includes securities issued by an affiliate of the company.

(j)	All or a portion of this investment has an unfunded commitment as of August 31, 2025. (See Note 9 to the consolidated financial statements).

(k)	As of August 31, 2025, the investment was on non-accrual status. The fair value of these investments was approximately $1.8 million, which represented 0.2% of the Company’s portfolio (see Note 2 to the consolidated financial statements).

(l)	Included within cash and cash equivalents and cash and cash equivalents, reserve accounts in the Company’s consolidated statements of assets and liabilities as of August 31, 2025.

(m)	This investment accruing PIK on 20% of the outstanding principal balance with the remaining 80% of the principal balance accruing interest payable in cash.

SOFR - Secured Overnight Financing Rate

1M USD TERM SOFR - The 1 month USD TERM SOFR rate as of August 31, 2025 was 4.27%.

3M USD TERM SOFR - The 3 month USD TERM SOFR rate as of August 31, 2025 was 4.17%.

See accompanying notes to consolidated financial statements.

Saratoga Investment Corp

Consolidated Schedule of Investments

February 28, 2025

Company(1)	Industry	Investment Interest Rate/ Maturity	Original Acquisition Date	Principal/ Number of Shares		Cost		Fair Value (c)		% of Net Assets
Non-control/Non-affiliate investments - 229.3% (b)
Altvia MidCo, LLC.	Alternative Investment Management Software	First Lien Term Loan (3M USD TERM SOFR+8.50%), 12.82% Cash, 7/18/2027	7/18/2022	$	8,835,600	$	8,775,378	$	8,845,319		2.3	%
Altvia MidCo, LLC. (h)	Alternative Investment Management Software	Series A-1 Preferred Shares	7/18/2022		2,000,000		2,000,000		2,730,236		0.7	%
		Total Alternative Investment Management Software					10,775,378		11,575,555		3.0	%
BQE Software, Inc. (d)	Architecture & Engineering Software	First Lien Term Loan (3M USD TERM SOFR+5.50%), 9.82% Cash, 4/13/2028	4/13/2023	$	24,500,000		24,328,507		24,541,650		6.3	%
BQE Software, Inc. (j)	Architecture & Engineering Software	Delayed Draw Term Loan (3M USD TERM SOFR+5.50%), 9.82% Cash, 4/13/2028	4/13/2023	$	750,000		746,569		751,275		0.2	%
		Total Architecture & Engineering Software					25,075,076		25,292,925		6.5	%
GrowthZone, LLC	Association Management Software	First Lien Term Loan (3M USD TERM SOFR+8.25%), 12.57% Cash, 5/10/2028	5/10/2023	$	23,336,753		23,044,093		23,402,096		6.0	%
Golden TopCo LP (h)	Association Management Software	Class A-2 Common Units	5/10/2023		1,072,394		1,072,394		1,447,602		0.4	%
		Total Association Management Software					24,116,487		24,849,698		6.4	%
Artemis Wax Corp. (d)(j)	Consumer Services	Delayed Draw Term Loan (1M USD TERM SOFR+7.50%), 11.82% Cash, 5/20/2026	5/20/2021	$	57,500,000		57,333,736		56,953,750		14.5	%
Artemis Wax Corp. (h)	Consumer Services	Series B-1 Preferred Stock	5/20/2021		934,463		1,500,000		338,044		0.1	%
Artemis Wax Corp. (h)	Consumer Services	Series D Preferred Stock	12/22/2022		331,640		1,711,866		2,147,020		0.5	%
		Total Consumer Services					60,545,602		59,438,814		15.1	%
Schoox, Inc. (h), (i)	Corporate Education Software	Series 1 Membership Interest	12/8/2020		1,050		475,698		3,978,192		1.0	%
		Total Corporate Education Software					475,698		3,978,192		1.0	%

Saratoga Investment Corp

Consolidated Schedule of Investments

February 28, 2025

Company(1)	Industry	Investment Interest Rate/ Maturity	Original Acquisition Date	Principal/ Number of Shares		Cost		Fair Value (c)		% of Net Assets
Innergy, Inc.	Custom Millwork Software	First Lien Term Loan (3M USD TERM SOFR+5.50%), 9.82% Cash, 1/31/2030	2/20/2025	$	32,000,000		31,721,847		31,721,600		8.1	%
Innergy, Inc. (j)	Custom Millwork Software	Delayed Draw Term Loan (3M USD TERM SOFR+5.50%), 9.82% Cash, 1/31/2030	2/20/2025	$	-		-		-		0.0	%
		Total Custom Millwork Software					31,721,847		31,721,600		8.1	%
GreyHeller LLC (h)	Cyber Security	Common Stock	11/10/2021		7,857,689		1,906,275		3,516,571		0.9	%
		Total Cyber Security					1,906,275		3,516,571		0.9	%
Gen4 Dental Partners Holdings, LLC	Dental Practice Management	First Lien Term Loan (1M USD TERM SOFR+5.75%), 10.07% Cash, 5/13/2030	5/13/2024	$	7,107,143		7,043,790		7,043,179		1.8	%
Gen4 Dental Partners Holdings, LLC (j)	Dental Practice Management	Delayed Draw Term Loan (1M USD TERM SOFR+5.75%), 10.07% Cash, 5/13/2030	5/13/2024	$	-		-		-		0.0	%
Gen4 Dental Partners Holdings, LLC (j)	Dental Practice Management	Revolving Credit Facility (1M USD TERM SOFR+5.75%), 10.07% Cash, 5/13/2030	5/13/2024	$	-		-		-		0.0	%
Gen4 Dental Partners Holdings, LLC (h)(i)	Dental Practice Management	Series A Preferred Units	2/8/2023		493,999		1,027,519		972,485		0.2	%
Modis Dental Partners OpCo, LLC	Dental Practice Management	First Lien Term Loan (1M USD TERM SOFR+9.41%), 13.74% Cash, 4/18/2028	4/18/2023	$	7,000,000		6,925,052		7,079,800		1.8	%
Modis Dental Partners OpCo, LLC (j)	Dental Practice Management	Delayed Draw Term Loan (1M USD TERM SOFR+9.41%), 13.74% Cash, 4/18/2028	4/18/2023	$	8,600,000		8,498,729		8,698,040		2.2	%
Modis Dental Partners OpCo, LLC (h)	Dental Practice Management	Class A Preferred Units	4/18/2023		2,950,000		2,950,000		2,552,488		0.7	%
New England Dental Partners	Dental Practice Management	First Lien Term Loan (3M USD TERM SOFR+8.00%), 12.47% Cash, 11/25/2025	11/25/2020	$	6,555,000		6,541,869		6,636,282		1.7	%
New England Dental Partners	Dental Practice Management	Delayed Draw Term Loan (3M USD TERM SOFR+8.00%), 12.47% Cash, 11/25/2025	11/25/2020	$	2,150,000		2,148,547		2,176,660		0.6	%
		Total Dental Practice Management					35,135,506		35,158,934		9.0	%

Saratoga Investment Corp

Consolidated Schedule of Investments

February 28, 2025

Company(1)	Industry	Investment Interest Rate/ Maturity	Original Acquisition Date	Principal/ Number of Shares		Cost		Fair Value (c)			% of Net Assets
Exigo, LLC (d)	Direct Selling Software	First Lien Term Loan (1M USD TERM SOFR+6.25%), 10.67% Cash, 3/16/2027	3/16/2022	$	24,065,038		23,961,810		23,352,713			5.9	%
Exigo, LLC (j)	Direct Selling Software	Revolving Credit Facility (1M USD TERM SOFR+6.25%), 10.67% Cash, 3/16/2027	3/16/2022	$	-		-		(18,500	)		0.0	%
Exigo, LLC (h), (i)	Direct Selling Software	Common Units	3/16/2022		1,041,667		1,041,667		729,464			0.2	%
		Total Direct Selling Software					25,003,477		24,063,677			6.1	%
C2 Educational Systems, Inc. (d)	Education Services	First Lien Term Loan (3M USD TERM SOFR+8.50%), 12.82% Cash, 5/31/2025	5/31/2017	$	23,000,000		22,993,974		22,990,800			5.9	%
C2 Educational Systems, Inc. (j)	Education Services	Delayed Draw Term Loan (3M USD TERM SOFR+8.50%), 12.82% Cash, 5/31/2025	4/28/2023	$	-		-		-			0.0	%
C2 Education Systems, Inc. (h)	Education Services	Series A-1 Preferred Stock	5/18/2021		3,127		499,904		605,383			0.2	%
		Total Education Services					23,493,878		23,596,183			6.1	%
GoReact	Education Software	First Lien Term Loan (3M USD TERM SOFR+7.50%), 12.02% Cash/1.00% PIK, 4/17/2025	1/17/2020	$	8,170,158		8,169,876		8,170,158			2.1	%
GoReact (j)	Education Software	Delayed Draw Term Loan (3M USD TERM SOFR+7.50%), 12.02% Cash/1.00% PIK, 4/17/2025	1/18/2022	$	-		-		-			0.0	%
Identity Automation Systems (h)	Education Software	Common Stock Class A-2 Units	8/25/2014		232,616		232,616		1,182,481			0.3	%
Identity Automation Systems (h)	Education Software	Common Stock Class A-1 Units	3/6/2020		43,715		171,571		329,237			0.1	%
Ready Education (d)	Education Software	First Lien Term Loan (3M USD TERM SOFR+7.00%), 11.32% Cash, 8/5/2027	8/5/2022	$	32,000,000		31,801,611		31,913,600			8.1	%
		Total Education Software					40,375,674		41,595,476			10.6	%
TG Pressure Washing Holdings, LLC (h)	Facilities Maintenance	Preferred Equity	8/12/2019		488,148		488,148		-			0.0	%
		Total Facilities Maintenance					488,148		-			0.0	%

Saratoga Investment Corp

Consolidated Schedule of Investments

February 28, 2025

Company(1)	Industry	Investment Interest Rate/ Maturity	Original Acquisition Date	Principal/ Number of Shares		Cost		Fair Value (c)			% of Net Assets
Davisware, LLC	Field Service Management	First Lien Term Loan (3M USD TERM SOFR+6.50%), 10.82% Cash, 11/30/2025	9/6/2019	$	6,000,000		6,000,000		6,012,000			1.5	%
Davisware, LLC (j)	Field Service Management	Delayed Draw Term Loan (3M USD TERM SOFR+6.50%), 10.82% Cash, 11/30/2025	9/6/2019	$	5,727,790		5,725,290		5,739,246			1.5	%
		Total Field Service Management					11,725,290		11,751,246			3.0	%
GDS Software Holdings, LLC	Financial Services	First Lien Term Loan (3M USD TERM SOFR+7.00%), 11.32% Cash, 12/30/2026	12/30/2021	$	22,713,926		22,655,802		22,654,870			5.8	%
GDS Software Holdings, LLC (d)	Financial Services	Delayed Draw Term Loan (3M USD TERM SOFR+7.00%), 11.32% Cash, 12/30/2026	12/30/2021	$	3,286,074		3,266,913		3,277,530			0.8	%
GDS Software Holdings, LLC (h)	Financial Services	Common Stock Class A Units	8/23/2018		250,000		250,000		370,057			0.1	%
		Total Financial Services					26,172,715		26,302,457			6.7	%
Ascend Software, LLC	Financial Services Software	First Lien Term Loan (3M USD TERM SOFR+7.50%), 12.08% Cash, 12/15/2026	12/15/2021	$	6,000,000		5,974,824		5,930,400			1.5	%
Ascend Software, LLC (j)	Financial Services Software	Delayed Draw Term Loan (3M USD TERM SOFR+7.50%), 12.08% Cash, 12/15/2026	12/15/2021	$	4,050,000		4,037,989		4,003,020			1.0	%
		Total Financial Services Software					10,012,813		9,933,420			2.5	%
Inspect Point Holdings, LLC	Fire Inspection Business Software	First Lien Term Loan (1M USD TERM SOFR+6.50%), 10.82% Cash, 07/19/2028	7/19/2023	$	10,000,000		9,927,042		10,178,000			2.6	%
Inspect Point Holdings, LLC (j)	Fire Inspection Business Software	Delayed Draw Term Loan (1M USD TERM SOFR+6.50%), 10.82% Cash, 07/19/2028	7/19/2023	$	-		-		-			0.0	%
		Total Fire Inspection Business Software					9,927,042		10,178,000			2.6	%
Stretch Zone Franchising, LLC (d)	Health/Fitness Franchisor	First Lien Term Loan (3M USD TERM SOFR+7.00%), 11.32% Cash, 3/31/2028	3/31/2023	$	28,717,271		28,525,975		27,327,355			7.0	%
Stretch Zone Franchising, LLC (j)	Health/Fitness Franchisor	Delayed Draw Term Loan (3M USD TERM SOFR+7.00%), 11.32% Cash, 3/31/2028	3/31/2023	$	-		-		(72,600	)		0.0	%
Stretch Zone Franchising, LLC (h)	Health/Fitness Franchisor	Class A Units	3/31/2023		20,000		2,000,000		1,198,117			0.3	%
		Total Health/Fitness Franchisor					30,525,975		28,452,872			7.3	%

Saratoga Investment Corp

Consolidated Schedule of Investments

February 28, 2025

Company(1)	Industry	Investment Interest Rate/ Maturity	Original Acquisition Date	Principal/ Number of Shares		Cost		Fair Value (c)		% of Net Assets
Alpha Aesthetics Partners OpCo, LLC	Healthcare Services	First Lien Term Loan (1M USD TERM SOFR+9.92%), 14.25% Cash, 3/20/2028	3/20/2023	$	3,900,000		3,858,168		3,952,260		1.1	%
Alpha Aesthetics Partners OpCo, LLC	Healthcare Services	Delayed Draw Term Loan (1M USD TERM SOFR+9.92%), 14.25% Cash, 3/20/2028	3/20/2023	$	15,100,000		14,915,338		15,302,340		3.9	%
Alpha Aesthetics Partners OpCo, LLC (h)	Healthcare Services	Class A Preferred Units	3/20/2023		3,675,000		3,675,000		3,822,369		1.0	%
Axiom Medical Consulting, LLC	Healthcare Services	First Lien Term Loan (3M USD TERM SOFR+6.00%), 10.32% Cash, 9/11/2028	9/11/2023	$	6,000,000		5,959,513		6,000,000		1.5	%
Axiom Medical Consulting, LLC (j)	Healthcare Services	Delayed Draw Term Loan (3M USD TERM SOFR+6.00%), 10.32% Cash, 9/11/2028	9/11/2023	$	-		-		-		0.0	%
Axiom Parent Holdings, LLC (h)	Healthcare Services	Class A Preferred Units	6/19/2018		400,000		258,389		884,831		0.2	%
ComForCare Health Care (d)	Healthcare Services	First Lien Term Loan (3M USD TERM SOFR+6.25%), 10.57% Cash, 12/31/2027	1/31/2017	$	55,000,000		54,766,528		55,187,000		14.1	%
		Total Healthcare Services					83,432,936		85,148,800		21.8	%
Procurement Partners, LLC	Healthcare Software	First Lien Term Loan (3M USD TERM SOFR+6.50%), 10.82% Cash, 5/12/2026	11/12/2020	$	35,125,000		35,033,286		35,125,000		8.9	%
Procurement Partners, LLC	Healthcare Software	Delayed Draw Term Loan (3M USD TERM SOFR+6.50%), 10.82% Cash, 5/12/2026	11/12/2020	$	10,300,000		10,287,080		10,300,000		2.6	%
Procurement Partners Holdings LLC (h)	Healthcare Software	Class A Units	11/12/2020		571,219		571,219		442,532		0.1	%
Procurement Partners Holdings LLC (h)	Healthcare Software	Class AA Units	11/12/2020		220,385		30,994		118,529		0.0	%
		Total Healthcare Software					45,922,579		45,986,061		11.6	%
Roscoe Medical, Inc. (h)	Healthcare Supply	Common Stock	3/26/2014		5,081		508,077		-		0.0	%
		Total Healthcare Supply					508,077		-		0.0	%

Saratoga Investment Corp

Consolidated Schedule of Investments

February 28, 2025

Company(1)	Industry	Investment Interest Rate/ Maturity	Original Acquisition Date	Principal/ Number of Shares		Cost		Fair Value (c)		% of Net Assets
Granite Comfort, LP (d)	HVAC Services and Sales	First Lien Term Loan (3M USD TERM SOFR+7.41%), 11.72% Cash, 5/16/2027	11/16/2020	$	43,000,000		42,842,108		41,937,900		10.7	%
Granite Comfort, LP (j)(d)	HVAC Services and Sales	Delayed Draw Term Loan (3M USD TERM SOFR+7.41%), 11.72% Cash, 5/16/2027	11/16/2020	$	16,207,805		16,101,236		15,520,041		4.0	%
		Total HVAC Services and Sales					58,943,344		57,457,941		14.7	%
Vector Controls Holding Co., LLC (h)	Industrial Products	Warrants to Purchase Limited Liability Company Interests, Expires 3/6/2025	5/31/2015		329		-		9,404,077		2.4	%
		Total Industrial Products					-		9,404,077		2.4	%
AgencyBloc, LLC	Insurance Software	First Lien Term Loan (1M USD TERM SOFR+7.76%), 12.09% Cash, 10/1/2026	10/1/2021	$	15,615,511		15,553,310		15,615,511		4.0	%
Panther ParentCo LLC (h)	Insurance Software	Class A Units	10/1/2021		2,500,000		2,500,000		4,729,353		1.2	%
		Total Insurance Software					18,053,310		20,344,864		5.2	%
Avantra	IT Services	First Lien Term Loan (3M USD TERM SOFR+7.97%), 12.29% Cash, 9/20/2029	9/19/2024	$	17,000,000		16,823,180		16,809,600		4.3	%
Maple Holdings Midco Limited (h)	IT Services	Class A Common Units	9/19/2024		2,000,000		2,000,000		2,000,000		0.5	%
		Total IT Services					18,823,180		18,809,600		4.8	%
ActiveProspect, Inc. (d)	Lead Management Software	First Lien Term Loan (3M USD TERM SOFR+6.00%), 10.52% Cash, 8/8/2027	8/8/2022	$	11,525,624		11,470,461		11,640,880		3.0	%
ActiveProspect, Inc. (j)	Lead Management Software	Delayed Draw Term Loan (3M USD TERM SOFR+6.00%), 10.52% Cash, 8/8/2027	8/8/2022	$	-		-		-		0.0	%
		Total Lead Management Software					11,470,461		11,640,880		3.0	%
Madison Logic, Inc. (d)(m)	Marketing Orchestration Software	First Lien Term Loan (1M USD TERM SOFR+7.50%), 11.82% Cash, 12/30/2028	12/30/2022	$	18,841,634		18,649,126		18,444,075		4.7	%
		Total Marketing Orchestration Software					18,649,126		18,444,075		4.7	%

Saratoga Investment Corp

Consolidated Schedule of Investments

February 28, 2025

Company(1)	Industry	Investment Interest Rate/ Maturity	Original Acquisition Date	Principal/ Number of Shares		Cost		Fair Value (c)		% of Net Assets
ARC Health OpCo LLC (d)	Mental Healthcare Services	First Lien Term Loan (3M USD TERM SOFR+8.40%), 12.72% Cash, 8/5/2027	8/5/2022	$	6,500,000		6,455,259		6,184,750		1.6	%
ARC Health OpCo LLC (d)	Mental Healthcare Services	Delayed Draw Term Loan (3M USD TERM SOFR+8.40%), 12.72% Cash, 8/5/2027	8/5/2022	$	26,914,577		26,907,840		25,609,220		6.5	%
ARC Health OpCo LLC (h)	Mental Healthcare Services	Class A Preferred Units	8/5/2022		3,818,400		4,169,599		610,944		0.2	%
		Total Mental Healthcare Services					37,532,698		32,404,914		8.3	%
Chronus LLC	Mentoring Software	First Lien Term Loan (3M USD TERM SOFR+5.25%), 9.72% Cash, 8/26/2026	8/26/2021	$	15,000,000		14,943,520		14,910,000		3.8	%
Chronus LLC (d)	Mentoring Software	First Lien Term Loan (3M USD TERM SOFR+6.00%), 10.47% Cash, 8/26/2026	8/26/2021	$	5,000,000		4,975,736		4,970,000		1.3	%
Chronus LLC (h)	Mentoring Software	Series A Preferred Stock	8/26/2021		3,000		3,000,000		2,146,574		0.5	%
		Total Mentoring Software					22,919,256		22,026,574		5.6	%
Cloudpermit	Municipal Government Software	First Lien Term Loan (3M USD TERM SOFR+5.75%), 10.07% Cash, 9/5/2029	9/5/2024	$	28,000,000		27,750,119		27,720,000		7.1	%
Cloudpermit (j)	Municipal Government Software	Delayed Draw Term Loan (3M USD TERM SOFR+5.75%), 10.07% Cash, 9/5/2029	9/5/2024	$	-		-		-		0.0	%
Cloudpermit (h)	Municipal Government Software	Limited Partner Interests	9/5/2024		2,000		2,000,000		2,000,000		0.5	%
		Total Municipal Government Software					29,750,119		29,720,000		7.6	%
Omatic Software, LLC (d)	Non-profit Services	First Lien Term Loan (3M USD TERM SOFR+8.00%), 12.58% Cash/1.00% PIK, 6/30/2025	5/29/2018	$	16,435,922		16,429,958		16,470,437		4.2	%
		Total Non-profit Services					16,429,958		16,470,437		4.2	%

Saratoga Investment Corp

Consolidated Schedule of Investments

February 28, 2025

Company(1)	Industry	Investment Interest Rate/ Maturity	Original Acquisition Date	Principal/ Number of Shares		Cost		Fair Value (c)		% of Net Assets
Emily Street Enterprises, L.L.C. (d)	Office Supplies	Senior Secured Note (3M USD TERM SOFR+6.75%), 11.07% Cash, 12/31/2028	12/28/2012	$	5,300,000		5,285,054		5,339,220		1.4	%
		Total Office Supplies					5,285,054		5,339,220		1.4	%
Buildout, Inc. (d)	Real Estate Services	First Lien Term Loan (3M USD TERM SOFR+7.00%), 11.42% Cash, 7/9/2025	7/9/2020	$	14,000,000		13,985,556		13,587,000		3.5	%
Buildout, Inc.	Real Estate Services	Delayed Draw Term Loan (3M USD TERM SOFR+7.00%), 11.42% Cash, 7/9/2025	2/12/2021	$	38,500,000		38,454,669		37,364,250		9.5	%
Buildout, Inc. (h)(i)	Real Estate Services	Limited Partner Interests	7/9/2020		1,250		1,372,557		798,892		0.2	%
		Total Real Estate Services					53,812,782		51,750,142		13.2	%
Wellspring Worldwide Inc.	Research Software	First Lien Term Loan (3M USD TERM SOFR+8.42%), 12.74% Cash, 12/22/2028	6/27/2022	$	9,492,000		9,428,229		9,492,000		2.4	%
Wellspring Worldwide Inc.	Research Software	Delayed DrawTerm Loan (3M USD TERM SOFR+8.42%), 12.74% Cash, 12/22/2028	6/27/2022	$	14,400,000		14,259,405		14,400,000		3.7	%
Archimedes Parent LLC (h)	Research Software	Class A Common Units	6/27/2022		2,475,160		2,475,160		2,387,902		0.6	%
		Total Research Software					26,162,794		26,279,902		6.7	%
LFR Chicken LLC	Restaurant	First Lien Term Loan (1M USD TERM SOFR+7.00%), 11.32% Cash, 11/19/2026	11/19/2021	$	12,000,000		11,952,144		12,000,000		3.1	%
LFR Chicken LLC (j)	Restaurant	Delayed Draw Term Loan (1M USD TERM SOFR+7.00%), 11.32% Cash, 11/19/2026	11/19/2021	$	18,000,000		17,906,382		18,000,000		4.6	%
LFR Chicken LLC (h)	Restaurant	Series B Preferred Units	11/19/2021		497,183		1,000,000		1,599,989		0.4	%
		Total Restaurant					30,858,526		31,599,989		8.1	%
Avionte Holdings, LLC (h)	Staffing Services	Class A Units	1/8/2014		100,000		100,000		3,426,460		0.9	%
		Total Staffing Services					100,000		3,426,460		0.9	%

Saratoga Investment Corp

Consolidated Schedule of Investments

February 28, 2025

Company(1)	Industry	Investment Interest Rate/ Maturity	Original Acquisition Date	Principal/ Number of Shares		Cost		Fair Value (c)		% of Net Assets
JDXpert	Talent Acquisition Software	First Lien Term Loan (3M USD TERM SOFR+8.50%), 13.08% Cash, 5/2/2027	5/2/2022	$	6,000,000		5,969,521		6,000,000		1.5	%
JDXpert	Talent Acquisition Software	Delayed Draw Term Loan (3M USD TERM SOFR+8.50%), 13.08% Cash, 5/2/2027	5/2/2022	$	1,000,000		993,974		1,000,000		0.3	%
JDXpert (j)	Talent Acquisition Software	Delayed Draw Term Loan (3M USD TERM SOFR+8.50%), 13.08% Cash, 5/2/2027	3/31/2023	$	500,000		496,237		500,000		0.1	%
Jobvite, Inc. (d)	Talent Acquisition Software	First Lien Term Loan (3M USD TERM SOFR+7.50%), 11.82% Cash, 8/5/2028	8/5/2022	$	20,000,000		19,900,196		19,834,000		5.1	%
		Total Talent Acquisition Software					27,359,928		27,334,000		7.0	%
VetnCare MSO, LLC (j)	Veterinary Services	Delayed Draw Term Loan (3M USD TERM SOFR+5.75%), 10.07% Cash, 5/12/2028	5/12/2023	$	12,680,505		12,580,925		12,666,554		3.2	%
		Total Veterinary Services					12,580,925		12,666,554		3.2	%
Sub Total Non-control/Non-affiliate investments							886,071,934		897,660,110		229.3	%
Affiliate investments - 10.3% (b)
ETU Holdings, Inc. (f)	Corporate Education Software	First Lien Term Loan (3M USD TERM SOFR+9.00%), 13.47% Cash, 8/18/2027	8/18/2022	$	7,000,000		6,959,248		6,980,400		1.8	%
ETU Holdings, Inc. (f)	Corporate Education Software	Second Lien Term Loan 15.00% PIK, 2/18/2028	8/18/2022	$	7,125,931		7,093,577		6,387,685		1.6	%
ETU Holdings, Inc. (f)(h)	Corporate Education Software	Series A Preferred Units	8/18/2022		3,000,000		3,000,000		-		0.0	%
		Total Corporate Education Software					17,052,825		13,368,085		3.4	%
Axero Holdings, LLC (f)	Employee Collaboration Software	First Lien Term Loan 4.50% Cash, (3M USD TERM SOFR + 2.50%) PIK, 12/31/2027	6/30/2021	$	15,933,063		15,913,591		15,933,063		4.1	%
Axero Holdings, LLC (f)	Employee Collaboration Software	Delayed Draw Term Loan 4.50% Cash, (3M USD TERM SOFR + 2.50%) PIK, 12/31/2027	6/30/2021	$	1,130,734		1,126,177		1,130,734		0.3	%

Saratoga Investment Corp

Consolidated Schedule of Investments

February 28, 2025

Company(1)	Industry	Investment Interest Rate/ Maturity	Original Acquisition Date	Principal/ Number of Shares		Cost		Fair Value (c)		% of Net Assets
Axero Holdings, LLC (f)(j)	Employee Collaboration Software	Revolving Credit Facility 4.50% Cash, (3M USD TERM SOFR + 2.50%) PIK, 12/31/2027	2/3/2022	$	-		-		-		0.0	%
Axero Holdings, LLC (f)(h)	Employee Collaboration Software	Series A Preferred Units	6/30/2021		2,055,609		2,055,609		3,529,000		0.9	%
Axero Holdings, LLC (f)(h)	Employee Collaboration Software	Series B Preferred Units	6/30/2021		2,055,609		2,055,609		6,586,550		1.6	%
		Total Employee Collaboration Software					21,150,986		27,179,347		6.9	%
Sub Total Affiliate investments							38,203,811		40,547,432		10.3	%
Control investments - 10.2% (b)
Zollege PBC (k)(g)	Education Services	First Lien Term Loan 4.84% PIK, 8/9/2027	5/11/2021	$	1,461,250		1,461,250		1,085,855		0.3	%
Zollege PBC (h)(g)	Education Services	Common Stock	5/11/2021		7,731,294		558,799		2,851,295		0.7	%
		Total Education Services					2,020,049		3,937,150		1.0	%
Pepper Palace, Inc. (k)(g)	Specialty Food Retailer	First Lien Term Loan 4.42% PIK, 12/31/2028	6/30/2021	$	2,400,000		2,400,000		1,326,000		0.3	%
Pepper Palace, Inc. (j)(k)(g)	Specialty Food Retailer	Delayed Draw Term Loan 4.42% PIK, 12/31/2028	6/30/2021	$	-		-		-		0.0	%
Pepper Palace, Inc. (j)(k)(g)	Specialty Food Retailer	Revolving Credit Facility 4.42% PIK, 12/31/2028	6/30/2021	$	400,000		400,000		221,000		0.1	%
Pepper Palace, Inc. (h)(g)	Specialty Food Retailer	Class A Units	6/30/2021		100,000		138,561		-		0.0	%
		Total Specialty Food Retailer					2,938,561		1,547,000		0.4	%

Saratoga Investment Corp

Consolidated Schedule of Investments

February 28, 2025

Company(1)	Industry	Investment Interest Rate/ Maturity	Original Acquisition Date	Principal/ Number of Shares		Cost		Fair Value (c)		% of Net Assets
Saratoga Investment Corp. CLO 2013-1, Ltd. (a)(e)(g)	Structured Finance Securities	Other/Structured Finance Securities 0.00%, 4/20/2033	1/22/2008	$	111,000,000		14,889,037		240,578		0.1	%
Saratoga Investment Corp. CLO 2013-1, Ltd. Class F-2-R-3 Note (a)(g)	Structured Finance Securities	Other/Structured Finance Securities (3M USD TERM SOFR+10.00%), 14.58%, 4/20/2033	8/9/2021	$	9,375,000		9,375,000		2,280,938		0.6	%
Saratoga Investment Corp. Senior Loan Fund 2022-1, Ltd. Class E Note (a)(g)	Structured Finance Securities	Other/Structured Finance Securities (3M USD TERM SOFR+8.55%), 12.87%, 10/20/2033	10/28/2022	$	12,250,000		11,392,500		12,250,000		3.1	%
		Total Structured Finance Securities					35,656,537		14,771,516		3.8	%
Saratoga Senior Loan Fund I JV, LLC (a)(g)(j)	Investment Fund	Unsecured Loan 10.00%, 10/20/2033	12/17/2021	$	17,618,954		17,618,954		16,533,626		4.2	%
Saratoga Senior Loan Fund I JV, LLC (a)(g)	Investment Fund	Membership Interest	12/17/2021		17,583,486		17,583,486		3,080,916		0.8	%
		Total Investment Fund					35,202,440		19,614,542		5.0	%
Sub Total Control investments							75,817,587		39,870,208		10.2	%
TOTAL INVESTMENTS - 249.8% (b)						$	1,000,093,332	$	978,077,750		249.8	%

	Number of Shares		Cost		Fair Value		% of Net Assets
Cash and cash equivalents and cash and cash equivalents, reserve accounts - 37.7% (b)
U.S. Bank Money Market (l)		148,218,491	$	148,218,491	$	148,218,491		37.7	%
Total cash and cash equivalents and cash and cash equivalents, reserve accounts		148,218,491	$	148,218,491	$	148,218,491		37.7	%

(1)

Securities are exempt from registration under Rule 144A of the Securities Act of 1933, as amended, and are restricted securities. Money market funds are valued at net asset value and are considered level 1 investments within the fair value hierarchy.

(a)

Represents an investment that is not a “qualifying asset” under Section 55(a) of the Investment Company Act of 1940, as amended (the 1940 Act”). As of February 28, 2025, non-qualifying assets represent 4.0% of the Company’s portfolio at fair value. As a BDC, the Company generally has to invest at least 70% of its total assets in qualifying assets.

(b)

Percentages are based on net assets of $392,665,468 as of February 28, 2025.

(c)

Because there is no “readily available market quotations” (as defined in the 1940 Act) for these investments, the fair values of these investments were determined using significant unobservable inputs and approved in good faith by our board of directors. These investments have been included as Level 3 in the Fair Value Hierarchy (see Note 3 to the consolidated financial statements).

(d)

These securities are either fully or partially pledged as collateral under the Company’s senior secured revolving credit facility (see Note 8 to the consolidated financial statements).

(e)

(f)

As defined in the 1940 Act, this portfolio company is an “affiliate” as we own between 5.0% and 25.0% of the outstanding voting securities. Transactions during the year ended February 28, 2025 in which the issuer was an affiliate are as follows:

Company	Fair Value at the Beginning of Year		Purchases		Sales		Total Interest from Investments		Management Fee Income		Net Realized Gain (Loss) from Investments		Net Change in Unrealized Appreciation (Depreciation)			Fair Value at End of Period
Axero Holdings, LLC	$	14,149,607	$	10,000,000	$	-	$	1,327,375	$	-	$	-	$	2,551,701		$	27,179,347
ETU Holdings, Inc.		13,599,530		-		-		2,035,631		-		-		(1,249,802	)		13,368,085
Total	$	27,749,137	$	10,000,000	$	-	$	3,363,006	$	-	$	-	$	1,301,899		$	40,547,432

Saratoga Investment Corp

Consolidated Schedule of Investments

February 28, 2025

(g)

As defined in the 1940 Act, we “control” this portfolio company because we own more than 25% of the portfolio company’s outstanding voting securities. Transactions during the year ended February 28, 2025 in which the issuer was both an affiliate and a portfolio company that we control are as follows:

Company	Fair Value at the Beginning of Year		Purchases		Sales		Total Interest from Investments		Total Dividends from Investments		Management Fee Income		Net Realized Gain (Loss) from Investments			Net Change in Unrealized Appreciation (Depreciation)			Fair Value at End of Period
Netreo Holdings, LLC	$	35,421,889	$	-	$	2,260,337	$	921,530	$	-	$	-	$	(5,445,808	)	$	3,802,854		$	-
Pepper Palace, Inc.		2,488,682		1,450,000		-		1,338		-		-		(34,007,427	)		(1,391,561	)		1,547,000
Zollege PBC		3,783,928		200,707		209,460		110,862		-		-		(15,110,835	)		1,917,101			3,937,150
Saratoga Investment Corp. CLO 2013-1, Ltd.		9,500,627		-		-		-		-		3,114,466		-			(2,147,199	)		240,578
Saratoga Investment Corp. Senior Loan Fund 2022-1, Ltd. Class E Note		12,250,000		-		-		1,685,977		-		-		-			-			12,250,000
Saratoga Investment Corp. CLO 2013-1, Ltd. Class F-2-R-3 Note		8,875,227		-		-		1,452,981		-		-		-			(6,594,289	)		2,280,938
Saratoga Senior Loan Fund I JV, LLC		15,818,297		-		-		1,761,895		-		-		-			715,329			16,533,626
Saratoga Senior Loan Fund I JV, LLC		9,403,996		-		-		-		3,973,584		-		-			(6,323,079	)		3,080,916
Total	$	97,542,646	$	1,650,707	$	2,469,797	$	5,934,583	$	3,973,584	$	3,114,466	$	(54,564,070	)	$	(10,020,844	)	$	39,870,208

(h)

Non-income producing at February 28, 2025.

(i)

Includes securities issued by an affiliate of the company.

(j)

All or a portion of this investment has an unfunded commitment as of February 28, 2025. (See Note 9 to the consolidated financial statements).

(k)

As of February 28, 2025, the investment was on non-accrual status. The fair value of these investments was approximately $2.6 million, which represented 0.3% of the Company’s portfolio (see Note 2 to the consolidated financial statements).

(l)

Included within cash and cash equivalents and cash and cash equivalents, reserve accounts in the Company’s consolidated statements of assets and liabilities as of February 28, 2025.

(m)

This investment elected to PIK 20% of accrued interest, with 80% of accrued interest payable in cash.

SOFR - Secured Overnight Financing Rate

1M USD TERM SOFR - The 1 month USD TERM SOFR rate as of February 28, 2025 was 4.32%.

3M USD TERM SOFR - The 3 month USD TERM SOFR rate as of February 28, 2025 was 4.32%.

PIK - Payment-in-Kind (see Note 2 to the consolidated financial statements).

See accompanying notes to consolidated financial statements

SARATOGA INVESTMENT CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

August 31, 2025

(unaudited)

Note 1. Organization

Saratoga Investment Corp. (the “Company”, “we”, “our” and “us”) is a non-diversified closed end management investment company incorporated in Maryland that has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). The Company commenced operations on March 23, 2007 as GSC Investment Corp. and completed the initial public offering (“IPO”) on March 28, 2007. The Company has elected, and intends to qualify annually, to be treated for U.S. federal income tax purposes as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”). The Company’s investment objective is to generate current income and, to a lesser extent, capital appreciation from its investments.

GSC Investment, LLC (the “LLC”) was organized in May 2006 as a Maryland limited liability company. On March 21, 2007, the Company was incorporated and concurrently therewith the LLC was merged with and into the Company, with the Company as the surviving entity, in accordance with the procedure for such merger in the LLC’s limited liability company agreement and Maryland law. In connection with such merger, each outstanding limited liability company interest of the LLC was converted into a share of common stock of the Company.

On July 30, 2010, the Company changed its name from “GSC Investment Corp.” to “Saratoga Investment Corp.” in connection with the consummation of a recapitalization transaction.

The Company is externally managed and advised by the investment adviser, Saratoga Investment Advisors, LLC (the “Manager” or “Saratoga Investment Advisors”), pursuant to an investment advisory and management agreement (the “Management Agreement”).

The Company has established wholly owned subsidiaries, SIA-AAP, Inc., SIA-ARC, Inc., SIA-Avionte, Inc., SIA-AX, Inc., SIA-G4, Inc., SIA-GH, Inc., SIA-MDP, Inc., SIA-PP Inc., SIA-SIQ, Inc., SIA-SZ, Inc., SIA-TG, Inc., SIA-TT, Inc. and SIA-Vector, Inc., which are structured as Delaware entities that are treated as corporations for U.S. federal income tax purposes and are intended to facilitate its compliance with the requirements to be treated as a RIC under the Code by holding equity or equity-like investments in portfolio companies organized as limited liability companies, or LLCs (or other forms of pass through entities). These entities are consolidated for accounting purposes but are not consolidated for U.S. federal income tax purposes and may incur U.S. federal income tax expenses as a result of their ownership of portfolio companies.

Our wholly owned subsidiaries, Saratoga Investment Corp. SBIC II LP (“SBIC II LP”) and Saratoga Investment Corp. SBIC III LP (“SBIC III LP”, and together with SBIC II LP, the “SBIC Subsidiaries”), received licenses to operate as small business investment companies from the SBA on August 14, 2019 and September 29, 2022, respectively. Each of the SBIC Subsidiaries provides up to $175.0 million in long-term capital in the form of debentures guaranteed by the SBA. Our wholly owned subsidiary Saratoga Investment Corp. SBIC LP (“SBIC LP”) repaid its outstanding debentures and subsequently surrendered its license to the SBA on January 3, 2024, providing the Company access to all undistributed capital of SBIC LP, and SBIC LP subsequently merged with and into the Company. Under current SBIC regulations, for two or more SBICs under common control, the maximum amount of outstanding SBA debentures cannot exceed $350.0 million with at least $175.0 million in combined regulatory capital.

The Company has formed wholly owned special purpose entities organized as Delaware limited liability companies, Saratoga Investment Funding II LLC (“SIF II”) and Saratoga Investment Funding III LLC (“SIF III”) for the purpose of the Encina Credit Facility and the Live Oak Credit Facility (each as defined below), respectively. The senior secured revolving credit facility (the “Encina Credit Facility) with Encina Lender Finance, LLC (“Encina”) is supported by loans held by SIF II and pledged to Encina, and the senior secured revolving credit facility (the “Live Oak Credit Facility”) with Live Oak Banking Company (“Live Oak”) is supported by loans held by SIF III and pledged to Live Oak.

On October 26, 2021, the Company and TJHA JV I LLC (“TJHA”) entered into a Limited Liability Company Agreement to co-manage Saratoga Senior Loan Fund I JV LLC (“SLF JV”). SLF JV is under joint control and is not consolidated. SLF JV is invested in Saratoga Investment Corp Senior Loan Fund 2022-1 Ltd. (“SLF 2022”), which is a wholly owned subsidiary of SLF JV. SLF 2022 was formed for the purpose of making investments in a diversified portfolio of broadly syndicated first lien and second lien term loans or bonds in the primary and secondary markets. On October 28, 2022, SLF 2022 issued $402.1 million of debt (the “2022 JV CLO Notes”) through a collateralized loan obligation trust (the “JV CLO trust”). The 2022 JV CLO Notes were issued pursuant to an indenture, dated October 28, 2022 (the “JV Indenture”), with U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association) (the “Trustee”) serving as the trustee.

Note 2. Summary of Significant Accounting Policies

Basis of Presentation

The accompanying consolidated financial statements have been prepared on the accrual basis of accounting in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”), are stated in U.S. Dollars and include the accounts of the Company and its wholly owned special purpose financing subsidiaries, SIF II, SIF III, SBIC II LP, SBIC III LP, SIA-AAP, Inc., SIA-ARC, Inc., SIA-Avionte, Inc., SIA-AX, Inc., SIA-G4, Inc., SIA-GH, Inc., SIA-MDP, Inc., SIA-PP, Inc., SIA-SIQ, Inc., SIA-SZ, Inc., SIA-TG, Inc., SIA-TT Inc., and SIA-Vector, Inc. All intercompany accounts and transactions have been eliminated in consolidation. All references made to the “Company,” “we,” and “us” herein include Saratoga Investment Corp. and its consolidated subsidiaries, except as stated otherwise.

The Company, SIF II, SIF III, SBIC II LP, and SBIC III LP are all considered to be investment companies for financial reporting purposes and have applied the guidance in the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 946, Financial Services—Investment Companies (“ASC 946”). There have been no changes to the Company, SIF II, SIF III, SBIC II LP, or SBIC III LP’s status as investment companies in accordance with ASC 946 during the three months ended August 31, 2025.

Principles of Consolidation

Under the investment company rules and regulations pursuant to ASC 946, the Company is precluded from consolidating any entity other than another investment company or controlled operating company whose business consists of providing services to the Company. As a result, the consolidated financial statements of the Company include only the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.

The Company has determined that SLF JV is an investment company under ASC 946; however, in accordance with such guidance the Company will generally not consolidate its investment in a company other than a wholly owned investment company subsidiary. SLF JV is not a wholly owned investment company subsidiary as the Company and TJHA each have an equal 50% voting interest in SLF JV and thus neither party has a controlling financial interest. Furthermore, FASB ASC Topic 810, Consolidation (“ASC 810”), concludes that in a joint venture where both members have equal decision-making authority, it is not appropriate for one member to consolidate the joint venture since neither has control. Accordingly, the Company does not consolidate its investment in SLF JV.

Use of Estimates in the Preparation of Financial Statements

The preparation of the accompanying consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities at the date of the financial statements, and income, gains (losses) and expenses during the period reported. Actual results could differ materially from those estimates.

Operating Segment

In accordance with ASC Topic 280, Segment Reporting, the Company operates through two separate operating segments, with one primary core business segment and one non-core segment, assessed as immaterial by management, resulting in only one reportable segment. The Company’s primary core segment invests in various industries and separately evaluates the performance of each of its investment relationships. However, because each of these investment relationships have similar business and economic characteristics, they have been aggregated into a single reportable segment. The Company’s management and independent Board of Directors are the Chief Operating Decision Makers (“CODM”). The Company and the CODM evaluate and monitor performance of the business on an aggregated basis. Further, each investment is evaluated and managed using similar processes and shared operations support functions such as deal origination, underwriting, loan and compliance administration in addition to administrative functions of human resources, legal, finance and information technology. As the Company’s operations comprise of a single reporting segment, the segment assets are reflected in the accompanying consolidated statement of operations.

The CODM uses our consolidated net investment income and net increase (decrease) in net assets resulting from operations as reported in the Consolidated Statements of Operations to assess the Company’s performance and when allocating resources. Net investment income is comprised of total investment income (“segment revenues”), and total expenses (“total segment expenses”) and operating expenses (“segment operating expenses”), which are considered the key segment measures of profit or loss received by the CODM. The expense categories included in the Company’s consolidated statement of operations are fully reflective of the significant expense categories and amounts that are regularly provided to the CODM. For the three months ended August 31, 2025 and 2024, operating expenses as defined by the CODM excluding interest expense, totaled $9.2 million and $11.7 million, respectively, and for the six months ended August 31, 2025 and 2024, totaled $18.9 million and $23.1 million, respectively.

Cash and Cash Equivalents

Cash and cash equivalents include short-term, liquid investments in a money market fund. The Company places its cash in financial institutions and, at times, such balances may be in excess of the Federal Deposit Insurance Corporation insurance limits. Cash and cash equivalents are carried at cost which approximates fair value. Pursuant to Section 12(d)(1)(A) of the 1940 Act, the Company may not invest in another investment company, such as a money market fund, if such investment would cause the Company to:

●

own more than 3.0% of the investment company’s total outstanding voting stock;

●

hold securities in the investment company having an aggregate value in excess of 5.0% of the value of the Company’s total assets; or

●

hold securities in investment companies having an aggregate value in excess of 10.0% of the value of the Company’s total assets.

As of August 31, 2025, the Company did not exceed any of these limitations.

Cash and Cash Equivalents, Reserve Accounts

Cash and cash equivalents, reserve accounts include amounts held in designated bank accounts in the form of cash and short-term liquid investments in money market funds, and, at times, such balances may be in excess of the Federal Deposit Insurance Corporation insurance limits, representing payments received on secured investments or other reserved amounts associated with the Encina Credit Facility or the Live Oak Credit Facility held by the Company’s wholly owned subsidiaries, SIF II and SIF III, respectively. The Company is required to use these amounts to pay interest expense, reduce borrowings, or pay other amounts in accordance with the terms of the Encina Credit Facility and the Live Oak Credit Facility.

In addition, cash and cash equivalents, reserve accounts also include amounts held in designated bank accounts, in the form of cash and short-term liquid investments in money market funds, within the Company’s wholly owned subsidiaries, SBIC II LP and SBIC III LP.

The statements of cash flows explain the change during the period in the total of cash, cash equivalents and amounts generally described as restricted cash and restricted cash equivalents when reconciling the beginning-of-period and end-of-period total amounts.

The following table provides a reconciliation of cash and cash equivalents and cash and cash equivalents, reserve accounts reported within the consolidated statements of assets and liabilities that sum to the total of the same such amounts shown in the consolidated statements of cash flows:

	August 31, 2025		February 28, 2025
Cash and cash equivalents		105,660,178	$	148,218,491
Cash and cash equivalents, reserve accounts		95,144,529		56,505,433
Total cash and cash equivalents and cash and cash equivalents, reserve accounts	$	200,804,707	$	204,723,924

Investment Classification

The Company classifies its investments in accordance with the requirements of the 1940 Act. Under the 1940 Act, “control investments” are defined as investments in companies in which the Company owns more than 25.0% of the voting securities or maintains greater than 50.0% of the board representation. Under the 1940 Act, “affiliated investments” are defined as those non-control investments in companies in which the Company owns between 5.0% and 25.0% of the voting securities. Under the 1940 Act, “non-affiliated investments” are defined as investments that are neither control investments nor affiliated investments.

Investment Valuation

The Company accounts for its investments at fair value in accordance with the FASB ASC Topic 820, Fair Value Measurement (“ASC 820”). ASC 820 defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the quality of inputs used to measure fair value and enhances disclosure requirements for fair value measurements. ASC 820 requires the Company to assume that its investments are to be sold or its liabilities are to be transferred at the measurement date in the principal market to independent market participants, or in the absence of a principal market, in the most advantageous market, which may be a hypothetical market. Market participants are defined as buyers and sellers in the principal or most advantageous market that are independent, knowledgeable, and willing and able to transact.

The Company undertakes a multi-step valuation process each quarter when valuing investments for which market quotations are not readily available, as described below:

●

each investment is initially valued by the responsible investment professionals of the Manager and preliminary valuation conclusions are documented, reviewed and discussed with our senior management; and

●

an independent valuation firm engaged by the Company’s board of directors independently reviews a selection of these preliminary valuations each quarter so that the valuation of each investment for which market quotes are not readily available is reviewed by the independent valuation firm at least once each fiscal year. The Company uses a third-party independent valuation firm to value its investment in the subordinated notes of Saratoga Investment Corp. CLO 2013-1, Ltd. (“Saratoga CLO”), the Class F-2-R-3 Notes of the Saratoga CLO, and the Class E Notes of the SLF 2022 every quarter.

In addition, all investments are subject to the following valuation process:

●

the audit committee of the Company’s board of directors reviews and approves each preliminary valuation and the Manager and independent valuation firm (if applicable) will supplement the preliminary valuation to reflect any comments provided by the audit committee; and

●

the Company’s board of directors discusses the valuations and approves the fair value of each investment, in good faith, based on the input of the Manager, independent valuation firm (to the extent applicable) and the audit committee of the board of directors.

The Company uses multiple techniques for determining fair value based on the nature of the investment and experience with those types of investments and specific portfolio companies. The selections of the valuation techniques and the inputs and assumptions used within those techniques often require subjective judgements and estimates. These techniques include market comparables, discounted cash flows and enterprise value waterfalls. Fair value is best expressed as a range of values from which the Company determines a single best estimate. The types of inputs and assumptions that may be considered in determining the range of values of the Company’s investments include the nature and realizable value of any collateral, the portfolio company’s ability to make payments, market yield trend analysis and volatility in future interest rates, call and put features, the markets in which the portfolio company does business, comparison to publicly traded companies, discounted cash flows and other relevant factors.

The Company’s investments in the subordinated notes of Saratoga CLO, Class F-2-R-3 Notes of the Saratoga CLO and the Class E Notes of SLF 2022 are carried at fair value, which is based on a discounted cash flow valuation technique that utilizes prepayment, re-investment and loss inputs based on historical experience and projected performance, economic factors, the characteristics of the underlying cash flow, and comparable yields for equity interests in collateralized loan obligation funds, when available, as determined by the Manager and recommended to the Company’s board of directors. Specifically, the Company uses Intex cash flows, or an appropriate substitute, to form the basis for the valuation of its investment in the subordinated notes of Saratoga CLO, Class F-2-R-3 Notes of the Saratoga CLO and the Class E Notes of SLF 2022. The inputs are based on available market data and projections provided by third parties as well as management estimates. The Company uses the output from the Intex models (i.e., the estimated cash flows) to perform a discounted cash flow analysis on expected future cash flows to determine the valuation for our investment in Saratoga CLO.

The Company’s equity investment in SLF JV is measured using the proportionate share of the net asset value (“NAV”), or equivalent, of SLF JV as a practical expedient for fair value, provided by ASC 820. The Company’s unsecured loan investment in SLF JV is based on a discounted cash flow valuation technique.

The Company’s investments in CLO BB and CLO BBB debt have been valued using recent actual market trades or an independent pricing service. The valuation methodology of the independent pricing service includes incorporating data comprised of observable market transactions, executable bids, broker quotes from dealers with two sided markets, as well as transaction activity from comparable securities to those being valued. As the independent pricing service contemplates real-time market data and no unobservable inputs or significant judgment has been used by the Manager in the valuation of the Company’s investments in CLO BB and CLO BBB debt, such positions are considered level II assets.

Because such valuations, and particularly valuations of private investments and private companies, are inherently uncertain, they may fluctuate over short periods of time and may be based on estimates. The determination of fair value may differ materially from the values that would have been used if a ready market for these investments existed. The Company’s NAV could be materially affected if the determinations regarding the fair value of its investments were materially higher or lower than the values that the Company ultimately realizes upon the disposal of such investments.

Rule 2a-5 under the 1940 Act (“Rule 2a-5”) establishes a regulatory framework for determining fair value in good faith for purposes of the 1940 Act. Rule 2a-5 permits boards of directors, subject to board oversight and certain other conditions, to designate the investment adviser to perform fair value determinations. Rule 2a-5 also defines when market quotations are “readily available” for purposes of the 1940 Act and the threshold for determining whether a fund must determine the fair value of a security. Rule 31a-4 under the 1940 Act (“Rule 31a-4”) provides for certain recordkeeping requirements associated with fair value determinations. While the Company’s board of directors has not elected to designate Saratoga Investment Advisors as the valuation designee, the Company has established policies and procedures in compliance with the applicable requirements of Rule 2a-5 and Rule 31a-4.

Derivative Financial Instruments

The Company accounts for derivative financial instruments in accordance with FASB ASC Topic 815, Derivatives and Hedging (“ASC 815”). ASC 815 requires recognizing all derivative instruments as either assets or liabilities on the consolidated statements of assets and liabilities at fair value. The Company values derivative contracts at the closing fair value provided by the counterparty. Changes in the values of derivative contracts are included in the consolidated statements of operations.

Investment Transactions and Income Recognition

Purchases and sales of investments and the related realized gains or losses are recorded on a trade-date basis. Interest income, adjusted for amortization of premium and accretion of discount, is recorded on an accrual basis to the extent that such amounts are expected to be collected. The Company stops accruing interest on its investments when it is determined that interest is no longer collectible. Discounts and premiums on investments purchased are accreted/amortized using the effective yield method. The amortized cost of investments represents the original cost adjusted for the accretion of discounts over the life of the investment and amortization of premiums on investments up to the earliest call date.

Loans are generally placed on non-accrual status when there is reasonable doubt that principal or interest will be collected. Accrued interest is generally reserved when a loan is placed on non-accrual status. Interest payments received on non-accrual loans may be recognized as a reduction in principal depending upon management’s judgment regarding collectability. Non-accrual loans are restored to accrual status when past due principal and interest is paid and, in management’s judgment, are likely to remain current, although management may make exceptions to this general rule if the loan has sufficient collateral value and is in the process of collection. At August 31, 2025 our investment in one portfolio company was on non-accrual status with a fair value of approximately $1.8 million, or 0.2% of the fair value of our portfolio. At February 28, 2025, our investments in two portfolio companies were on non-accrual status with a fair value of approximately $2.6 million, or 0.3% of the fair value of our portfolio.

Interest income on our investment in the subordinated note of Saratoga CLO is recorded using the effective interest method in accordance with the provisions of ASC Topic 325-40, Investments—Other, Beneficial Interests in Securitized Financial Assets, based on the anticipated yield and the estimated cash flows over the projected life of the investment. Yields are revised when there are changes in actual or estimated cash flows due to changes in prepayments and/or re-investments, credit losses or asset pricing. Changes in estimated yield are recognized as an adjustment to the estimated yield over the remaining life of the investment from the date the estimated yield was changed.

Payment-in-Kind Interest

The Company may hold debt and preferred equity investments in its portfolio that contain a payment-in-kind (“PIK”) interest provision. The PIK interest, which represents contractually deferred interest added to the investment balance that is generally due at maturity, is generally recorded on an accrual basis to the extent such amounts are expected to be collected. The Company stops accruing PIK interest if it is expected that the issuer will not be able to pay all principal and interest when due. The Company restores to accrual status when past due principal and interest is paid and, in management’s judgment, are likely to remain current, although management may make exceptions to this general rule if the loan has sufficient collateral value and is in the process of collection.

Dividend Income

Dividend income is recorded in the consolidated statements of operations when earned.

Structuring and Advisory Fee Income

Structuring and advisory fee income represents various fee income earned and received for performing certain investment structuring and advisory activities during the closing of new investments.

Other Income

Other income includes prepayment income fees, and monitoring, administration, redemption and amendment fees and is recorded in the consolidated statements of operations when earned.

Deferred Debt Financing Costs

Financing costs incurred in connection with our credit facility and notes are deferred and amortized using the straight-line method over the life of the respective facility and debt securities. Financing costs incurred in connection with the SBA debentures of SBIC II LP and SBIC III LP are deferred and amortized using the straight-line method over the life of the debentures. Any discount or premium on the issuance of any debt is accreted and amortized using the effective interest method over the life of the respective debt security.

The Company presents deferred debt financing costs on the balance sheet as a contra-liability, which is a direct deduction from the carrying amount of that debt liability, consistent with debt discounts.

Realized Loss on Extinguishment of Debt

Upon the repayment of debt obligations that are deemed to be extinguishments, the difference between the principal amount due at maturity adjusted for any unamortized debt issuance costs is recognized as a loss (i.e., the unamortized debt issuance costs are recognized as a loss upon extinguishment of the underlying debt obligation).

Contingencies

In the ordinary course of business, the Company may enter into contracts or agreements that contain indemnifications or warranties. Future events could occur that lead to the execution of these provisions against the Company. Based on its history and experience, management reasonably believes that the likelihood of such an event is remote. Therefore, the Company has not accrued any liabilities in connection with such indemnifications.

In the ordinary course of business, the Company may directly or indirectly be a defendant or plaintiff in legal actions with respect to bankruptcy, insolvency or other types of proceedings. Such lawsuits may involve claims that could adversely affect the value of certain financial instruments owned by the Company.

Income Taxes

The Company has elected, and intends to qualify annually, to be treated for U.S. federal income tax purposes as a RIC under Subchapter M of the Code. By meeting these requirements, the Company generally will not be subject to U.S. federal income tax on ordinary income or capital gains timely distributed to stockholders. Therefore, no provision has been recorded for federal income taxes, except as related to the Corporate Blockers (as defined below) and long-term capital gains, when applicable.

In order to qualify as a RIC, among other requirements, the Company generally is required to timely distribute to its stockholders at least 90% of its “investment company taxable income”, as defined by the Code, for each fiscal tax year. The Company will be subject to U.S. federal income tax imposed at corporate rates on its investment company taxable income and net capital gains that it does not timely distribute to shareholders. The Company will be subject to a non-deductible U.S. federal excise tax of 4% on undistributed income if it does not distribute at least (1) 98% of its net ordinary income in any calendar year, (2) 98.2% of its capital gain net income for each one-year period ending on October 31and (3) any net ordinary income and capital gain net income that it recognized for preceding years, but were not distributed during such year, and on which the Company paid no U.S federal income tax.

Depending on the level of investment company taxable income earned in a tax year and the amount of net capital gains recognized in such tax year, the Company may choose to carry forward investment company taxable income and net capital gains in excess of current year dividend distributions into the next tax year and pay U.S. federal income tax, and possibly the 4% U.S. federal excise tax on such income, as required. To the extent that the Company determines that its estimated current year annual investment company taxable income will be in excess of estimated current year dividend distributions for U.S. federal excise tax purposes, the Company accrues the U.S. federal excise tax, if any, on estimated excess taxable income as taxable income is earned. For the years ended February 28, 2025, February 29, 2024 and February 28, 2023, the excise tax accrual on estimated excess taxable income was $2.4 million, $1.8 million and $1.1 million, respectively.

In accordance with U.S. Treasury regulations and published guidance issued by the Internal Revenue Service (“IRS”), a publicly offered RIC may treat a distribution of its own stock as counting toward its RIC distribution requirements if each stockholder may elect to receive his, her, or its entire distribution in either cash or stock of the RIC. This published guidance indicates that the rule will apply where the aggregate amount of cash to be distributed to all stockholders is not at least 20% of the aggregate declared distribution. Under the published guidance, if too many stockholders elect to receive cash, the cash available for distribution must be allocated among the stockholders electing to receive cash (with the balance of the distribution paid in stock). In no event will any stockholder, electing to receive cash, receive less than 20% of his or her entire distribution in cash. If these and certain other requirements are met, for U.S. federal income tax purposes, the amount of the dividend paid in stock will be equal to the amount of cash that could have been received instead of stock.

The Company may utilize wholly owned holding companies that are treated as corporations for U.S. federal income tax purposes when making equity investments in portfolio companies taxed as pass-through entities to meet its source-of-income requirements as a RIC (“Corporate Blockers”). Corporate Blockers are consolidated in the Company’s U.S. GAAP financial statements and may result in current and deferred U.S. federal and state income tax expense with respect to income derived from those investments. Such income, net of applicable income taxes, is not included in the Company’s tax-basis net investment income until distributed by the Corporate Blocker, which may result in timing and character differences between the Company’s U.S. GAAP and tax-basis net investment income and realized gains and losses. Income tax expense or benefit from Corporate Blockers related to net investment income are included in total operating expenses, while any expense or benefit related to federal or state income tax originated for capital gains and losses are included together with the applicable net realized or unrealized gain or loss line item. Deferred tax assets of the Corporate Blockers are reduced by a valuation allowance when, in the opinion of management, it is more likely than-not that some portion or all of the deferred tax assets will not be realized.

FASB ASC Topic 740, Income Taxes (“ASC 740”), provides guidance for how uncertain tax positions should be recognized, measured, presented and disclosed in the financial statements. ASC 740 requires the evaluation of tax positions taken or expected to be taken in the course of preparing the Company’s tax returns to determine whether the tax positions are “more-likely-than-not” of being sustained by the applicable tax authority. Tax positions deemed to meet a “more-likely-than-not” threshold would be recorded as a tax benefit or expense in the current period. The Company recognizes interest and penalties, if any, related to unrecognized tax benefits as income tax expense on the consolidated statements of operations. During the fiscal year ended February 28, 2025, February 29, 2024 and February 28, 2023 the Company did not incur any interest or penalties. Although we file federal and state tax returns, our major tax jurisdiction is federal. The 2022, 2023, 2024 and 2025 federal tax years for the Company remain subject to examination by the IRS. At August 31, 2025 and February 28, 2025, there were no uncertain tax positions. The Company is not aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will change significantly in the next 12 months.

Dividends

Dividends to common stockholders are recorded on the ex-dividend date. The amount to be paid out as a dividend is determined by the board of directors. Net realized capital gains, if any, are generally distributed at least annually, although we may decide to retain some or all of our net capital gains for reinvestment.

We have adopted a dividend reinvestment plan (“DRIP”) that provides for reinvestment of our dividend distributions on behalf of our stockholders unless a stockholder elects to receive cash. As a result, if our board of directors authorizes, and we declare, a cash dividend, then our stockholders who have not “opted out” of the DRIP by the dividend record date will have their cash dividends automatically reinvested into additional shares of our common stock, rather than receiving the cash dividends. We have the option to satisfy the share requirements of the DRIP through the issuance of new shares of common stock or through open market purchases of common stock by the DRIP plan administrator.

Capital Gains Incentive Fee

The Company records an expense accrual on the consolidated statements of operations relating to the capital gains incentive fee payable to the Manager, as recorded on the consolidated statements of assets and liabilities when the net realized and unrealized gain on its investments exceed all net realized and unrealized capital losses on its investments, as a capital gains incentive fee would be owed to the Manager if the Company were to liquidate its investment portfolio at such time.

The actual incentive fee payable to the Manager related to capital gains will be determined and payable in arrears at the end of each fiscal year and only reflect those realized capital gains net of realized and unrealized losses for the period.

Recent Accounting Pronouncements

In December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures (“ASU 2023-09”), which requires additional disaggregated information on income taxes paid. This amended guidance is effective for annual periods beginning after December 15, 2024. Early adoption is permitted, however the Company has not elected to early adopt this provision as of the date of the financial statements contained in this report. The Company is currently evaluating the impact of the new guidance on the Company’s consolidated financial statements and related disclosures.

In November 2024, the FASB issued ASU 2024-03, Disaggregation of Income Statement Expenses, which requires additional disclosure of the nature of expenses included in the income statement in response to requests from investors for more information about an entity’s expenses. The new standard requires disaggregation of certain expense captions into specified categories in disclosures within the footnotes to the financial statements. The new guidance is effective for annual periods beginning after December 15, 2026, and interim periods within the annual reporting periods beginning after December 15, 2027. Early adoption permitted. The Company is currently evaluating the impact of the new standard on the Company’s consolidated financial statements and related disclosures and does not believe it will have a material impact on its consolidated financial statements or its disclosures.

Risk Management

In the ordinary course of its business, the Company manages a variety of risks, including market and credit risk. Market risk is the risk of potential adverse changes to the value of investments because of changes in market conditions such as interest rate movements and volatility in investment prices.

Credit risk is the risk of default or non-performance by portfolio companies, equivalent to the investment’s carrying amount. The Company is also exposed to credit risk related to maintaining all of its cash and cash equivalents, including those in reserve accounts, at a major financial institution and credit risk related to any of its derivative counterparties.

The Company has investments in lower rated and comparable quality unrated high yield bonds and bank loans. Investments in high yield investments are accompanied by a greater degree of credit risk. The risk of loss due to default by the issuer is significantly greater for holders of high yield securities, because such investments are generally unsecured and are often subordinated to other creditors of the issuer.

Note 3. Investments

As noted above, the Company values all investments in accordance with ASC 820. As defined in ASC 820, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between independent market participants at the measurement date.

ASC 820 establishes a hierarchal disclosure framework which prioritizes and ranks the level of market price observability of inputs used in measuring investments at fair value. Market price observability is affected by a number of factors, including the type of investment and the characteristics specific to the investment. Investments with readily available active quoted prices or for which fair value can be measured from actively quoted prices generally will have a higher degree of market price observability and a lesser degree of judgment used in measuring fair value.

Based on the observability of the inputs used in the valuation techniques, the Company is required to provide disclosures on fair value measurements according to the fair value hierarchy. The fair value hierarchy ranks the observability of the inputs used to determine fair values. Investments carried at fair value are classified and disclosed in one of the following three categories:

●

Level 1—Valuations based on quoted prices in active markets for identical assets or liabilities that the Company has the ability to access.

●

Level 2— Pricing inputs are other than quoted prices in active markets, which are either directly or indirectly observable as of the reporting date. Such inputs may be quoted prices for similar assets or liabilities, quoted markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full character of the financial instrument, or inputs that are derived principally from, or corroborated by, observable market information. Investments that are generally included in this category include illiquid debt securities and less liquid, privately held or restricted equity securities, for which some level of recent trading activity has been observed.

●

Level 3—Pricing inputs are unobservable for the investment and includes situations where there is little, if any, market activity for the investment. The inputs may be based on the Company’s own assumptions about how market participants would price the asset or liability or may use Level 2 inputs, as adjusted, to reflect specific investment attributes relative to a broader market assumption. Even if observable market data for comparable performance or valuation measures (earnings multiples, discount rates, other financial/valuation ratios, etc.) are available, such investments are grouped as Level 3 if any significant data point that is not also market observable (private company earnings, cash flows, etc.) is used in the valuation technique. We use multiple techniques for determining fair value based on the nature of the investment and experience with those types of investments and specific portfolio companies. The selections of the valuation techniques and the inputs and assumptions used within those techniques often require subjective judgements and estimates. These techniques include market comparables, discounted cash flows and enterprise value waterfalls. Fair value is best expressed as a range of values from which the Company determines a single best estimate. The types of inputs and assumptions that may be considered in determining the range of values of our investments include the nature and realizable value of any collateral, the portfolio company’s ability to make payments, market yield trend analysis and volatility in future interest rates, call and put features, the markets in which the portfolio company does business, comparison to publicly traded companies, discounted cash flows and other relevant factors.

In addition to using the above inputs in investment valuations, the Company continues to employ the valuation policy approved by the board of directors that is consistent with ASC 820 and the 1940 Act (see Note 2. Summary of Significant Accounting Policies). Consistent with our valuation policy, the Company evaluates the source of inputs, including any markets in which its investments are trading, in determining fair value.

The following table presents fair value measurements of investments, by major class, as of August 31, 2025 (dollars in thousands), according to the fair value hierarchy:

	Fair Value Measurements						Valued Using Net Asset
	Level 1		Level 2		Level 3		Value*		Total
First lien term loans	$	-	$	-	$	839,483	$	-	$	839,483
Second lien term loans		-		-		6,826		-		6,826
Unsecured term loans		-		-		16,790		-		16,790
Structured finance securities		-		39,667		13,684		-		53,351
Equity interests		-		-		75,961		2,884		78,845
Total	$	-	$	39,667	$	952,744	$	2,884	$	995,295

The Company’s equity investment in SLF JV is measured using the proportionate share of the NAV, or equivalent, as a practical expedient and thus has not been classified in the fair value hierarchy. The Company’s unsecured loan investment in SLF JV is based on a discounted cash flow valuation technique.

The following table presents fair value measurements of investments, by major class, as of February 28, 2025 (dollars in thousands), according to the fair value hierarchy:

	Fair Value Measurements						Valued Using Net Asset
	Level 1		Level 2		Level 3		Value*		Total
First lien term loans	$	-	$	-	$	867,866	$	-	$	867,866
Second lien term loans		-		-		6,388		-		6,388
Unsecured term loans		-		-		16,534		-		16,534
Structured finance securities		-		-		14,772		-		14,772
Equity interests		-		-		69,437		3,081		72,518
Total	$	-	$	-	$	974,997	$	3,081	$	978,078

The following table provides a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the six months ended August 31, 2025 (dollars in thousands):

	First lien term loans			Second lien term loans			Unsecured term loans		Structured finance securities			Equity interests			Total
Balance as of February 28, 2025	$	867,867		$	6,388		$	16,534	$	14,771		$	69,437		$	974,997
Payment-in-kind and other adjustments to cost		974			548			-		(460	)		-			1,062
Net accretion of discount on investments		1,158			6			-		-			-			1,164
Net change in unrealized appreciation (depreciation) on investments		1,600			(116	)		256		(627	)		3,322			4,435
Purchases		59,468			-			-		-			3,607			63,075
Sales and repayments		(91,584	)		-			-		-			(3,359	)		(94,943	)
Net realized gain (loss) from investments		-			-			-		-			2,954			2,954
Balance as of August 31, 2025	$	839,483		$	6,826		$	16,790	$	13,684		$	75,961		$	952,744
Net change in unrealized appreciation (depreciation) for the period relating to those Level 3 assets that were still held by the Company at the end of the period	$	1,821		$	(116	)	$	258	$	(194	)	$	4,429		$	6,198

Purchases, PIK and other adjustments to cost include purchases of new investments at cost, effects of refinancing/restructuring, accretion/amortization of income from discount/premium on debt securities, and PIK interests.

Sales and repayments represent net proceeds received from investments sold and principal paydowns received during the period.

Transfers and restructurings, if any, are recognized at the beginning of the period in which they occur. There were no transfers or restructurings in or out of Levels 1, 2, or 3 during the six months ended August 31, 2025.

The following table provides a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the six months ended August 31, 2024 (dollars in thousands):

	First lien term loans			Second lien term loans		Unsecured term loans		Structured finance securities			Equity interests			Total
Balance as of February 29, 2024	$	976,423		$	18,097	$	15,818	$	30,626		$	88,426		$	1,129,390
Payment-in-kind and other adjustments to cost		1,627			7,745		-		(3,430	)		631			6,573
Net accretion of discount on investments		1,281			4		-		-			-			1,285
Net change in unrealized appreciation (depreciation) on investments		46,044			515		462		(3,899	)		3,815			46,937
Purchases		41,348			-		-		-			538			41,886
Sales and repayments		(132,875	)		-		-		-			(2,968	)		(135,843	)
Net realized gain (loss) from investments		(47,672	)		-		-		-			(6,972	)		(54,644	)
Balance as of August 31, 2024	$	886,176		$	26,361	$	16,280	$	23,297		$	83,470		$	1,035,584
Net change in unrealized appreciation (depreciation) for the year relating to those Level 3 assets that were still held by the Company at the end of the period	$	(70,736	)	$	515	$	462	$	(3,899	)	$	3,879		$	(69,779	)

The valuation techniques and significant unobservable inputs used in recurring Level 3 fair value measurements of assets as of August 31, 2025 were as follows (dollars in thousands):

	Fair Value		Valuation Technique	Unobservable Input	Range	Weighted Average*
First lien term loans	$	839,483	Market Comparables	Market Yield (%)	9.2% - 44.0%	13.6%
Second lien term loans		6,826	Market Comparables	Market Yield (%)	20.8%	20.8%
Unsecured term loans		16,790	Discounted Cash Flow	Discount Rate (%)	10.3%	10.3%
Structured finance securities		13,684	Discounted Cash Flow	Discount Rate (%)	8.0% - 70.0%	13.2%
				Recovery Rate (%)	70.00%	70.0%
				Prepayment Rate (%)	20.0%	20.0%
Equity interests		75,961	Enterprise Value Waterfall	Revenue Multiples (x)	0.1x - 8.5x	6.2x
				EBITDA Multiples (x)	3.5x - 13.5x	7.5x
Total	$	952,744

The weighted average in the table above is calculated based on each investment’s fair value weighting, using the applicable unobservable input.

The valuation techniques and significant unobservable inputs used in recurring Level 3 fair value measurements of assets as of February 28, 2025 were as follows (dollars in thousands):

Fair Value

Valuation Technique

Unobservable Input

Range

Weighted Average*

First lien term loans

867,866

Market Comparables

Market Yield (%)

9.8% - 22.0%

12.4%

Revenue Multiples (x)

2.5x

EBITDA Multiples (x)

6.8x

Second lien term loans

6,388

Market Comparables

Market Yield (%)

19.7%

Unsecured term loans

16,534

Discounted Cash Flow

Discount Rate (%)

10.0%

Structured finance securities

14,772

Discounted Cash Flow

Discount Rate (%)

8.0% - 70.0%

14.1%

Recovery Rate (%)

70.0%

Prepayment Rate (%)

20.0%

Equity interests

69,437

Enterprise Value Waterfall

EBITDA Multiples (x)

1.1x - 13.9x

8.2x

Revenue Multiples (x)

0.1x - 9.0x

6.3x

Total

974,997

The weighted average in the table above is calculated based on each investment’s fair value weighting, using the applicable unobservable input.

For investments utilizing a market comparables valuation technique, a significant increase (decrease) in the market yield, in isolation, would result in a significantly lower (higher) fair value measurement, and a significant increase (decrease) in any of the earnings before interest, tax, depreciation and amortization (“EBITDA”) or revenue valuation multiples, in isolation, would result in a significantly higher (lower) fair value measurement. For investments utilizing a discounted cash flow valuation technique, a significant increase (decrease) in the discount rate, and prepayment rate, in isolation, would result in a significantly lower (higher) fair value measurement while a significant increase (decrease) in recovery rate, in isolation, would result in a significantly higher (lower) fair value measurement. For investments utilizing a market quote, third party bid or net asset value in deriving a value, a significant increase (decrease) in the market quote, bid or net asset value in isolation, would result in a significantly higher (lower) fair value measurement.

The composition of our investments as of August 31, 2025 at amortized cost and fair value was as follows (dollars in thousands):

	Investments at Amortized Cost		Amortized Cost Percentage of Total Portfolio			Investments at Fair Value		Fair Value Percentage of Total Portfolio
First lien term loans	$	843,359		83.2	%	$	839,483		84.3	%
Second lien term loans		7,648		0.8			6,826		0.7
Unsecured term loans		17,619		1.7			16,790		1.7
Structured finance securities		74,430		7.4			53,351		5.4
Equity interests		69,583		6.9			78,845		7.9
Total	$	1,012,639		100.0	%	$	995,295		100.0	%

The composition of our investments as of February 28, 2025 at amortized cost and fair value was as follows (dollars in thousands):

	Investments at Amortized Cost		Amortized Cost Percentage of Total Portfolio			Investments at Fair Value		Fair Value Percentage of Total Portfolio
First lien term loans	$	873,342		87.3	%	$	867,866		88.7	%
Second lien term loans		7,094		0.7			6,388		0.7
Unsecured term loans		17,619		1.8			16,534		1.7
Structured finance securities		35,657		3.6			14,772		1.5
Equity interests		66,381		6.6			72,518		7.4
Total	$	1,000,093		100.0	%	$	978,078		100.0	%

For loans and debt securities for which market quotations are not readily available, the Company determines their fair value based on third party indicative broker quotes, where available, or the inputs that a hypothetical market participant would use to value the security in a current hypothetical sale using a market comparables valuation technique. In applying the market comparables valuation technique, the Company determines the fair value based on such factors as market participant inputs including synthetic credit ratings, estimated remaining life, current market yield and interest rate spreads of similar securities as of the measurement date. If, in the Company’s judgment, the market comparables technique is not sufficient or appropriate, the Company may use additional techniques such as an asset liquidation or expected recovery model.

For equity securities of portfolio companies and partnership interests, the Company determines the fair value using an enterprise value waterfall valuation technique. Under the enterprise value waterfall valuation technique, the Company determines the enterprise fair value of the portfolio company and then waterfalls the enterprise value over the portfolio company’s securities in order of their preference relative to one another. To estimate the enterprise value of the portfolio company, the Company weighs some or all of the traditional market valuation techniques and factors based on the individual circumstances of the portfolio company in order to estimate the enterprise value. The techniques for performing investments may be based on, among other things: valuations of comparable public companies, recent sales of private and public comparable companies, black-scholes modeling, discounting the forecasted cash flows of the portfolio company, third party valuations of the portfolio company, considering offers from third parties to buy the company, estimating the value to potential strategic buyers and considering the value of recent investments in the equity securities of the portfolio company. For non-performing investments, the Company may estimate the liquidation or collateral value of the portfolio company’s assets and liabilities. The Company also takes into account historical and anticipated financial results.

For CLO BB and CLO BBB debt, the Company determines the fair value by using recent actual market trades or an independent pricing service. The valuation methodology of the independent pricing service includes incorporating data comprised of observable market transactions, executable bids, broker quotes from dealers with two sided markets, as well as transaction activity from comparable securities to those being valued.

The Company’s investments in Saratoga CLO and SLF 2022 are carried at fair value, which is based on a discounted cash flow valuation technique that utilizes prepayment, re-investment and loss inputs based on historical experience and projected performance, economic factors, the characteristics of the underlying cash flow, and comparable yields for equity interests in collateralized loan obligation funds similar to Saratoga CLO and SLF 2022, when available, as determined by the Manager and recommended to the Company’s board of directors. Specifically, the Company uses Intex cash flows, or an appropriate substitute, to form the basis for the valuation of the investment in Saratoga CLO and SLF 2022. The cash flows use a set of inputs including projected default rates, recovery rates, reinvestment rates and prepayment rates in order to arrive at estimated valuations. The inputs are based on available market data and projections provided by third parties as well as management estimates. The Company ran Intex models based on inputs about the refinanced Saratoga CLO’s structure and the SLF 2022 structure, including capital structure, cost of liabilities and reinvestment period. The Company uses the output from the Intex models (i.e., the estimated cash flows) to perform a discounted cash flow analysis on expected future cash flows to determine a valuation for our investments in Saratoga CLO and SLF 2022 at August 31, 2025. The inputs at August 31, 2025 for the valuation model include:

●

Default rate: 2.0%

●

Recovery rate: 70%

●

Discount rate: 8.0%–70.0%

●

Prepayment rate: 20.0%

●

Reinvestment rate / price: S+365bps / $99.00

The Company’s equity investment in SLF JV is measured using the proportionate share of the NAV of SLF JV, or equivalent, as practical expedient.

Investment Concentration

Set forth is a brief description of each portfolio company in which the fair value of the Company’s investment represents greater than 5% of the Company’s total assets as of August 31, 2025, excluding Saratoga CLO, SLF JV and SLF 2022 (see Note 4. Investment in Saratoga CLO and Note 5. Investment in SLF JV for more information on Saratoga CLO, SLF JV and SLF 2022, respectively).

Artemis Wax Corp.

Artemis Wax Corporation is a U.S. based retail aggregator of European Wax Center (“EWC”) franchise locations with a concentration in the northeast. Founded in 2004, EWC is the largest U.S. body waxing national chain with more than 800 locations across the country.

Note 4. Investment in Saratoga CLO

On January 22, 2008, the Company entered into a collateral management agreement with Saratoga CLO, pursuant to which the Company acts as its collateral manager. The Saratoga CLO was initially refinanced in October 2013 and November 2016 with its reinvestment period extended to October 2016 and October 2018, respectively.

On December 14, 2018, the Company completed a third refinancing and upsize of the Saratoga CLO (the “2013-1 Reset CLO Notes”). The third Saratoga CLO refinancing, which, among other things, extended its reinvestment period to January 2021, and extended its legal maturity date to January 2030, and added a non-call period of January 2020. Following this refinancing, the Saratoga CLO portfolio increased its aggregate principal amount from approximately $300.0 million to approximately $500.0 million of predominantly senior secured first lien term loans.

On February 11, 2020, the Company entered into an unsecured loan agreement (“CLO 2013-1 Warehouse 2 Loan”) with Saratoga Investment Corp. CLO 2013-1 Warehouse 2, Ltd. (“CLO 2013-1 Warehouse 2”), a wholly owned subsidiary of Saratoga CLO, which was fully repaid. During the fourth quarter ended February 28, 2021, the CLO 2013-1 Warehouse 2 Ltd. was repaid in full.

On February 26, 2021, the Company completed the fourth refinancing of the Saratoga CLO, which, among other things, extended the Saratoga CLO reinvestment period to April 2024, extended its legal maturity to April 2033, and added a non-call period of February 2022. In addition, and as part of the refinancing, the Saratoga CLO was upsized from $500 million in assets to approximately $650 million. As part of this refinancing and upsizing, the Company invested an additional $14.0 million in all of the newly issued subordinated notes of the Saratoga CLO, and purchased $17.9 million in aggregate principal amount of the Class F-R-3 Notes tranche at par. Concurrently with the fourth refinancing of the Saratoga CLO, the existing $2.5 million of Class F-R-2 Notes, $7.5 million of Class G-R-2 Notes and $25.0 million of the CLO 2013-1 Warehouse 2 Loan were repaid. The Company also paid $2.6 million of transaction costs related to the refinancing and upsizing on behalf of the Saratoga CLO, to be reimbursed from future equity distributions. At August 31, 2021, the outstanding receivable of $2.6 million was repaid in full.

On August 9, 2021, the Company exchanged its existing $17.9 million Class F-R-3 Note for $8.5 million Class F-1-R-3 Notes and $9.4 million Class F-2-R-3 Notes at par. On August 11, 2021, the Company sold its Class F-1-R-3 Notes to third parties, resulting in a realized loss of $0.1 million.

On June 10, 2024, the Company completed its fifth refinancing of the Saratoga CLO, which adjusted the interest rate of two of the existing Notes. Saratoga CLO issued $422.5 million notes (the “2013-1 2024 Reset CLO Notes”), consisting of Class A-1-R-4 and Class A-2-R-4. The 2013-1 2024 Reset CLO Notes were issued pursuant to the indenture with the same trustee. Proceeds of the issuance of the 2013-1 2024 Reset CLO Notes were used along with existing assets of the Saratoga CLO to redeem the existing Class A-1-R-3 and Class A-2-R-3 Notes. No other Notes were refinanced as part of this refinancing. The Saratoga CLO paid $0.5 million of transaction costs related to the refinancing.

The Saratoga CLO remains effectively 100% owned and managed by the Company. The Company receives a base management fee of 0.10% per annum and a subordinated management fee of 0.40% per annum of the outstanding principal amount of Saratoga CLO’s assets, paid quarterly to the extent of available proceeds. Following the third refinancing and the issuance of the 2013-1 Reset CLO Notes on December 14, 2018, the Company is no longer entitled to an incentive management fee equal to 20.0% of excess cash flow to the extent the Saratoga CLO subordinated notes receive an internal rate of return paid in cash equal to or greater than 12.0%.

For the three months ended August 31, 2025 and August 31, 2024, the Company accrued management fee income of $0.7 million and $0.8 million, respectively, and interest income of $0.0 million and $0.0 million, respectively, from the subordinated notes of Saratoga CLO.

For the six months ended August 31, 2025 and August 31, 2024, the Company accrued management fee income of $1.4 million and $1.6 million, respectively, and interest income of $0.0 million and $0.0 million, respectively, from the subordinated notes of Saratoga CLO.

As of August 31, 2025, the aggregate principal amounts of the Company’s investments in the subordinated notes and Class F-2-R-3 Notes of the Saratoga CLO was $111.0 million and $9.4 million, respectively, which had a corresponding fair value of $0.1 million and $1.3 million, respectively. The Company determines the fair value of its investment in the subordinated notes of Saratoga CLO based on the present value of the projected future cash flows of the subordinated notes over the life of Saratoga CLO. As of August 31, 2025, Saratoga CLO had investments with a principal balance of $462.9 million and a weighted average spread over SOFR of 3.6% and had debt with a principal balance of $474.9 million with a weighted average spread over SOFR of 2.4%. As a result, Saratoga CLO earns a “spread” between the interest income it receives on its investments and the interest expense it pays on its debt and other operating expenses, which is distributed quarterly to the Company as the holder of its subordinated notes. As of August 31, 2025, the present value of the projected future cash flows of the subordinated notes was approximately $0.1 million, using a 70% discount rate. The Company’s total investment in the subordinate notes of Saratoga CLO is $57.8 million, which consists of additional investments of $30 million in January 2008, $13.8 million in December 2018 and $14.0 million in February 2021; to date, the Company has received distributions of $92.2 million, management fees of $39.6 million and incentive fees of $1.2 million.

As of February 28, 2025, the Company determined that the fair value of its investment in the subordinated notes of Saratoga CLO was $0.2 million. As of February 28, 2025, the fair value of its investment in the Class F-R-3 Notes of Saratoga CLO was $2.3 million. As of February 28, 2025, Saratoga CLO had investments with a principal balance of $527.1 million and a weighted average spread over SOFR of 3.7% and had debt with a principal balance of $524.2 million with a weighted average spread over SOFR of 2.3%. As of February 28, 2025, the present value of the projected future cash flows of the subordinated notes, was approximately $0.2 million, using a 40% discount rate. The Company’s total investment in the subordinate notes of Saratoga CLO is $57.8 which consists of additional investments of $30 million in January 2008, $13.8 million in December 2018 and $14.0 million in February 2021. To date the Company has since received distributions of $91.7 million, management fees of $38.3 million and incentive fees of $1.2 million.

Below is certain financial information from the separate financial statements of Saratoga CLO as of August 31, 2025 (unaudited) and February 28, 2025 and for the three and six months ended August 31, 2025 (unaudited) and August, 2024 (unaudited).

Saratoga Investment Corp. CLO 2013-1, Ltd.

Statements of Assets and Liabilities

	August 31, 2025			February 28, 2025
	(unaudited)
ASSETS
Investments at fair value
Loans at fair value (amortized cost of $453,068,091 and $517,757,349, respectively)	$	426,918,030		$	490,510,660
Equities at fair value (amortized cost of $2,817,735 and $2,578,454, respectively)		2,573,711			1,684,429
Total investments at fair value (amortized cost of $455,885,826 and $520,335,803, respectively)		429,491,741			492,195,089
Cash and cash equivalents		27,961,213			21,272,327
Receivable from open trades		4,410,340			1,138,899
Interest receivable (net of reserve of $1,150,673 and $1,121,546, respectively)		2,296,674			2,380,214
Due from affiliate (See Note 7)		1,591			801
Prepaid expenses and other assets		182,348			101,453
Total assets	$	464,343,907		$	517,088,783

LIABILITIES
Interest payable	$	3,718,502		$	3,739,343
Accrued base management fee		55,754			62,839
Accrued subordinated management fee		223,015			251,354
Accounts payable and accrued expenses		172,557			143,135
Saratoga Investment Corp. CLO 2013-1, Ltd. Notes:
Class A-1-R-4 Senior Secured Floating Rate Notes		221,465,117			270,719,300
Class A-2-R-4 Senior Secured Floating Rate Notes		65,000,000			65,000,000
Class B-FL-R-3 Senior Secured Floating Rate Notes		60,500,000			60,500,000
Class B-FXD-R-3 Senior Secured Fixed Rate Notes		11,000,000			11,000,000
Class C-FL-R-3 Deferrable Mezzanine Floating Rate Notes		26,000,000			26,000,000
Class C-FXD-R-3 Deferrable Mezzanine Fixed Rate Notes		6,500,000			6,500,000
Class D-R-3 Deferrable Mezzanine Floating Rate Notes		39,000,000			39,000,000
Discount on Class D-R-3 Notes		(183,900	)		(196,033	)
Class E-R-3 Deferrable Mezzanine Floating Rate Notes		27,625,000			27,625,000
Discount on Class E-R-3 Notes		(1,910,522	)		(2,036,565	)
Class F-1-R-3 Notes Deferrable Junior Floating Rate Notes		8,500,000			8,500,000
Class F-2-R-3 Notes Deferrable Junior Floating Rate Notes		9,375,000			9,375,000
Deferred debt financing costs		(1,155,286	)		(1,229,456	)
Subordinated Notes		111,000,000			111,000,000
Discount on Subordinated Notes		(30,216,942	)		(32,210,459	)
Total liabilities		556,668,295			603,743,458

Commitments and contingencies

NET ASSETS
Ordinary equity, par value $1.00, 250 ordinary shares authorized, 250 and 250 common shares issued and outstanding, respectively		250			250
Total distributable earnings (loss)		(92,324,638	)		(86,654,925	)
Total net deficit		(92,324,388	)		(86,654,675	)
Total liabilities and net assets	$	464,343,907		$	517,088,783

See accompanying notes to financial statements.

Saratoga Investment Corp. CLO 2013-1, Ltd.

Statements of Operations

(unaudited)

	For the three months ended						For the six months ended
	August 31, 2025			August 30, 2024			August 31, 2025			August 30, 2024
INVESTMENT INCOME
Total interest from investments	$	10,546,800		$	14,579,025		$	21,960,657		$	30,653,197
Interest from cash and cash equivalents		222,520			330,398			430,629			563,896
Other income		104,263			465,627			110,122			1,100,396
Total investment income		10,873,583			15,375,050			22,501,408			32,317,489

EXPENSES
Interest and debt financing expenses		9,652,379			14,011,087			19,596,740			29,197,508
Base management fee		126,689			158,465			273,761			319,356
Subordinated management fee		536,943			633,859			1,095,046			1,277,423
Professional fees		(14,059	)		83,491			174,066			142,296
Trustee expenses		47,403			61,273			96,263			123,478
Other expense		89,347			71,025			225,823			176,563
Total expenses		10,438,702			15,019,200			21,461,699			31,236,624
NET INVESTMENT INCOME (LOSS)		434,881			355,850			1,039,709			1,080,865

REALIZED AND UNREALIZED LOSS ON INVESTMENTS
Net realized loss from investments		(6,389,175	)		(2,795,356	)		(8,456,051	)		(7,193,885	)
Net change in unrealized depreciation on investments		6,769,038			(3,662,317	)		1,746,629			(719,366	)
Net realized and unrealized gain (loss) on investments		379,863			6,457,673			(6,709,422	)		(7,913,251	)
Realized losses on extinguishment of debt		-			(579,213	)		-			(579,213	)
NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS	$	814,744		$	(6,681,036	)	$	(5,669,713	)	$	(7,411,599	)

See accompanying notes to financial statements.

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

August 31, 2025

(unaudited)

Issuer Name	Industry	Asset Name	Asset Type	Reference Rate/Spread			SOFR/LIBOR Floor			Current Rate (All In)			Maturity Date	Principal/ Number of Shares		Cost		Fair Value
ALTISOURCE PORTFOLIO SOL	Banking, Finance, Insurance & Real Estate	Common Stock	Equity												37,028	$	216,246	$	424,345
Altisource Portfolio Solutions - CS Warrant	Banking, Finance, Insurance & Real Estate	Warrants	Equity												990		3,736		624
Altisource Portfolio Solutions - NS Warrant	Banking, Finance, Insurance & Real Estate	Warrants	Equity												990		3,129		554
Envision Parent Inc	Healthcare & Pharmaceuticals	Common Stock	Equity												4,410		175,000		72,765
Envision Parent Inc	Healthcare & Pharmaceuticals	Warrants	Equity												92,837		-		4,642
Franchise Group Inc	Services: Consumer	Common Stock	Equity												32,460		746,579		941,340
Instant Brands Litigation Trust	Consumer Goods: Durable	Equity Interests	Equity												8,572		-		456,444
Isagenix International, LLC	Beverage, Food & Tobacco	Common Stock	Equity												86,398		-		-
Mallinckrodt CS	Healthcare & Pharmaceuticals	Common Stock	Equity												6,218		638,464		600,037
Resolute Investment Managers (American Beacon), Inc.	Banking, Finance, Insurance & Real Estate	Common Stock	Equity												24,320		1,034,581		72,960
Wellpath Correct Care	Healthcare & Pharmaceuticals	Common Stock	Equity												19,309		-		-
1011778 B.C Unltd Liability Co	Beverage, Food & Tobacco	Term Loan B6	Loan	1M USD SOFR+	1.75	%		0.00	%		6.07	%	9/20/2030		1,429,442		1,413,675		1,423,196
19TH HOLDINGS GOLF, LLC	Consumer goods: Durable	Term Loan	Loan	1M USD SOFR+	3.25	%		0.50	%		7.69	%	2/7/2029		2,435,977		2,370,689		2,419,729
888 Acquisitions Limited	Hotel, Gaming & Leisure	Term Loan B	Loan	3M USD SOFR+	5.25	%		0.00	%		9.66	%	7/8/2028		3,021,162		2,812,994		2,854,998
Adtalem Global Education Inc.	Services: Business	Term Loan B (08/24)	Loan	1M USD SOFR+	2.75	%		0.75	%		7.07	%	8/12/2028		352,462		350,854		352,610
Agiliti Health Inc.	Healthcare & Pharmaceuticals	Term Loan B (03/23)	Loan	3M USD SOFR+	3.00	%		0.00	%		7.29	%	5/1/2030		2,143,239		2,131,066		2,062,868
AHEAD DB Holdings, LLC	Services: Business	Term Loan B3 (07/24)	Loan	3M USD SOFR+	2.75	%		0.75	%		7.05	%	2/1/2031		2,881,141		2,828,152		2,881,746
Air Canada	Transportation: Consumer	Term Loan B (03/24)	Loan	1M USD SOFR+	2.00	%		0.00	%		6.32	%	3/21/2031		987,500		985,648		986,572
AIT Worldwide Logistics Holdings, Inc.	Transportation: Cargo	Term Loan B (01/25)	Loan	3M USD SOFR+	4.00	%		0.75	%		8.25	%	4/8/2030		2,443,418		2,339,059		2,446,472

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

August 31, 2025

(unaudited)

Issuer Name	Industry	Asset Name	Asset Type	Reference Rate/Spread			SOFR/LIBOR Floor			Current Rate (All In)			Maturity Date	Principal/ Number of Shares		Cost		Fair Value
AlixPartners, LLP	Banking, Finance, Insurance & Real Estate	Term Loan (08/25)	Loan	1M USD SOFR+	2.00	%		0.00	%		6.32	%	8/12/2032		239,374	$	239,362	$	238,376
Allen Media, LLC	Media: Diversified & Production	Term Loan (7/21)	Loan	3M USD SOFR+	5.50	%		0.00	%		9.95	%	2/10/2027		4,281,281		4,272,133		2,855,614
Alliant Holdings Intermediate, LLC	Banking, Finance, Insurance & Real Estate	Term Loan (8/25)	Loan	1M USD SOFR+	2.50	%		0.00	%		6.82	%	9/19/2031		793,026		793,026		791,091
Alterra Mountain Company (Intrawest Resort Holdings)	Hotel, Gaming & Leisure	Term Loan B8 (07/25)	Loan	1M USD SOFR+	2.50	%		0.00	%		6.82	%	5/31/2030		248,128		248,128		248,284
Altisource Solutions S.a r.l.	Banking, Finance, Insurance & Real Estate	Term Loan (Specified) B	Loan	3M USD SOFR+	6.50	%		3.50	%		10.90	%	2/20/2029		498,750		487,684		498,750
Altium Packaging LLC	Containers, Packaging & Glass	Term Loan B	Loan	1M USD SOFR+	2.50	%		0.00	%		6.82	%	6/11/2031		480,150		479,207		471,450
American Axle & Manufacturing Inc.	Automotive	Term Loan (12/22)	Loan	1M USD SOFR+	3.00	%		0.50	%		7.36	%	12/13/2029		480,000		470,203		479,160
American Greetings Corporation	Media: Advertising, Printing & Publishing	Term Loan B (04/24)	Loan	1M USD SOFR+	5.75	%		0.00	%		10.07	%	10/30/2029		2,889,522		2,888,588		2,891,343
American Trailer World Corp	Automotive	Term Loan	Loan	1M USD SOFR+	3.75	%		0.75	%		8.17	%	3/3/2028		1,357,439		1,357,480		1,140,859
Amynta Agency Borrower Inc.	Banking, Finance, Insurance & Real Estate	Term Loan B (7/25)	Loan	1M USD SOFR+	2.75	%		0.00	%		7.07	%	12/29/2031		3,398,530		3,336,552		3,396,423
Anastasia Parent LLC	Consumer goods: Non-durable	Term Loan	Loan	1M USD SOFR+	3.75	%		0.00	%		8.22	%	9/10/2025		932,500		932,500		803,116
Anchor Packaging, LLC	Containers, Packaging & Glass	Term Loan (12/24)	Loan	1M USD SOFR+	3.25	%		0.00	%		7.61	%	7/18/2029		1,934,626		1,920,111		1,936,560
AP Core Holdings II LLC	High Tech Industries	Term Loan B1	Loan	1M USD SOFR+	5.50	%		0.75	%		9.93	%	9/1/2027		1,624,732		1,615,163		1,563,398
AP Core Holdings II LLC	High Tech Industries	Term Loan B2	Loan	1M USD SOFR+	5.50	%		0.75	%		9.93	%	9/1/2027		500,000		497,060		480,835
APEX GROUP TREASURY LLC	Banking, Finance, Insurance & Real Estate	Term Loan (2/25)	Loan	3M USD SOFR+	3.50	%		0.00	%		7.75	%	2/27/2032		488,812		468,794		488,935
Aramark Services, Inc.	Services: Consumer	Term Loan B8 (03/24)	Loan	1M USD SOFR+	2.00	%		0.00	%		6.32	%	6/22/2030		2,242,497		2,219,623		2,244,358
Aramark Services, Inc.	Services: Consumer	Term Loan (08/25)	Loan	1M USD SOFR+	1.75	%		0.00	%		6.07	%	4/6/2028		1,753,715		1,750,502		1,754,084
ARC FALCON I INC.	Chemicals, Plastics, & Rubber	Term Loan	Loan	1M USD SOFR+	3.50	%		0.50	%		7.92	%	9/23/2028		966,274		965,081		966,515

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

August 31, 2025

(unaudited)

Issuer Name	Industry	Asset Name	Asset Type	Reference Rate/Spread			SOFR/LIBOR Floor			Current Rate (All In)			Maturity Date	Principal/ Number of Shares		Cost		Fair Value
ARCIS GOLF LLC	Services: Consumer	Term Loan B (01/25)	Loan	1M USD SOFR+	2.75	%		0.50	%		7.07	%	11/24/2028		491,848	$	488,654	$	492,669
Aretec Group, Inc.	Banking, Finance, Insurance & Real Estate	Term Loan B (12/24)	Loan	1M USD SOFR+	3.50	%		0.00	%		7.82	%	8/9/2030		2,609,783		2,597,857		2,610,957
Ascensus Group Holdings, Inc	Banking, Finance, Insurance & Real Estate	Term Loan	Loan	1M USD SOFR+	3.00	%		0.00	%		7.32	%	8/2/2028		492,150		489,595		492,253
Aspire Bakeries Holdings, LLC	Beverage, Food & Tobacco	Term Loan B (6/25)	Loan	1M USD SOFR+	3.50	%		0.00	%		7.83	%	12/23/2030		891,000		884,050		893,789
Asurion, LLC	Banking, Finance, Insurance & Real Estate	Term Loan B10	Loan	1M USD SOFR+	4.00	%		0.00	%		8.42	%	8/19/2028		1,945,000		1,889,436		1,936,792
Asurion, LLC	Banking, Finance, Insurance & Real Estate	Term Loan B12	Loan	1M USD SOFR+	4.25	%		0.00	%		8.61	%	9/19/2030		2,897,582		2,894,767		2,859,102
ATHENAHEALTH GROUP INC.	Healthcare & Pharmaceuticals	Term Loan B (2/22)	Loan	1M USD SOFR+	2.75	%		0.50	%		7.07	%	2/15/2029		1,300,539		1,297,949		1,299,187
Avolon TLB Borrower 1 (US) LLC	Capital Equipment	Term Loan B6	Loan	1M USD SOFR+	1.75	%		0.00	%		6.09	%	6/22/2030		1,465,259		1,428,750		1,465,024
Axalta Coating Systems US Holdings	Chemicals, Plastics, & Rubber	Term Loan B (11/24)	Loan	3M USD SOFR+	1.75	%		0.50	%		6.05	%	12/20/2029		846,793		841,241		848,808
B&G Foods, Inc.	Beverage, Food & Tobacco	Term Loan B	Loan	1M USD SOFR+	3.50	%		0.00	%		7.82	%	10/10/2029		529,619		528,215		501,549
Baldwin Insurance Group Holdings, LLC	Banking, Finance, Insurance & Real Estate	Term Loan B-1 (12/24)	Loan	1M USD SOFR+	3.00	%		0.00	%		7.37	%	5/27/2031		1,632,077		1,623,050		1,632,763
Belfor Holdings Inc.	Services: Consumer	Term Loan B	Loan	1M USD SOFR+	2.75	%		0.50	%		7.07	%	11/4/2030		1,422,330		1,411,384		1,428,559
Bengal Debt Merger Sub LLC	Beverage, Food & Tobacco	Second Out Term Loan	Loan	3M USD SOFR+	3.25	%		0.50	%		7.65	%	1/24/2029		1,164,083		733,690		828,827
Bengal Debt Merger Sub LLC (c)	Beverage, Food & Tobacco	Third Out Term Loan	Loan	3M USD SOFR+	1.00	%		0.50	%		5.40	%	1/24/2030		392,782		143,837		160,255
Blackstone Mortgage Trust, Inc.	Banking, Finance, Insurance & Real Estate	Term Loan B	Loan	1M USD SOFR+	2.25	%		0.00	%		6.68	%	4/23/2026		342,601		342,217		341,745
Bombardier Recreational Products, Inc.	Consumer goods: Durable	Term Loan	Loan	1M USD SOFR+	2.75	%		0.00	%		7.07	%	1/22/2031		1,418,532		1,415,785		1,420,873
Bombardier Recreational Products, Inc.	Consumer goods: Durable	Term Loan B3	Loan	1M USD SOFR+	2.75	%		0.50	%		7.07	%	12/13/2029		486,325		478,042		487,011
Boost Newco Borrower, LLC (Worldpay)	Banking, Finance, Insurance & Real Estate	Term Loan B (01/25)	Loan	3M USD SOFR+	2.00	%		0.00	%		6.30	%	1/31/2031		497,503		495,549		497,628
Boxer Parent Company, Inc.	High Tech Industries	Term Loan	Loan	3M USD SOFR+	3.00	%		0.00	%		7.20	%	7/30/2031		1,004,676		1,000,955		1,002,837

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

August 31, 2025

(unaudited)

Issuer Name	Industry	Asset Name	Asset Type	Reference Rate/Spread			SOFR/LIBOR Floor			Current Rate (All In)			Maturity Date	Principal/ Number of Shares		Cost		Fair Value
BroadStreet Partners, Inc.	Banking, Finance, Insurance & Real Estate	Term Loan B-4	Loan	1M USD SOFR+	2.75	%		0.00	%		7.07	%	6/16/2031		2,881,775	$	2,880,258	$	2,879,815
Brookfield WEC Holdings Inc.	Energy: Electricity	Term Loan B	Loan	1M USD SOFR+	2.25	%		0.00	%		6.60	%	1/27/2031		1,433,212		1,433,212		1,432,968
Brookfield Property REIT Inc.	Banking, Finance, Insurance & Real Estate	Term Loan B (05/25)	Loan	1M USD SOFR+	3.50	%		0.00	%		7.82	%	5/16/2030		1,739,305		1,773,219		1,744,749
BROWN GROUP HOLDING, LLC	Aerospace & Defense	Term Loan B-2	Loan	3M USD SOFR+	2.75	%		0.00	%		6.95	%	7/1/2031		488,822		479,950		488,729
Buckeye Partners, L.P.	Utilities: Oil & Gas	Term Loan B (01/25)	Loan	1M USD SOFR+	1.75	%		0.00	%		6.07	%	11/22/2030		661,679		659,934		662,162
Buckeye Partners, L.P.	Utilities: Oil & Gas	Term Loan B5 (09/24)	Loan	1M USD SOFR+	1.75	%		0.00	%		6.07	%	11/2/2026		478,489		477,793		478,537
BW Gas & Convenience Holdings LLC	Beverage, Food & Tobacco	Term Loan B	Loan	1M USD SOFR+	3.50	%		0.50	%		7.93	%	3/31/2028		2,400,000		2,389,829		2,383,992
Callaway Golf Company	Retail	Term Loan B	Loan	1M USD SOFR+	3.00	%		0.00	%		7.32	%	3/16/2030		468,750		465,337		460,547
Calpine Corporation	Utilities: Electric	Term Loan B10 (01/24)	Loan	1M USD SOFR+	1.75	%		0.00	%		6.07	%	1/31/2031		1,990,000		1,982,087		1,987,712
Camping World, Inc.	Retail	Term Loan B (5/21)	Loan	1M USD SOFR+	2.50	%		0.75	%		6.93	%	6/5/2028		2,394,245		2,269,522		2,346,121
CAPSTONE BORROWER INC	Services: Business	Term Loan B	Loan	3M USD SOFR+	2.75	%		0.00	%		7.05	%	6/17/2030		868,306		858,624		866,291
CareerBuilder, LLC (b) (c)	Services: Business	Term Loan B3	Loan	1M USD SOFR+	2.50	%		0.00	%		6.93	%	7/31/2026		4,133,751		4,126,751		186,019
Castle US Holding Corporation (c)	Media: Advertising, Printing & Publishing	Term Loan (4/25)	Loan	3M USD SOFR+	5.00	%		2.00	%		9.20	%	4/29/2030		219,371		213,317		220,578
Castle US Holding Corporation	Media: Advertising, Printing & Publishing	Term Loan B1	Loan	3M USD SOFR+	4.25	%		0.00	%		8.72	%	5/31/2030		1,748,013		1,195,249		799,716
CBL & Associates Limited Partnership	Retail	Term Loan 11/21	Loan	1M USD SOFR+	2.75	%		1.00	%		7.22	%	11/1/2025		2,028,959		2,001,612		1,924,975
CCC Intelligent Solutions Inc.	Services: Business	Term Loan B	Loan	1M USD SOFR+	2.00	%		0.50	%		6.32	%	1/23/2032		241,288		241,129		241,213
CCRR Parent, Inc.	Healthcare & Pharmaceuticals	Term Loan	Loan	3M USD SOFR+	4.25	%		0.50	%		8.55	%	3/6/2028		975,000		948,389		292,500
CCRR Parent, Inc.	Healthcare & Pharmaceuticals	Term Loan B	Loan	3M USD SOFR+	4.25	%		0.75	%		8.71	%	3/6/2028		957,500		955,751		287,250
CDK GLOBAL, INC.	High Tech Industries	Term Loan B (05/24)	Loan	3M USD SOFR+	3.25	%		0.00	%		7.55	%	7/6/2029		985,056		966,148		821,990
Charlotte Buyer, Inc.	Services: Business	Term Loan B (01/25)	Loan	3M USD SOFR+	4.25	%		0.50	%		8.48	%	2/11/2028		1,466,437		1,413,209		1,464,604

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

August 31, 2025

(unaudited)

Issuer Name	Industry	Asset Name	Asset Type	Reference Rate/Spread			SOFR/LIBOR Floor			Current Rate (All In)			Maturity Date	Principal/ Number of Shares		Cost		Fair Value
Chemours Company, (The)	Chemicals, Plastics, & Rubber	Term Loan B3 (08/23)	Loan	1M USD SOFR+	3.00	%		0.50	%		7.32	%	8/18/2028		2,357,721	$	2,331,330	$	2,351,827
Churchill Downs Incorporated	Hotel, Gaming & Leisure	Term Loan B1 (3/21)	Loan	1M USD SOFR+	1.75	%		0.00	%		6.07	%	3/17/2028		478,750		478,436		477,855
CIMPRESS PUBLIC LIMITED COMPANY	Media: Advertising, Printing & Publishing	Term Loan B	Loan	1M USD SOFR+	2.50	%		0.50	%		6.82	%	5/17/2028		1,930,461		1,884,378		1,925,635
CITADEL SECURITIES LP	Banking, Finance, Insurance & Real Estate	Term Loan (10/24)	Loan	1M USD SOFR+	2.00	%		0.00	%		6.32	%	10/31/2031		4,802,755		4,802,755		4,813,753
Citco Funding LLC	Banking, Finance, Insurance & Real Estate	Term Loan B (06/24)	Loan	6M USD SOFR+	2.75	%		0.50	%		6.93	%	4/27/2028		982,563		979,856		985,834
Clarios Global LP	Automotive	Term Loan B (07/24)	Loan	1M USD SOFR+	2.50	%		0.00	%		6.82	%	5/6/2030		1,191,015		1,186,977		1,190,419
Cloud Software Group Inc	High Tech Industries	Term Loan B	Loan	3M USD SOFR+	3.25	%		0.00	%		7.48	%	8/16/2032		497,500		497,114		498,639
CLYDESDALE ACQUISITION HOLDINGS, INC.	Containers, Packaging & Glass	Term Loan B	Loan	1M USD SOFR+	3.18	%		0.50	%		7.49	%	4/13/2029		1,220,000		1,201,808		1,218,316
Columbus McKinnon Corporation	Capital Equipment	Term Loan (03/24)	Loan	3M USD SOFR+	2.50	%		0.50	%		6.80	%	5/14/2028		353,788		353,479		353,788
Connect Finco SARL	Telecommunications	Term Loan B (03/24)	Loan	1M USD SOFR+	4.50	%		0.50	%		8.82	%	9/27/2029		2,851,406		2,792,932		2,810,432
Corelogic, Inc.	Services: Business	Term Loan (4/21)	Loan	1M USD SOFR+	3.50	%		0.50	%		7.93	%	6/2/2028		2,406,250		2,401,654		2,397,828
Creative Artists Agency, LLC	Media: Diversified & Production	Term Loan B (7/25)	Loan	1M USD SOFR+	2.50	%		0.00	%		6.82	%	10/1/2031		1,568,214		1,560,628		1,570,456
CROCS INC	Consumer goods: Durable	Term Loan B (01/24)	Loan	1M USD SOFR+	2.25	%		0.50	%		6.57	%	2/19/2029		750,000		732,631		752,348
Cross Financial Corp	Banking, Finance, Insurance & Real Estate	Term Loan B4 (07/25)	Loan	1M USD SOFR+	2.75	%		0.00	%		7.07	%	10/31/2031		482,637		481,652		483,641
Crown Subsea Communications Holding, Inc.	Construction & Building	Term Loan B (7/25)	Loan	3M USD SOFR+	3.50	%		0.75	%		7.82	%	1/30/2031		2,376,000		2,357,187		2,393,083
Dave & Buster's Inc.	Hotel, Gaming & Leisure	Term Loan B (1/24)	Loan	3M USD SOFR+	3.25	%		0.50	%		7.56	%	6/29/2029		762,038		737,900		734,849
Delek US Holdings, Inc.	Utilities: Oil & Gas	Term Loan B (11/22)	Loan	1M USD SOFR+	3.50	%		0.50	%		7.92	%	11/16/2029		5,265,000		5,187,985		5,240,570
Derby Buyer LLC	Chemicals, Plastics, & Rubber	Term Loan B (12/24)	Loan	1M USD SOFR+	3.00	%		0.00	%		7.36	%	11/1/2030		617,211		609,935		618,945
DexKo Global, Inc. (Dragon Merger)	Automotive	Term Loan (9/21)	Loan	1M USD SOFR+	3.75	%		0.50	%		8.18	%	10/4/2028		967,500		965,678		943,970

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

August 31, 2025

(unaudited)

Issuer Name	Industry	Asset Name	Asset Type	Reference Rate/Spread			SOFR/LIBOR Floor			Current Rate (All In)			Maturity Date	Principal/ Number of Shares		Cost		Fair Value
Diamond Sports Group, LLC	Media: Broadcasting & Subscription	1st Priority Term Loan	Loan	1M USD SOFR+	10.00	%		1.00	%		14.45	%	5/25/2026		29,734	$	29,546	$	25,869
DIRECTV FINANCING, LLC	Media: Broadcasting & Subscription	Term Loan (1/24)	Loan	3M USD SOFR+	5.25	%		0.75	%		9.82	%	8/2/2029		2,759,350		2,746,400		2,736,944
DISCOVERY PURCHASER CORPORATION	Chemicals, Plastics, & Rubber	Term Loan	Loan	3M USD SOFR+	3.75	%		0.50	%		8.08	%	10/4/2029		1,466,558		1,388,321		1,461,674
Dispatch Acquisition Holdings, LLC	Environmental Industries	Term Loan B (3/21)	Loan	3M USD SOFR+	4.25	%		0.75	%		8.70	%	3/25/2028		480,000		478,103		467,899
DOMTAR CORPORATION	Forest Products & Paper	Term Loan 9/21	Loan	1M USD SOFR+	5.50	%		0.75	%		9.93	%	11/30/2028		2,985,141		2,947,533		2,753,792
DRI HOLDING INC.	Media: Advertising, Printing & Publishing	Term Loan (12/21)	Loan	1M USD SOFR+	5.25	%		0.50	%		9.67	%	12/15/2028		3,872,425		3,782,249		3,814,338
DRW Holdings, LLC	Banking, Finance, Insurance & Real Estate	Term Loan B (06/24)	Loan	1M USD SOFR+	3.50	%		0.00	%		7.82	%	6/17/2031		6,241,950		6,219,462		6,234,148
DTZ U.S. Borrower, LLC	Construction & Building	Term Loan B1 (01/25)	Loan	1M USD SOFR+	2.75	%		0.50	%		7.07	%	1/31/2030		1,708,945		1,708,752		1,712,500
DTZ U.S. Borrower, LLC	Construction & Building	Term Loan (7/25)	Loan	1M USD SOFR+	2.75	%		0.50	%		7.07	%	1/31/2030		1,042,250		1,022,948		1,043,115
Dye & Durham Corporation	Services: Business	Term Loan B (04/24)	Loan	3M USD SOFR+	4.25	%		1.00	%		8.65	%	4/11/2031		1,424,464		1,406,381		1,425,803
EAB Global, Inc.	Services: Business	Term Loan (08/21)	Loan	1M USD SOFR+	3.00	%		0.50	%		7.32	%	8/16/2030		965,281		963,550		948,389
Echo Global Logistics, Inc.	Services: Business	Term Loan	Loan	1M USD SOFR+	3.75	%		0.50	%		8.17	%	11/23/2028		1,935,000		1,934,156		1,860,019
Edelman Financial Group Inc., The	Banking, Finance, Insurance & Real Estate	Term Loan (12/24)	Loan	1M USD SOFR+	3.00	%		0.00	%		7.32	%	4/7/2028		2,144,595		2,142,267		2,146,418
ELECTRON BIDCO INC.	Healthcare & Pharmaceuticals	Term Loan	Loan	1M USD SOFR+	2.75	%		0.50	%		7.07	%	11/1/2028		486,281		485,441		487,161
Embecta Corp	Healthcare & Pharmaceuticals	Term Loan B	Loan	1M USD SOFR+	3.00	%		0.50	%		7.32	%	3/30/2029		2,620,797		2,585,908		2,616,132
Emrld Borrower LP	Capital Equipment	Term Loan B (04/23)	Loan	3M USD SOFR+	2.25	%		0.00	%		6.45	%	5/31/2030		985,000		981,531		983,257
Endo Finance Holdings, Inc.	Healthcare & Pharmaceuticals	Term Loan B	Loan	1M USD SOFR+	4.00	%		0.50	%		8.32	%	4/23/2031		1,985,000		1,968,495		1,991,451
Endure Digital, Inc.	High Tech Industries	Term Loan B	Loan	1M USD SOFR+	3.50	%		0.75	%		7.96	%	2/10/2028		2,400,000		2,396,288		1,233,000
Entain Holdings (Gibraltar) Limited	Hotel, Gaming & Leisure	Term Loan B3 (5/24)	Loan	6M USD SOFR+	2.75	%		0.50	%		7.02	%	10/31/2029		1,468,906		1,457,844		1,467,070

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

August 31, 2025

(unaudited)

Issuer Name	Industry	Asset Name	Asset Type	Reference Rate/Spread			SOFR/LIBOR Floor			Current Rate (All In)			Maturity Date	Principal/ Number of Shares		Cost		Fair Value
EOS U.S. FINCO LLC (b) (c)	Transportation: Cargo	Term Loan	Loan	6M USD SOFR+	0.00	%		0.50	%		0.00	%	10/9/2029		962,028	$	911,597	$	238,237
Equiniti Group PLC	Services: Business	Term Loan (03/25)	Loan	6M USD SOFR+	3.75	%		0.00	%		7.92	%	12/11/2028		965,206		960,015		968,584
Evertec Group LLC	Banking, Finance, Insurance & Real Estate	Term Loan B (09/23)	Loan	1M USD SOFR+	2.25	%		0.50	%		6.61	%	10/30/2030		1,125,000		1,111,758		1,126,406
Fiesta Purchaser, Inc.	Beverage, Food & Tobacco	Second Refinancing Term Loan (8/25)	Loan	1M USD SOFR+	2.75	%		0.00	%		7.07	%	2/12/2031		495,009		491,075		494,673
Finco I LLC	Banking, Finance, Insurance & Real Estate	Term Loan B (07/25)	Loan	1M USD SOFR+	1.75	%		0.00	%		6.07	%	6/27/2029		2,781,585		2,780,209		2,774,631
First Brands Group, LLC	Automotive	1st Lien Term Loan (3/21)	Loan	3M USD SOFR+	5.00	%		1.00	%		9.57	%	3/30/2027		4,787,500		4,763,536		4,548,125
First Student Bidco Inc.	Transportation: Consumer	Term Loan (8/25)	Loan	3M USD SOFR+	2.50	%		0.00	%		6.71	%	8/15/2030		707,702		705,351		707,702
First Student Bidco Inc.	Transportation: Consumer	Term Loan C (8/25)	Loan	3M USD SOFR+	2.50	%		0.00	%		6.71	%	8/15/2030		216,966		216,269		216,899
Fitness International, LLC (LA Fitness)	Services: Consumer	Term Loan B (1/24)	Loan	1M USD SOFR+	4.50	%		1.00	%		8.82	%	2/5/2029		1,185,000		1,159,146		1,190,629
Flutter Financing B.V.	Hotel, Gaming & Leisure	Term Loan	Loan	3M USD SOFR+	1.75	%		0.50	%		6.05	%	11/29/2030		3,693,750		3,686,250		3,672,511
Franklin Square Holdings, L.P.	Banking, Finance, Insurance & Real Estate	Term Loan B (04/24)	Loan	1M USD SOFR+	2.25	%		0.00	%		6.57	%	4/25/2031		4,209,947		4,205,917		4,215,210
Froneri International (R&R Ice Cream)	Beverage, Food & Tobacco	Term Loan B4 (10/24)	Loan	6M USD SOFR+	2.00	%		0.00	%		6.20	%	9/16/2031		1,910,213		1,910,201		1,894,243
Fusion Buyer LLC	Services: Consumer	Term Loan (06/25)	Loan	3M USD SOFR+	8.00	%		0.00	%		12.40	%	6/6/2030		1,426,523		1,426,523		1,436,038
Garrett LX III S.a r.l.	Automotive	Term Loan (1/25)	Loan	3M USD SOFR+	2.00	%		0.50	%		6.31	%	1/20/2032		1,447,622		1,444,639		1,448,534
Genesee & Wyoming, Inc.	Transportation: Cargo	Term Loan B (03/24)	Loan	3M USD SOFR+	1.75	%		0.00	%		6.05	%	4/10/2031		1,488,750		1,482,575		1,481,470

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

August 31, 2025

(unaudited)

Issuer Name	Industry	Asset Name	Asset Type	Reference Rate/Spread			SOFR/LIBOR Floor			Current Rate (All In)			Maturity Date	Principal/ Number of Shares		Cost		Fair Value
GIP Pilot Acquisition Partners, L.P.	Energy: Oil & Gas	Term Loan B	Loan	3M USD SOFR+	2.00	%		0.00	%		6.29	%	10/4/2030		389,241	$	387,824	$	388,268
Global Tel*Link Corporation	Telecommunications	Term Loan (6/24)	Loan	1M USD SOFR+	7.50	%		3.00	%		11.82	%	7/31/2029		4,784,943		4,723,629		4,666,802
Go Daddy Operating Company, LLC	High Tech Industries	Term Loan B7	Loan	1M USD SOFR+	1.75	%		0.00	%		6.07	%	5/30/2031		935,507		935,507		935,507
GOLDEN WEST PACKAGING GROUP LLC (c)	Forest Products & Paper	Term Loan B1 (06/25)	Loan	1M USD SOFR+	5.25	%		0.75	%		9.72	%	6/27/2031		1,750,000		1,743,956		1,312,499
GOTO GROUP, INC.	High Tech Industries	First Lien Term Loan	Loan	3M USD SOFR+	4.75	%		0.00	%		9.22	%	4/30/2028		1,239,107		849,686		1,068,470
GOTO GROUP, INC.	High Tech Industries	Second-Out Term Loan (02/24)	Loan	3M USD SOFR+	4.75	%		0.00	%		9.22	%	4/30/2028		1,711,148		1,653,174		606,243
Graham Packaging Co Inc	Containers, Packaging & Glass	Term Loan B (07/24)	Loan	1M USD SOFR+	2.50	%		0.00	%		6.82	%	8/4/2027		817,017		815,147		817,254
Great Outdoors Group, LLC	Retail	Term Loan (1/25)	Loan	1M USD SOFR+	3.25	%		0.75	%		7.57	%	1/20/2032		955,443		953,654		957,353
Griffon Corporation	Consumer goods: Durable	Term Loan B	Loan	1M USD SOFR+	2.00	%		0.00	%		6.30	%	1/24/2029		140,938		140,828		141,407
Grosvenor Capital Management Holdings, LLLP	Banking, Finance, Insurance & Real Estate	Term Loan B (5/24)	Loan	1M USD SOFR+	2.25	%		0.00	%		6.57	%	2/25/2030		2,772,706		2,772,677		2,781,024
Groupe Solmax Inc.	Environmental Industries	Term Loan (6/21)	Loan	1M USD SOFR+	4.75	%		0.75	%		9.18	%	5/27/2028		2,399,438		2,158,754		1,839,169
GYP HOLDINGS III CORP.	Construction & Building	Term Loan (1/24)	Loan	1M USD SOFR+	2.25	%		0.00	%		6.57	%	5/12/2030		245,634		244,768		245,327
Hertz Corporation (The)	Transportation: Consumer	Term Loan B	Loan	3M USD SOFR+	3.75	%		0.00	%		8.06	%	6/30/2028		2,072,450		2,031,487		1,761,582
Hillman Group Inc. (The) (New)	Consumer goods: Durable	Term Loan B-1 (2/21)	Loan	1M USD SOFR+	2.00	%		0.50	%		6.36	%	7/14/2028		2,696,572		2,696,268		2,697,543
Hilton Domestic Operating Company Inc.	Hotel, Gaming & Leisure	Term Loan B 4	Loan	1M USD SOFR+	1.75	%		0.00	%		6.08	%	11/8/2030		1,500,000		1,497,541		1,501,815
HLF Financing SARL (Herbalife)	Consumer goods: Non-durable	Term Loan	Loan	1M USD SOFR+	6.75	%		0.50	%		11.07	%	4/12/2029		2,960,580		2,960,079		3,004,989
Holley Purchaser, Inc	Automotive	Term Loan (11/21)	Loan	1M USD SOFR+	3.75	%		0.75	%		8.18	%	11/17/2028		2,176,501		2,172,543		2,112,751
Hudson River Trading LLC	Banking, Finance, Insurance & Real Estate	Term Loan (10/24)	Loan	1M USD SOFR+	3.00	%		0.00	%		7.37	%	3/29/2030		5,746,575		5,670,420		5,757,379
Hunter Douglas Inc	Consumer goods: Durable	Term Loan B (1/25)	Loan	3M USD SOFR+	3.25	%		0.00	%		7.55	%	1/19/2032		2,221,485		2,038,893		2,220,552
Hyperion Refinance S.a.r.l.	Banking, Finance, Insurance & Real Estate	Term Loan	Loan	1M USD SOFR+	2.75	%		0.50	%		7.07	%	2/15/2031		2,962,613		2,952,482		2,963,027

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

August 31, 2025

(unaudited)

Issuer Name	Industry	Asset Name	Asset Type	Reference Rate/Spread			SOFR/LIBOR Floor			Current Rate (All In)			Maturity Date	Principal/ Number of Shares		Cost		Fair Value
Idera, Inc.	High Tech Industries	Term Loan (06/24)	Loan	3M USD SOFR+	3.50	%		0.75	%		7.80	%	3/2/2028		4,702,328	$	4,699,659	$	4,354,073
IMA Financial Group, Inc.	Banking, Finance, Insurance & Real Estate	Term Loan (10/21)	Loan	1M USD SOFR+	3.00	%		0.50	%		7.32	%	11/1/2028		2,427,946		2,422,075		2,428,456
INEOS 226 Ltd.	Chemicals, Plastics, & Rubber	Term Loan 3/23	Loan	1M USD SOFR+	3.75	%		0.00	%		8.17	%	3/13/2030		490,000		486,425		423,032
Ineos US Finance LLC	Chemicals, Plastics, & Rubber	Term Loan C	Loan	1M USD SOFR+	3.25	%		0.00	%		7.57	%	2/18/2030		985,056		978,061		902,144
INEOS US PETROCHEM LLC	Chemicals, Plastics, & Rubber	Term Loan B	Loan	1M USD SOFR+	4.25	%		0.00	%		8.67	%	4/2/2029		2,680,938		2,638,791		2,406,142
Informatica Inc.	High Tech Industries	Term Loan B (06/24)	Loan	1M USD SOFR+	2.25	%		0.00	%		6.57	%	10/27/2028		483,750		483,750		484,355
Ingram Micro Inc.	Wholesale	Term Loan B (6/25)	Loan	3M USD SOFR+	2.25	%		0.00	%		6.56	%	9/22/2031		599,923		596,753		603,301
Inmar, Inc.	Services: Business	Term Loan B (06/25)	Loan	3M USD SOFR+	4.50	%		0.50	%		8.80	%	10/30/2031		3,283,355		3,236,017		3,285,424
Innophos, Inc.	Chemicals, Plastics, & Rubber	Term Loan B	Loan	1M USD SOFR+	4.25	%		0.00	%		8.68	%	3/16/2029		473,750		471,042		472,447
Instant Brands Litigation Trust (b) (c)	Consumer goods: Durable	Instant Brands TL	Loan	3M USD SOFR+	0.00	%		0.00	%		0.00	%	2/26/2031		43,556		36,277		43,556
IRB Holding Corporation	Beverage, Food & Tobacco	Term Loan B	Loan	1M USD SOFR+	2.50	%		0.75	%		6.82	%	12/15/2027		490,025		487,430		489,544
Isagenix International, LLC (c)	Beverage, Food & Tobacco	Term Loan	Loan	3M USD SOFR+	2.50	%		0.00	%		2.50	%	4/13/2028		1,440,755		1,128,812		100,853
Isolved Inc.	Services: Business	Infinisource/iSolved 7/25 Cov-lite TL B	Loan	1M USD SOFR+	2.75	%		0.00	%		7.07	%	10/15/2030		617,215		612,288		619,338
Jane Street Group	Banking, Finance, Insurance & Real Estate	Term Loan B	Loan	3M USD SOFR+	2.00	%		0.00	%		6.20	%	12/15/2031		3,820,000		3,819,989		3,806,019
Journey Personal Care Corp.	Consumer goods: Non-durable	Term Loan B (11/24)	Loan	3M USD SOFR+	3.75	%		0.75	%		8.05	%	3/1/2028		2,880,488		2,848,746		2,788,686
JP Intermediate B, LLC (b)	Consumer goods: Non-durable	Term Loan 7/23	Loan	Prime	6.50	%		1.00	%		14.00	%	11/20/2027		3,413,673		3,405,489		102,410
Kleopatra Finco S.a r.l.	Containers, Packaging & Glass	Term Loan (1/21) (USD)	Loan	6M USD SOFR+	4.73	%		0.50	%		9.02	%	2/12/2026		-		7,181		-
Koppers Inc	Chemicals, Plastics, & Rubber	Term Loan	Loan	1M USD SOFR+	2.50	%		0.50	%		6.83	%	4/10/2030		980,143		958,693		982,898
Lakeland Tours, LLC (c)	Hotel, Gaming & Leisure	Holdco Fixed Term Loan	Loan	Fixed	0.00	%		0.00	%		8.00	%	9/27/2027		1,127,568		743,425		28,189
Latham Pool Products, Inc.	Consumer goods: Durable	Term Loan 2/22	Loan	3M USD SOFR+	4.00	%		0.50	%		8.35	%	2/23/2029		986,016		974,810		978,620

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

August 31, 2025

(unaudited)

Issuer Name	Industry	Asset Name	Asset Type	Reference Rate/Spread			SOFR/LIBOR Floor			Current Rate (All In)			Maturity Date	Principal/ Number of Shares		Cost		Fair Value
Lealand Finance Company B.V. (c)	Energy: Oil & Gas	Exit Term Loan	Loan	1M USD SOFR+	1.00	%		0.00	%		5.43	%	12/31/2027		372,321	$	372,321	$	199,192
LHS BORROWER, LLC	Construction & Building	Term Loan (02/22)	Loan	1M USD SOFR+	4.75	%		0.50	%		9.17	%	2/16/2029		2,437,363		2,142,188		2,337,431
Lifetime Brands, Inc	Consumer goods: Non-durable	Term Loan	Loan	1M USD SOFR+	5.50	%		1.00	%		9.97	%	8/26/2027		1,534,865		1,531,822		1,381,378
LOYALTY VENTURES INC. (b)	Services: Business	Loyalty Ventures Claims	Term Loan B	Prime	5.50	%		0.50	%		14.00	%	11/3/2027		2,913,525		2,906,885		233,082
LSF11 TRINITY BIDCO INC	Aerospace & Defense	Term Loan B (12/24)	Loan	1M USD SOFR+	3.00	%		0.00	%		7.32	%	6/14/2030		966,008		955,215		969,631
LSF9 Atlantis Holdings, LLC (A Wireless)	Retail	Term Loan	Loan	3M USD SOFR+	4.25	%		0.75	%		8.55	%	3/29/2029		2,605,010		2,551,268		2,609,073
MAGNITE, INC.	Services: Business	Term Loan B	Loan	1M USD SOFR+	3.00	%		0.00	%		7.32	%	2/6/2031		3,225,686		3,199,764		3,225,686
Marriott Ownership Resorts, Inc.	Hotel, Gaming & Leisure	Term Loan B (3/24)	Loan	1M USD SOFR+	2.25	%		0.00	%		6.57	%	4/1/2031		1,303,903		1,303,903		1,302,273
Max US Bidco Inc.	Beverage, Food & Tobacco	Term Loan B	Loan	1M USD SOFR+	5.00	%		0.50	%		9.32	%	10/3/2030		1,975,000		1,868,869		1,961,827
McGraw-Hill Education, Inc.	Media: Advertising, Printing & Publishing	Term Loan (1/25)	Loan	1M USD SOFR+	3.25	%		0.50	%		7.57	%	8/6/2031		791,013		786,732		793,607
Michaels Companies Inc	Retail	Term Loan B (Magic Mergeco)	Loan	3M USD SOFR+	4.25	%		0.75	%		8.81	%	4/8/2028		2,404,824		2,396,476		2,006,393
MIWD Holdco II LLC	Construction & Building	Term Loan B2 (03/24)	Loan	1M USD SOFR+	2.75	%		0.00	%		7.07	%	3/21/2031		495,000		493,007		496,935
MKS Instruments, Inc.	High Tech Industries	Term Loan B (01/25)	Loan	1M USD SOFR+	2.00	%		0.50	%		6.32	%	8/17/2029		1,168,945		1,167,734		1,168,454
Momentive Performance Materials Inc.	Chemicals, Plastics, & Rubber	Term Loan (03/23)	Loan	1M USD SOFR+	4.00	%		0.00	%		8.32	%	3/28/2028		316,397		309,002		317,584
Moneygram International, Inc.	Services: Business	Term Loan B	Loan	3M USD SOFR+	4.75	%		0.50	%		9.07	%	6/1/2030		2,948,919		2,642,745		2,617,165
MPH Acquisition Holdings LLC (Multiplan)	Services: Business	First-Out Term Loan (01/25)	Loan	3M USD SOFR+	3.75	%		0.50	%		8.06	%	12/31/2030		314,822		286,894		313,956

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

August 31, 2025

(unaudited)

Issuer Name	Industry	Asset Name	Asset Type	Reference Rate/Spread			SOFR/LIBOR Floor			Current Rate (All In)			Maturity Date	Principal/ Number of Shares		Cost		Fair Value
MPH Acquisition Holdings LLC (Multiplan)	Services: Business	Second-Out Term Loan (01/25)	Loan	3M USD SOFR+	4.60	%		0.50	%		9.17	%	12/31/2030		1,609,667	$	1,509,082	$	1,471,509
NAB Holdings, LLC (North American Bancard)	Banking, Finance, Insurance & Real Estate	Term Loan B (2/25)	Loan	3M USD SOFR+	2.50	%		0.50	%		6.80	%	11/24/2028		2,895,954		2,893,709		2,798,939
Napa Management Services Corp	Healthcare & Pharmaceuticals	Term Loan B (02/22)	Loan	1M USD SOFR+	5.25	%		0.75	%		9.67	%	2/22/2029		2,924,433		2,527,452		1,894,623
Natgasoline LLC	Chemicals, Plastics, & Rubber	Term Loan (3/25)	Loan	1M USD SOFR+	5.50	%		0.00	%		9.82	%	3/25/2030		3,249,415		3,154,627		3,271,089
National Mentor Holdings, Inc.	Healthcare & Pharmaceuticals	Term Loan 2/21	Loan	3M USD LIBOR+	3.75	%		0.75	%		8.48	%	3/2/2028		2,666,424		2,663,417		2,629,280
National Mentor Holdings, Inc.	Healthcare & Pharmaceuticals	Term Loan C 2/21	Loan	3M USD SOFR+	3.75	%		0.75	%		8.15	%	3/2/2028		87,464		87,307		86,245
Next Level Apparel, Inc.	Retail	Term Loan	Loan	3M USD SOFR+	7.50	%		1.00	%		12.89	%	8/9/2026		2,338,948		2,333,517		1,789,295
Nielsen Consumer Inc.	Services: Business	Term Loan (08/25)	Loan	1M USD SOFR+	2.50	%		0.50	%		6.82	%	10/7/2030		2,165,401		2,164,934		2,151,867
NortonLifeLock Inc.	High Tech Industries	Term Loan B (05/24)	Loan	1M USD SOFR+	1.75	%		0.50	%		6.07	%	9/12/2029		962,500		960,073		960,363
Nouryon Finance B.V.	Chemicals, Plastics, & Rubber	Term Loan B (10/24)	Loan	1M USD SOFR+	3.25	%		0.00	%		7.60	%	4/3/2028		481,483		478,655		482,085
Novae LLC	Automotive	Term Loan B	Loan	3M USD SOFR+	5.00	%		0.75	%		9.45	%	12/22/2028		1,935,000		1,927,405		1,770,525
Olaplex, Inc.	Consumer goods: Non-durable	Term Loan (2/22)	Loan	3M USD SOFR+	3.50	%		0.50	%		7.80	%	2/23/2029		1,319,846		1,283,921		1,271,447
Open Text Corporation	High Tech Industries	Term Loan B (08/23)	Loan	1M USD SOFR+	1.75	%		0.50	%		6.07	%	1/31/2030		914,383		895,013		913,468
Oxbow Carbon, LLC	Metals & Mining	Term Loan B (04/23)	Loan	1M USD SOFR+	3.50	%		0.50	%		7.82	%	5/2/2030		462,758		455,842		461,023
PACIFIC DENTAL SERVICES, LLC	Healthcare & Pharmaceuticals	Term Loan B (02//24)	Loan	1M USD SOFR+	2.75	%		0.00	%		7.09	%	3/17/2031		1,185,000		1,184,561		1,186,481
Padagis LLC	Healthcare & Pharmaceuticals	Term Loan	Loan	3M USD SOFR+	4.75	%		0.50	%		9.29	%	7/6/2028		930,329		925,810		832,645
PAR PETROLEUM LLC	Energy: Oil & Gas	Term Loan B	Loan	3M USD SOFR+	3.75	%		0.50	%		8.03	%	2/28/2030		2,446,244		2,427,781		2,440,740
PATAGONIA HOLDCO LLC	Telecommunications	Term Loan B	Loan	3M USD SOFR+	5.75	%		0.50	%		9.98	%	8/1/2029		2,932,310		2,645,937		2,332,095
Pathway Partners Vet Management Company LLC	Consumer goods: Non-durable	Term Loan Tranch A	Loan	3M USD SOFR+	5.00	%		1.00	%		9.31	%	6/30/2028		131,927		128,091		132,351
Pathway Partners Vet Management Company LLC (c)	Consumer goods: Non-durable	Term Loan B (03/25)	Loan	3M USD SOFR+	5.00	%		1.00	%		9.31	%	6/30/2028		419,907		416,689		337,127

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

August 31, 2025

(unaudited)

Issuer Name	Industry	Asset Name	Asset Type	Reference Rate/Spread			SOFR/LIBOR Floor			Current Rate (All In)			Maturity Date	Principal/ Number of Shares		Cost		Fair Value
PCI Gaming Authority	Hotel, Gaming & Leisure	Term Loan	Loan	1M USD SOFR+	2.00	%		0.00	%		6.32	%	7/18/2031		786,545	$	786,030	$	784,398
PEARLS (Netherlands) Bidco B.V.	Chemicals, Plastics, & Rubber	USD Term Loan (02/22)	Loan	3M USD SOFR+	3.25	%		0.50	%		7.56	%	2/28/2029		967,811		967,314		933,938
PEDIATRIC ASSOCIATES HOLDING COMPANY, LLC	Healthcare & Pharmaceuticals	Term Loan (12/22)	Loan	3M USD SOFR+	3.25	%		0.50	%		7.82	%	12/29/2028		1,452,125		1,449,475		1,325,979
Penn National Gaming, Inc	Hotel, Gaming & Leisure	Term Loan B	Loan	1M USD SOFR+	2.50	%		0.50	%		6.82	%	5/3/2029		970,000		967,420		970,611
Peraton Corp.	Aerospace & Defense	Term Loan B	Loan	1M USD SOFR+	3.75	%		0.75	%		8.17	%	2/1/2028		5,153,821		5,149,031		4,427,287
Phoenix Guarantor Inc.	Healthcare & Pharmaceuticals	Term Loan B (12/24)	Loan	1M USD SOFR+	2.50	%		0.00	%		6.82	%	2/21/2031		960,380		960,380		960,783
PHYSICIAN PARTNERS, LLC	Healthcare & Pharmaceuticals	Term Loan A (1/25)	Loan	3M USD SOFR+	6.00	%		0.00	%		10.30	%	12/31/2029		657,276		574,670		553,210
PHYSICIAN PARTNERS, LLC (c)	Healthcare & Pharmaceuticals	Term Loan B1 (1/25)	Loan	3M USD SOFR+	1.50	%		0.00	%		5.95	%	12/31/2029		1,841,921		893,833		865,703
Plastipak Holdings Inc.	Containers, Packaging & Glass	Term Loan B	Loan	1M USD SOFR+	2.25	%		0.50	%		6.57	%	12/1/2028		1,795,294		1,791,426		1,797,161
Playtika Holding Corp.	High Tech Industries	Term Loan B (3/21)	Loan	1M USD SOFR+	2.75	%		0.00	%		7.18	%	3/13/2028		4,308,750		4,305,427		4,242,051
PMHC II, INC.	Chemicals, Plastics, & Rubber	Term Loan (02/22)	Loan	3M USD SOFR+	4.25	%		0.50	%		8.73	%	4/21/2029		1,945,000		1,940,172		1,536,958
PointClickCare Technologies, Inc.	High Tech Industries	Term Loan (07/25)	Loan	3M USD SOFR+	2.75	%		0.00	%		7.08	%	11/3/2031		480,162		479,151		481,065
Polymer Process Holdings, Inc.	Containers, Packaging & Glass	Term Loan	Loan	1M USD SOFR+	4.75	%		0.75	%		9.18	%	2/12/2028		4,020,266		4,005,820		3,656,754
Pre-Paid Legal Services, Inc.	Services: Consumer	Term Loan (12/21)	Loan	1M USD SOFR+	3.25	%		0.50	%		7.57	%	12/15/2028		2,902,913		2,890,135		2,882,708
Prime Security Services Borrower, LLC (ADT)	Services: Consumer	Term Loan B	Loan	6M USD SOFR+	2.00	%		0.00	%		6.13	%	10/13/2030		1,980,062		1,965,031		1,977,033
Primo Brands Corporation	Beverage, Food & Tobacco	Term Loan B (01/25)	Loan	3M USD SOFR+	2.25	%		0.50	%		6.55	%	3/31/2028		1,440,268		1,437,265		1,441,463
PRIORITY HOLDINGS, LLC	Services: Consumer	Term Loan B (07/25)	Loan	1M USD SOFR+	3.75	%		0.50	%		8.07	%	7/30/2032		2,872,211		2,858,018		2,873,102
PriSo Acquisition Corporation	Construction & Building	Term Loan (01/21)	Loan	3M USD SOFR+	3.25	%		0.75	%		7.80	%	12/28/2027		478,737		477,896		476,741
Project Leopard Holdings, Inc. (NEW)	High Tech Industries	Term Loan B (06/22)	Loan	3M USD SOFR+	5.25	%		0.50	%		9.66	%	7/20/2029		975,000		930,991		874,653
Propulsion (BC) Finco	Aerospace & Defense	Term Loan (06/24)	Loan	3M USD SOFR+	2.75	%		0.50	%		7.04	%	9/14/2029		738,736		733,010		742,614
PUG LLC	Services: Consumer	Term Loan B (03/24)	Loan	1M USD SOFR+	4.75	%		0.00	%		9.07	%	3/15/2030		463,390		462,778		447,171

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

August 31, 2025

(unaudited)

Issuer Name	Industry	Asset Name	Asset Type	Reference Rate/Spread			SOFR/LIBOR Floor			Current Rate (All In)			Maturity Date	Principal/ Number of Shares		Cost		Fair Value
Quartz AcquireCo, LLC	High Tech Industries	Term Loan (2/25)	Loan	3M USD SOFR+	2.25	%		0.00	%		6.55	%	6/28/2030		1,228,741	$	1,221,427	$	1,225,153
Quikrete Holdings, Inc.	Construction & Building	Term Loan (2/25)	Loan	1M USD SOFR+	2.25	%		0.00	%		6.57	%	4/14/2031		987,538		985,765		986,925
Rackspace Technology Global, Inc.	High Tech Industries	Term Loan (3/24)	Loan	1M USD SOFR+	2.75	%		0.75	%		7.22	%	5/15/2028		2,029,524		1,230,720		1,020,851
Rackspace Technology Global, Inc.	High Tech Industries	Super-Priority Term Loan (03/24)	Loan	1M USD SOFR+	6.25	%		0.75	%		10.72	%	5/15/2028		544,154		540,248		549,400
RAND PARENT LLC	Transportation: Cargo	Term Loan B (01/25)	Loan	3M USD SOFR+	3.00	%		0.00	%		7.30	%	3/18/2030		2,444,124		2,380,786		2,432,783
RealPage, Inc.	High Tech Industries	Term Loan (04/21)	Loan	3M USD SOFR+	3.00	%		0.50	%		7.56	%	4/24/2028		962,500		962,183		960,864
Rent-A-Center, Inc.	Retail	Term Loan B (08/25)	Loan	1M USD SOFR+	2.75	%		0.50	%		7.10	%	8/13/2032		1,830,090		1,809,465		1,828,571
Research Now Group, Inc	Media: Advertising, Printing & Publishing	Term Loan (07/24)	Loan	3M USD SOFR+	5.00	%		1.00	%		9.46	%	7/15/2028		337,035		333,448		333,455
Research Now Group, Inc	Media: Advertising, Printing & Publishing	Second-Out Term Loan	Loan	3M USD SOFR+	5.50	%		1.00	%		10.09	%	10/15/2028		2,872,918		2,768,223		2,329,448
Resideo Funding Inc.	Services: Consumer	Term Loan B (12/24)	Loan	1M USD SOFR+	2.00	%		0.00	%		6.36	%	2/14/2028		674,488		674,488		674,488
Resolute Investment Managers (American Beacon), Inc. (c)	Banking, Finance, Insurance & Real Estate	Term Loan (12/23)	Loan	3M USD SOFR+	6.50	%		1.00	%		11.06	%	4/30/2027		1,958,018		1,958,018		1,768,737
Restoration Hardware, Inc.	Retail	Term Loan (9/21)	Loan	1M USD SOFR+	2.50	%		0.50	%		6.93	%	10/20/2028		3,374,781		3,372,652		3,233,985
Reynolds Consumer Products LLC	Containers, Packaging & Glass	Term Loan B (2/25)	Loan	1M USD SOFR+	1.75	%		0.00	%		6.07	%	3/4/2032		994,213		994,213		995,873
Russell Investments US Inst'l Holdco, Inc. (c)	Banking, Finance, Insurance & Real Estate	Term Loan B PIK (3/24)	Loan	3M USD SOFR+	5.00	%		1.00	%		9.31	%	5/30/2027		5,771,416		5,763,991		5,511,702
Ryan Specialty Group LLC	Banking, Finance, Insurance & Real Estate	Term Loan B (09/24)	Loan	1M USD SOFR+	2.00	%		0.00	%		6.32	%	9/15/2031		1,448,654		1,441,818		1,451,913
S&S HOLDINGS LLC	Services: Business	Term Loan	Loan	1M USD SOFR+	5.00	%		0.50	%		9.42	%	3/10/2028		2,396,156		2,369,093		2,378,688
Sally Holdings LLC	Retail	Term Loan B	Loan	1M USD SOFR+	1.75	%		0.00	%		6.07	%	2/28/2030		370,000		368,052		370,000
Schweitzer-Mauduit International, Inc.	High Tech Industries	Term Loan B	Loan	1M USD SOFR+	3.75	%		0.75	%		8.18	%	4/20/2028		939,236		937,609		929,843
Scientific Games Holdings LP	Hotel, Gaming & Leisure	Term Loan B	Loan	3M USD SOFR+	3.00	%		0.50	%		7.29	%	4/4/2029		488,806		488,328		483,205

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

August 31, 2025

(unaudited)

Issuer Name	Industry	Asset Name	Asset Type	Reference Rate/Spread			SOFR/LIBOR Floor			Current Rate (All In)			Maturity Date	Principal/ Number of Shares		Cost		Fair Value
Sedgwick Claims Management Services, Inc.	Services: Business	Term Loan B 2/23	Loan	1M USD SOFR+	2.50	%		0.00	%		6.82	%	7/31/2031		980,094	$	974,535	$	982,544
SETANTA AIRCRAFT LEASING DAC	Aerospace & Defense	Term Loan B (05/24)	Loan	3M USD SOFR+	1.75	%		0.00	%		6.05	%	11/5/2028		350,000		349,650		351,624
Sitel Worldwide Corporation	Services: Business	USD Term Loan (7/21)	Loan	1M USD SOFR+	3.75	%		0.50	%		8.18	%	8/28/2028		1,925,000		1,921,437		796,873
SiteOne Landscape Supply, LLC	Services: Business	Term Loan B (06/24)	Loan	1M USD SOFR+	1.75	%		0.50	%		6.11	%	3/23/2030		1,251,405		1,247,528		1,251,931
Smyrna Ready Mix Concrete, LLC	Construction & Building	Term Loan B	Loan	1M USD SOFR+	3.00	%		0.00	%		7.32	%	4/2/2029		507,803		505,546		509,072
Sparta U.S. HoldCo LLC	Chemicals, Plastics, & Rubber	Term Loan	Loan	1M USD SOFR+	3.00	%		0.00	%		7.35	%	8/2/2030		1,930,000		1,926,312		1,894,411
Specialty Pharma III Inc.	Services: Business	Term Loan	Loan	1M USD SOFR+	4.50	%		0.75	%		8.92	%	3/31/2028		1,925,089		1,917,423		1,901,025
Spin Holdco, Inc.	Services: Consumer	Term Loan 3/21	Loan	3M USD SOFR+	4.00	%		0.75	%		8.56	%	3/4/2028		-		10,646		-
SRAM, LLC	Consumer goods: Durable	Term Loan (02/25)	Loan	1M USD SOFR+	2.00	%		0.00	%		6.32	%	2/23/2032		2,257,745		2,256,812		2,243,635
STANDARD INDUSTRIES INC.	Construction & Building	Term Loan B	Loan	1M USD SOFR+	1.75	%		0.50	%		6.09	%	9/22/2028		205,250		204,488		205,599
Staples, Inc.	Wholesale	Term Loan B	Loan	3M USD SOFR+	5.75	%		0.50	%		10.05	%	9/4/2029		4,242,126		4,194,242		3,881,545
Star Parent, Inc.	Services: Business	Term Loan B (09/23)	Loan	3M USD SOFR+	4.00	%		0.00	%		8.30	%	9/27/2030		1,234,375		1,219,989		1,226,660
Storable, Inc	High Tech Industries	Term Loan B (3/25)	Loan	1M USD SOFR+	3.25	%		0.00	%		7.57	%	4/16/2031		483,788		483,650		485,239
Superannuation & Investments US LLC	Banking, Finance, Insurance & Real Estate	Term Loan	Loan	1M USD SOFR+	3.00	%		0.50	%		7.32	%	12/1/2028		965,000		960,238		966,004
SupplyOne, Inc	Wholesale	Term Loan B (03/24)	Loan	1M USD SOFR+	3.50	%		0.00	%		7.82	%	3/27/2031		493,763		489,561		497,056
Sweetwater Borrower, LLC	Retail	Term Loan (8/21)	Loan	1M USD SOFR+	4.25	%		0.75	%		8.68	%	8/2/2028		2,032,304		1,980,419		2,029,764
Syncsort Incorporated	High Tech Industries	Term Loan B (10/21)	Loan	3M USD SOFR+	4.00	%		0.75	%		8.57	%	4/24/2028		2,407,456		2,407,189		2,238,934
Ta TT Buyer LLC	Media: Broadcasting & Subscription	Term Loan B (6/24)	Loan	3M USD SOFR+	4.75	%		0.50	%		9.05	%	4/2/2029		975,107		969,125		960,071
Tenable Holdings, Inc.	Services: Business	Term Loan B (6/21)	Loan	1M USD SOFR+	2.75	%		0.50	%		7.18	%	7/7/2028		965,000		964,430		965,608

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

August 31, 2025

(unaudited)

Issuer Name	Industry	Asset Name	Asset Type	Reference Rate/Spread			SOFR/LIBOR Floor			Current Rate (All In)			Maturity Date	Principal/ Number of Shares		Cost		Fair Value
Thor Industries, Inc.	Automotive	Term Loan B (06/24)	Loan	1M USD SOFR+	2.25	%		0.00	%		6.57	%	11/15/2030		112,970	$	112,117	$	112,970
Torrid LLC	Wholesale	Term Loan 5/21	Loan	1M USD SOFR+	5.50	%		0.75	%		9.93	%	6/14/2028		3,014,990		2,750,703		2,607,966
TORY BURCH LLC	Retail	Term Loan	Loan	1M USD SOFR+	3.25	%		0.50	%		7.68	%	4/17/2028		2,272,574		2,182,462		2,251,077
Tosca Services, LLC (c)	Containers, Packaging & Glass	Term Loan A (08/24)	Loan	1M USD SOFR+	5.50	%		1.50	%		9.82	%	11/30/2028		80,509		79,712		81,717
Trans Union LLC	Banking, Finance, Insurance & Real Estate	Term Loan B9 (11/24)	Loan	1M USD SOFR+	1.75	%		0.00	%		6.07	%	6/24/2031		602,957		602,525		602,203
Tronox Finance LLC	Chemicals, Plastics, & Rubber	Term Loan (09/24)	Loan	3M USD SOFR+	2.25	%		0.00	%		6.55	%	4/4/2029		1,990,013		1,976,606		1,808,623
Tronox Finance LLC	Chemicals, Plastics, & Rubber	Term Loan B (09/24)	Loan	1M USD SOFR+	2.50	%		0.00	%		6.82	%	9/30/2031		345,188		345,009		302,748
TruGreen Limited Partnership	Services: Consumer	Term Loan	Loan	1M USD SOFR+	4.00	%		0.75	%		8.42	%	11/2/2027		930,151		927,908		903,995
Ultra Clean Holdings, Inc.	High Tech Industries	Term Loan B (09/24)	Loan	1M USD SOFR+	3.25	%		0.00	%		7.57	%	2/25/2028		1,218,236		1,216,241		1,223,572
Univision Communications Inc.	Media: Broadcasting & Subscription	Term Loan B (05/24)	Loan	1M USD SOFR+	3.50	%		0.50	%		7.93	%	1/31/2029		2,391,444		2,390,777		2,383,480
Univision Communications Inc.	Media: Broadcasting & Subscription	Term Loan B (6/22)	Loan	3M USD SOFR+	4.25	%		0.50	%		8.55	%	6/25/2029		242,500		237,948		242,258
Vaco Holdings, LLC	Services: Business	Term Loan (01/22)	Loan	3M USD SOFR+	5.00	%		0.75	%		9.45	%	1/19/2029		2,283,064		2,241,056		1,981,517
Vericast Corp. (c)	Media: Advertising, Printing & Publishing	Extended Term Loan (07/24)	Loan	3M USD SOFR+	7.75	%		1.00	%		12.05	%	6/16/2026		1,278,457		1,278,350		1,252,888
Verifone Systems, Inc. (c)	Banking, Finance, Insurance & Real Estate	Term Loan (03/25)	Loan	3M USD SOFR+	5.50	%		0.00	%		10.07	%	8/21/2028		1,194,763		1,194,349		1,135,025
Vertex Aerospace Services Corp	Aerospace & Defense	Term Loan (10/21)	Loan	1M USD SOFR+	2.25	%		0.75	%		6.57	%	12/6/2030		967,861		966,091		969,680
Vertiv Group Corporation	Capital Equipment	Term Loan	Loan	1M USD SOFR+	1.75	%		0.00	%		6.10	%	8/12/2032		1,911,157		1,911,157		1,909,838
Viasat Inc	Telecommunications	Term Loan (2/22)	Loan	1M USD SOFR+	4.50	%		0.50	%		8.93	%	3/5/2029		2,922,192		2,879,276		2,899,867
Virtus Investment Partners, Inc.	Banking, Finance, Insurance & Real Estate	Term Loan B (9/21)	Loan	1M USD SOFR+	2.25	%		0.00	%		6.68	%	9/28/2028		2,560,227		2,556,968		2,561,303
Vistra Operations Company LLC	Energy: Electricity	2018 Incremental Term Loan	Loan	1M USD SOFR+	1.75	%		0.00	%		6.07	%	12/20/2030		1,861,052		1,859,511		1,862,856
VM Consolidated, Inc.	Construction & Building	Term Loan B	Loan	1M USD SOFR+	2.25	%		0.00	%		6.57	%	3/24/2028		1,806,019		1,805,809		1,808,277

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

August 31, 2025

(unaudited)

Issuer Name	Industry	Asset Name	Asset Type	Reference Rate/Spread			SOFR/LIBOR Floor			Current Rate (All In)			Maturity Date	Principal/ Number of Shares		Cost		Fair Value
Warner Music Group Corp. (WMG Acquisition Corp.)	Hotel, Gaming & Leisure	Term Loan J	Loan	3M USD SOFR+	1.75	%		0.00	%		5.95	%	1/24/2031		1,250,000	$	1,250,000	$	1,250,788
Watlow Electric Manufacturing Company	High Tech Industries	Term Loan B (03/21)	Loan	3M USD SOFR+	3.00	%		0.50	%		7.31	%	3/2/2028		2,646,585		2,641,551		2,645,209
WeddingWire, Inc.	Services: Consumer	Term Loan B (12/24)	Loan	1M USD SOFR+	3.75	%		0.00	%		8.07	%	1/31/2028		4,748,992		4,748,931		4,747,995
WEX Inc.	Services: Business	Term Loan B (11/24)	Loan	1M USD SOFR+	1.75	%		0.00	%		6.07	%	3/31/2028		2,881,141		2,877,931		2,876,127
Windsor Holdings III, LLC	Chemicals, Plastics, & Rubber	Term Loan B (02/25)	Loan	1M USD SOFR+	2.75	%		0.00	%		7.07	%	8/1/2030		492,537		492,537		492,744
Wyndham Hotels & Resorts, Inc.	Hotel, Gaming & Leisure	Term Loan (05/24)	Loan	1M USD SOFR+	1.75	%		0.00	%		6.07	%	5/24/2030		982,575		979,174		985,385
Xperi Corporation	High Tech Industries	Term Loan (1/25)	Loan	1M USD SOFR+	2.50	%		0.00	%		6.82	%	6/8/2028		1,593,091		1,592,494		1,601,056
Zayo Group, LLC	Telecommunications	Term Loan 4/22	Loan	1M USD SOFR+	4.18	%		0.50	%		8.49	%	3/9/2027		967,500		958,358		946,670
ZEBRA BUYER (Allspring) LLC	Banking, Finance, Insurance & Real Estate	Term Loan B (12/24)	Loan	3M USD SOFR+	3.00	%		0.50	%		7.31	%	11/1/2030		1,847,630		1,841,451		1,853,414
Zekelman Industries, Inc.	Metals & Mining	Term Loan B (03/24)	Loan	1M USD SOFR+	2.25	%		0.00	%		6.57	%	1/24/2031		1,435,853		1,435,079		1,435,839
Zest Acquisition Corp.	Healthcare & Pharmaceuticals	Term Loan (1/23)	Loan	3M USD SOFR+	5.25	%		0.00	%		9.56	%	2/8/2028		1,950,000		1,896,959		1,935,375
Zodiac Pool Solutions	Consumer goods: Durable	Term Loan (1/22)	Loan	1M USD SOFR+	1.93	%		0.50	%		6.34	%	1/29/2029		482,500		482,125		481,897
TOTAL INVESTMENTS																$	455,885,826	$	429,491,741

	Number of Shares		Cost		Fair Value
Cash and cash equivalents
U.S. Bank Money Market (a)		17,490,859	$	17,490,859	$	17,490,859
Total cash and cash equivalents		17,490,859	$	17,490,859	$	17,490,859

(a)

Included within cash and cash equivalents in Saratoga CLO's Statements of Assets and Liabilities as of August 31, 2025.

(b)

As of August 31, 2025, the investment was in default and on non-accrual status.

(c)

Investments include Payment-in-Kind Interest.

(d)

All or a portion of this investment has an unfunded commitment as of August 31, 2025.

SOFR - Secured Overnight Financing Rate

1M SOFR - The 1-month SOFR rate as of August 31, 2025 was 4.32%.

3M SOFR - The 3-month SOFR rate as of August 31, 2025 was 4.32%.

6M SOFR - The 6-month SOFR rate as of August 31, 2025 was 4.26%.

Prime - The Prime Rate as of August 31, 2025 was 7.50%.

See accompanying notes to financial statements.

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 28, 2025

Issuer Name	Industry	Asset Name	Asset Type	Reference Rate/Spread			SOFR/LIBOR Floor			Current Rate (All In)			Maturity Date	Principal/ Number of Shares		Cost		Fair Value
ALTISOURCE PORTFOLIO SOL	Banking, Finance, Insurance & Real Estate	Common Stock	Equity												296,227	$	216,246	$	204,397
Altisource Portfolio Solutions - CS Warrant	Banking, Finance, Insurance & Real Estate	Warrants	Equity												7,917		3,736		2,895
Altisource Portfolio Solutions - NS Warrant	Banking, Finance, Insurance & Real Estate	Warrants	Equity												7,917		3,129		2,883
Endo Finance Holdings, Inc.	Healthcare & Pharmaceuticals	Common Stock	Equity												24,148		670,107		682,181
Envision Parent Inc	Healthcare & Pharmaceuticals	Common Stock	Equity												4,410		175,000		50,715
Envision Parent Inc	Healthcare & Pharmaceuticals	Warrants	Equity												92,837		-		4,642
Instant Brands Litigation Trust	Consumer goods: Durable	Equity Interests	Equity												51,095		35,250		151,056
Isagenix International, LLC	Beverage, Food & Tobacco	Common Stock	Equity												86,398		-		-
Resolute Investment Managers (American Beacon), Inc.	Banking, Finance, Insurance & Real Estate	Common Stock	Equity												24,320		1,034,581		231,040
URS TOPCO, LLC	Transportation: Cargo	Common Stock	Equity												25,330		440,405		354,620
Wellpath Holdings LLC	Healthcare & Pharmaceuticals	Common Stock	Equity												41,758		-		-
1011778 B.C Unltd Liability Co	Beverage, Food & Tobacco	Term Loan B6	Loan	1M USD SOFR+	1.75	%		0.00	%		6.07	%	9/20/2030	$	1,436,662		1,419,292		1,429,076
19TH HOLDINGS GOLF, LLC	Consumer goods: Durable	Term Loan	Loan	1M USD SOFR+	3.25	%		0.50	%		7.66	%	2/7/2029		2,448,533		2,374,623		2,398,044
888 Acquisitions Limited	Hotel, Gaming & Leisure	Term Loan B	Loan	6M USD SOFR+	5.25	%		0.00	%		9.50	%	7/8/2028		3,036,695		2,797,339		2,936,484
Adtalem Global Education Inc.	Services: Business	Term Loan B (08/24)	Loan	1M USD SOFR+	2.75	%		0.75	%		7.07	%	8/12/2028		352,462		350,628		352,902

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 28, 2025

Issuer Name	Industry	Asset Name	Asset Type	Reference Rate/Spread			SOFR/LIBOR Floor			Current Rate (All In)			Maturity Date	Principal/ Number of Shares		Cost		Fair Value
Aegis Sciences Corporation	Healthcare & Pharmaceuticals	Term Loan	Loan	3M USD SOFR+	5.50	%		1.00	%		10.28	%	5/9/2025		2,267,140		2,265,721		1,271,865
Agiliti Health Inc.	Healthcare & Pharmaceuticals	Term Loan B (03/23)	Loan	6M USD SOFR+	3.00	%		0.00	%		7.26	%	5/1/2030		2,154,146		2,140,760		2,093,119
AHEAD DB Holdings, LLC	Services: Business	Term Loan B3 (07/24)	Loan	1M USD SOFR+	3.00	%		0.75	%		7.30	%	2/1/2031		2,895,655		2,838,488		2,902,228
Air Canada	Transportation: Consumer	Term Loan B (03/24)	Loan	3M USD SOFR+	2.00	%		0.00	%		6.34	%	3/21/2031		992,500		990,413		995,607
AIT Worldwide Logistics Holdings, Inc.	Transportation: Cargo	Term Loan B (01/25)	Loan	3M USD SOFR+	4.00	%		0.75	%		8.30	%	4/8/2030		2,455,696		2,341,381		2,458,250
AlixPartners, LLP	Banking, Finance, Insurance & Real Estate	Term Loan B (01/21)	Loan	1M USD SOFR+	2.50	%		0.50	%		6.94	%	2/4/2028		240,624		240,582		241,166
Allen Media, LLC	Media: Diversified & Production	Term Loan (7/21)	Loan	3M USD SOFR+	5.50	%		0.00	%		9.98	%	2/10/2027		4,303,877		4,290,645		2,571,566
Alliant Holdings Intermediate, LLC	Banking, Finance, Insurance & Real Estate	Term Loan B6 (09/24)	Loan	1M USD SOFR+	2.75	%		0.00	%		7.07	%	9/19/2031		797,021		797,021		795,579
Allied Universal Holdco LLC	Services: Business	Term Loan 4/21	Loan	1M USD SOFR+	3.75	%		0.50	%		8.17	%	5/12/2028		1,935,000		1,930,761		1,936,529
Alterra Mountain Company (Intrawest Resort Holdings)	Hotel, Gaming & Leisure	First Lien Term Loan	Loan	1M USD SOFR+	3.00	%		0.00	%		7.32	%	5/31/2030		249,375		249,375		249,532
Altisource Solutions S.a r.l.	Banking, Finance, Insurance & Real Estate	Term Loan B	Loan	3M USD SOFR+	6.50	%		3.50	%		10.92	%	2/20/2029		500,000		487,543		500,000
Altisource Solutions S.a r.l.	Banking, Finance, Insurance & Real Estate	Term Loan B (02/25)	Loan	3M USD SOFR+	6.50	%		3.50	%		10.92	%	4/30/2030		545,284		545,284		539,831
Altium Packaging LLC	Containers, Packaging & Glass	Term Loan B	Loan	1M USD SOFR+	2.50	%		0.00	%		6.82	%	6/11/2031		482,575		481,544		477,547
American Axle & Manufacturing Inc.	Automotive	Term Loan (12/22)	Loan	1M USD SOFR+	3.00	%		0.50	%		7.32	%	12/13/2029		480,000		469,318		478,200
American Greetings Corporation	Media: Advertising, Printing & Publishing	Term Loan B (04/24)	Loan	1M USD SOFR+	5.75	%		0.00	%		10.07	%	10/30/2029		2,926,807		2,925,603		2,945,099

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 28, 2025

Issuer Name	Industry	Asset Name	Asset Type	Reference Rate/Spread			SOFR/LIBOR Floor			Current Rate (All In)			Maturity Date	Principal/ Number of Shares		Cost		Fair Value
American Trailer World Corp	Automotive	Term Loan	Loan	1M USD SOFR+	3.75	%		0.75	%		8.17	%	3/3/2028		1,357,439		1,356,879		1,140,588
Anastasia Parent LLC	Consumer goods: Non-durable	Term Loan	Loan	3M USD SOFR+	3.75	%		0.00	%		8.34	%	8/11/2025		937,500		937,084		765,084
Anchor Packaging, LLC	Containers, Packaging & Glass	Term Loan (12/24)	Loan	1M USD SOFR+	3.25	%		0.00	%		7.57	%	7/18/2029		1,944,396		1,928,125		1,945,408
AP Core Holdings II LLC	High Tech Industries	Term Loan B1	Loan	1M USD SOFR+	5.50	%		0.75	%		9.94	%	9/1/2027		1,674,963		1,662,638		1,576,559
AP Core Holdings II LLC	High Tech Industries	Term Loan B2	Loan	1M USD SOFR+	5.50	%		0.75	%		9.94	%	9/1/2027		500,000		496,326		467,625
APEX GROUP TREASURY LLC	Banking, Finance, Insurance & Real Estate	Term Loan (2/25)	Loan	3M USD SOFR+	4.00	%		0.00	%		8.29	%	7/27/2028		490,038		468,587		491,875
Apollo Commercial Real Estate Finance, Inc.	Banking, Finance, Insurance & Real Estate	Term Loan B	Loan	1M USD SOFR+	2.75	%		0.00	%		7.19	%	5/15/2026		2,878,173		2,868,237		2,874,575
Apollo Commercial Real Estate Finance, Inc.	Banking, Finance, Insurance & Real Estate	Term Loan B1 (2/21)	Loan	1M USD SOFR+	3.50	%		0.50	%		7.94	%	3/6/2028		962,500		957,781		957,688
Aramark Services, Inc.	Services: Consumer	Term Loan B7 (03/24)	Loan	1M USD SOFR+	2.00	%		0.00	%		6.32	%	4/6/2028		1,753,715		1,750,058		1,758,538
Aramark Services, Inc.	Services: Consumer	Term Loan B8 (03/24)	Loan	1M USD SOFR+	2.00	%		0.00	%		6.32	%	6/22/2030		2,331,250		2,305,337		2,337,078
ARC FALCON I INC.	Chemicals, Plastics, & Rubber	Term Loan	Loan	1M USD SOFR+	3.50	%		0.50	%		7.92	%	9/23/2028		971,274		969,846		971,711
ARCIS GOLF LLC	Services: Consumer	Term Loan B (01/25)	Loan	1M USD SOFR+	2.75	%		0.50	%		7.07	%	11/24/2028		493,000		489,289		494,543
Aretec Group, Inc.	Banking, Finance, Insurance & Real Estate	Term Loan B (12/24)	Loan	1M USD SOFR+	3.50	%		0.00	%		7.82	%	8/9/2030		2,622,898		2,610,006		2,616,891
Ascensus Group Holdings, Inc	Banking, Finance, Insurance & Real Estate	Term Loan	Loan	1M USD SOFR+	3.00	%		0.00	%		7.32	%	8/2/2028		494,767		491,912		493,035
Aspire Bakeries Holdings, LLC	Beverage, Food & Tobacco	Term loan	Loan	1M USD SOFR+	4.25	%		0.00	%		8.57	%	12/23/2030		893,250		885,649		895,483

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 28, 2025

Issuer Name	Industry	Asset Name	Asset Type	Reference Rate/Spread			SOFR/LIBOR Floor			Current Rate (All In)			Maturity Date	Principal/ Number of Shares		Cost		Fair Value
Assuredpartners Inc.	Banking, Finance, Insurance & Real Estate	Term Loan B5 (02/24)	Loan	1M USD SOFR+	3.50	%		0.50	%		7.82	%	2/14/2031		1,290,250		1,289,103		1,290,082
Asurion, LLC	Banking, Finance, Insurance & Real Estate	Term Loan B10	Loan	1M USD SOFR+	4.00	%		0.00	%		8.42	%	8/19/2028		1,955,000		1,890,928		1,949,780
Asurion, LLC	Banking, Finance, Insurance & Real Estate	Term Loan B12	Loan	1M USD SOFR+	4.25	%		0.00	%		8.56	%	9/19/2030		2,912,179		2,908,959		2,898,521
ATHENAHEALTH GROUP INC.	Healthcare & Pharmaceuticals	Term Loan B (2/22)	Loan	1M USD SOFR+	3.00	%		0.50	%		7.32	%	2/15/2029		1,303,799		1,300,749		1,300,070
Avolon TLB Borrower 1 (US) LLC	Capital Equipment	Term Loan B6	Loan	1M USD SOFR+	1.75	%		0.00	%		6.07	%	6/22/2030		1,472,622		1,429,929		1,472,136
Axalta Coating Systems US Holdings	Chemicals, Plastics, & Rubber	Term Loan B (11/24)	Loan	3M USD SOFR+	1.75	%		0.50	%		6.08	%	12/20/2029		851,048		844,987		852,546
AZURITY PHARMACEUTICALS, INC.	Healthcare & Pharmaceuticals	Term Loan B	Loan	1M USD SOFR+	6.62	%		0.75	%		11.05	%	9/20/2027		425,000		418,550		422,344
B&G Foods, Inc.	Beverage, Food & Tobacco	Term Loan B	Loan	1M USD SOFR+	3.50	%		0.00	%		7.82	%	10/10/2029		532,287		530,730		528,849
Baldwin Insurance Group Holdings, LLC	Banking, Finance, Insurance & Real Estate	Term Loan B-1 (12/24)	Loan	1M USD SOFR+	3.00	%		0.00	%		7.31	%	5/27/2031		1,640,279		1,630,478		1,642,329
Belfor Holdings Inc.	Services: Consumer	Term Loan 4/23	Loan	1M USD SOFR+	3.00	%		0.50	%		7.32	%	11/1/2030		1,490,834		1,478,738		1,498,288
Bengal Debt Merger Sub LLC	Beverage, Food & Tobacco	Term Loan	Loan	3M USD SOFR+	3.00	%		0.50	%		7.43	%	1/24/2029		1,950,000		1,949,473		1,175,753
Blackstone Mortgage Trust, Inc.	Banking, Finance, Insurance & Real Estate	Term Loan B	Loan	1M USD SOFR+	2.25	%		0.00	%		6.69	%	4/23/2026		342,601		341,898		341,317
Bombardier Recreational Products, Inc.	Consumer goods: Durable	Term Loan	Loan	1M USD SOFR+	2.75	%		0.00	%		7.07	%	1/22/2031		1,425,751		1,422,525		1,423,712
Bombardier Recreational Products, Inc.	Consumer goods: Durable	Term Loan B3	Loan	1M USD SOFR+	2.75	%		0.50	%		7.06	%	12/13/2029		488,806		479,686		488,669
Boost Newco Borrower, LLC (Worldpay)	Banking, Finance, Insurance & Real Estate	Term Loan B (01/25)	Loan	3M USD SOFR+	2.00	%		0.00	%		6.29	%	1/31/2031		498,750		496,603		498,127

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 28, 2025

Issuer Name	Industry	Asset Name	Asset Type	Reference Rate/Spread			SOFR/LIBOR Floor			Current Rate (All In)			Maturity Date	Principal/ Number of Shares		Cost		Fair Value
Boxer Parent Company, Inc.	High Tech Industries	Term Loan	Loan	3M USD SOFR+	3.00	%		0.00	%		7.29	%	7/30/2031		1,007,194		1,003,006		1,004,766
BroadStreet Partners, Inc.	Banking, Finance, Insurance & Real Estate	Term Loan B-4	Loan	1M USD SOFR+	3.00	%		0.00	%		7.31	%	6/16/2031		2,896,329		2,894,596		2,894,794
Brookfield WEC Holdings Inc.	Energy: Electricity	Term Loan B	Loan	1M USD SOFR+	2.25	%		0.00	%		6.56	%	1/27/2031		1,440,450		1,440,450		1,437,396
BROWN GROUP HOLDING, LLC	Aerospace & Defense	Term Loan B-2	Loan	3M USD SOFR+	2.50	%		0.00	%		6.81	%	7/1/2031		491,284		481,764		490,464
Buckeye Partners, L.P.	Utilities: Oil & Gas	Term Loan B (01/25)	Loan	1M USD SOFR+	1.75	%		0.00	%		6.07	%	11/22/2030		663,337		661,343		663,430
Buckeye Partners, L.P.	Utilities: Oil & Gas	Term Loan B5 (09/24)	Loan	1M USD SOFR+	1.75	%		0.00	%		6.07	%	11/2/2026		483,028		482,076		482,897
BW Gas & Convenience Holdings LLC	Beverage, Food & Tobacco	Term Loan B	Loan	1M USD SOFR+	3.50	%		0.50	%		7.94	%	3/31/2028		2,412,500		2,400,434		2,418,531
Callaway Golf Company	Retail	Term Loan B	Loan	1M USD SOFR+	3.00	%		0.00	%		7.32	%	3/16/2030		471,250		467,499		465,458
Calpine Corporation	Utilities: Electric	Term Loan B10 (01/24)	Loan	1M USD SOFR+	1.75	%		0.00	%		6.07	%	1/31/2031		1,990,000		1,981,632		1,987,513
Camping World, Inc.	Retail	Term Loan B (5/21)	Loan	1M USD SOFR+	2.50	%		0.75	%		6.94	%	6/5/2028		2,436,709		2,289,886		2,386,586
CAPSTONE BORROWER INC	Services: Business	Term Loan B (05/24)	Loan	3M USD SOFR+	3.25	%		0.00	%		7.58	%	6/17/2030		872,669		862,196		874,851
CareerBuilder, LLC	Services: Business	Term Loan B3	Loan	1M USD SOFR+	2.50	%		0.00	%		6.94	%	7/31/2026		4,089,659		4,079,749		204,483
Castle US Holding Corporation	Media: Advertising, Printing & Publishing	Term Loan B (USD)	Loan	3M USD SOFR+	3.75	%		0.00	%		8.32	%	1/27/2027		1,929,894		1,925,694		1,192,520
CBL & Associates Limited Partnership	Retail	Term Loan 11/21	Loan	1M USD SOFR+	2.75	%		1.00	%		7.17	%	11/1/2025		2,085,112		1,976,819		1,978,250
CCC Intelligent Solutions Inc.	Services: Business	Term Loan (01/25)	Loan	1M USD SOFR+	2.00	%		0.50	%		6.32	%	9/16/2028		242,500		242,288		241,894

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 28, 2025

Issuer Name	Industry	Asset Name	Asset Type	Reference Rate/Spread			SOFR/LIBOR Floor			Current Rate (All In)			Maturity Date	Principal/ Number of Shares		Cost		Fair Value
CCI Buyer, Inc	Telecommunications	Term Loan	Loan	3M USD SOFR+	4.00	%		0.75	%		8.33	%	12/17/2027		240,625		239,544		241,426
CCRR Parent, Inc.	Healthcare & Pharmaceuticals	Term Loan	Loan	3M USD SOFR+	4.25	%		0.50	%		8.66	%	3/6/2028		980,000		948,779		395,263
CCRR Parent, Inc.	Healthcare & Pharmaceuticals	Term Loan B	Loan	3M USD SOFR+	4.25	%		0.75	%		8.82	%	3/6/2028		962,500		960,608		399,438
CCS-CMGC Holdings, Inc.	Healthcare & Pharmaceuticals	Term Loan	Loan	3M USD SOFR+	5.50	%		0.00	%		10.28	%	9/25/2025		1,140,869		1,139,841		386,047
CDK GLOBAL, INC.	High Tech Industries	Term Loan B (05/24)	Loan	3M USD SOFR+	3.25	%		0.00	%		7.58	%	7/6/2029		990,019		968,890		903,640
CENTURI GROUP, INC.	Construction & Building	Term Loan B	Loan	1M USD SOFR+	2.50	%		0.50	%		6.94	%	8/28/2028		616,921		613,611		617,470
Charlotte Buyer, Inc.	Services: Business	Term Loan B (01/25)	Loan	1M USD SOFR+	4.25	%		0.50	%		8.57	%	2/11/2028		1,473,806		1,410,924		1,469,886
Chemours Company, (The)	Chemicals, Plastics, & Rubber	Term Loan B3 (08/23)	Loan	1M USD SOFR+	3.00	%		0.50	%		7.32	%	8/18/2028		2,369,720		2,339,142		2,358,866
Churchill Downs Incorporated	Hotel, Gaming & Leisure	Term Loan B1 (3/21)	Loan	1M USD SOFR+	1.75	%		0.00	%		6.07	%	3/17/2028		481,250		480,828		480,047
CIMPRESS PUBLIC LIMITED COMPANY	Media: Advertising, Printing & Publishing	Term Loan B	Loan	1M USD SOFR+	2.50	%		0.50	%		6.82	%	5/17/2028		1,940,187		1,883,647		1,930,486
CITADEL SECURITIES LP	Banking, Finance, Insurance & Real Estate	Term Loan (10/24)	Loan	3M USD SOFR+	2.00	%		0.00	%		6.33	%	10/31/2031		4,826,890		4,826,890		4,832,344
Citco Funding LLC	Banking, Finance, Insurance & Real Estate	Term Loan B (06/24)	Loan	6M USD SOFR+	2.75	%		0.50	%		7.31	%	4/27/2028		987,538		984,246		994,529
Clarios Global LP	Automotive	Term Loan B (07/24)	Loan	1M USD SOFR+	2.50	%		0.00	%		6.82	%	5/6/2030		1,197,000		1,192,661		1,191,015
Claros Mortgage Trust, Inc	Banking, Finance, Insurance & Real Estate	Term Loan B-1 (11/21)	Loan	1M USD SOFR+	4.50	%		0.50	%		8.92	%	8/10/2026		3,368,637		3,360,331		3,099,146
CLYDESDALE ACQUISITION HOLDINGS, INC.	Containers, Packaging & Glass	Term Loan B	Loan	1M USD SOFR+	3.18	%		0.50	%		7.50	%	4/13/2029		1,220,000		1,199,733		1,219,244

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 28, 2025

Issuer Name	Industry	Asset Name	Asset Type	Reference Rate/Spread			SOFR/LIBOR Floor			Current Rate (All In)			Maturity Date	Principal/ Number of Shares		Cost		Fair Value
Columbus McKinnon Corporation	Capital Equipment	Term Loan (03/24)	Loan	3M USD SOFR+	2.50	%		0.50	%		6.83	%	5/14/2028		361,967		361,543		361,062
Connect Finco SARL	Telecommunications	Term Loan B (03/24)	Loan	1M USD SOFR+	4.50	%		0.50	%		8.82	%	9/27/2029		2,865,844		2,801,249		2,491,679
Consolidated Communications, Inc.	Telecommunications	Term Loan B	Loan	1M USD SOFR+	3.50	%		0.75	%		7.94	%	10/2/2027		2,714,005		2,592,779		2,700,788
Corelogic, Inc.	Services: Business	Term Loan (4/21)	Loan	1M USD SOFR+	3.50	%		0.50	%		7.94	%	6/2/2028		2,418,750		2,413,203		2,406,656
Cortes NP Acquisition Corp (Vertiv)	Capital Equipment	Term Loan B (12/24)	Loan	1M USD SOFR+	1.75	%		0.00	%		6.06	%	3/2/2027		1,920,785		1,920,785		1,918,921
Creative Artists Agency, LLC	Media: Diversified & Production	Term Loan B (09/24)	Loan	1M USD SOFR+	2.75	%		0.00	%		7.07	%	10/1/2031		1,576,094		1,568,099		1,576,536
CROCS INC	Consumer goods: Durable	Term Loan B (01/24)	Loan	3M USD SOFR+	2.25	%		0.50	%		6.58	%	2/19/2029		750,000		730,356		752,723
Cross Financial Corp	Banking, Finance, Insurance & Real Estate	Term Loan B2 (10/24)	Loan	1M USD SOFR+	3.25	%		0.00	%		7.57	%	10/24/2031		485,063		483,905		485,974
Crown Subsea Communications Holding, Inc.	Construction & Building	Term Loan B	Loan	1M USD SOFR+	4.00	%		0.75	%		8.31	%	1/30/2031		2,388,000		2,367,977		2,397,695
CTS Midco, LLC	High Tech Industries	Term Loan B	Loan	3M USD SOFR+	6.00	%		1.00	%		10.55	%	11/2/2027		1,919,403		1,894,257		1,919,403
Dave & Buster’s Inc.	Hotel, Gaming & Leisure	Term Loan B (1/24)	Loan	3M USD SOFR+	3.25	%		0.50	%		7.56	%	6/29/2029		762,038		735,302		721,079
DCert Buyer, Inc.	High Tech Industries	Term Loan	Loan	1M USD SOFR+	4.00	%		0.00	%		8.32	%	10/16/2026		1,439,547		1,439,547		1,394,748
Delek US Holdings, Inc.	Utilities: Oil & Gas	Term Loan B (11/22)	Loan	1M USD SOFR+	3.50	%		0.50	%		7.92	%	11/16/2029		5,292,000		5,206,553		5,270,514
Derby Buyer LLC	Chemicals, Plastics, & Rubber	Term Loan B (12/24)	Loan	1M USD SOFR+	3.00	%		0.00	%		7.31	%	11/1/2030		620,320		612,532		620,475
DexKo Global, Inc. (Dragon Merger)	Automotive	Term Loan (9/21)	Loan	3M USD SOFR+	3.75	%		0.50	%		8.34	%	10/4/2028		972,500		970,335		916,251

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 28, 2025

Issuer Name	Industry	Asset Name	Asset Type	Reference Rate/Spread			SOFR/LIBOR Floor			Current Rate (All In)			Maturity Date	Principal/ Number of Shares		Cost		Fair Value
Diamond Sports Group, LLC	Media: Broadcasting & Subscription	1st Priority Term Loan	Loan	1M USD SOFR+	10.00	%		1.00	%		14.41	%	5/25/2026		29,734		29,407		26,463
DIRECTV FINANCING, LLC	Media: Broadcasting & Subscription	Term Loan (1/24)	Loan	3M USD SOFR+	5.25	%		0.75	%		9.80	%	8/2/2029		2,902,900		2,887,032		2,882,115
DISCOVERY PURCHASER CORPORATION	Chemicals, Plastics, & Rubber	Term Loan	Loan	3M USD SOFR+	4.00	%		0.50	%		8.29	%	10/4/2029		1,470,233		1,383,873		1,465,749
Dispatch Acquisition Holdings, LLC	Environmental Industries	Term Loan B (3/21)	Loan	3M USD SOFR+	4.25	%		0.75	%		8.73	%	3/25/2028		482,500		480,166		454,496
DOMTAR CORPORATION	Forest Products & Paper	Term Loan 9/21	Loan	1M USD SOFR+	5.50	%		0.75	%		9.94	%	11/30/2028		3,071,416		3,028,380		2,973,530
DOTDASH MEREDITH, INC.	Media: Advertising, Printing & Publishing	Term Loan B (11/24)	Loan	1M USD SOFR+	3.50	%		0.50	%		7.81	%	12/1/2028		1,911,111		1,778,613		1,920,667
DRI HOLDING INC.	Media: Advertising, Printing & Publishing	Term Loan (12/21)	Loan	1M USD SOFR+	5.25	%		0.50	%		9.67	%	12/15/2028		3,892,437		3,790,333		3,773,718
DRW Holdings, LLC	Banking, Finance, Insurance & Real Estate	Term Loan B (06/24)	Loan	3M USD SOFR+	3.50	%		0.00	%		7.79	%	6/17/2031		6,305,000		6,280,258		6,283,311
DTZ U.S. Borrower, LLC	Construction & Building	Term Loan B1 (01/25)	Loan	1M USD SOFR+	2.75	%		0.50	%		7.07	%	1/31/2030		2,014,107		2,013,573		2,009,072
DTZ U.S. Borrower, LLC	Construction & Building	2024-3 Term Loan (09/24)	Loan	1M USD SOFR+	3.25	%		0.50	%		7.57	%	1/31/2030		1,097,250		1,075,232		1,098,161
Dye & Durham Corporation	Services: Business	Term Loan B (04/24)	Loan	3M USD SOFR+	4.25	%		1.00	%		8.68	%	4/11/2031		1,431,964		1,412,492		1,443,148
EAB Global, Inc.	Services: Business	Term Loan (08/21)	Loan	1M USD SOFR+	3.00	%		0.50	%		7.32	%	8/16/2028		970,169		967,824		967,336
Echo Global Logistics, Inc.	Services: Business	Term Loan	Loan	1M USD SOFR+	3.75	%		0.50	%		8.16	%	11/23/2028		1,945,000		1,943,317		1,923,663
Edelman Financial Group Inc., The	Banking, Finance, Insurance & Real Estate	Term Loan (12/24)	Loan	1M USD SOFR+	3.00	%		0.00	%		7.32	%	4/7/2028		2,155,371		2,152,592		2,158,281
ELECTRON BIDCO INC.	Healthcare & Pharmaceuticals	Term Loan	Loan	1M USD SOFR+	2.75	%		0.50	%		7.07	%	11/1/2028		487,500		486,541		486,769

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 28, 2025

Issuer Name	Industry	Asset Name	Asset Type	Reference Rate/Spread			SOFR/LIBOR Floor			Current Rate (All In)			Maturity Date	Principal/ Number of Shares		Cost		Fair Value
ELO Touch Solutions, Inc.	Media: Diversified & Production	Term Loan (12/18)	Loan	1M USD SOFR+	6.50	%		0.00	%		10.94	%	12/15/2025		2,137,656		2,124,478		2,137,656
Embecta Corp	Healthcare & Pharmaceuticals	Term Loan B	Loan	1M USD SOFR+	3.00	%		0.50	%		7.31	%	3/30/2029		2,885,658		2,843,183		2,880,262
Emrld Borrower LP	Capital Equipment	Term Loan B (04/23)	Loan	6M USD SOFR+	2.50	%		0.00	%		6.93	%	5/31/2030		990,000		986,329		986,594
Endo Finance Holdings, Inc.	Healthcare & Pharmaceuticals	Term Loan B	Loan	1M USD SOFR+	4.00	%		0.50	%		8.32	%	4/23/2031		1,995,000		1,977,056		1,995,000
Endure Digital, Inc.	High Tech Industries	Term Loan B	Loan	1M USD SOFR+	3.50	%		0.75	%		7.92	%	2/10/2028		2,412,500		2,407,887		1,668,654
Entain Holdings (Gibraltar) Limited	Hotel, Gaming & Leisure	Term Loan B3 (5/24)	Loan	3M USD SOFR+	2.75	%		0.50	%		7.08	%	10/31/2029		1,476,325		1,464,198		1,477,476
EOS U.S. FINCO LLC	Transportation: Cargo	Term Loan	Loan	6M USD SOFR+	6.00	%		0.50	%		10.28	%	10/9/2029		950,000		893,353		397,813
Equiniti Group PLC	Services: Business	Term Loan (12/24)	Loan	6M USD SOFR+	3.75	%		0.50	%		8.03	%	12/11/2028		970,069		964,262		976,937
Evertec Group LLC	Banking, Finance, Insurance & Real Estate	Term Loan B (09/23)	Loan	1M USD SOFR+	2.75	%		0.50	%		7.07	%	10/30/2030		1,125,000		1,110,800		1,130,625
Fiesta Purchaser, Inc.	Beverage, Food & Tobacco	Term Loan B (12/24)	Loan	1M USD SOFR+	3.25	%		0.00	%		7.57	%	2/12/2031		497,503		493,271		497,011
Finco I LLC	Banking, Finance, Insurance & Real Estate	Term Loan B (9/24)	Loan	1M USD SOFR+	2.25	%		0.00	%		6.57	%	6/27/2029		2,795,563		2,793,344		2,794,389
First Brands Group, LLC	Automotive	1st Lien Term Loan (3/21)	Loan	3M USD SOFR+	5.00	%		1.00	%		9.55	%	3/30/2027		4,812,500		4,781,859		4,607,969
First Eagle Investment Management	Banking, Finance, Insurance & Real Estate	Term Loan B (02/24)	Loan	3M USD SOFR+	3.00	%		0.00	%		7.33	%	3/5/2029		5,053,465		5,046,585		5,052,454
First Student Bidco Inc.	Transportation: Consumer	Term Loan B (12/24)	Loan	3M USD SOFR+	2.50	%		0.50	%		6.89	%	7/21/2028		709,476		706,708		707,603
First Student Bidco Inc.	Transportation: Consumer	Term Loan C	Loan	3M USD SOFR+	2.50	%		0.50	%		6.89	%	7/21/2028		216,966		216,137		216,393

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 28, 2025

Issuer Name	Industry	Asset Name	Asset Type	Reference Rate/Spread			SOFR/LIBOR Floor			Current Rate (All In)			Maturity Date	Principal/ Number of Shares		Cost		Fair Value
Fitness International, LLC (LA Fitness)	Services: Consumer	Term Loan B (1/24)	Loan	1M USD SOFR+	5.25	%		1.00	%		9.57	%	2/5/2029		1,191,000		1,161,999		1,204,030
Flutter Financing B.V.	Hotel, Gaming & Leisure	Term Loan	Loan	3M USD SOFR+	1.75	%		0.50	%		6.08	%	11/29/2030		3,712,500		3,704,077		3,699,729
Franchise Group, Inc.	Services: Consumer	New Money Term Commitments	Loan	1M USD SOFR+	9.00	%		1.00	%		13.43	%	5/6/2025		257,225		254,175		257,225
Franchise Group, Inc.	Services: Consumer	First Out Term Loan	Loan	6M USD SOFR+	4.75	%		0.75	%		9.30	%	3/10/2026		827,674		825,735		412,802
Franchise Group, Inc.	Services: Consumer	Term Loan B	Loan	3M USD SOFR+	4.75	%		0.75	%		9.30	%	3/10/2026		3,041,686		2,988,228		1,517,041
Franchise Group, Inc.	Services: Consumer	Term Loan DIP New Money	Loan	1M USD SOFR+	9.00	%		1.00	%		13.43	%	5/6/2025		355,828		353,546		355,828
Franklin Square Holdings, L.P.	Banking, Finance, Insurance & Real Estate	Term Loan B (04/24)	Loan	1M USD SOFR+	2.25	%		0.00	%		6.57	%	4/25/2031		4,231,210		4,225,781		4,231,210
Froneri International (R&R Ice Cream)	Beverage, Food & Tobacco	Term Loan B4 (10/24)	Loan	6M USD SOFR+	2.00	%		0.00	%		6.24	%	9/16/2031		1,915,000		1,914,701		1,905,751
Garrett LX III S.a r.l.	Automotive	Term Loan (1/25)	Loan	3M USD SOFR+	2.25	%		0.50	%		6.54	%	1/20/2032		1,451,250		1,447,746		1,438,552
Genesee & Wyoming, Inc.	Transportation: Cargo	Term Loan B (03/24)	Loan	3M USD SOFR+	1.75	%		0.00	%		6.08	%	4/10/2031		1,496,250		1,489,525		1,489,711
GGP Inc.	Banking, Finance, Insurance & Real Estate	Term Loan B	Loan	1M USD SOFR+	2.50	%		0.00	%		2.96	%	8/27/2025		2,323,401		2,300,582		2,318,312
GIP Pilot Acquisition Partners, L.P.	Energy: Oil & Gas	Term Loan B	Loan	3M USD SOFR+	2.00	%		0.00	%		6.30	%	10/4/2030		415,684		414,006		414,387
Global Tel*Link Corporation	Telecommunications	Term Loan (6/24)	Loan	1M USD SOFR+	7.50	%		3.00	%		11.82	%	7/31/2029		4,809,048		4,741,980		4,798,757
Go Daddy Operating Company, LLC	High Tech Industries	Term Loan B7	Loan	1M USD SOFR+	1.75	%		0.00	%		6.07	%	5/30/2031		940,231		940,231		938,473
GOLDEN WEST PACKAGING GROUP LLC	Forest Products & Paper	Term Loan (11/21)	Loan	6M USD SOFR+	5.25	%		0.75	%		9.92	%	12/1/2027		1,775,000		1,767,298		1,434,786

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 28, 2025

Issuer Name	Industry	Asset Name	Asset Type	Reference Rate/Spread			SOFR/LIBOR Floor			Current Rate (All In)			Maturity Date	Principal/ Number of Shares		Cost		Fair Value
GOTO GROUP, INC.	High Tech Industries	First Lien Term Loan	Loan	3M USD SOFR+	4.75	%		0.00	%		9.19	%	4/30/2028		1,245,381		804,484		1,151,043
GOTO GROUP, INC.	High Tech Industries	Second-Out Term Loan (02/24)	Loan	3M USD SOFR+	4.75	%		0.00	%		9.19	%	4/30/2028		1,719,812		1,651,916		832,389
Graham Packaging Co Inc	Containers, Packaging & Glass	Term Loan B (07/24)	Loan	1M USD SOFR+	2.50	%		0.00	%		6.82	%	8/4/2027		830,576		828,359		830,161
Great Outdoors Group, LLC	Retail	Term Loan (1/25)	Loan	1M USD SOFR+	3.25	%		0.75	%		7.55	%	1/20/2032		960,244		958,144		962,049
Griffon Corporation	Consumer goods: Durable	Term Loan B	Loan	1M USD SOFR+	2.00	%		0.00	%		6.31	%	1/24/2029		142,188		142,044		142,898
Grosvenor Capital Management Holdings, LLLP	Banking, Finance, Insurance & Real Estate	Term Loan B (5/24)	Loan	1M USD SOFR+	2.25	%		0.00	%		6.57	%	2/25/2030		2,786,709		2,786,614		2,791,057
Groupe Solmax Inc.	Environmental Industries	Term Loan (6/21)	Loan	1M USD SOFR+	4.75	%		0.75	%		9.19	%	5/27/2028		2,412,086		2,134,984		2,133,827
GYP HOLDINGS III CORP.	Construction & Building	Term Loan (1/24)	Loan	1M USD SOFR+	2.25	%		0.00	%		6.57	%	5/12/2030		246,881		245,937		247,037
Hertz Corporation (The)	Transportation: Consumer	Term Loan B	Loan	1M USD SOFR+	3.75	%		0.00	%		8.07	%	6/30/2028		2,082,970		2,035,333		1,807,726
Hillman Group Inc. (The) (New)	Consumer goods: Durable	Term Loan B-1 (2/21)	Loan	1M USD SOFR+	2.00	%		0.50	%		6.31	%	7/14/2028		2,714,525		2,713,474		2,704,780
Hilton Domestic Operating Company Inc.	Hotel, Gaming & Leisure	Term Loan B 4	Loan	1M USD SOFR+	1.75	%		0.00	%		6.07	%	11/8/2030		1,500,000		1,497,236		1,505,160
HLF Financing SARL (Herbalife)	Consumer goods: Non-durable	Term Loan	Loan	1M USD SOFR+	6.75	%		0.50	%		11.07	%	4/12/2029		3,038,490		3,037,561		3,036,606
Holley Purchaser, Inc	Automotive	Term Loan (11/21)	Loan	1M USD SOFR+	3.75	%		0.75	%		8.19	%	11/17/2028		2,189,325		2,184,763		2,130,935
Hudson River Trading LLC	Banking, Finance, Insurance & Real Estate	Term Loan (10/24)	Loan	1M USD SOFR+	3.00	%		0.00	%		7.31	%	3/29/2030		5,775,525		5,692,371		5,770,327

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 28, 2025

Issuer Name	Industry	Asset Name	Asset Type	Reference Rate/Spread			SOFR/LIBOR Floor			Current Rate (All In)			Maturity Date	Principal/ Number of Shares		Cost		Fair Value
Hunter Douglas Inc	Consumer goods: Durable	Term Loan B (1/25)	Loan	3M USD SOFR+	3.25	%		0.00	%		7.55	%	1/19/2032		2,232,648		2,038,638		2,215,904
Hyperion Refinance S.a.r.l.	Banking, Finance, Insurance & Real Estate	Term Loan B (11/24)	Loan	1M USD SOFR+	3.00	%		0.50	%		7.32	%	2/18/2031		2,977,538		2,966,717		2,968,992
Idera, Inc.	High Tech Industries	Term Loan (06/24)	Loan	3M USD SOFR+	3.50	%		0.75	%		7.79	%	3/2/2028		4,726,151		4,723,056		4,447,167
IMA Financial Group, Inc.	Banking, Finance, Insurance & Real Estate	Term Loan (10/21)	Loan	1M USD SOFR+	3.00	%		0.50	%		7.32	%	11/1/2028		2,440,193		2,433,243		2,440,193
INDY US BIDCO, LLC	Services: Business	Term Loan (01/25)	Loan	1M USD SOFR+	3.50	%		0.50	%		7.82	%	3/6/2028		2,170,828		2,170,359		2,166,313
INEOS 226 Ltd.	Chemicals, Plastics, & Rubber	Term Loan 3/23	Loan	1M USD SOFR+	3.75	%		0.00	%		8.17	%	3/13/2030		492,500		488,601		474,031
Ineos US Finance LLC	Chemicals, Plastics, & Rubber	Term Loan C	Loan	1M USD SOFR+	3.25	%		0.00	%		7.57	%	2/18/2030		990,019		982,264		973,931
INEOS US PETROCHEM LLC	Chemicals, Plastics, & Rubber	Term Loan B	Loan	1M USD SOFR+	4.25	%		0.00	%		8.67	%	4/2/2029		2,694,512		2,647,631		2,627,149
Informatica Inc.	High Tech Industries	Term Loan B (06/24)	Loan	1M USD SOFR+	2.25	%		0.00	%		6.57	%	10/27/2028		486,250		486,237		485,642
Ingram Micro Inc.	Wholesale	Term Loan B	Loan	3M USD SOFR+	2.75	%		0.00	%		7.08	%	9/17/2031		693,439		689,636		697,343
Inmar, Inc.	Services: Business	Term Loan (06/23)	Loan	3M USD SOFR+	5.00	%		1.00	%		9.31	%	10/30/2031		3,299,855		3,234,272		3,303,980
Innophos, Inc.	Chemicals, Plastics, & Rubber	Term Loan B	Loan	1M USD SOFR+	4.25	%		0.00	%		8.69	%	3/16/2029		476,250		472,714		475,826
IRB Holding Corporation	Beverage, Food & Tobacco	Term Loan B	Loan	1M USD SOFR+	2.50	%		0.75	%		6.82	%	12/15/2027		492,487		489,357		491,935
Isagenix International, LLC	Beverage, Food & Tobacco	Term Loan	Loan	6M USD SOFR+	2.50	%		0.00	%		2.50	%	4/13/2028		1,378,403		1,025,602		186,084
Isolved Inc.	Services: Business	Term Loan B (11/24)	Loan	1M USD SOFR+	3.25	%		0.00	%		7.57	%	10/15/2030		620,324		614,960		624,394

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 28, 2025

Issuer Name	Industry	Asset Name	Asset Type	Reference Rate/Spread			SOFR/LIBOR Floor			Current Rate (All In)			Maturity Date	Principal/ Number of Shares		Cost		Fair Value
Jane Street Group	Banking, Finance, Insurance & Real Estate	Term Loan B	Loan	3M USD SOFR+	2.00	%		0.00	%		6.30	%	12/15/2031		3,840,000		3,839,989		3,790,810
Journey Personal Care Corp.	Consumer goods: Non-durable	Term Loan B (11/24)	Loan	1M USD SOFR+	3.75	%		0.75	%		8.07	%	3/1/2028		2,895,000		2,858,590		2,872,072
JP Intermediate B, LLC	Consumer goods: Non-durable	Term Loan 7/23	Loan	Prime	6.50	%		1.00	%		14.00	%	11/20/2027		3,370,462		3,360,549		134,818
Kleopatra Finco S.a r.l.	Containers, Packaging & Glass	Term Loan (1/21) (USD)	Loan	6M USD SOFR+	4.73	%		0.50	%		9.23	%	2/12/2026		1,443,750		1,443,745		1,348,304
Koppers Inc	Chemicals, Plastics, & Rubber	Term Loan	Loan	1M USD SOFR+	2.50	%		0.50	%		6.82	%	4/10/2030		985,081		961,555		988,775
KREF Holdings X LLC	Banking, Finance, Insurance & Real Estate	Term Loan (11/21)	Loan	3M USD SOFR+	3.50	%		0.50	%		8.06	%	9/1/2027		481,363		476,486		481,363
Lakeland Tours, LLC	Hotel, Gaming & Leisure	Holdco Fixed Term Loan	Loan	Fixed	0.00	%		0.00	%		8.00	%	9/27/2027		1,127,568		680,756		28,189
Latham Pool Products, Inc.	Consumer goods: Durable	Term Loan 2/22	Loan	3M USD SOFR+	3.75	%		0.50	%		8.19	%	2/23/2029		991,609		978,723		970,954
Lealand Finance Company B.V.	Energy: Oil & Gas	Exit Term Loan	Loan	1M USD SOFR+	1.00	%		0.00	%		5.43	%	12/31/2027		366,724		366,724		149,257
LHS BORROWER, LLC	Construction & Building	Term Loan (02/22)	Loan	1M USD SOFR+	4.75	%		0.50	%		9.17	%	2/16/2029		2,450,166		2,120,597		2,266,403
Lifetime Brands, Inc	Consumer goods: Non-durable	Term Loan	Loan	1M USD SOFR+	5.50	%		1.00	%		9.93	%	8/26/2027		1,576,347		1,572,295		1,500,163
Liquid Tech Solutions Holdings, LLC	Services: Business	Term Loan	Loan	1M USD SOFR+	3.75	%		0.75	%		8.18	%	3/17/2028		967,500		966,360		969,919
LOYALTY VENTURES INC.	Services: Business	Loyalty Ventures Claims	Term Loan B	Prime	5.50	%		0.50	%		14.00	%	11/3/2027		2,913,525		2,905,305		211,231
LSF11 A5 HOLDCO LLC	Chemicals, Plastics, & Rubber	Term Loan B (06/24)	Loan	1M USD SOFR+	3.50	%		0.50	%		7.93	%	10/15/2028		1,622,206		1,607,812		1,621,622
LSF11 TRINITY BIDCO INC	Aerospace & Defense	Term Loan B (12/24)	Loan	1M USD SOFR+	3.00	%		0.00	%		7.32	%	6/14/2030		970,924		959,085		970,924

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 28, 2025

Issuer Name	Industry	Asset Name	Asset Type	Reference Rate/Spread			SOFR/LIBOR Floor			Current Rate (All In)			Maturity Date	Principal/ Number of Shares		Cost		Fair Value
LSF9 Atlantis Holdings, LLC (A Wireless)	Retail	Term Loan Extended	Loan	1M USD SOFR+	5.25	%		0.75	%		9.57	%	3/29/2029		2,671,805		2,610,533		2,680,167
Lumen Technologies Inc	Telecommunications	Term Loan B1 (3/24)	Loan	1M USD SOFR+	2.35	%		2.00	%		6.79	%	4/16/2029		1,608,268		1,607,707		1,512,785
Lumen Technologies Inc	Telecommunications	Term Loan B2 (3/24)	Loan	1M USD SOFR+	2.35	%		2.00	%		6.79	%	4/15/2030		1,608,268		1,607,702		1,507,767
MAGNITE, INC.	Services: Business	Term Loan B (09/24)	Loan	1M USD SOFR+	3.75	%		0.00	%		8.07	%	2/6/2031		3,233,770		3,205,941		3,278,235
Marriott Ownership Resorts, Inc.	Hotel, Gaming & Leisure	Term Loan B (3/24)	Loan	1M USD SOFR+	2.25	%		0.00	%		6.57	%	4/1/2031		1,310,489		1,310,489		1,310,489
Max US Bidco Inc.	Beverage, Food & Tobacco	Term Loan B	Loan	3M USD SOFR+	5.00	%		0.50	%		9.31	%	10/3/2030		1,985,000		1,870,513		1,942,819
Mayfield Agency Borrower Inc. (FeeCo)	Banking, Finance, Insurance & Real Estate	Term Loan B (12/24)	Loan	3M USD SOFR+	3.00	%		0.00	%		7.29	%	12/29/2031		3,415,608		3,349,332		3,405,634
McGraw-Hill Education, Inc.	Media: Advertising, Printing & Publishing	Term Loan (1/25)	Loan	3M USD SOFR+	3.25	%		0.50	%		7.55	%	8/6/2031		1,244,525		1,236,501		1,251,134
Michaels Companies Inc	Retail	Term Loan B (Magic Mergeco)	Loan	3M USD SOFR+	4.25	%		0.75	%		8.84	%	4/8/2028		2,417,349		2,407,248		1,957,038
MIWD Holdco II LLC	Construction & Building	Term Loan B2 (03/24)	Loan	1M USD SOFR+	3.00	%		0.00	%		7.32	%	3/21/2031		497,500		495,226		498,067
MKS Instruments, Inc.	High Tech Industries	Term Loan B (01/25)	Loan	1M USD SOFR+	2.00	%		0.50	%		6.32	%	8/17/2029		1,280,586		1,278,776		1,281,227
Momentive Performance Materials Inc.	Chemicals, Plastics, & Rubber	Term Loan (03/23)	Loan	1M USD SOFR+	4.00	%		0.00	%		8.32	%	3/28/2028		491,250		477,801		490,331
Moneygram International, Inc.	Services: Business	Term Loan B	Loan	3M USD SOFR+	4.75	%		0.50	%		9.15	%	6/1/2030		2,963,850		2,633,472		2,846,363
Mosel Bidco SE	High Tech Industries	Term Loan B	Loan	3M USD SOFR+	4.50	%		0.50	%		8.83	%	9/28/2030		500,000		495,844		501,250
MPH Acquisition Holdings LLC (Multiplan)	Services: Business	First-Out Term Loan (01/25)	Loan	3M USD SOFR+	3.75	%		0.00	%		8.04	%	12/31/2030		315,611		285,615		313,638

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 28, 2025

Issuer Name	Industry	Asset Name	Asset Type	Reference Rate/Spread			SOFR/LIBOR Floor			Current Rate (All In)			Maturity Date	Principal/ Number of Shares		Cost		Fair Value
MPH Acquisition Holdings LLC (Multiplan)	Services: Business	Second-Out Term Loan (01/25)	Loan	3M USD SOFR+	4.60	%		0.00	%		9.15	%	12/31/2030		2,616,207		2,460,718		2,198,556
NAB Holdings, LLC (North American Bancard)	Banking, Finance, Insurance & Real Estate	Term Loan B (2/25)	Loan	3M USD SOFR+	2.50	%		0.50	%		6.82	%	11/24/2028		2,910,506		2,906,771		2,886,873
Napa Management Services Corp	Healthcare & Pharmaceuticals	Term Loan B (02/22)	Loan	1M USD SOFR+	5.25	%		0.75	%		9.67	%	2/22/2029		2,939,547		2,497,131		2,712,966
Natgasoline LLC	Chemicals, Plastics, & Rubber	Term Loan	Loan	6M USD SOFR+	3.50	%		0.00	%		8.17	%	11/14/2025		3,269,852		3,265,583		3,253,503
National Mentor Holdings, Inc.	Healthcare & Pharmaceuticals	Term Loan 2/21	Loan	3M USD SOFR+	3.75	%		0.75	%		8.48	%	3/2/2028		2,680,348		2,676,078		2,623,658
National Mentor Holdings, Inc.	Healthcare & Pharmaceuticals	Term Loan C 2/21	Loan	3M USD SOFR+	3.75	%		0.75	%		8.18	%	3/2/2028		87,464		87,262		85,614
Nexstar Broadcasting, Inc. (Mission Broadcasting)	Media: Broadcasting & Subscription	Term Loan	Loan	1M USD SOFR+	2.50	%		0.00	%		6.94	%	9/18/2026		571,911		570,138		571,356
Next Level Apparel, Inc.	Retail	Term Loan	Loan	3M USD SOFR+	7.50	%		1.00	%		11.90	%	8/9/2026		2,382,698		2,373,272		1,894,245
NorthPole Newco S.a.r.l	Aerospace & Defense	Term Loan	Loan	Prime	7.00	%		0.00	%		14.50	%	3/3/2025		-		-		-
NortonLifeLock Inc.	High Tech Industries	Term Loan B (05/24)	Loan	1M USD SOFR+	1.75	%		0.50	%		6.07	%	9/12/2029		970,000		967,278		967,507
Nouryon Finance B.V.	Chemicals, Plastics, & Rubber	Term Loan B (10/24)	Loan	3M USD SOFR+	3.25	%		0.00	%		7.55	%	4/3/2028		483,926		480,497		485,591
Novae LLC	Automotive	Term Loan B	Loan	1M USD SOFR+	5.00	%		0.75	%		9.42	%	12/22/2028		1,945,000		1,935,728		1,819,800
Olaplex, Inc.	Consumer goods: Non-durable	Term Loan (2/22)	Loan	1M USD SOFR+	3.50	%		0.50	%		7.92	%	2/23/2029		2,442,273		2,367,591		2,262,498
Open Text Corporation	High Tech Industries	Term Loan B (08/23)	Loan	1M USD SOFR+	1.75	%		0.50	%		6.07	%	1/31/2030		921,883		900,638		920,731
Oxbow Carbon, LLC	Metals & Mining	Term Loan B (04/23)	Loan	1M USD SOFR+	3.50	%		0.50	%		7.82	%	5/2/2030		492,500		484,592		491,269

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 28, 2025

Issuer Name	Industry	Asset Name	Asset Type	Reference Rate/Spread			SOFR/LIBOR Floor			Current Rate (All In)			Maturity Date	Principal/ Number of Shares		Cost		Fair Value
PACIFIC DENTAL SERVICES, LLC	Healthcare & Pharmaceuticals	Term Loan B (02//24)	Loan	1M USD SOFR+	2.75	%		0.00	%		7.07	%	3/17/2031		1,191,000		1,190,157		1,194,347
PACTIV EVERGREEN GROUP HOLDINGS INC.	Containers, Packaging & Glass	Term Loan B4 (05/24)	Loan	1M USD SOFR+	2.50	%		0.00	%		6.82	%	9/24/2028		921,247		919,105		920,841
Padagis LLC	Healthcare & Pharmaceuticals	Term Loan	Loan	3M USD SOFR+	4.75	%		0.50	%		9.30	%	7/6/2028		941,176		935,900		876,866
PAR PETROLEUM LLC	Energy: Oil & Gas	Term Loan B	Loan	3M USD SOFR+	3.75	%		0.50	%		8.04	%	2/28/2030		2,458,727		2,438,711		2,448,474
PATAGONIA HOLDCO LLC	Telecommunications	Term Loan B	Loan	3M USD SOFR+	5.75	%		0.50	%		10.05	%	8/1/2029		2,947,386		2,631,038		2,597,384
Pathway Partners Vet Management Company LLC	Services: Business	Term Loan	Loan	3M USD SOFR+	3.75	%		0.00	%		8.34	%	3/31/2027		476,580		472,582		387,545
PCI Gaming Authority	Hotel, Gaming & Leisure	Term Loan	Loan	1M USD SOFR+	2.00	%		0.00	%		6.32	%	7/18/2031		790,518		789,679		788,834
PEARLS (Netherlands) Bidco B.V.	Chemicals, Plastics, & Rubber	USD Term Loan (02/22)	Loan	1M USD SOFR+	3.25	%		0.50	%		7.57	%	2/28/2029		973,627		972,968		969,246
PEDIATRIC ASSOCIATES HOLDING COMPANY, LLC	Healthcare & Pharmaceuticals	Term Loan (12/22)	Loan	3M USD SOFR+	3.25	%		0.50	%		7.80	%	12/29/2028		1,459,630		1,456,242		1,379,350
Penn National Gaming, Inc	Hotel, Gaming & Leisure	Term Loan B	Loan	1M USD SOFR+	2.50	%		0.50	%		6.82	%	5/3/2029		975,000		971,989		976,463
Peraton Corp.	Aerospace & Defense	Term Loan B	Loan	1M USD SOFR+	3.75	%		0.75	%		8.17	%	2/1/2028		5,181,328		5,175,310		4,677,754
Phoenix Guarantor Inc.	Healthcare & Pharmaceuticals	Term Loan B (12/24)	Loan	1M USD SOFR+	2.50	%		0.00	%		6.82	%	2/21/2031		965,218		965,218		961,444
PHYSICIAN PARTNERS, LLC	Healthcare & Pharmaceuticals	Term Loan	Loan	3M USD SOFR+	4.00	%		0.50	%		8.74	%	12/22/2028		2,928,567		2,881,253		1,156,784
Plastipak Holdings Inc.	Containers, Packaging & Glass	Term Loan B	Loan	1M USD SOFR+	2.25	%		0.50	%		6.57	%	12/1/2028		1,795,294		1,791,011		1,796,892
Playtika Holding Corp.	High Tech Industries	Term Loan B (3/21)	Loan	1M USD SOFR+	2.75	%		0.00	%		7.19	%	3/13/2028		4,331,250		4,327,202		4,316,351

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 28, 2025

Issuer Name	Industry	Asset Name	Asset Type	Reference Rate/Spread			SOFR/LIBOR Floor			Current Rate (All In)			Maturity Date	Principal/ Number of Shares		Cost		Fair Value
PMHC II, INC.	Chemicals, Plastics, & Rubber	Term Loan (02/22)	Loan	3M USD SOFR+	4.25	%		0.50	%		8.69	%	4/21/2029		1,955,000		1,949,220		1,890,368
PointClickCare Technologies, Inc.	High Tech Industries	Term Loan B (10/24)	Loan	3M USD SOFR+	3.25	%		0.00	%		7.58	%	11/3/2031		482,575		481,443		483,178
Polymer Process Holdings, Inc.	Containers, Packaging & Glass	Term Loan	Loan	1M USD SOFR+	4.75	%		0.75	%		9.19	%	2/12/2028		4,020,266		4,001,931		3,897,648
Pre-Paid Legal Services, Inc.	Services: Consumer	Term Loan (12/21)	Loan	1M USD SOFR+	3.25	%		0.50	%		7.69	%	12/15/2028		2,917,500		2,903,248		2,917,500
Prime Security Services Borrower, LLC (ADT)	Services: Consumer	Term Loan B	Loan	1M USD SOFR+	2.00	%		0.00	%		6.31	%	10/13/2030		1,990,013		1,973,564		1,985,834
Primo Brands Corporation	Beverage, Food & Tobacco	Term Loan B (01/25)	Loan	3M USD SOFR+	2.25	%		0.50	%		6.56	%	3/31/2028		1,447,505		1,443,799		1,448,620
PRIORITY HOLDINGS, LLC	Services: Consumer	Term Loan B (5/24)	Loan	1M USD SOFR+	4.75	%		0.50	%		9.07	%	5/16/2031		2,872,211		2,857,095		2,875,802
PriSo Acquisition Corporation	Construction & Building	Term Loan (01/21)	Loan	3M USD SOFR+	3.25	%		0.75	%		7.82	%	12/28/2027		481,239		480,294		466,152
Project Leopard Holdings, Inc. (NEW)	High Tech Industries	Term Loan B (06/22)	Loan	3M USD SOFR+	5.25	%		0.50	%		9.64	%	7/20/2029		980,000		930,969		871,387
Propulsion (BC) Finco	Aerospace & Defense	Term Loan B (10/24)	Loan	3M USD SOFR+	3.25	%		0.50	%		7.58	%	9/14/2029		742,457		736,171		745,509
PUG LLC	Services: Consumer	Term Loan B (03/24)	Loan	1M USD SOFR+	4.75	%		0.00	%		9.07	%	3/15/2030		465,765		465,063		465,570
Quartz AcquireCo, LLC	High Tech Industries	Term Loan (2/25)	Loan	3M USD SOFR+	2.25	%		0.00	%		6.57	%	6/28/2030		1,234,994		1,226,841		1,233,450
Quikrete Holdings, Inc.	Construction & Building	Term Loan (2/25)	Loan	1M USD SOFR+	2.25	%		0.00	%		6.57	%	4/14/2031		992,500		990,531		990,981
Rackspace Technology Global, Inc.	High Tech Industries	Term Loan (3/24)	Loan	1M USD SOFR+	2.75	%		0.75	%		7.17	%	5/15/2028		2,040,103		1,143,598		1,165,409
Rackspace Technology Global, Inc.	High Tech Industries	Super-Priority Term Loan (03/24)	Loan	1M USD SOFR+	6.25	%		0.75	%		10.67	%	5/15/2028		546,909		542,424		563,705

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 28, 2025

Issuer Name	Industry	Asset Name	Asset Type	Reference Rate/Spread			SOFR/LIBOR Floor			Current Rate (All In)			Maturity Date	Principal/ Number of Shares		Cost		Fair Value
RAND PARENT LLC	Transportation: Cargo	Term Loan B (01/25)	Loan	3M USD SOFR+	3.00	%		0.00	%		7.30	%	3/18/2030		2,456,406		2,386,949		2,452,108
RealPage, Inc.	High Tech Industries	Term Loan (04/21)	Loan	3M USD SOFR+	3.00	%		0.50	%		7.59	%	4/24/2028		967,500		966,881		960,747
Rent-A-Center, Inc.	Retail	Term Loan B2 (9/21)	Loan	3M USD SOFR+	2.75	%		0.50	%		7.04	%	2/17/2028		1,840,124		1,815,493		1,839,351
Research Now Group, Inc	Media: Advertising, Printing & Publishing	Term Loan (07/24)	Loan	3M USD SOFR+	5.00	%		1.00	%		9.58	%	7/15/2028		338,737		334,497		339,018
Research Now Group, Inc	Media: Advertising, Printing & Publishing	Second-Out Term Loan	Loan	3M USD SOFR+	5.50	%		1.00	%		10.08	%	7/15/2028		2,887,427		2,767,310		2,721,400
Resideo Funding Inc.	Services: Consumer	Term Loan B (12/24)	Loan	1M USD SOFR+	1.75	%		0.00	%		6.06	%	2/14/2028		674,488		674,302		675,756
Resolute Investment Managers (American Beacon), Inc.	Banking, Finance, Insurance & Real Estate	Term Loan (12/23)	Loan	3M USD SOFR+	6.50	%		1.00	%		11.09	%	4/30/2027		1,948,473		1,948,473		1,930,449
Restoration Hardware, Inc.	Retail	Term Loan (9/21)	Loan	1M USD SOFR+	2.50	%		0.50	%		6.94	%	10/20/2028		3,392,312		3,389,647		3,339,595
Reynolds Consumer Products LLC	Containers, Packaging & Glass	Term Loan	Loan	1M USD SOFR+	1.75	%		0.00	%		6.17	%	2/4/2027		996,705		996,705		996,944
Russell Investments US Inst’l Holdco, Inc.	Banking, Finance, Insurance & Real Estate	Term Loan B PIK (3/24)	Loan	3M USD SOFR+	5.00	%		1.00	%		9.29	%	5/30/2027		5,764,065		5,754,497		5,539,266
RV Retailer LLC	Automotive	Term Loan	Loan	1M USD SOFR+	3.75	%		0.75	%		8.17	%	2/8/2028		2,897,881		2,869,896		2,714,039
Ryan Specialty Group LLC	Banking, Finance, Insurance & Real Estate	Term Loan B (09/24)	Loan	1M USD SOFR+	2.25	%		0.00	%		6.57	%	9/15/2031		1,455,934		1,448,552		1,453,750
S&S HOLDINGS LLC	Services: Business	Term Loan	Loan	1M USD SOFR+	5.00	%		0.50	%		9.42	%	3/10/2028		2,408,668		2,376,694		2,403,996
Sally Holdings LLC	Retail	Term Loan B	Loan	1M USD SOFR+	1.75	%		0.00	%		6.07	%	2/28/2030		441,250		438,790		440,147
Schweitzer-Mauduit International, Inc.	High Tech Industries	Term Loan B	Loan	1M USD SOFR+	3.75	%		0.75	%		8.19	%	4/20/2028		939,236		936,933		933,365

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 28, 2025

Issuer Name	Industry	Asset Name	Asset Type	Reference Rate/Spread			SOFR/LIBOR Floor			Current Rate (All In)			Maturity Date	Principal/ Number of Shares		Cost		Fair Value
Scientific Games Holdings LP	Hotel, Gaming & Leisure	Term Loan B	Loan	3M USD SOFR+	3.00	%		0.50	%		7.30	%	4/4/2029		491,269		490,668		491,087
Sedgwick Claims Management Services, Inc.	Services: Business	Term Loan B 2/23	Loan	3M USD SOFR+	3.00	%		0.00	%		7.31	%	7/31/2031		985,031		978,594		985,297
SETANTA AIRCRAFT LEASING DAC	Aerospace & Defense	Term Loan B (05/24)	Loan	3M USD SOFR+	1.75	%		0.00	%		6.08	%	11/5/2028		500,000		499,374		501,500
Sitel Worldwide Corporation	Services: Business	USD Term Loan (7/21)	Loan	3M USD SOFR+	3.75	%		0.50	%		8.18	%	8/28/2028		1,935,000		1,930,481		1,248,733
SiteOne Landscape Supply, LLC	Services: Business	Term Loan B (06/24)	Loan	1M USD SOFR+	1.75	%		0.50	%		6.06	%	3/23/2030		1,257,709		1,253,356		1,257,709
Smyrna Ready Mix Concrete, LLC	Construction & Building	Term Loan B	Loan	1M USD SOFR+	3.00	%		0.00	%		7.32	%	4/2/2029		509,075		506,578		510,984
Sparta U.S. HoldCo LLC	Chemicals, Plastics, & Rubber	Term Loan	Loan	1M USD SOFR+	3.00	%		0.00	%		7.31	%	8/2/2030		1,940,000		1,935,791		1,945,820
Specialty Pharma III Inc.	Services: Business	Term Loan	Loan	1M USD SOFR+	4.25	%		0.75	%		8.67	%	3/31/2028		1,935,000		1,925,487		1,847,925
Spin Holdco, Inc.	Services: Consumer	Term Loan 3/21	Loan	3M USD SOFR+	4.00	%		0.75	%		8.71	%	3/4/2028		2,887,500		2,880,793		2,496,128
SRAM, LLC	Consumer goods: Durable	Term Loan (02/25)	Loan	1M USD SOFR+	2.75	%		0.50	%		7.94	%	5/12/2028		2,269,091		2,267,559		2,274,764
STANDARD INDUSTRIES INC.	Construction & Building	Term Loan B	Loan	1M USD SOFR+	1.75	%		0.50	%		6.07	%	9/22/2028		210,250		209,230		210,250
Staples, Inc.	Wholesale	Term Loan B	Loan	3M USD SOFR+	5.75	%		0.50	%		10.04	%	9/4/2029		4,263,551		4,210,817		4,001,726
Star Parent, Inc.	Services: Business	Term Loan B (09/23)	Loan	3M USD SOFR+	4.00	%		0.00	%		8.33	%	9/27/2030		1,240,625		1,225,176		1,214,088
Storable, Inc	High Tech Industries	Term Loan B	Loan	1M USD SOFR+	3.50	%		0.50	%		7.82	%	4/17/2028		485,000		484,751		484,913
Superannuation & Investments US LLC	Banking, Finance, Insurance & Real Estate	Term Loan	Loan	1M USD SOFR+	3.75	%		0.50	%		8.19	%	12/1/2028		970,000		964,328		974,608

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 28, 2025

Issuer Name	Industry	Asset Name	Asset Type	Reference Rate/Spread			SOFR/LIBOR Floor			Current Rate (All In)			Maturity Date	Principal/ Number of Shares		Cost		Fair Value
SupplyOne, Inc	Wholesale	Term Loan B (03/24)	Loan	1M USD SOFR+	3.75	%		0.00	%		8.07	%	3/27/2031		496,250		491,740		498,811
Sweetwater Borrower, LLC	Retail	Term Loan (8/21)	Loan	1M USD SOFR+	4.25	%		0.75	%		8.69	%	8/2/2028		2,083,452		2,022,885		2,083,452
Syncsort Incorporated	High Tech Industries	Term Loan B (10/21)	Loan	3M USD SOFR+	4.00	%		0.75	%		8.55	%	4/24/2028		2,419,962		2,419,490		2,377,105
Ta TT Buyer LLC	Media: Broadcasting & Subscription	Term Loan B (6/24)	Loan	3M USD SOFR+	4.75	%		0.50	%		9.08	%	4/2/2029		980,032		973,273		969,624
Tenable Holdings, Inc.	Services: Business	Term Loan B (6/21)	Loan	1M USD SOFR+	2.75	%		0.50	%		7.19	%	7/7/2028		970,000		969,283		971,213
Teneo Holdings LLC	Banking, Finance, Insurance & Real Estate	Term Loan B (03/24)	Loan	1M USD SOFR+	4.75	%		1.00	%		9.07	%	3/13/2031		3,473,750		3,442,264		3,500,880
Ten-X, LLC	Banking, Finance, Insurance & Real Estate	Term Loan 5/23	Loan	6M USD SOFR+	6.00	%		0.00	%		10.25	%	5/25/2028		1,860,000		1,860,000		1,616,340
Thor Industries, Inc.	Automotive	Term Loan B (06/24)	Loan	1M USD SOFR+	2.25	%		0.00	%		6.57	%	11/15/2030		291,839		289,445		292,569
TIBCO Software Inc	High Tech Industries	Term Loan (Cov-Lite) (10/24)	Loan	3M USD SOFR+	3.75	%		0.50	%		8.08	%	3/21/2031		498,750		498,297		500,137
Torrid LLC	Wholesale	Term Loan 5/21	Loan	3M USD SOFR+	5.50	%		0.75	%		10.07	%	6/14/2028		3,107,759		2,794,667		2,863,582
TORY BURCH LLC	Retail	Term Loan	Loan	1M USD SOFR+	3.25	%		0.50	%		7.69	%	4/17/2028		2,284,411		2,178,846		2,279,773
Tosca Services, LLC	Containers, Packaging & Glass	Term Loan A (08/24)	Loan	1M USD SOFR+	5.50	%		1.50	%		9.82	%	11/30/2028		80,509		79,712		82,925
Tosca Services, LLC	Containers, Packaging & Glass	Superpriority Second-Out Term Loan B	Loan	1M USD SOFR+	1.50	%		0.00	%		5.92	%	11/30/2028		6,878		10,704		5,932
Trans Union LLC	Banking, Finance, Insurance & Real Estate	Term Loan B9 (11/24)	Loan	1M USD SOFR+	1.75	%		0.00	%		6.07	%	6/24/2031		605,987		605,382		604,878
Tronox Finance LLC	Chemicals, Plastics, & Rubber	Term Loan (09/24)	Loan	3M USD SOFR+	2.25	%		0.00	%		6.60	%	4/4/2029		1,995,000		1,979,840		1,967,070

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 28, 2025

Issuer Name	Industry	Asset Name	Asset Type	Reference Rate/Spread			SOFR/LIBOR Floor			Current Rate (All In)			Maturity Date	Principal/ Number of Shares		Cost		Fair Value
Tronox Finance LLC	Chemicals, Plastics, & Rubber	Term Loan B (09/24)	Loan	1M USD SOFR+	2.50	%		0.00	%		6.82	%	9/30/2031		346,923		346,684		342,458
TruGreen Limited Partnership	Services: Consumer	Term Loan	Loan	1M USD SOFR+	4.00	%		0.75	%		8.42	%	11/2/2027		935,021		932,096		885,933
Ultra Clean Holdings, Inc.	High Tech Industries	Term Loan B (09/24)	Loan	1M USD SOFR+	3.25	%		0.00	%		7.57	%	2/25/2028		1,233,755		1,230,873		1,237,358
Univision Communications Inc.	Media: Broadcasting & Subscription	Term Loan B (05/24)	Loan	1M USD SOFR+	3.50	%		0.50	%		7.94	%	1/31/2029		2,403,522		2,402,406		2,379,486
Univision Communications Inc.	Media: Broadcasting & Subscription	Term Loan B (6/22)	Loan	3M USD SOFR+	4.25	%		0.50	%		8.58	%	6/25/2029		243,750		238,712		240,094
Vaco Holdings, LLC	Services: Business	Term Loan (01/22)	Loan	3M USD SOFR+	5.00	%		0.75	%		9.48	%	1/19/2029		2,294,893		2,247,090		2,098,680
Vericast Corp.	Media: Advertising, Printing & Publishing	Extended Term Loan (07/24)	Loan	6M USD SOFR+	7.75	%		1.00	%		12.03	%	6/16/2026		1,297,729		1,297,560		1,235,438
Verifone Systems, Inc.	Banking, Finance, Insurance & Real Estate	Term Loan (7/18)	Loan	3M USD SOFR+	4.00	%		0.00	%		8.58	%	8/20/2025		1,339,456		1,338,547		1,272,175
Vertex Aerospace Services Corp	Aerospace & Defense	Term Loan (10/21)	Loan	1M USD SOFR+	2.25	%		0.75	%		6.57	%	12/6/2030		972,724		970,725		966,509
Viasat Inc	Telecommunications	Term Loan (2/22)	Loan	1M USD SOFR+	4.50	%		0.50	%		8.94	%	3/5/2029		2,937,255		2,888,468		2,689,057
Virtus Investment Partners, Inc.	Banking, Finance, Insurance & Real Estate	Term Loan B (9/21)	Loan	1M USD SOFR+	2.25	%		0.00	%		6.69	%	9/28/2028		2,575,227		2,570,947		2,575,227
Vistra Operations Company LLC	Energy: Electricity	2018 Incremental Term Loan	Loan	1M USD SOFR+	1.75	%		0.00	%		6.07	%	12/20/2030		1,870,499		1,866,269		1,868,554
VM Consolidated, Inc.	Construction & Building	Term Loan B	Loan	1M USD SOFR+	2.25	%		0.00	%		6.57	%	3/24/2028		1,817,804		1,817,479		1,816,895
Walker & Dunlop, Inc.	Banking, Finance, Insurance & Real Estate	Term Loan	Loan	1M USD SOFR+	2.25	%		0.50	%		6.67	%	12/15/2028		491,202		484,449		491,816
Warner Music Group Corp. (WMG Acquisition Corp.)	Hotel, Gaming & Leisure	Term Loan J	Loan	3M USD SOFR+	1.75	%		0.00	%		6.04	%	1/24/2031		1,250,000		1,250,000		1,248,050

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 28, 2025

Issuer Name	Industry	Asset Name	Asset Type	Reference Rate/Spread			SOFR/LIBOR Floor			Current Rate (All In)			Maturity Date	Principal/ Number of Shares		Cost		Fair Value
Watlow Electric Manufacturing Company	High Tech Industries	Term Loan B (03/21)	Loan	3M USD SOFR+	3.50	%		0.50	%		7.79	%	3/2/2028		2,661,649		2,655,782		2,671,072
WeddingWire, Inc.	Services: Consumer	Term Loan B (12/24)	Loan	1M USD SOFR+	3.75	%		0.00	%		8.07	%	1/31/2028		4,772,917		4,772,450		4,784,849
Wellpath Holdings LLC	Healthcare & Pharmaceuticals	Term Loan	Loan	3M USD SOFR+	6.93	%		2.00	%		11.23	%	1/27/2030		693,228		693,228		693,228
WEX Inc.	Services: Business	Term Loan B (11/24)	Loan	1M USD SOFR+	1.75	%		0.00	%		6.07	%	3/31/2028		2,895,655		2,891,840		2,886,621
Windsor Holdings III, LLC	Chemicals, Plastics, & Rubber	Term Loan B (09/24)	Loan	1M USD SOFR+	3.50	%		0.00	%		7.82	%	8/1/2030		495,013		495,013		493,156
Wyndham Hotels & Resorts, Inc.	Hotel, Gaming & Leisure	Term Loan (05/24)	Loan	1M USD SOFR+	1.75	%		0.00	%		6.07	%	5/24/2030		987,538		983,680		987,814
Xperi Corporation	High Tech Industries	Term Loan (1/25)	Loan	1M USD SOFR+	2.50	%		0.00	%		6.82	%	6/8/2028		1,690,908		1,690,037		1,690,908
Zayo Group, LLC	Telecommunications	Term Loan 4/22	Loan	1M USD SOFR+	4.25	%		0.50	%		8.57	%	3/9/2027		972,500		960,739		935,185
ZEBRA BUYER (Allspring) LLC	Banking, Finance, Insurance & Real Estate	Term Loan B (12/24)	Loan	3M USD SOFR+	3.00	%		0.50	%		7.38	%	11/1/2030		1,852,261		1,845,463		1,852,261
Zekelman Industries, Inc.	Metals & Mining	Term Loan B (03/24)	Loan	1M USD SOFR+	2.25	%		0.00	%		6.56	%	1/24/2031		1,443,124		1,442,200		1,444,812
Zest Acquisition Corp.	Healthcare & Pharmaceuticals	Term Loan (1/23)	Loan	3M USD SOFR+	5.25	%		0.00	%		9.54	%	2/8/2028		1,960,000		1,896,443		1,979,600
Zodiac Pool Solutions	Consumer goods: Durable	Term Loan (1/22)	Loan	1M USD SOFR+	1.93	%		0.50	%		6.35	%	1/29/2029		485,000		484,495		484,267
TOTAL INVESTMENTS																$	520,335,803	$	492,195,089

	Number of Shares		Cost		Fair Value
Cash and cash equivalents
U.S. Bank Money Market (a)		21,272,327	$	21,272,327	$	21,272,327
Total cash and cash equivalents		21,272,327	$	21,272,327	$	21,272,327

(a)

Included within cash and cash equivalents in Saratoga CLO’s Statements of Assets and Liabilities as of February 28, 2025.

(b)

As of February 28, 2025, the investment was in default and on non-accrual status.

(c)

Investments include Payment-in-Kind Interest.

(d)

All or a portion of this investment has an unfunded commitment as of February 28, 2025.

SOFR - Secured Overnight Financing Rate

1M SOFR - The 1-month SOFR rate as of February 28, 2025 was 4.32%.

3M SOFR - The 3-month SOFR rate as of February 28, 2025 was 4.32%.

6M SOFR - The 6-month SOFR rate as of February 28, 2025 was 4.26%.

Prime - The Prime Rate as of February 28, 2025 was 7.50%.

See accompanying notes to financial statements.

Note 5. Investment in SLF JV

On October 26, 2021, the Company and TJHA entered into the LLC Agreement to co-manage SLF JV. SLF JV is invested in Saratoga Investment Corp Senior Loan Fund 2022-1, Ltd (“SLF 2021”), which is a wholly owned subsidiary of SLF JV. SLF 2021 was formed for the purpose of making investments in a diversified portfolio of broadly syndicated first lien and second lien term loans or bonds in the primary and secondary markets.

On September 30, 2022, SLF 2021 was renamed to Saratoga Investment Corp Senior Loan Fund 2022-1, Ltd. (“SLF 2022”).

The following table shows the schedule of investments for SLF JV as of August 31, 2025:

Company	Industry	Investment Interest Rate/ Maturity	Original Acquistion Date	Principal/Number of Shares		Cost		Fair Value		% of Net Assets
Saratoga Investment Corp Senior Loan Fund 2022-1, Ltd	Structured Finance Securities	Other/Structured Finance Securities, 3.58%, 10/20/2033	10/28/2022		40,100,000	$	28,145,337	$	23,438,159		711.2	%
TOTAL INVESTMENT						$	28,145,337	$	23,438,159		711.2	%

	Number of Shares		Cost		Fair Value		% of Net Assets
Cash and cash equivalents and cash and cash equivalents, reserve accounts
U.S. Bank Money Market		75,470	$	75,470	$	75,470		2.3	%
Total cash and cash equivalents and cash and cash equivalents, reserve accounts		75,740	$	75,740	$	75,470		2.3	%

The following table shows the schedule of investments for SLF JV as of February 28, 2025:

Company	Industry	Investment Interest Rate/ Maturity	Original Acquistion Date	Principal/Number of Shares		Cost		Fair Value		% of Net Assets
Saratoga Investment Corp Senior Loan Fund 2022-1, Ltd	Structured Finance Securities	Other/Structured Finance Securities, 3.00%, 10/20/2033	10/28/2022		40,100,000	$	30,410,415	$	23,676,606		672.4	%
TOTAL INVESTMENTS						$	30,410,415	$	23,676,606		672.4	%

	Number of Shares		Cost		Fair Value		% of Net Assets
Cash and cash equivalents and cash and cash equivalents, reserve accounts
U.S. Bank Money Market		71,444	$	71,444	$	71,444		2.0	%
Total cash and cash equivalents and cash and cash equivalents, reserve accounts		71,444	$	71,444	$	71,444		2.0	%

The Company and TJHA have equal voting interest on all material decisions with respect to SLF JV, including those involving its investment portfolio, and equal control of corporate governance. No management fee is charged to SLF JV as control and management of SLF JV is shared equally.

The Company and TJHA have committed to provide up to a combined $50.0 million of financing to SLF JV through cash contributions, with the Company providing $43.75 million and TJHA providing $6.25 million, resulting in an 87.5% and 12.5% ownership between the two parties. The financing is issued in the form of an unsecured loan and equity. The unsecured loan pays a fixed-rate of 10% per annum and is due and payable in full on October 20, 2033. As of August 31, 2025, the Company and TJHA’s investment in SLF JV consisted of an unsecured loan of $17.6 million and $2.5 million, respectively; and membership interest of $17.6 million and $2.5 million, respectively. As of February 28, 2025, the Company and TJHA’s investment in SLF JV consisted of an unsecured loan of $17.6 million and $2.5 million, respectively; and membership interest of $17.6 million and $2.5 million, respectively. As of August 31, 2025, and February 28, 2025, the Company’s investment in the unsecured note of SLF JV had a fair value of $16.8 million and $16.5 million, respectively, and the Company’s investment in the membership interests of SLF JV had a fair value of $2.9 million and $3.1 million, respectively.

The Company has determined that SLF JV is an investment company under ASC 946; however, in accordance with such guidance the Company will generally not consolidate its investment in a company other than a wholly owned investment company subsidiary. SLF JV is not a wholly owned investment company subsidiary as the Company and TJHA each have an equal 50% voting interest in SLF JV and thus neither party has a controlling financial interest. Furthermore, ASC 810 concludes that in a joint venture where both members have equal decision-making authority, it is not appropriate for one member to consolidate the joint venture since neither has control. Accordingly, the Company does not consolidate SLF JV.

For the three months ended August 31, 2025 and August 31, 2024, the Company earned $0.4 million and $0.4 million, respectively, of interest income related to SLF JV, which is included in interest income. For the six months ended August 31, 2025 and August 31, 2024, the Company earned $0.9 million and $0.9 million, respectively, of interest income related to SLF JV, which is included in interest income. As of August 31, 2025 and February 28, 2025, $0.2 million and $0.2 million, respectively, of interest income related to SLF JV was included in interest receivable on the Statements of Assets and Liabilities.

For the three months ended August 31, 2025 and August 31, 2024, the Company earned $0.9 million and $0.9 million, respectively, of dividend related to SLF JV, which is included in dividend income on control investments. For the six months ended August 31, 2025 and August 31, 2024, the Company earned $1.3 million and $2.2 million, respectively, of dividend related to SLF JV, which is included in dividend income on control investments. As of August 31, 2025 and February 28, 2025, $0.0 million and $0.0 million, respectively, of dividend income related to SLF JV was included in dividend receivable on the Statements of Assets and Liabilities.

SLF JV’s initial investment in SLF 2022 was in the form of an unsecured loan. The unsecured loan paid a floating rate of LIBOR plus 7.00% per annum and was paid in full on June 9, 2023. The unsecured loan was repaid in full on October 28, 2022, as part of the CLO closing.

On October 28, 2022, SLF 2022 issued $402.1 million of the 2022 JV CLO Notes through the JV CLO trust. The 2022 JV CLO Notes were issued pursuant to the JV Indenture, with the Trustee. As part of the transaction, the Company purchased 87.50% of the Class E Notes from SLF 2022 with a par value of $12.25 million. As of August 31, 2025 and February 28, 2025, the fair value of these Class E Notes were $12.3 million and $12.3 million, respectively.

Note 6. Income Taxes

SIA-AAP, Inc., SIA-ARC, Inc., SIA-Avionte, Inc., SIA-AX, Inc., SIA-G4, Inc., SIA-GH, Inc.,, SIA-MDP, Inc., SIA-PP Inc., SIA-SIQ, Inc., SIA-SZ, Inc., SIA-TG, Inc., SIA-TT Inc., and SIA-Vector, Inc. each 100% owned by the Company, are each filing standalone C Corporation tax returns for U.S. federal and state tax purposes. As separately regarded entities for tax purposes, these entities are subject to U.S. federal income tax at corporate rates. For tax purposes, any distributions by the entities to the parent company would generally need to be distributed to the Company’s shareholders. Generally, such distributions of the entities’ income to the Company’s shareholders will be considered as qualified dividends for tax purposes. The entities’ taxable net income will differ from U.S. GAAP net income because of deferred tax temporary differences arising from net operating losses and unrealized appreciation and deprecation of securities held. Deferred tax assets and liabilities are measured using enacted corporate federal and state tax rates expected to apply to taxable income in the years in which those net operating losses are utilized and the unrealized gains and losses are realized. Deferred tax assets and deferred tax liabilities are netted off by entity, as allowed. The recoverability of deferred tax assets is assessed and a valuation allowance is recorded to the extent that it is more likely than not that any portion of the deferred tax asset will not be realized on the basis of a history of operating losses combined with insufficient projected taxable income or other taxable events in the Corporate Blockers.

The Company may distribute a portion of its realized net long term capital gains in excess of realized net short term capital losses to its stockholders, but may also decide to retain a portion, or all, of its net capital gains and elect to pay the 21% U.S. federal tax on the net capital gain, potentially in the form of a “deemed distribution” to its stockholders. Income tax (provision) relating to an election to retain its net capital gains, including in the form of a deemed distribution, is included as a component of income tax (provision) benefit from realized gains on investments, depending on the character of the underlying taxable income (ordinary or capital gains), on the consolidated statements of operations.

Deferred tax assets and liabilities, and related valuation allowance as of August 31, 2025 and February 28, 2025 were as follows:

	August 31, 2025			February 28, 2025
Total deferred tax assets	$	2,111,484		$	1,786,943
Total deferred tax liabilities		(4,865,328	)		(4,968,693	)
Valuation allowance on net deferred tax assets		(1,805,262	)		(1,707,579	)
Net deferred tax liability	$	(4,559,105	)	$	(4,889,329	)

As of August 31, 2025, the valuation allowance on deferred tax assets was $1.8 million, which represents the federal and state tax effect of net operating losses and unrealized losses that the Company does not believe will be realized through future taxable income. Any adjustments to the Company’s valuation allowance will depend on estimates of future taxable income and will be made in the period such determination is made.

Net income tax expense for the three months ended August 31, 2025 includes ($0.4) million deferred tax expense (benefit) on net change in unrealized appreciation (depreciation) on investments, $0.0 million income tax provision/benefit from realized gain/(loss) on investments and $0.0 million net change in total operating expense in the consolidated statement of operations, respectively. Net income tax expense for the three months ended August 31, 2024 includes $0.2 million deferred tax expense (benefit) on net change in unrealized appreciation (depreciation) on investments, and $0.0 million income tax provision/benefit from realized gain/(loss) on investments and $0.12 million net change in total operating expense, in the consolidated statement of operations, respectively.

Net income tax expense for the six months ended August 31, 2025 includes ($0.4) million deferred tax expense (benefit) on net change in unrealized appreciation (depreciation) on investments, and $0.0 million income tax provision/benefit from realized gain/(loss) on investments and $0.04 million net change in total operating expense in the consolidated statement of operations, respectively. Net income tax expense for the six months ended August 31, 2024 includes $0.6 million deferred tax expense (benefit) on net change in unrealized appreciation (depreciation) on investments, and $0.0 million income tax provision/benefit from realized gain/(loss) on investments and $0.06 million net change in total operating expense, in the consolidated statement of operations, respectively.

Deferred tax temporary differences may include differences for state taxes and joint venture interests.

Federal and state income tax (provisions) benefit on investments for three and six months ended August 31, 2025 and August 31, 2024:

	For the three months ended					For the six months ended
	August 31, 2025			August 31, 2024		August 31, 2025			August 31, 2024
Current
Federal	$	-		$	-	$	-		$	-
State		-			-					-
Net current expense		-			-		-			-
Deferred
Federal		(338,262	)		268,114		(239,486	)		590,581
State		(97,049	)		12,993		(90,737	)		36,150
Net deferred expense		(435,312	)		281,107		(330,224	)		626,731
Net tax provision	$	(435,312	)	$	281,107	$	(330,224	)	$	626,731

Note 7. Agreements and Related Party Transactions

Investment Advisory and Management Agreement

On July 30, 2010, the Company entered into the Management Agreement with the Manager. The initial term of the Management Agreement was two years from its effective date, with one-year renewals thereafter subject to certain approvals by the Company’s board of directors and/or the Company’s stockholders. Most recently, on July 7, 2025, the Company’s board of directors approved the renewal of the Management Agreement for an additional one-year term. Pursuant to the Management Agreement, the Manager implements the Company’s business strategy on a day-to-day basis and performs certain services for the Company, subject to oversight by the board of directors. The Manager is responsible for, among other duties, determining investment criteria, sourcing, analyzing and executing investments transactions, asset sales, financings and performing asset management duties. Under the Management Agreement, the Company pays the Manager a management fee for investment advisory and management services consisting of a base management fee and an incentive management fee.

Base Management Fee and Incentive Management Fee

The base management fee of 1.75% per year is calculated based on the average value of our gross assets (other than cash or cash equivalents, but including assets purchased with borrowed funds) at the end of the two most recently completed fiscal quarters. The base management fee is paid quarterly following the filing of the most recent quarterly report on Form 10-Q.

The incentive management fee consists of the following two parts:

The first, payable quarterly in arrears, equals 20% of the Company’s pre-incentive fee net investment income, expressed as a rate of return on the value of our net assets at the end of the immediately preceding quarter, that exceeds a 1.875% quarterly hurdle rate measured as of the end of each fiscal quarter, subject to a “catch-up” provision. Under this provision, in any fiscal quarter, the Manager receives no incentive fee unless our pre-incentive fee net investment income exceeds the hurdle rate of 1.875%. The Manager will receive 100% of pre-incentive fee net investment income, if any, that exceeds the hurdle rate but is less than or equal to 2.344% in any fiscal quarter; and 20% of the amount of our pre-incentive fee net investment income, if any, that exceeds 2.344% in any fiscal quarter. There is no accumulation of amounts on the hurdle rate from quarter to quarter, and accordingly there is no claw back of amounts previously paid if subsequent quarters are below the quarterly hurdle rate, and there is no delay of payment if prior quarters are below the quarterly hurdle rate.

The second part of the incentive fee is determined and payable in arrears as of the end of each fiscal year (or upon termination of the Management Agreement) and equals 20.0% of the Company’s “incentive fee capital gains,” which equals the Company’s realized capital gains on a cumulative basis from May 31, 2010 through the end of the fiscal year, if any, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis on each investment in the Company’s portfolio, less the aggregate amount of any previously paid capital gain incentive fee. Importantly, the capital gains portion of the incentive fee is based on realized gains and realized and unrealized losses from May 31, 2010. Therefore, realized and unrealized losses incurred prior to such time will not be taken into account when calculating the capital gains portion of the incentive fee, and the Manager will be entitled to 20.0% of incentive fee capital gains that arise after May 31, 2010. In addition, for the purpose of the “incentive fee capital gains” calculations, the cost basis for computing realized gains and losses on investments held by us as of May 31, 2010 will equal the fair value of such investments as of such date.

For the three months ended August 31, 2025 and August 31, 2024, the Company incurred $4.4 million and $4.8 million in base management fees, respectively. For the three months ended August 31, 2025 and August 31, 2024, the Company incurred $2.3 million and $4.6 million in incentive fees related to pre-incentive fee net investment income, respectively. For the three months ended August 31, 2025 and August 31, 2024, the Company accrued an expense (benefit) of ($0.8) million and ($0.0) million in incentive fees related to capital gains.

For the six months ended August 31, 2025 and August 31, 2024, the Company incurred $8.7 million and $9.7 million in base management fees, respectively. For the six months ended August 31, 2025 and August 31, 2024, the Company incurred $4.8 million and $8.1 million in incentive fees related to pre-incentive fee net investment income, respectively. For the six months ended August 31, 2025 and August 31, 2024, the Company accrued an expense (benefit) of ($0.3) million and ($0.0) million in incentive fees related to capital gains.

The accrual is calculated using both realized and unrealized capital gains for the period. The actual incentive fee related to capital gains will be determined and payable in arrears at the end of the fiscal year and will include only realized capital gains for the period. As of August 31, 2025, the base management fees accrual was $4.4 million and the incentive fees accrual was $2.3 million and is included in base management and incentive fees payable in the accompanying consolidated statements of assets and liabilities. As of February 28, 2025, the base management fees accrual was $4.2 million and the incentive fees accrual was $2.0 million and are included in base management and incentive fees payable in the accompanying consolidated statements of assets and liabilities.

Administration Agreement

On July 30, 2010, the Company entered into a separate administration agreement (the “Administration Agreement”) with the Manager, pursuant to which the Manager, as the Company’s administrator, has agreed to furnish the Company with the facilities and administrative services necessary to conduct day-to-day operations and provide managerial assistance on the Company’s behalf to those portfolio companies to which the Company is required to provide such assistance. The initial term of the Administration Agreement was two years from its effective date, with one-year renewals thereafter subject to certain approvals by the Company’s board of directors and/or the Company’s stockholders Since its inception the amount of expenses payable or reimbursable by the Company under the Administration Agreement has been subject to a cap that is reviewed annually in connection with the renewal of the Administration Agreement. Most recently, on July 7, 2025, the Company’s board of directors approved the renewal of the Administration Agreement for an additional one-year term, and subsequently also determined to increase the cap on the payment or reimbursement of expenses by the Company from $5.0 million to $5.4 million, effective August 1, 2025. The Company’s board of directors will continue to assess the cap on payment or reimbursement of expenses on an annual basis.

For the three months ended August 31, 2025 and August 31, 2024, the Company recognized $1.3 million and $1.1 million in administrator expenses, respectively, pertaining to bookkeeping, recordkeeping and other administrative services provided to the Company in addition to the Company’s allocable portion of rent and other overhead related expenses.

For the six months ended August 31, 2025 and August 31, 2024, the Company recognized $2.5 million and $2.2 million in administrator expenses, respectively, pertaining to bookkeeping, recordkeeping and other administrative services provided to the Company in addition to the Company’s allocable portion of rent and other overhead related expenses.

As of August 31, 2025 and February 28, 2025, $0.6 million and $0.3 million, respectively, of administrator expenses were accrued and included in due to the Manager in the accompanying consolidated statements of assets and liabilities.

Saratoga CLO

See Note 4. Investment in Saratoga CLO for more information regarding Saratoga CLO.

For the three months ended August 31, 2025 and August 31, 2024, the Company recognized management fee income of $0.7 million and $0.8 million, respectively, related to the Saratoga CLO.

For the six months ended August 31, 2025 and August 31, 2024, the Company recognized management fee income of $1.4 million and $1.6 million, respectively, related to the Saratoga CLO.

For the six months ended August 31, 2025 and August 31, 2024, the Company neither bought nor sold any investments from the Saratoga CLO.

SLF JV

See Note 5. Investment in SLF JV for more information about SLF JV.

As of August 31, 2025, the Company’s investment in the SLF JV had a fair value of $19.7 million, consisting of an unsecured loan of $16.8 million and membership interest of $2.9 million. For the three months ended August 31, 2025, the Company had $0.4 million of interest income related to SLF JV, of which $0.2 million was included in interest receivable as of August 31, 2025. For the three months ended August 31, 2024, the Company had $0.4 million of interest income related to SLF JV, of which $0.2 million was included in interest receivable on the Statements of Assets and Liabilities as of August 31, 2024.

For the six months ended August 31, 2025, the Company had $0.9 million of interest income related to SLF JV, of which $0.2 million was included in interest receivable as of August 31, 2025. For the six months ended August 31, 2024, the Company had $0.9 million of interest income related to SLF JV, of which $0.2 million was included in interest receivable on the Statements of Assets and Liabilities as of August 31, 2024.

As part of the JV CLO trust transaction, the Company purchased 87.50% of the Class E Notes from SLF 2022 with a principal value of $12.3 million and fair value of $12.3 million, respectively.

Note 8. Borrowings

As a BDC, we are only allowed to employ leverage to the extent that our asset coverage, as defined in the 1940 Act, equals at least 200% after giving effect to such leverage, or, 150% if certain requirements under the 1940 Act are met. On April 16, 2018, as permitted by the Small Business Credit Availability Act, which was signed into law on March 23, 2018, our board of directors, including a majority of our directors who are not “interested persons” (as defined in Section 2(a)(19) of the 1940 Act”) of the Company (“independent directors”), approved a minimum asset coverage ratio of 150%, which became effective on April 16, 2019. The amount of leverage that we employ at any time depends on our assessment of the market and other factors at the time of any proposed borrowing. Our asset coverage ratio, as defined in the 1940 Act, was 166.6% as of August 31, 2025 and 162.9% as of February 28, 2025.

Encina Credit Facility

On October 4, 2021, the Company entered into the Credit and Security Agreement (the “Encina Credit Agreement”) relating to a $50.0 million senior secured revolving credit facility with Encina, supported by loans held by SIF II and pledged to the Encina Credit Facility. The terms of the Encina Credit Facility required a minimum drawn amount of $12.5 million at all times during the first six months following the closing date, which increased to the greater of $25.0 million or 50% of the commitment amount in effect at any time thereafter. Advances under the Encina Credit Facility originally bore interest at a floating rate per annum equal to LIBOR plus 4.0%, with LIBOR having a floor of 0.75%, with customary provisions related to the selection by Encina and the Company of a replacement benchmark rate.

On January 27, 2023, we entered into the first amendment to the Encina Credit Agreement to, among other things:

●

increased the borrowings available under the Encina Credit Facility from up to $50.0 million to up to $65.0 million;

●

changed the underlying benchmark used to compute interest under the Encina Credit Agreement from LIBOR to Term SOFR for a one-month tenor plus a 0.10% credit spread adjustment;

●

increased the applicable effective margin rate on borrowings from 4.00% to 4.25%;

●

extended the revolving period from October 4, 2024 to January 27, 2026;

●

extended the period during which the borrower may request one or more increases in the borrowings available under the Encina Credit Facility (each such increase, a “Facility Increase”) from October 4, 2023 to January 27, 2025, and increased the maximum borrowings available pursuant to the Encina Facility Increase from $75.0 million to $150.0 million;

●

revised the eligibility criteria for eligible collateral loans to exclude certain industries in which an obligor or related guarantor may be involved; and

●

amended the provisions permitting the borrower to request an extension in the Commitment Termination Date (as defined in the Encina Credit Agreement) to allow requests to extend any applicable Commitment Termination Date, rather than a one-time request to extend the original Commitment Termination Date, subject to a notice requirement.

In addition to any fees or other amounts payable under the terms of the Encina Credit Facility, an administrative agent fee per annum equal to $0.1 million is payable in equal monthly installments in arrears.

As of August 31, 2025 and February 28, 2025, there were $32.5 million and $32.5 million outstanding borrowings under the Encina Credit Facility. During the applicable periods, the Company was in compliance with all of the limitations and requirements under the Encina Credit Agreement. Financing costs of $2.0 million related to the Encina Credit Facility have been capitalized and are being amortized over the term of the facility, with all existing financing costs amortized through January 27, 2026 from the date of the amendment and extension.

For the three months ended August 31, 2025 and August 31, 2024, we recorded $0.8 million and $0.8 million of interest expense related to the Encina Credit Facility, respectively, which includes commitment and administrative agent fees. For the three months ended August 31, 2025 and August 31, 2024, we recorded $0.1 million and $0.1 million of deferred financing costs related to the Encina Credit Facility, respectively. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the three months ended August 31, 2025 and August 31, 2024, the weighted average interest rate on the outstanding borrowings under the Encina Credit Facility was 8.9% and 9.9%, respectively, and the average dollar amount of outstanding borrowings under the Encina Credit Facility was $32.5 million and $32.5 million, respectively.

For the six months ended August 31, 2025 and August 31, 2024, we recorded $1.6 million and $1.7 million of interest expense related to the Encina Credit Facility, respectively, which includes commitment and administrative agent fees. For the six months ended August 31, 2025 and August 31, 2024, we recorded $0.2 million and $0.2 million of deferred financing costs related to the Encina Credit Facility, respectively. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the six months ended August 31, 2025 and August 31, 2024, the weighted average interest rate on the outstanding borrowings under the Encina Credit Facility was 8.9% and 9.9%, respectively, and the average dollar amount of outstanding borrowings under the Encina Credit Facility was $32.5 million and $33.6 million, respectively

The Encina Credit Facility contains limitations as to how borrowed funds may be used, such as restrictions on industry concentrations, asset size, weighted average life, currency denomination and collateral interests. The Encina Credit Facility also includes certain requirements relating to portfolio performance, the violation of which could result in the limit of further advances and, in some cases, result in an event of default, allowing the lenders to accelerate repayment of amounts owed thereunder. Availability on the Encina Credit Facility will be subject to a borrowing base calculation, based on, among other things, applicable advance rates (which vary from 50.0% to 75.0% of par or fair value depending on the type of loan asset) and the value of certain “eligible” loan assets included as part of the borrowing base. Funds may be borrowed at the greater of the prevailing one-month SOFR rate, plus an applicable effective margin of 4.25%. In addition, the Company will pay the lender a commitment fee of 0.75% per year (or 0.50% if the ratio of advances outstanding to aggregate commitments is greater than or equal to 50%) on the unused amount of the Encina Credit Facility.

Our borrowing base under the Encina Credit Facility was $78.4 million subject to the Encina Credit Facility cap of $65.0 million at August 31, 2025. For purposes of determining the borrowing base, most assets are assigned the values set forth in our most recent Annual Report on Form 10-K or Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission (“SEC”). Accordingly, the August 31, 2025 borrowing base relies upon the valuations set forth in the Quarterly Report on Form 10-Q for the period ended May 31, 2025. The valuations presented in this Quarterly Report on Form 10-Q will not be incorporated into the borrowing base until after this Quarterly Report on Form 10-Q is filed with the SEC.

Live Oak Credit Facility

On March 27, 2024, the Company and its wholly owned special purpose subsidiary, SIF III, entered into a credit and security agreement (the “Live Oak Credit Agreement”), by and among SIF III, as borrower, the Company, as collateral manager and equity holder, the lenders from time to time parties thereto, Live Oak, as administrative agent and collateral agent, U.S. Bank National Association, as custodian, and U.S. Bank Trust Company, National Association, as collateral administrator, relating to Live Oak Credit Facility.

The Live Oak Credit Facility originally provided for borrowings in U.S. dollars in an aggregate amount of up to $50.0 million. During the first two years following the closing date, SIF III may request one or more increases in the commitment amount from $50.0 million to an amount not to exceed $150.0 million, subject to certain terms and conditions and a customary fee. The terms of the Live Oak Credit Agreement required a minimum drawn amount of $12.5 million at all times during the period ended March 27, 2025 and, thereafter, the greater of: (i) $25.0 million and (ii) 50% of the facility amount in effect at such time. The Live Oak Credit Facility matures on March 27, 2027. Advances are available during the term of the Live Oak Credit Facility and must be repaid in full at maturity. SIF III may request an extension of the maturity date by an additional one year, subject to the agreement of the lenders and an extension fee.

On June 14, 2024, the Company entered into the first amendment to the Live Oak Credit Agreement (the “Amendment”). The Amendment, among other things:

●

increased the borrowings available under the Live Oak Credit Facility from up to $50.0 million to up to $75.0 million, subject to a borrowing base requirement;

●

replaced administrative agent approval with “Required Lender” (as defined in the Live Oak Credit Agreement) approval with respect to certain matters;

●

replaced Required Lender approval with 100% lender approval with respect to certain matters; and

●

added new lenders (as identified in the Amendment) to the Live Oak Credit Agreement;

●

changed the definition of Required Lender to require the approval of at least two unaffiliated lenders.

Advances under the Live Oak Credit Facility are subject to a borrowing base calculation, and the Live Oak Credit Facility has various eligibility criteria for loans to be included in the borrowing base. Advances under the Live Oak Credit Facility bear interest at a floating rate per annum equal to Adjusted Term SOFR plus an applicable margin between 3.50% and 4.25% based on the Live Oak Credit Facility’s utilization. The Live Oak Credit Agreement also provides for an unused fee of 0.50% on the unused commitments. SIF III’s obligations to the lenders under the Live Oak Credit Facility are secured by a first priority security interest in substantially all of SIF III’s assets. In addition, SIF III’s obligations to the lenders under the Live Oak Credit Facility are secured by a pledge by the Company of its equity interests in SIF III, which is evidenced by the equity pledge agreement, dated as of March 27, 2024, by and between the Company, as pledgor, and Live Oak, as collateral agent for the benefit of the secured parties.

In connection with the Live Oak Credit Agreement, the Company entered into a loan sale and contribution agreement with SIF III, dated as of March 27, 2024, by and between the Company, as seller, and SIF III, as purchaser, pursuant to which the Company will sell or contribute certain loans held by the Company to SIF III to be used to support the borrowing base under the Live Oak Credit Facility. The Live Oak Credit Facility permits loan proceeds and excess cash in SIF III’s collection accounts to be distributed to us at any time based on three business days advance notice, subject to compliance with various conditions, including the absence of a default or event of default, the absence of an over-advance against the borrowing base and the absence of a violation of the financial covenant.

As of August 31, 2025 and February 28, 2025, there were $37.5 million and $20.0 million in outstanding borrowings under the Live Oak Credit Facility. During the applicable period, the Company was in compliance with all of the limitations and requirements under the Live Oak Credit Agreement.

For the three months ended August 31, 2025 and August 31, 2024, we recorded $0.9 million and $0.5 million of interest expense related to the Live Oak Credit Facility, respectively, which includes commitment and administrative agent fees. For the three months ended August 31, 2025 and August 31, 2024, we recorded $0.1 million and $0.1 million of deferred financing costs related to the Live Oak Credit Facility. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the three months ended August 31, 2025 and August 31, 2024, the weighted average interest rate on the outstanding borrowings under the Live Oak Credit Facility was 8.5% and 9.6% respectively, and the average dollar amount of outstanding borrowings under the Live Oak Credit Facility was $37.5 million and $19.0 million, respectively.

For the six months ended August 31, 2025 and August 31, 2024, we recorded $1.6 million and $0.8 million of interest expense related to the Live Oak Credit Facility, respectively, which includes commitment and administrative agent fees. For the six months ended August 31, 2025 and August 31, 2024, we recorded $0.2 million and $0.1 million of deferred financing costs related to the Live Oak Credit Facility. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the six months ended August 31, 2025 and August 31, 2024, the weighted average interest rate on the outstanding borrowings under the Live Oak Credit Facility was 8.5% and 9.5% respectively, and the average dollar amount of outstanding borrowings under the Live Oak Credit Facility was $37.5 million and $16.0 million, respectively.

Our borrowing base under the Live Oak Credit Facility was $77.3 million subject to the Live Oak Credit Facility cap of $75.0 million at August 31, 2025. For purposes of determining the borrowing base, most assets are assigned the values set forth in our most recent Annual Report on Form 10-K or Quarterly Report on Form 10-Q filed with the SEC. Accordingly, the August 31, 2025 borrowing base relies upon the valuations set forth in the Quarterly Report on Form 10-Q for the period ended May 31, 2025. The valuations presented in this Quarterly Report on Form 10-Q will not be incorporated into the borrowing base until after this Quarterly Report on Form 10-Q is filed with the SEC.

SBA Debentures

The Company’s wholly owned subsidiaries, SBIC II LP and SBIC III LP, received SBIC licenses from the SBA on August 14, 2019 and September 29, 2022, respectively. Each of the SBIC Subsidiaries provide up to $175.0 million in long-term capital in the form of debentures guaranteed by the SBA. The Company’s wholly owned subsidiary, SBIC LP, repaid its outstanding debentures and subsequently surrendered its license to the SBA on January 3, 2024, providing the Company access to all undistributed capital of SBIC LP, and SBIC LP subsequently merged with and into the Company. Under current SBIC regulations, for two or more SBICs under common control, the maximum amount of outstanding SBA debentures cannot exceed $350.0 million.

SBICs are designed to stimulate the flow of private equity capital to eligible small businesses. Under SBA regulations, SBICs may make loans to eligible small businesses and invest in the equity securities of small businesses. Under present SBA regulations, eligible small businesses include businesses that have a tangible net worth not exceeding $24.0 million and have average annual fully taxed net income not exceeding $8.0 million for the two most recent fiscal years. In addition, an SBIC must devote 25.0% of its investment activity to “smaller enterprises” as defined by the SBA. A smaller enterprise is one that has a net worth not exceeding $6.0 million and has an average annual fully taxed net income not exceeding $2.0 million for the two most recent fiscal years. SBA regulations also provide alternative size standard criteria to determine eligibility, which depend on the industry in which the business is engaged and are based on such factors as the number of employees and gross sales. According to SBA regulations, SBICs may make long-term loans to small businesses, invest in the equity securities of such businesses and provide them with consulting and advisory services.

The SBIC Subsidiaries are able to borrow funds from the SBA against each SBIC’s regulatory capital (which generally approximates equity capital in the respective SBIC). The SBIC Subsidiaries are subject to customary regulatory requirements including but not limited to, a periodic examination by the SBA and requirements to maintain certain minimum financial ratios and other covenants. Receipt of an SBIC license does not assure that the SBIC Subsidiaries will receive SBA-guaranteed debenture funding, which is dependent upon the SBIC Subsidiaries complying with SBA regulations and policies. The SBA, as a creditor, will have a superior claim to each SBIC Subsidiary’s assets over the Company’s stockholders and debtholders in the event that the Company liquidates such SBIC Subsidiary or the SBA exercises its remedies under the SBA-guaranteed debentures issued by the SBIC Subsidiary upon an event of default.

The Company received exemptive relief from the SEC to permit it to exclude the debentures guaranteed by the SBA of the SBIC Subsidiaries from the definition of senior securities in the asset coverage test under the 1940 Act. This allows the Company increased flexibility under the asset coverage requirement by permitting it to borrow up to $350.0 million more than it would otherwise be able to absent the receipt of this exemptive relief.

As of August 31, 2025, we have funded SBIC II LP and SBIC III LP with an aggregate total of equity capital of $87.5 million and $87.5 million, respectively, and have $170.0 million in SBA-guaranteed debentures outstanding, of which $131.0 million was held by SBIC II LP and $39.0 million held in SBIC III LP.

As noted above, as of August 31, 2025, there was $170.0 million of SBA debentures outstanding and as of February 28, 2025, there was $170.0 million of SBA debentures outstanding. The carrying amount of the amount outstanding of SBA debentures approximates its fair value, which is based on a waterfall analysis showing adequate collateral coverage and would be classified as a Level 3 liability within the fair value hierarchy. Financing costs of $6.0 million, and $0.4 million related to the SBA debentures issued by SBIC II LP and SBIC III LP, respectively, have been capitalized and are being amortized over the term of the commitment and drawdown.

For the three months ended August 31, 2025 and August 31, 2024, the Company recorded $1.3 million and $1.8 million of interest expense related to the SBA debentures, respectively. For the three months ended August 31, 2025 and August 31, 2024, the Company recorded $0.2 million and $0.2 million of amortization of deferred financing costs related to the SBA debentures, respectively. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. The weighted average interest rate during the three months ended August 31, 2025 and August 31, 2024 on the outstanding borrowings of the SBA debentures was 3.0% and 3.3%, respectively. During the three months ended August 31, 2025 and August 31, 2024, the average dollar amount of SBA debentures outstanding was $170.0 million and $214.0 million, respectively.

For the six months ended August 31, 2025 and August 31, 2024, the Company recorded $2.6 million and $3.6 million of interest expense related to the SBA debentures, respectively. For the six months ended August 31, 2025 and August 31, 2024, the Company recorded $0.4 million and $0.5 million of amortization of deferred financing costs related to the SBA debentures, respectively. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. The weighted average interest rate during the six months ended August 31, 2025 and August 31, 2024 on the outstanding borrowings of the SBA debentures was 3.0% and 3.35%, respectively. During the six months ended August 31, 2025 and August 31, 2024, the average dollar amount of SBA debentures outstanding was $170.0 million and $214.0 million, respectively.

Notes

7.75% 2025 Notes

On July 9, 2020, the Company issued $5.0 million in aggregate principal amount of 7.75% fixed-rate notes due in 2025 (the “7.75% 2025 Notes”) for net proceeds of $4.8 million after deducting underwriting commissions of approximately $0.2 million. Offering costs incurred were approximately $0.1 million. Interest on the 7.75% 2025 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 7.75% per year. The 7.75% 2025 Notes mature on July 9, 2025 and may be redeemed in whole or in part at any time or from time to time at the Company’s option subject to a fee depending on the date of repayment. The net proceeds from the offering were used for general corporate purposes in accordance with the Company’s investment objective and strategies. Financing costs of $0.3 million related to the 7.75% 2025 Notes have been capitalized and are being amortized over the term of the 7.75% 2025 Notes.

On July 9, 2025, $5.0 million in aggregate principal amount of the issued and outstanding 7.75% 2025 Notes was repaid in full.

For the three months ended August 31, 2025 and August 31, 2024, the Company recorded $0.04 million and $0.1 million, respectively, of interest expense and $0.01 million and $0.01 million, respectively, of amortization of deferred financing costs related to the 7.75% 2025 Notes. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the three months ended August 31, 2025 and August 31, 2024, the average dollar amount of 7.75% 2025 Notes outstanding was $2.1 million and $5.0 million, respectively.

For the six months ended August 31, 2025 and August 31, 2024, the Company recorded $0.1 million and $0.2 million, respectively, of interest expense and $0.02 million and $0.02 million, respectively, of amortization of deferred financing costs related to the 7.75% 2025 Notes. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the six months ended August 31, 2025 and August 31, 2024, the average dollar amount of 7.75% 2025 Notes outstanding was $3.5 million and $5.0 million, respectively.

6.25% 2027 Notes

On December 29, 2020, the Company issued $5.0 million in aggregate principal amount of 6.25% fixed-rate notes due in 2027 (the “6.25% 2027 Notes”). Offering costs incurred were approximately $0.1 million. Interest on the 6.25% 2027 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 6.25% per year. The 6.25% 2027 Notes mature on December 29, 2027 and may be redeemed in whole or in part at any time or from time to time at the Company’s option, on or after December 29, 2024. The net proceeds from the offering were used for general corporate purposes in accordance with the Company’s investment objective and strategies. Financing costs of $0.1 million related to the 6.25% 2027 Notes have been capitalized and are being amortized over the term of the Notes.

On January 28, 2021, the Company issued an additional $10.0 million in aggregate principal amount of the 6.25% 2027 Notes for net proceeds of $9.7 million after deducting underwriting commissions of approximately $0.3 million (the “Additional 6.25% 2027 Notes”). Offering costs incurred were approximately $0.1 million. The Additional 6.25% 2027 Notes are treated as a single series with the existing 6.25% 2027 Notes under the indenture and have the same terms as the existing 6.25% 2027 Notes. Interest on the 6.25% 2027 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 6.25% per year. The 6.25% 2027 Notes mature on January 28, 2027 and commencing January 28, 2023, may be redeemed in whole or in part at any time or from time to time at the Company’s option. The net proceeds from the offering were used for general corporate purposes in accordance with the Company’s investment objective and strategies. Financing costs of $0.4 million related to the 6.25% 2027 Notes have been capitalized and are being amortized over the term of the 6.25% 2027 Notes. The 6.25% 2027 Notes are not listed and have a par value of $25.00 per note.

As of August 31, 2025, the total amount of 6.25% 2027 Notes outstanding was $15.0 million. The 6.25% 2027 Notes are not listed and have a par value of $25.00 per note. The carrying amount of the outstanding 6.25% 2027 Notes had a fair value of $14.7 million, which is based on a market yield analysis and would be classified as a Level 3 liability within the fair value hierarchy. As of February 28, 2025, the carrying amount and fair value of the 6.25% 2027 Notes was $15.0 million and $14.2 million, respectively.

For the three months ended August 31, 2025 and August 31, 2024, the Company recorded $0.2 million and $0.2 million, respectively, of interest expense and $0.02 million and $0.02 million, respectively, of amortization of deferred financing costs related to the 6.25% 2027 Notes. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the three months ended August 31, 2025 and August 31, 2024 the average dollar amount of 6.25% 2027 Notes outstanding was $15.0 million and $15.0 million, respectively.

For the six months ended August 31, 2025 and August 31, 2024, the Company recorded $0.5 million and $0.5 million, respectively, of interest expense and $0.04 million and $0.04 million, respectively, of amortization of deferred financing costs related to the 6.25% 2027 Notes. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the six months ended August 31, 2025 and August 31, 2024 the average dollar amount of 6.25% 2027 Notes outstanding was $15.0 million and $15.0 million, respectively.

4.375% 2026 Notes

On March 10, 2021, the Company issued $50.0 million in aggregate principal amount of 4.375% fixed-rate notes due 2026 (the “4.375% 2026 Notes”) for net proceeds of $49.0 million after deducting underwriting commissions of approximately $1.0 million. Offering costs incurred were approximately $0.3 million. Interest on the 4.375% 2026 Notes is paid semi-annually in arrears on February 28 and August 28, at a rate of 4.375% per year. The 4.375% 2026 Notes mature on February 28, 2026 and may be redeemed in whole or in part at any time on or after November 28, 2025 at par plus a “make-whole” premium, and thereafter at par. The net proceeds from the offering were used for general corporate purposes in accordance with the Company’s investment objective and strategies. Financing costs of $1.3 million related to the 4.375% 2026 Notes have been capitalized and are being amortized over the term of the 4.375% 2026 Notes.

On July 15, 2021, the Company issued an additional $125.0 million in aggregate principal amount of the 4.375% 2026 Notes (the “Additional 4.375% 2026 Notes”) for net proceeds for approximately $123.8 million, based on the public offering price of 101.00% of the aggregate principal amount of the Additional 4.375% 2026 Notes, after deducting the underwriting commissions of $2.5 million. Offering costs incurred were approximately $0.2 million. The Additional 4.375% 2026 Notes are treated as a single series with the existing 4.375% 2026 Notes under the indenture and have the same terms as the existing 4.375% 2026 Notes. The net proceeds from the offering were used to redeem all of the outstanding 6.25% 2025 Notes (as described above), and for general corporate purposes in accordance with the Company’s investment objective and strategies. Financing costs of $2.7 million have been capitalized and are being amortized over the term of the additional 4.375% 2026 Notes.

As of August 31, 2025, the total amount of 4.375% 2026 Notes outstanding was $175.0 million. The 4.375% 2026 Notes are not listed and are issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof. The carrying amount of the outstanding 4.375% 2026 Notes had a fair value of $171.0 million, which is based on a market yield analysis and would be classified as a Level 3 liability within the fair value hierarchy. As of February 28, 2025, the carrying amount and fair value of the 4.375% 2026 Notes was $175.0 million and $163.4 million, respectively.

For the three months ended August 31, 2025 and August 31, 2024, the Company recorded $1.9 million and $1.9 million, respectively, of interest expense, $0.2 million and $0.1 million, respectively, of amortization of deferred financing costs and $0.06 million and $0.06 million, respectively, of amortization of premium on issuance of 4.375% Notes due 2026 (inclusive of the issuance of the Additional 4.375% 2026 Notes). Interest expense, amortization of deferred financing costs and amortization of premium on issuance of notes are reported as interest and debt financing expense on the consolidated statements of operations. During the three months ended August 31, 2025 and August 31, 2024, the average dollar amount of 4.375% 2026 Notes outstanding was $175.0 million and $175.0 million, respectively.

For the six months ended August 31, 2025 and August 31, 2024, the Company recorded $3.8 million and $3.8 million, respectively, of interest expense, $0.3 million and $0.3 million, respectively, of amortization of deferred financing costs and $0.1 million and $0.1 million, respectively, of amortization of premium on issuance of 4.375% Notes due 2026 (inclusive of the issuance of the Additional 4.375% 2026 Notes). Interest expense, amortization of deferred financing costs and amortization of premium on issuance of notes are reported as interest and debt financing expense on the consolidated statements of operations. During the six months ended August 31, 2025 and August 31, 2024, the average dollar amount of 4.375% 2026 Notes outstanding was $175.0 million and $175.0 million, respectively.

4.35% 2027 Notes

On January 19, 2022, the Company issued $75.0 million in aggregate principal amount of 4.35% fixed-rate notes due in 2027 (the “4.35% 2027 Notes”) for net proceeds of $73.0 million, based on the public offering price of 99.317% of the aggregate principal amount of the 4.35% 2027 Notes, after deducting the underwriting commissions of approximately $1.5 million. Offering costs incurred were approximately $0.3 million. Interest on the 4.35% 2027 Notes is paid semi-annually in arrears on February 28 and August 28, at a rate of 4.35% per year. The 4.35% 2027 Notes mature on February 28, 2027 and may be redeemed in whole or in part at the Company’s option at any time prior to November 28, 2026, at par plus a “make-whole” premium, and thereafter at par. The net proceeds from the offering were used for general corporate purposes in accordance with the Company’s investment objective and strategies. Financing costs of $1.8 million related to the 4.35% 2027 Notes have been capitalized and are being amortized over the term of the 4.35% 2027 Notes

As of August 31, 2025, the total amount of 4.35% 2027 Notes outstanding was $75.0 million. The 4.35% 2027 Notes are not listed. The carrying amount of the outstanding 4.35% 2027 Notes had a fair value of $71.2 million, which is based on a market yield analysis and would be classified as a Level 3 liability within the fair value hierarchy. As of February 28, 2025, the carrying amount and fair value of the 4.35% 2027 Notes was $75.0 million and $64.5 million, respectively.

For the three months ended August 31, 2025 and August 31, 2024, the Company recorded $0.8 million and $0.8 million, respectively, of interest expense, $0.1 million and $0.1 million, respectively, of amortization of deferred financing costs and $0.03 million and $0.03 million, respectively, of amortization of on issuance of the 4.35% Notes due 2027 (inclusive of the issuance of the Additional 4.35% 2027 Notes). Interest expense, amortization of deferred financing costs, and amortization of discount on issuance of notes and deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the three months ended August 31, 2025 and August 31, 2024, the average dollar amount of 4.35% 2027 Notes outstanding was $75.0 million and $75.0 million, respectively.

For the six months ended August 31, 2025 and August 31, 2024, the Company recorded $1.6 million and $1.6 million, respectively, of interest expense, $0.2 million and $0.2 million, respectively, of amortization of deferred financing costs and $0.06 million and $0.06 million, respectively, of amortization of on issuance of the 4.35% Notes due 2027 (inclusive of the issuance of the Additional 4.35% 2027 Notes). Interest expense, amortization of deferred financing costs, and amortization of discount on issuance of notes and deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the six months ended August 31, 2025 and August 31, 2024, the average dollar amount of 4.35% 2027 Notes outstanding was $75.0 million and $75.0 million, respectively.

6.00% 2027 Notes

On April 27, 2022, the Company issued $87.5 million in aggregate principal amount of 6.00% fixed-rate notes due 2027 (the “6.00% 2027 Notes”) for net proceeds of $84.8 million after deducting underwriting commissions of approximately $2.7 million. Offering costs incurred were approximately $0.1 million. On May 10, 2022, the underwriters partially exercised their option to purchase an additional $10.0 million in aggregate principal amount of the 6.00% 2027 Notes. Net proceeds to the Company were $9.7 million after deducting underwriting commissions of approximately $0.3 million. Interest on the 6.00% 2027 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 6.00% per year. The 6.00% 2027 Notes mature on April 30, 2027 and commencing April 27, 2024, may be redeemed in whole or in part at any time or from time to time at the Company’s option. The net proceeds from the offering were used for general corporate purposes in accordance with the Company’s investment objective and strategies. Financing costs of $3.3 million related to the 6.00% 2027 Notes have been capitalized and are being amortized over the term of the 6.00% 2027 Notes. The 6.00% 2027 Notes are listed on the NYSE under the trading symbol “SAT” with a par value of $25.00 per note.

On August 15, 2022, the Company issued an additional $8.0 million in aggregate principal amount of the 6.00% 2027 Notes (the “Additional 6.00% 2027 Notes”) for net proceeds of $7.8 million, based on the public offering price of 97.80% of the aggregate principal amount of the 6.00% 2027 Notes. Additional offering costs incurred were approximately $0.2 million. The Additional 6.00% 2027 Notes are treated as a single series with the existing 6.00% 2027 Notes under the indenture and have the same terms as the existing 6.00% 2027 Notes. The net proceeds from the offering were used for general corporate purposes in accordance with the Company’s investment objective and strategies. Additional financing costs of $0.03 million related to the 6.00% 2027 Notes have been capitalized and are being amortized over the term of the 6.00% 2027 Notes.

As of August 31, 2025, the carrying amount and fair value of the 6.00% 2027 Notes was $105.5 million and $105.0 million, respectively. The fair value of the 6.00% 2027 Notes, which are publicly traded, is based upon closing market quotes as of the measurement date and would be classified as a Level 1 liability within the fair value hierarchy. As of February 28, 2025, the carrying amount and fair value of the 6.00% 2027 Notes was $105.5 million and $100.7 million, respectively.

For the three months ended August 31, 2025 and August 31, 2024, the Company recorded $1.6 million and $1.6 million, respectively, of interest expense, $0.2 million and $0.2 million, respectively, of amortization of deferred financial costs and $0.01 million and $0.01 million, respectively, of amortization of discount on issuance of 6.00% Notes due 2027. Interest expense and amortization of discount and deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the three months ended August 31, 2025 and August 31, 2024, the average dollar amount of 6.00% 2027 Notes outstanding was $105.5 million and $105.5 million, respectively.

For the six months ended August 31, 2025 and August 31, 2024, the Company recorded $3.2 million and $3.2 million, respectively, of interest expense, $0.4 million and $0.4 million, respectively, of amortization of deferred financial costs and $0.02 million and $0.02 million, respectively, of amortization of discount on issuance of 6.00% Notes due 2027. Interest expense and amortization of discount and deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the six months ended August 31, 2025 and August 31, 2024, the average dollar amount of 6.00% 2027 Notes outstanding was $105.5 million and $105.5 million, respectively.

7.00% 2025 Notes

On September 8, 2022, the Company issued $12.0 million in aggregate principal amount of 7.00% fixed-rate notes due 2025 (the “7.00% 2025 Notes”) for net proceeds of $11.6 million after deducting underwriting discounts of approximately $0.4 million. Additional offering costs incurred were approximately $0.05 million. Interest on the 7.00% 2025 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 7.00% per year. The 7.00% 2025 Notes mature on September 8, 2025 and commencing September 8, 2024, may be redeemed in whole or in part at any time or from time to time at the Company’s option. The net proceeds from the offering were used for general corporate purposes in accordance with the Company’s investment objective and strategies. Financing costs of $0.04 million related to the 7.00% 2025 Notes have been capitalized and are being amortized over the term of the 7.00% 2025 Notes.

As of August 31, 2025, the total amount of 7.00% 2025 Notes outstanding was $12.0 million. The 7.00% 2025 Notes are not listed. The carrying amount of the outstanding 7.00% 2025 Notes had a fair value of $12.0 million, which is based on a market yield analysis and would be classified as a Level 3 liability within the fair value hierarchy. As of February 28, 2025, the carrying amount and fair value of the 7.00% 2025 Notes was $12.0 million and $11.8 million, respectively.

For the three months ended August 31, 2025 and August 31, 2024, the Company recorded $0.2 million and $0.2 million, respectively, of interest expense, $0.04 million and $0.03 million, respectively, of amortization of deferred financial costs and $0.04 million and $0.03 million, respectively, of amortization of discount on issuance of 7.00% 2025 Notes. Interest expense and amortization of discount and deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the three months ended August 31, 2025 and August 31, 2024, the average dollar amount of 7.00% 2025 Notes outstanding was $12.0 million and $12.0 million, respectively.

For the six months ended August 31, 2025 and August 31, 2024, the Company recorded $0.4 million and $0.4 million, respectively, of interest expense, $0.07 million and $0.07 million, respectively, of amortization of deferred financial costs and $0.07 million and $0.06 million, respectively, of amortization of discount on issuance of 7.00% 2025 Notes. Interest expense and amortization of discount and deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the six months ended August 31, 2025 and August 31, 2024, the average dollar amount of 7.00% 2025 Notes outstanding was $12.0 million and $12.0 million, respectively.

8.00% 2027 Notes

On October 27, 2022, the Company issued $40.0 million in aggregate principal amount of our 8.00% fixed-rate notes due 2027 (the “8.00% 2027 Notes”) for net proceeds of $38.7 million after deducting underwriting commissions of approximately $1.3 million. Offering costs incurred were approximately $0.2 million. On November 10, 2022, the underwriters partially exercised their option to purchase an additional $6.0 million in aggregate principal amount of the 8.00% 2027 Notes. Net proceeds to the Company were $5.8 million after deducting underwriting commissions of approximately $0.2 million. Interest on the 8.00% 2027 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 8.00% per year. The 8.00% 2027 Notes mature on October 31, 2027 and commencing October 27, 2024, may be redeemed in whole or in part at any time or from time to time at the Company’s option. The net proceeds from the offering were used for general corporate purposes in accordance with the Company’s investment objective and strategies. Financing costs of $1.7 million related to the 8.00% 2027 Notes have been capitalized and are being amortized over the term of the 8.00% 2027 Notes. The 8.00% 2027 Notes are listed on the NYSE under the trading symbol “SAJ” with a par value of $25.00 per note.

As of August 31, 2025, the carrying amount and fair value of the 8.00% 2027 Notes was $46.0 million and $46.9 million, respectively. The fair value of the 8.00% 2027 Notes, which are publicly traded, is based upon closing market quotes as of the measurement date and would be classified as a Level 1 liability within the fair value hierarchy. As of February 28, 2025, the carrying amount and fair value of the 8.00% 2027 Notes was $46.0 million and $46.2 million, respectively.

For the three months ended August 31, 2025 and August 31, 2024, the Company recorded $0.9 million and $0.9 million, respectively, of interest expense and $0.09 million and $0.09 million, respectively, of amortization of deferred financing costs related to the 8.00% 2027 Notes. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the three months ended August 31, 2025 and August 31, 2024, the average dollar amount of 8.00% 2027 Notes outstanding was $46.0 million and $46.0 million, respectively.

For the six months ended August 31, 2025 and August 31, 2024, the Company recorded $1.8 million and $1.8 million, respectively, of interest expense and $0.2 million and $0.2 million, respectively, of amortization of deferred financing costs related to the 8.00% 2027 Notes. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the six months ended August 31, 2025 and August 31, 2024, the average dollar amount of 8.00% 2027 Notes outstanding was $46.0 million and $46.0 million, respectively

8.125% 2027 Notes

On December 13, 2022, the Company issued $52.5 million in aggregate principal amount of 8.125% fixed-rate notes due 2027 (the “8.125% 2027 Notes”) for net proceeds of $50.8 million after deducting underwriting commissions of approximately $1.6 million. Offering costs incurred were approximately $0.1 million. On December 21, 2022, the underwriters fully exercised their option to purchase an additional $7.9 million in aggregate principal amount of the 8.125% 2027 Notes. Net proceeds to the Company were $7.6 million after deducting underwriting commissions of approximately $0.2 million. Interest on the 8.125% 2027 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 8.125% per year. The 8.125% 2027 Notes mature on December 31, 2027 and commencing December 13, 2024, may be redeemed in whole or in part at any time or from time to time at the Company’s option. The net proceeds from this offering were used to make investments in middle-market companies (including investments made through our SBIC Subsidiaries) in accordance with the Company’s investment objective and strategies and for general corporate purposes. Financing costs of $2.0 million related to the 8.125% 2027 Notes have been capitalized and are being amortized over the term of the 8.125% 2027 Notes. The 8.125% 2027 Notes are listed on the NYSE under the trading symbol “SAY” with a par value of $25.00 per note

As of August 31, 2025, the carrying amount and fair value of the 8.125% 2027 Notes was $60.4 million and $61.6 million, respectively. The fair value of the 8.125% 2027 Notes, which are publicly traded, is based upon closing market quotes as of the measurement date and would be classified as a Level 1 liability within the fair value hierarchy. As of February 28, 2025, the carrying amount and fair value of the 8.125% 2027 Notes was $60.4 million and $61.0 million, respectively.

For the three months ended August 31, 2025 and August 31, 2024, the Company recorded $1.2 million and $1.2 million, respectively, of interest expense and $0.1 million and $0.1 million, respectively, of amortization of deferred financing costs related to the 8.125% 2027 Notes. Interest expense and amortization of discount and deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the three months ended August 31, 2025 and August 31, 2024 the average dollar amount of 8.125% 2027 Notes outstanding was $60.4 million and $60.4 million, respectively.

For the six months ended August 31, 2025 and August 31, 2024, the Company recorded $2.5 million and $2.5 million, respectively, of interest expense and $0.2 million and $0.2 million, respectively, of amortization of deferred financing costs related to the 8.125% 2027 Notes. Interest expense and amortization of discount and deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the six months ended August 31, 2025 and August 31, 2024 the average dollar amount of 8.125% 2027 Notes outstanding was $60.4 million and $60.4 million, respectively.

8.75% 2025 Notes

On March 31, 2023, the Company issued $10.0 million in aggregate principal amount of 8.75% fixed-rate notes due 2024 (the “8.75% 2025 Notes”) for net proceeds of $9.7 million after deducting underwriting discounts of approximately $0.4 million. On May 1, 2023, the Company issued an additional $10.0 million in aggregate principal amount of the 8.75% 2025 Notes for net proceeds of $9.7 million after deducting underwriting discounts of approximately $0.4 million. Offering costs incurred were approximately $0.03 million. Interest on the 8.75% 2025 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 8.75% per year. On February 2, 2024, pursuant to the terms of the indenture governing the 8.75% 2025 Notes, the Company elected to exercise its option to extend the maturity date of the 8.75% 2025 Notes from March 31, 2024 to March 31, 2025. Net proceeds from this offering were used to make investments in middle-market companies (including investments made through the SBIC Subsidiaries) in accordance with the Company’s investment objective and strategies and general corporate purposes. Financing costs and discounts of $0.7 million related to the 8.75% 2025 Notes have been capitalized and are being amortized over the term of the 8.75% 2025 Notes.

On March 31, 2025, $20.0 million in aggregate principal amount of the issued and outstanding 8.75% 2025 Notes was repaid in full.

For the three months ended August 31, 2025 and August 31, 2024, the Company recorded $0.0 million and $0.4 million, respectively, of interest expense, $0.00 million and $0.03 million, respectively, of amortization of deferred financial costs and $0.00 million and $0.03 million, respectively, of amortization of discount related to the 8.75% 2025 Notes. Interest expense and amortization of discount and deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the three months ended August 31, 2025 and August 31, 2024 the average dollar amount of 8.75% 2025 Notes outstanding was $0.0 million and $20.0 million, respectively.

For the six months ended August 31, 2025 and August 31, 2024, the Company recorded $0.1 million and $0.9 million, respectively, of interest expense, $0.01 million and $0.05 million, respectively, of amortization of deferred financial costs and $0.01 million and $0.05 million, respectively, of amortization of discount related to the 8.75% 2025 Notes. Interest expense and amortization of discount and deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the six months ended August 31, 2025 and August 31, 2024 the average dollar amount of 8.75% 2025 Notes outstanding was $3.3 million and $20.0 million, respectively.

8.50% 2028 Notes

On April 14, 2023, the Company issued $50.0 million in aggregate principal amount of 8.50% fixed-rate notes due 2028 (the “8.50% 2028 Notes”) for net proceeds of $48.4 million after deducting underwriting commissions of approximately $1.6 million. Offering costs incurred were approximately $0.03 million. On April 26, 2023, the underwriters fully exercised their option to purchase an additional $7.5 million in aggregate principal amount of the 8.50% 2028 Notes. Net proceeds to the Company were $7.3 million after deducting underwriting commissions of approximately $0.2 million. Interest on the 8.50% 2028 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 8.50% per year. The 8.50% 2028 Notes mature on April 15, 2028, and commencing April 14, 2025, may be redeemed in whole or in part at any time or from time to time at the Company’s option. Net proceeds from this offering were used to repay a portion of the outstanding indebtedness under the Encina Credit Facility, make investments in middle-market companies (including investments made through our SBIC Subsidiaries) in accordance with the Company’s investment objective and strategies and for general corporate purposes. Financing costs of $2.0 million related to the 8.50% 2028 Notes have been capitalized and are being amortized over the term of the 8.50% 2028 Notes.

As of August 31, 2025, the total amount of 8.50% 2028 Notes outstanding was $57.5 million. The 8.50% 2028 Notes are listed on the NYSE under the trading symbol “SAZ” with a par value of $25.00 per note. As of August 31, 2025, the carrying amount and fair value of the 8.50% 2028 Notes was $57.5 million and $58.6 million, respectively. The fair value of the 8.50% 2028 Notes, which are publicly traded, is based upon closing market quotes as of the measurement date and would be classified as a Level 1 liability within the fair value hierarchy. As of February 28, 2025, the carrying amount and fair value of the 8.50% 2028 Notes was $57.5 million and $58.3 million, respectively.

For the three months ended August 31, 2025 and August 31, 2024, the Company recorded $1.2 million and $1.2 million, respectively, of interest expense and $0.1 million and $0.1 million, respectively, of amortization of deferred financing costs related to the 8.50% 2028 Notes. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the three months ended August 31, 2025 and August 31, 2024 the average dollar amount of 8.50% 2028 Notes outstanding was $57.5 million and $57.5 million, respectively.

For the six months ended August 31, 2025 and August 31, 2024, the Company recorded $2.4 million and $2.4 million, respectively, of interest expense and $0.2 million and $0.2 million, respectively, of amortization of deferred financing costs related to the 8.50% 2028 Notes. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the six months ended August 31, 2025 and August 31, 2024 the average dollar amount of 8.50% 2028 Notes outstanding was $57.5 million and $57.5 million, respectively.

SENIOR SECURITIES

(dollar amounts in thousands, except per share data)

Class and Year (1)(2)	Total Amount Outstanding Exclusive of Treasury Securities(3)		Asset Coverage per Unit(4)		Involuntary Liquidating Preference per Share(5)		Average Market Value per Share(6)
	(in thousands)
Credit Facility with Encina Lender Finance, LLC
Fiscal year 2026 (as of August 31, 2025)	$	32,500	$	1,666				N/A
Fiscal year 2025 (as of February 28, 2025)	$	32,500	$	1,629		-		N/A
Fiscal year 2024 (as of February 29, 2024)	$	35,000	$	1,610		-		N/A
Fiscal year 2023 (as of February 28, 2023)	$	32,500	$	1,659		-		N/A
Fiscal year 2022 (as of February 28, 2022)	$	12,500	$	2,093		-		N/A
Credit Facility with Live Oak Banking Company
Fiscal year 2026 (as of August 31, 2025)	$	37,500	$	1,666				N/A
Fiscal year 2025 (as of February 28, 2025)	$	20,000	$	1,629		-		N/A
Credit Facility with Madison Capital Funding(14)
Fiscal year 2021 (as of February 28, 2021)		-	$	3,471		-		N/A
Fiscal year 2020 (as of February 29, 2020)		-	$	6,071		-		N/A
Fiscal year 2019 (as of February 28, 2019)		-	$	2,345		-		N/A
Fiscal year 2018 (as of February 28, 2018)		-	$	2,930		-		N/A
Fiscal year 2017 (as of February 28, 2017)		-	$	2,710		-		N/A
Fiscal year 2016 (as of February 29, 2016)		-	$	3,025		-		N/A
Fiscal year 2015 (as of February 28, 2015)	$	9,600	$	3,117		-		N/A
Fiscal year 2014 (as of February 28, 2014)		-	$	3,348		-		N/A
Fiscal year 2013 (as of February 28, 2013)	$	24,300	$	5,421		-		N/A
Fiscal year 2012 (as of February 29, 2012)	$	20,000	$	5,834		-		N/A
Fiscal year 2011 (as of February 28, 2011)	$	4,500	$	20,077		-		N/A
7.50% Notes due 2020(7)
Fiscal year 2017 (as of February 28, 2017)	$	-	$	-		-		N/A
Fiscal year 2016 (as of February 29, 2016)	$	61,793	$	3,025		-	$	25.24	(8)
Fiscal year 2015 (as of February 28, 2015)	$	48,300	$	3,117		-	$	25.46	(8)
Fiscal year 2014 (as of February 28, 2014)	$	48,300	$	3,348		-	$	25.18	(8)
6.75% Notes due 2023(9)
Fiscal year 2020 (as of February 29, 2020)	$	-	$	-		-		N/A
Fiscal year 2019 (as of February 28, 2019)	$	74,451	$	2,345		-	$	25.74	(10)
Fiscal year 2018 (as of February 28, 2018)	$	74,451	$	2,930		-	$	26.05	(10)
Fiscal year 2017 (as of February 28, 2017)	$	74,451	$	2,710		-	$	25.89	(10)
8.75% Notes due 2025
Fiscal year 2026 (as of August 31, 2025)	$	-		-		-		N/A	(18)
Fiscal year 2025 (as of February 28, 2025)	$	20,000	$	1,629		-	$	25.00	(12)
Fiscal year 2024 (as of February 29, 2024)	$	20,000	$	1,610		-	$	25.00	(12)
6.25% Notes due 2025(13)
Fiscal year 2022 (as of February 28, 2022)		-		-		-		N/A
Fiscal year 2021 (as of February 28, 2021)	$	60,000	$	3,471		-	$	24.24	(11)
Fiscal year 2020 (as of February 29, 2020)	$	60,000	$	6,071		-	$	25.75	(11)
Fiscal year 2019 (as of February 28, 2019)	$	60,000	$	2,345		-	$	24.97	(11)
7.00% Notes due 2025
Fiscal year 2026 (as of August 31, 2025)	$	12,000	$	1,666			$	25.00	(12)
Fiscal year 2025 (as of February 28, 2025)	$	12,000	$	1,629		-	$	25.00	(12)
Fiscal year 2024 (as of February 29, 2024)	$	12,000	$	1,610		-	$	25.00	(12)
Fiscal year 2023 (as of February 28, 2023)	$	12,000	$	1,659		-	$	25.00	(12)
7.25% Notes due 2025(17)
Fiscal year 2023 (as of February 28, 2023)		-		-		-		N/A
Fiscal year 2022 (as of February 28, 2022)	$	43,125	$	2,093		-	$	25.46	(11)
Fiscal year 2021 (as of February 28, 2021)	$	43,125	$	3,471		-	$	25.77	(11)

SENIOR SECURITIES

(dollar amounts in thousands, except per share data)

Class and Year (1)(2)	Total Amount Outstanding Exclusive of Treasury Securities(3)		Asset Coverage per Unit(4)		Involuntary Liquidating Preference per Share(5)		Average Market Value per Share(6)
	(in thousands)
7.75% Notes due 2025
Fiscal year 2026 (as of August 31, 2025)	$	-	$	-		-		N/A	(19)
Fiscal year 2025 (as of February 28, 2025)	$	5,000	$	1,629		-	$	25.00	(12)
Fiscal year 2024 (as of February 29, 2024)	$	5,000	$	1,610		-	$	25.00	(12)
Fiscal year 2023 (as of February 28, 2023)	$	5,000	$	1,659		-	$	25.00	(12)
Fiscal year 2022 (as of February 28, 2022)	$	5,000	$	2,093		-	$	25.00	(12)
Fiscal year 2021 (as of February 28, 2021)	$	5,000	$	3,471		-	$	25.00	(12)
4.375% Notes due 2026
Fiscal year 2026 (as of August 31, 2025)	$	175,000	$	1,666		-	$	25.00	(12)
Fiscal year 2025 (as of February 28, 2025)	$	175,000	$	1,629		-	$	25.00	(12)
Fiscal year 2024 (as of February 29, 2024)	$	175,000	$	1,610		-	$	25.00	(12)
Fiscal year 2023 (as of February 28, 2023)	$	175,000	$	1,659		-	$	25.00	(12)
Fiscal year 2022 (as of February 28, 2022)	$	175,000	$	2,093		-	$	25.00	(12)
4.35% Notes due 2027
Fiscal year 2026 (as of August 31, 2025)	$	75,000	$	1,666		-	$	25.00	(12)
Fiscal year 2025 (as of February 28, 2025)	$	75,000	$	1,629		-	$	25.00	(12)
Fiscal year 2024 (as of February 29, 2024)	$	75,000	$	1,610		-	$	25.00	(12)
Fiscal year 2023 (as of February 28, 2023)	$	75,000	$	1,659		-	$	25.00	(12)
Fiscal year 2022 (as of February 28, 2022)	$	75,000	$	2,093		-	$	25.00	(12)
6.00% Notes due 2027
Fiscal year 2026 (as of August 31, 2025)	$	105,500	$	1,666		-	$	24.62	(15)
Fiscal year 2025 (as of February 28, 2025)	$	105,500	$	1,629		-	$	24.36	(15)
Fiscal year 2024 (as of February 29, 2024)	$	105,500	$	1,610		-	$	23.51	(15)
Fiscal year 2023 (as of February 28, 2023)	$	105,500	$	1,659		-	$	23.97	(15)
6.25% Notes due 2027
Fiscal year 2026 (as of August 31, 2025)	$	15,000	$	1,666		-	$	25.00	(12)
Fiscal year 2025 (as of February 28, 2025)	$	15,000	$	1,629		-	$	25.00	(12)
Fiscal year 2024 (as of February 29, 2024)	$	15,000	$	1,610		-	$	25.00	(12)
Fiscal year 2023 (as of February 28, 2023)	$	15,000	$	1,659		-	$	25.00	(12)
Fiscal year 2022 (as of February 28, 2022)	$	15,000	$	2,093		-	$	25.00	(12)
Fiscal year 2021 (as of February 28, 2021)	$	15,000	$	3,471		-	$	25.00	(12)
8.00% Notes due 2027
Fiscal year 2026 (as of August 31, 2025)	$	46,000	$	1,666			$	25.50	(15)
Fiscal year 2025 (as of February 28, 2025)	$	46,000	$	1,629		-	$	25.21	(15)
Fiscal year 2024 (as of February 29, 2024)	$	46,000	$	1,610		-	$	25.00	(15)
8.125% Notes due 2027
Fiscal year 2026 (as of August 31, 2025)	$	60,375	$	1,666		-	$	25.37	(15)
Fiscal year 2025 (as of February 28, 2025)	$	60,375	$	1,629		-	$	25.27	(15)
Fiscal year 2024 (as of February 29, 2024)	$	60,375	$	1,610		-	$	25.05	(15)
Fiscal year 2023 (as of February 28, 2023)	$	60,375	$	1,659		-	$	25.10	(15)
8.50% Notes due 2028
Fiscal year 2026 (as of August 31, 2025)	$	57,500	$	1,666		-	$	25.37	(17)
Fiscal year 2025 (as of February 28, 2025)	$	57,500	$	1,629		-	$	25.47	(17)
Fiscal year 2024 (as of February 29, 2024)	$	57,500	$	1,610		-	$	25.17	(17)

(1)	We have excluded our SBA-guaranteed debentures from this table because the SEC has granted us exemptive relief that permits us to exclude such debentures from the definition of senior securities in the 150% asset coverage ratio we are required to maintain under the 1940 Act.

(2)	This table does not include the senior securities of our predecessor entity, GSC Investment Corp., relating to a revolving securitized credit facility with Deutsche Bank, in light of the fact that the Company was under different management during the time that such credit facility was outstanding.
(3)	Total amount of senior securities outstanding at the end of the period presented.
(4)	Asset coverage per unit is the ratio of our total assets, less all liabilities and indebtedness not represented by senior securities, to the aggregate amount of senior securities representing indebtedness. Asset coverage per unit is expressed in terms of dollar amounts per $1,000 of indebtedness, calculated on a total basis.
(5)	The amount to which such class of senior security would be entitled upon the involuntary liquidation of the issuer in preference to any security junior to it. The “—” indicates information which the Securities and Exchange Commission expressly does not require to be disclosed for certain types of senior securities.
(6)	Not applicable for credit facility because not registered for public trading.
(7)	On January 13, 2017, the Company redeemed in full its 2020 Notes. The Company used a portion of the net proceeds from the 2023 Notes offering, which was completed in December 2016, to redeem the 2020 Notes in full.
(8)	Based on the average daily trading price of the 2020 Notes on the NYSE.
(9)	On December 21, 2019 and February 7, 2020, the Company redeemed $50.0 million and $24.45 million, respectively, in aggregate principal amount of the $74.45 million in aggregate principal amount of issued and outstanding 2023 Notes.
(10)	Based on the average daily trading price of the 2023 Notes on the NYSE.
(11)	Based on the average daily trading price of the 2025 Notes on the NYSE.
(12)	The carrying value of this unlisted security approximates its fair value, based on a waterfall analysis showing adequate collateral coverage.
(13)	On August 31, 2021, the Company redeemed $60.0 million in aggregate principal amount of the issued and outstanding 6.25% 2025 Notes. The Company used a portion of the net proceeds from the 4.375% 2026 Notes offering, which was completed in July 2021, to redeem the 6.25% 2025 Notes in full.
(14)	On October 4, 2021, the Company repaid all remaining amounts outstanding under the Madison Credit Facility and the credit agreement relating to the Madison Credit Facility was terminated.
(15)	Based on the average daily trading price of the 2027 Notes on the NYSE.
(16)	Based on the average daily trading price of the 2028 Notes on the NYSE.
(17)	On July 14, 2022, the Company redeemed $43.1 million in aggregate principal amount of the issued and outstanding 7.25% 2025 Notes.
(18)	On March 31, 2025, we repaid $20.0 million in aggregate principal amount of the issued and outstanding 8.75% 2025 Notes.
(19)	On July 9, 2025, we repaid $5.0 million in aggregate principal amount of the issued and outstanding 7.75% 2025 Notes.

Note 9. Commitments and Contingencies

Contractual Obligations

The following table shows our payment obligations for repayment of debt and other contractual obligations at August 31, 2025:

			Payment Due by Period
Long-Term Debt Obligations	Total		Less Than 1 Year		1 - 3 Years		3 - 5 Years		More Than 5 Years
	($ in thousands)
Revolving credit facility	$	32,500	$	32,500	$	-	$	-	$	-
Live Oak credit facility		37,500		-		37,500		-		-
SBA debentures		170,000		-		-		20,000		150,000
7.00% 2025 Notes		12,000		12,000		-		-		-
4.375% 2026 Notes		175,000		175,000		-		-		-
4.35% 2027 Notes		75,000		-		75,000		-		-
6.25% 2027 Notes		15,000		-		15,000		-		-
6.00% 2027 Notes		105,500		-		105,500		-		-
8.00% 2027 Notes		46,000		-		46,000		-		-
8.125% 2027 Notes		60,375		-		60,375		-		-
8.5% 2028 Notes		57,500		-		57,500		-		-
Total Long-Term Debt Obligations	$	786,375	$	219,500	$	396,875	$	20,000	$	150,000

Off-Balance Sheet Arrangements

As of August 31, 2025 and February 28, 2025, the Company’s off-balance sheet arrangements consisted of $96.2 million and $126.7 million, respectively, of unfunded commitments outstanding to provide debt financing to its portfolio companies or to fund limited partnership interests. Such commitments are generally up to the Company’s discretion to approve, or the satisfaction of certain financial and nonfinancial covenants and involve, to varying degrees, elements of credit risk in excess of the amount recognized in the Company’s consolidated statements of assets and liabilities and are not reflected in the Company’s consolidated statements of assets and liabilities.

A summary of the unfunded commitments outstanding as of August 31, 2025 and February 28, 2025 is shown in the table below (dollars in thousands):

	August 31, 2025		February 28, 2025
At Company’s discretion
ActiveProspect, Inc.	$	10,000	$	10,000
Artemis Wax Corp.		-		23,500
Ascend Software, LLC		-		5,000
C2 Educational Systems		-		2,000
Davisware, LLC		-		1,000
JDXpert		4,500		4,500
Lee’s Famous Recipe Chicken		10,000		10,000
Pepper Palace, Inc.		1,200		1,200
Procurement Partners, LLC		-		-
Saratoga Senior Loan Fund I JV, LLC		8,548		8,548
VetnCare MSO, LLC		10,000		10,000
StockIQ Technologies, LLC		5,000		-
Total	$	49,248	$	75,748

At portfolio company’s discretion - satisfaction of certain financial and nonfinancial covenants required
Axero Holdings, LLC - Revolver		500		500
Axiom Medical Consulting, LLC		1,000		1,500
BQE Software, Inc.		250		2,250
Cloudpermit Intermediate Holding Company		5,000		5,000
Davisware, LLC		-		1,750
Exigo, LLC - Revolver		625		625
Gen4 Dental Partners Holdings, LLC		2,381		2,857
Granite Comfort, LP		-		11,637
Innergy, Inc.		5,000		5,000
Inspect Point Holding, LLC		2,000		1,500
Modis Dental Partners OpCo, LLC		4,500		8,900
Pepper Palace, Inc. - Revolver		-		600
Stretch Zone Franchising, LLC		-		1,500
VetnCare MSO, LLC		6,709		7,319
StockIQ Technologies, LLC		2,000		-
SmartAC.com, Inc.		17,000		-
		46,965		50,938
Total	$	96,213	$	126,686

The Company believes its assets will provide adequate coverage to satisfy these unfunded commitments. As of August 31, 2025, the Company had cash and cash equivalents of $105.7 million, $32.5 million in available borrowings under the Encina Credit Facility, and $37.5 million in available borrowings under the Live Oak Credit Facility.

100

Note 10. Directors Fees

The independent directors of the Company’s board of directors each receive an annual fee of $90,000. They also receive $3,500 plus reimbursement of reasonable out-of-pocket expenses incurred in connection with attending each board meeting and receive $2,000 plus reimbursement of reasonable out-of-pocket expenses incurred in connection with attending each committee meeting. In addition, the chairman of the audit committee receives an annual fee of $15,000 and the chairman of each other committee receives an annual fee of $8,000 for their additional services in these capacities. In addition, we have purchased directors and officers liability insurance on behalf of our directors and officers. Independent directors have the option to receive their directors fees in the form of our common stock issued at a price per share equal to the greater of NAV or the market price at the time of payment. No compensation is paid to directors who are “interested persons” of the Company (as defined in Section 2(a)(19) of the 1940 Act). For the three months ended August 31, 2025 and August 31, 2024, the Company incurred $0.1 million and $0.1 million for directors fees and expenses, respectively. For the six months ended August 31, 2025 and August 31, 2024, the Company incurred $0.3 million and $0.2 million for directors fees and expenses, respectively. As of August 31, 2025 and February 28, 2025, $0.0 million and $0.0 million in directors fees and expenses were accrued and unpaid, respectively. As of August 31, 2025, the Company had not issued any common stock to our directors as compensation for their services.

Note 11. Stockholders’ Equity

Share Repurchases

On September 24, 2014, the Company announced the approval of an open market share repurchase plan that originally allowed it to repurchase up to 200,000 shares of its common stock at prices below its NAV as reported in its then most recently published consolidated financial statements (the “Share Repurchase Plan”). Since September 24, 2014, the Share Repurchase Plan has been extended annually, and the Company has periodically increased the amount of shares of common stock that may be purchased under the Share Repurchase Plan, most recently to 1.7 million shares of common stock. On January 7, 2025, the Company’s board of directors extended the Share Repurchase Plan for another year to January 15, 2026. As of August 31, 2025, the Company had purchased 1,035,203 shares of common stock, at an average price of $22.05 for approximately $22.8 million pursuant to the Share Repurchase Plan. During the three and six months ended August 31, 2025, the Company did not purchase any shares of common stock pursuant to the Share Repurchase Plan.

Public Equity Offering

On July 13, 2018, the Company issued 1,150,000 shares of its common stock priced at $25.00 per share (par value $0.001 per share) at an aggregate total of $28.75 million. The net proceeds, after deducting underwriting commissions of $1.15 million and offering costs of approximately $0.2 million, amounted to approximately $27.4 million. The Company also granted the underwriters a 30-day option to purchase up to an additional 172,500 shares of its common stock, which was not exercised.

Equity ATM Program

On March 16, 2017, the Company entered into an equity distribution agreement with Ladenburg Thalmann & Co. Inc. (“Ladenburg”), through which the Company offered for sale, from time to time, up to $30.0 million of the Company’s common stock through an ATM offering. Subsequent to this, BB&T Capital Markets and B. Riley FBR, Inc. were also added to the agreement. On July 11, 2019, the amount of the common stock to be offered was increased to $70.0 million, and on October 8, 2019, the amount of the common stock to be offered was increased to $130.0 million. This agreement was terminated as of July 29, 2021, and as of that date, the Company had sold 3,922,018 shares for gross proceeds of $97.1 million at an average price of $24.77 for aggregate net proceeds of $95.9 million (net of transaction costs).

On July 30, 2021, the Company entered into an equity distribution agreement (the “Equity Distribution Agreement”) with Ladenburg and Compass Point Research and Trading, LLC (“Compass Point”), through which the Company may offer for sale, from time to time, up to $150.0 million of the Company’s common stock through the Agents (as defined below), or to them, as principal for their account (the “ATM Program”).

On July 6, 2023, the Company amended the Equity Distribution Agreement to increase the maximum amount of shares of our common stock to be sold through the ATM Program to $300.0 million from $150.0 million. On July 19, 2023, the Company amended the Equity Distribution Agreement to add an additional distribution agent, Raymond James & Associates, Inc. (“Raymond James”). On May 15, 2024, the Company amended the Equity Distribution Agreement to add an additional distribution agent, Lucid Capital Markets, LLC (“Lucid” and together with Ladenburg, Compass Point, and Raymond James, the “Agents”). The sales price per share of the Company’s common stock offered under the ATM Program, less the Agents’ commission, will not be less than the NAV per share of the Company’s common stock at the time of such sale. Consistent with the terms of the ATM Program, the Manager may, from time to time and in its sole discretion, contribute proceeds necessary to ensure that no sales are made at a price below the then-current NAV per share.

As of August 31, 2025, the Company sold 8,532,953 shares for gross proceeds of $225.7 million at an average price of $26.37 for aggregate net proceeds of $224.0 million (net of transaction costs). During the three months ended August 31, 2025, the Company sold 443,406 shares for gross proceeds of $11.4 million at an average price of $25.61 for aggregate net proceeds of $11.4 million (net of transaction costs). During the six months ended August 31, 2025, the Company sold 688,237 shares for gross proceeds of $17.8 million at an average price of $25.86 for aggregate net proceeds of $17.8 million (net of transaction costs).

101

The Company adopted Rule 3-04/Rule 8-03(a)(5) under Regulation S-X (Note 2). Pursuant to Regulation S-X, the Company has presented a reconciliation of the changes in each significant caption of stockholders’ equity as shown in the tables below:

							Capital			Total
	Common Stock						in Excess			Distributable
	Shares			Amount			of Par Value			Earnings (Loss)			Net Assets
Balance at February 28, 2023		11,890,500		$	11,891		$	321,893,806		$	25,052,345		$	346,958,042
Increase (Decrease) from Operations:
Net investment income		-			-			-			15,958,950			15,958,950
Net realized gain (loss) from investments		-			-			-			90,691			90,691
Net change in unrealized appreciation (depreciation) on investments		-			-			-			(16,322,307	)		(16,322,307	)
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments		-			-			-			59,407			59,407
Decrease from Shareholder Distributions:
Distributions of investment income		-			-			-			(8,193,402	)		(8,193,402	)
Capital Share Transactions:
Stock dividend distribution		45,818			47			1,058,797			-			1,058,844
Repurchases of common stock		(88,576	)		(90	)		(2,157,515	)		-			(2,157,605	)
Repurchase fees		-			-			(1,772	)		-			(1,772	)
Balance at May 31, 2023		11,847,742		$	11,848		$	320,793,316		$	16,645,684		$	337,450,848
Increase (Decrease) from Operations:
Net investment income		-			-			-			13,964,784			13,964,784
Realized losses on extinguishment of debt		-			-			-			(110,056	)		(110,056	)
Net change in unrealized appreciation (depreciation) on investments		-			-			-			(5,737,571	)		(5,737,571	)
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments		-			-			-			(221,206	)		(221,206	)
Decrease from Shareholder Distributions:
Distributions of investment income		-			-			-			(8,352,335	)		(8,352,335	)
Capital Share Transactions:
Proceeds from issuance of common stock		852,412			852			22,497,265			-			22,498,117
Capital contribution from Manager		-			-			2,050,288			-			2,050,288
Stock dividend distribution		29,627			30			749,283			-			749,313
Offfering costs		-			-			(213,427	)		-			(213,427	)
Balance at August 31, 2023		12,729,781		$	12,730		$	345,876,725		$	16,189,300		$	362,078,755
Increase (Decrease) from Operations:
Net investment income		-			-			-			14,166,063			14,166,063
Net realized gain (loss) from investments		-			-			-			60,565			60,565
Net change in unrealized appreciation (depreciation) on investments		-			-			-			(17,866,353	)		(17,866,353	)
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments		-			-			-			(415,894	)		(415,894	)
Decrease from Shareholder Distributions:
Distributions of investment income		-			-			-			(9,286,642	)		(9,286,642	)
Capital Share Transactions:
Proceeds from issuance of common stock		350,000			350			9,012,150			-			9,012,500
Capital contribution from Manager		-			-			1,043,000			-			1,043,000
Stock dividend distribution		35,196			35			858,960			-			858,995
Offering costs		-			-			(92,240	)		-			(92,240	)
Balance at November 30, 2023		13,114,977		$	13,115		$	356,698,595		$	2,847,039		$	359,558,749

102

					Capital			Total
	Common Stock				in Excess			Distributable
	Shares		Amount		of Par Value			Earnings (Loss)			Net Assets
Increase (Decrease) from Operations:
Net investment income		-		-		-			12,784,511			12,784,511
Net realized gain (loss) from investments		-		-		-			2,327			2,327
Net change in unrealized appreciation (depreciation) on investments		-		-		-			(7,164,613	)		(7,164,613	)
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments		-		-		-			(315,473	)		(315,473	)
Decrease from Shareholder Distributions:
Distributions of investment income		-		-		-			(9,803,576	)		(9,803,576	)
Capital Share Transactions:
Proceeds from issuance of common stock		501,105		501		13,028,269			-			13,028,770
Capital contribution from Manager		-		-		1,382,009			-			1,382,009
Stock dividend distribution		37,394		38		915,155			-			915,193
Offering costs		-		-		(163,789	)		-			(163,789	)
Tax reclassification of stockholders’ equity in accordance with generally accepted accounting principles		-		-		(779,040	)		779,040			-
Balance at February 29, 2024		13,653,476	$	13,654	$	371,081,199		$	(870,745	)	$	370,224,108
Increase (Decrease) from Operations:
Net investment income		-		-		-			14,335,005			14,335,005
Net realized gain (loss) from investments		-		-		-			(21,194,997	)		(21,194,997	)
Net change in unrealized appreciation (depreciation) on investments		-		-		-			13,931,431			13,931,431
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments		-		-		-			(461,001	)		(461,001	)
Decrease from Shareholder Distributions:
Distributions of investment income		-		-		-			(9,967,036	)		(9,967,036	)
Capital Share Transactions:
Proceeds from issuance of common stock		-		-		-			-			-
Capital contribution from Manager		-		-		-			-			-
Stock dividend distribution		45,490		45		987,527			-			987,572
Offering costs		-		-		-			-			-
Balance at May 31, 2024		13,698,966	$	13,699	$	372,068,726		$	(4,227,343	)	$	367,855,082
Increase (Decrease) from Operations:
Net investment income		-		-		-			18,197,398			18,197,398
Net realized gain (loss) from investments		-		-		-			(33,448,727	)		(33,448,727	)
Net change in unrealized appreciation (depreciation) on investments		-		-		-			28,728,155			28,728,155
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments		-		-		-			(159,187	)		(159,187	)
Decrease from Shareholder Distributions:
Distributions of investment income		-		-		-			(10,137,233	)		(10,137,233	)
Capital Share Transactions:
Stock dividend distribution		46,803		47		1,018,307			-			1,018,354
Balance at August 31, 2024	$	13,745,769	$	13,746	$	373,087,033		$	(1,046,937	)	$	372,053,842

103

					Capital			Total
	Common Stock				in Excess			Distributable
	Shares		Amount		of Par Value			Earnings (Loss)			Net Assets
Increase (Decrease) from Operations:
Net investment income		-		-		-			12,435,655			12,435,655
Net realized gain (loss) from investments		-		-		-			5,444,745			5,444,745
Net change in unrealized appreciation (depreciation) on investments		-		-		-			(8,918,583	)		(8,918,583	)
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments		-		-		-			(126,875	)		(126,875	)
Decrease from Shareholder Distributions:
Distributions of investment income		-		-		-			(10,171,868	)		(10,171,868	)
Capital Share Transactions:
Proceeds from issuance of common stock		108,438		108		2,777,318			-			2,777,426
Capital contribution from Manager		-		-		199,652			-			199,652
Stock dividend distribution		54,999		55		1,214,181			-			1,214,236
Offering costs		-		-		(42,575	)		-			(42,575	)
Balance at November 30, 2024	$	13,909,206	$	13,909	$	377,235,609		$	(2,383,863	)	$	374,865,655
Increase (Decrease) from Operations:
Net investment income		-		-		-			8,034,545			8,034,545
Net realized gain (loss) from investments		-		-		-			7,169,655			7,169,655
Income tax (provision) benefit from realized gain on investments		-		-		-			-			-
Realized losses on extinguishment of debt		-		-		-			(800,452	)		(800,452	)
Net change in unrealized appreciation (depreciation) on investments		-		-		-			(14,766,637	)		(14,766,637	)
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments		-		-		-			(313,873	)		(313,873	)
Decrease from Shareholder Distributions:
Distributions of investment income		-		-		-			(15,548,742	)		(15,548,742	)
Capital Share Transactions:
Proceeds from issuance of common stock		1,192,400		1,193		30,223,409			-			30,224,602
Capital contribution from Manager		-		-		2,152,115			-			2,152,115
Stock dividend distribution		81,472		81		1,857,389			-			1,857,470
Offering costs		-		-		(208,870	)		-			(208,870	)
Tax reclassification of stockholders’ equity in accordance with generally accepted accounting principles		-		-		1,653,945			(1,653,945	)		-
Balance at February 28, 2025	$	15,183,078	$	15,183	$	412,913,597		$	(20,263,312	)	$	392,665,468

104

					Capital			Total
	Common Stock				in Excess			Distributable
	Shares		Amount		of Par Value			Earnings (Loss)			Net Assets
Increase (Decrease) from Operations:
Net investment income		-		-		-			10,142,033			10,142,033
Net realized gain (loss) from investments		-		-		-			2,901,339			2,901,339
Income tax (provision) benefit from realized gain on investments		-		-		-			-			-
Realized losses on extinguishment of debt		-		-		-			-			-
Net change in unrealized appreciation (depreciation) on investments		-		-		-			943,977			943,977
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments		-		-		-			(55,085	)		(55,085	)
Decrease from Shareholder Distributions:
Distributions of investment income		-		-		-			(18,980,079	)		(18,980,079	)
Capital Share Transactions:
Proceeds from issuance of common stock		244,831		245		6,143,575			-			6,143,820
Capital contribution from Manager		-		-		297,770			-			297,770
Stock dividend distribution		101,482		101		2,312,052			-			2,312,153
Offering costs		-		-		(2,080	)		-			(2,080	)
Tax reclassification of stockholders’ equity in accordance with generally accepted accounting principles		-		-					-			-
Balance at May 31, 2025	$	15,529,391	$	15,529	$	421,664,914		$	(25,311,127	)	$	396,369,316
Net investment income		-		-		-			9,080,732			9,080,732
Net realized gain (loss) from investments		-		-		-			52,691			52,691
Income tax (provision) benefit from realized gain on investments		-		-		-			-			-
Realized losses on extinguishment of debt		-		-		-			-			-
Net change in unrealized appreciation (depreciation) on investments		-		-		-			3,727,713			3,727,713
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments		-		-		-			423,998			423,998
Decrease from Shareholder Distributions:
Distributions of investment income		-		-		-			(11,797,313	)		(11,797,313	)
Capital Share Transactions:
Proceeds from issuance of common stock		443,406		443		11,101,401			-			11,101,844
Capital contribution from Manager		-		-		271,552			-			271,552
Stock dividend distribution		54,515		55		1,289,733			-			1,289,788
Offering costs		-		-		(20,753	)		-			(20,753	)
Tax reclassification of stockholders’ equity in accordance with generally accepted accounting principles		-		-					-			-
Balance at August 31, 2025	$	16,027,312	$	16,027	$	434,306,847		$	(23,823,306	)	$	410,499,568

105

Note 12. Earnings Per Share

In accordance with the provisions of FASB ASC Topic 260, Earnings per Share, basic earnings per share is computed by dividing earnings available to common shareholders by the weighted average number of shares outstanding during the period. Other potentially dilutive common shares, and the related impact to earnings, are considered when calculating earnings per share on a diluted basis.

The following information sets forth the computation of the weighted average basic and diluted net increase (decrease) in net assets resulting from operations per share for the three and six months ended August 31, 2025 and August 31, 2024 (dollars in thousands except share and per share amounts):

	For the three months ended				For the six months ended
Basic and Diluted	August 31, 2025		August 31, 2024		August 31, 2025		August 31, 2024
Net increase (decrease) in net assets resulting from operations	$	13,285	$	13,318	$	27,217	$	19,928
Weighted average common shares outstanding		15,775,387		13,726,142		15,560,114		13,704,759
Weighted average earnings (loss) per common share	$	0.84	$	0.97	$	1.75	$	1.45

Note 13. Dividend

The following table summarizes dividends declared for the six months ended August 31, 2025 (dollars in thousands except per share amounts):

			Amount		Total
Date Declared	Record Date	Payment Date	Per Share		Amount*
March 6, 2025	March 6, 2025	March 25, 2025	$	0.74	$	11,303
April 8, 2025	April 8, 2025	April 24, 2025		0.25		3,836
May 6, 2025	May 6, 2025	May 22, 2025		0.25		3,841
June 5, 2025	June 5, 2025	June 24, 2025		0.25		3,892
July 8, 2025	July 8, 2025	July 24,2025		0.25		3,917
August 6, 2025	August 6, 2025	August 21, 2025		0.25		3,988
Total dividends declared			$	1.99	$	30,777

*	Total amount is calculated based on the number of shares outstanding at the date of record.

The following table summarizes dividends declared for the six months ended August 31, 2024 (dollars in thousands except per share amounts):

Date Declared	Record Date	Payment Date	Amount Per Share		Total Amount*
August 22, 2024	September 11, 2024	September 26, 2024	$	0.74	$	10,172
May 23, 2024	June 13, 2024	June 27, 2024		0.74		10,137
Total dividends declared			$	1.48	$	20,309

*	Total amount is calculated based on the number of shares outstanding at the date of record.

106

Note 14. Financial Highlights

The following is a schedule of financial highlights as of and for the six months ended August 31, 2025 and August 31, 2024:

Per share data	August 31, 2025			August 31, 2024
Net asset value at beginning of period	$	25.86		$	27.12
Net investment income(1)		1.24			2.37
Net realized and unrealized gain and losses on investments(1)		0.51			(0.92	)
Net increase in net assets resulting from operations		1.75			1.45
Distributions declared from net investment income		(1.99	)		(1.47	)
Total distributions to stockholders		(1.99	)		(1.47	)
Issuance of common stock at net asset value (2)		(0.04	)		-
Capital contribution from Manager for the issuance of common stock (14)		0.04			-
Repurchases of common stock(3)		-			-
Dilution(4)		(0.01	)		(0.03	)
Net asset value at end of period	$	25.61		$	27.07
Net assets at end of period	$	410,499,568		$	372,053,842
Shares outstanding at end of period		16,027,312			13,745,769
Per share market value at end of period	$	25.54		$	23.57
Total return based on market value(5)(6)		4.79	%		6.70	%
Total return based on net asset value(5)(7)		7.52	%		6.68	%
Ratio/Supplemental data:
Ratio of net investment income to average net assets(8)		10.72	%		19.60	%
Expenses:
Ratios of operating expenses and income taxes to average net assets*(9)		6.90	%		8.16	%
Ratio of incentive management fees to average net assets(5)		1.20	%		2.20	%
Ratio of interest and debt financing expenses to average net assets(9)		12.32	%		13.99	%
Ratio of total expenses and income taxes to average net assets*(8)		20.42	%		24.35	%
Portfolio turnover rate(5)(10)		9.68	%		3.84	%
Asset coverage ratio per unit(11)		1,666			1,596
Average market value per unit
Revolving Credit Facilities(12)		N/A			N/A
SBA Debentures Payable(12)		N/A			N/A
8.75% Notes Payable 2025(12)		N/A			N/A
7.00% Notes Payable 2025(12)		N/A			N/A
7.25% Notes Payable 2025(13)		N/A			N/A
7.75% Notes Payable 2025(12)		N/A			N/A
4.375% Notes Payable 2026(12)		N/A			N/A
4.35% Notes Payable 2027(12)		N/A			N/A
6.00% Notes Payable 2027	$	24.62		$	24.18
6.25% Notes Payable 2027(12)		N/A			N/A
8.00% Notes Payable 2027	$	25.50		$	25.11
8.125% Notes Payable 2027	$	25.37		$	25.20
8.50% Notes Payable 2028	$	25.37		$	25.34

*	Certain prior period amounts have been reclassified to conform to current period presentation.

(1)	Per share amounts are calculated using the weighted average shares outstanding during the period.
(2)	The continuous issuance of common stock may cause an incremental decrease in NAV per share due to the sale of shares at the then prevailing public offering price and the receipt of net proceeds per share by the Company less than NAV per share on each subscription closing date. The per share data was derived by computing (i) the sum of (A) the number of shares issued in connection with subscriptions and/or distribution reinvestment on each share transaction date multiplied by (B) the differences between the net proceeds per share and the NAV per share on each share transaction date, divided by (ii) the total shares outstanding during the period.
(3)	Represents the anti-dilutive impact on the NAV of the Company due to the repurchase of common shares. See Note 11. Stockholders’ Equity.

107

(4)	Represents the dilutive effect of issuing common stock below NAV per share during the period in connection with the satisfaction of the Company’s annual RIC distribution requirement and may include the impact of the different share amounts used for different items (weighted average basic common shares outstanding for the corresponding year and actual common shares outstanding at the end of the year) in the per common share data calculation and rounding impacts. See Note 13. Dividend.
(5)	Ratios are not annualized.
(6)	Total investment return is calculated assuming a purchase of common shares at the current market value on the first day and a sale at the current market value on the last day of the periods reported. Dividends and distributions, if any, are assumed for purposes of this calculation to be reinvested at prices obtained under the DRIP. Total investment return does not reflect brokerage commissions.
(7)	Total investment return is calculated assuming a purchase of common shares at the current NAV on the first day and a sale at the current net asset value on the last day of the periods reported. Dividends and distributions, if any, are assumed for purposes of this calculation to be reinvested at prices obtained under the DRIP. Total investment return does not reflect brokerage commissions.
(8)	Ratios are annualized. Incentive management fees included within the ratio are not annualized.
(9)	Ratios are annualized, except for income taxes
(10)	Portfolio turnover rate is calculated using the lesser of year-to-date sales or year-to-date purchases over the average of the invested assets at fair value.
(11)	Asset coverage ratio per unit is the ratio of the carrying value of our total consolidated assets, less all liabilities and indebtedness not represented by senior securities, to the aggregate amount of senior securities representing indebtedness. Asset coverage ratio per unit is expressed in terms of dollar amounts per $1,000 of indebtedness. Asset coverage ratio per unit does not include unfunded commitments. The inclusion of unfunded commitments in the calculation of the asset coverage ratio per unit would not cause us to be below the required amount of regulatory coverage.
(12)	The Revolving Credit Facilities, SBA Debentures, 8.75% Notes Payable 2025, 7.00% Notes Payable 2025, 7.75% Notes Payable 2025, 4.375% Notes Payable 2026, 4.35% Notes Payable 2027 and 6.25% Notes Payable 2027 are not registered for public trading.
(13)	On July 14, 2022, the Company redeemed $43.1 million in aggregate principal amount of the $43.1 million in aggregate principal amount of issued and outstanding 7.25% 2025 Notes and are no longer listed on the NYSE.
(14)	The Manager agreed to reimburse the Company to the extent the per share price of the shares to the public, less underwriting fees, was less than net asset value per share.

Note 15. Subsequent Events

On September 24, 2025, the Company completed the first refinancing of the Saratoga Investment Corp. Senior Loan Fund 2022-1, Ltd. This refinancing, among other things, extended the Saratoga CLO investment period to October 2028. As part of this refinancing, the Company purchased $10.0 million of the SLF 2022-1 Class E Notes tranche at par. Concurrently, the existing $12.25 million of the SLF 2022-1 Class E Notes were repaid. The Company also paid $1.6 million of additional equity investment related to the refinancing to Saratoga Senior Loan Fund I JV LLC.

On September 11, 2025, the Company declared the following dividends for the quarter ended November 30, 2025. Shareholders have the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the DRIP.

Month	Amount per Share		Record Date	Payment Date
September 2025	$	0.25	October 7, 2025	October 23, 2025
October 2025	$	0.25	November 4, 2025	November 20, 2025
November 2025	$	0.25	December 2, 2025	December 18, 2025

108

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion should be read in conjunction with our consolidated financial statements and related notes and other financial information appearing elsewhere in this Quarterly Report on Form 10-Q. In addition to historical information, the following discussion and other parts of this Quarterly Report contain forward-looking information that involves risks and uncertainties. Our actual results could differ materially from those anticipated by such forward-looking information due to the factors discussed under “Note about Forward-Looking Statements” and Part I, Item 1A. “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended February 28, 2025.

The forward-looking statements are based on our beliefs, assumptions and expectations of our future performance, taking into account all information currently available to us. These beliefs, assumptions and expectations can change as a result of many possible events or factors, not all of which are known to us or are within our control. If a change occurs, our business, financial condition, liquidity and results of operations may vary materially from those expressed in our forward-looking statements.

The forward-looking statements contained in this Quarterly Report on Form 10-Q involve risks and uncertainties, including statements as to:

●

our future operating results;

●

the introduction, withdrawal, success and timing of business initiatives and strategies;

●

changes in political, economic or industry conditions, the interest rate environment or financial and capital markets, which could result in changes in the value of our assets;

●

the relative and absolute investment performance and operations of our Manager;

●

the impact of increased competition;

●

our ability to turn potential investment opportunities into transactions and thereafter into completed and successful investments;

●

the unfavorable resolution of any future legal proceedings;

●

our business prospects and the operational and financial performance of our portfolio companies, including their ability to achieve our respective objectives as a result of the current economic conditions caused by, among other things, elevated levels of inflation, and uncertainty relating to the interest rate environment, and the effects of the disruptions caused thereby on our ability to continue to effectively manage our business;

●

interest rate volatility, including the uncertainty relating to the interest rate environment, could adversely affect our results, particularly if we elect to use leverage as part of our investment strategy;

●

the impact of investments that we expect to make and future acquisitions and divestitures;

●

our contractual arrangements and relationships with third parties;

●

the dependence of our future success on the general economy and its impact on the industries in which we invest;

●

the ability of our portfolio companies to achieve their objectives;

●

our expected financings and investments;

●

our regulatory structure and tax treatment, including our ability to operate as a business development company (“BDC”), or to operate our small business investment company (“SBIC”) subsidiaries, and to continue to qualify to be taxed as a regulated investment company (“RIC”);

109

●

the adequacy of our cash resources and working capital;

●

the timing of cash flows, if any, from the operations of our portfolio companies;

●

the impact of supply chain constraints and labor difficulties on our portfolio companies and the global economy;

●

the elevated level of inflation, and its impact on our portfolio companies and on the industries in which we invest;

●

the uncertainty associated with the imposition of tariffs and trade barriers and changes in trade policy and its impact on our portfolio companies and the global economy;

●

the impact of geopolitical conditions on our portfolio companies and on the industries in which we invest;

●

the impact of legislative and regulatory actions and reforms and regulatory, supervisory or enforcement actions of government agencies relating to us or our Manager;

●

the impact of changes to tax legislation and, generally, our tax position;

●

our ability to access capital and any future financings by us;

●

the ability of our Manager to attract and retain highly talented professionals; and

●

the ability of our Manager to locate suitable investments for us and to monitor and effectively administer our investments.

Such forward-looking statements may include statements preceded by, followed by or that otherwise include terms such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “project,” “should,” “will” and “would” or the negative of these terms or other comparable terminology.

We have based the forward-looking statements included in this Quarterly Report on Form 10-Q on information available to us on the date of this Quarterly Report on Form 10-Q, and we assume no obligation to update any such forward-looking statements. Actual results could differ materially from those anticipated in our forward-looking statements, and future results could differ materially from historical performance. We undertake no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise, unless required by law or SEC rule or regulation. You are advised to consult any additional disclosures that we may make directly to you or through reports that we in the future may file with the U.S. Securities and Exchange Commission (the “SEC”), including annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K.

The following analysis of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and the related notes thereto contained elsewhere in this Quarterly Report on Form 10-Q.

110

OVERVIEW

We are a Maryland corporation that has elected to be regulated as a BDC under the Investment Company Act of 1940, as amended (the “1940 Act”). Our investment objective is to create attractive risk-adjusted returns by generating current income and long-term capital appreciation from our investments. We invest primarily in senior and unitranche leveraged loans and mezzanine debt issued by private U.S. middle-market companies, which we define as companies having earnings before interest, tax, depreciation and amortization (“EBITDA”) of between $2 million and $50 million, both through direct lending and through participation in loan syndicates. We may also invest up to 30.0% of the portfolio in opportunistic investments in order to seek to enhance returns to stockholders. Such investments may include investments in distressed debt, which may include securities of companies in bankruptcy, foreign debt, private equity, securities of public companies that are not thinly traded and structured finance vehicles such as collateralized loan obligation funds. Although we have no current intention to do so, to the extent we invest in private equity funds, we will limit our investments in entities that are excluded from the definition of “investment company” under Section 3(c)(1) or Section 3(c)(7) of the 1940 Act, which includes private equity funds, to no more than 15.0% of our net assets. We have elected and qualified to be treated as a RIC under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).

Corporate History

We commenced operations, at the time known as GSC Investment Corp., on March 23, 2007 and completed an initial public offering of shares of common stock on March 28, 2007. Prior to July 30, 2010, we were externally managed and advised by GSCP (NJ), L.P., an entity affiliated with GSC Group, Inc. In connection with the consummation of a recapitalization transaction on July 30, 2010, as described below we engaged Saratoga Investment Advisors to replace GSCP (NJ), L.P. as our investment adviser and changed our name to Saratoga Investment Corp.

Our wholly owned subsidiaries, Saratoga Investment Corp. SBIC II LP (“SBIC II LP”) and Saratoga Investment Corp. SBIC III LP (“SBIC III LP”, and together with SBIC II LP, the “SBIC Subsidiaries”), received SBIC licenses from the SBA on August 14, 2019 and September 29, 2022, respectively. Each of the SBIC Subsidiaries provides up to $175.0 million in long-term capital in the form of debentures guaranteed by the SBA. With all debentures repaid to the SBA, SBIC LP’s (“SBIC LP”) license was surrendered on January 3, 2024, providing the Company access to all undistributed capital of SBIC LP, and SBIC LP subsequently merged with and into the Company. Under current SBIC regulations, for two or more SBICs under common control, the maximum amount of outstanding SBA debentures cannot exceed $350.0 million with at least $175.0 million in combined regulatory capital.

On June 10, 2024, we completed the fifth refinancing of the Saratoga CLO. This refinancing, among other things, did not extend the Saratoga CLO reinvestment period nor extend its legal maturity, while adjusting the interest rate of two of the existing Notes. The Issuer issued $422.5 million of notes (the “2013-1 2024 Reset CLO Notes”), consisting of Class A-1-R-4 and Class A-2-R-4. The 2013-1 2024 Reset CLO Notes were issued pursuant to the Indenture with the same Trustee. Proceeds of the issuance of the 2013-1 2024 Reset CLO Notes were used along with existing assets of the Saratoga CLO to redeem the existing Class A-1-R-3 and Class A-2-R-3 Notes. No other Notes were refinanced as part of this refinancing. The Saratoga CLO paid $0.5 million of transaction costs related to the refinancing.

We have formed a wholly owned special purpose entity, Saratoga Investment Funding II LLC, a Delaware limited liability company (“SIF II”), for the purpose of entering into a senior secured revolving credit facility with Encina Lender Finance, LLC (“Encina”), supported by loans held by SIF II and pledged to Encina under the credit facility (the “Encina Credit Facility). The Encina Credit Facility closed on October 4, 2021. During the first two years following the closing date, SIF II may request an increase in the commitment amount under the Encina Credit Facility to up to $75.0 million. The terms of the Encina Credit Facility require a minimum drawn amount of $12.5 million at all times during the first six months following the closing date, which increases to the greater of $25.0 million or 50% of the commitment amount in effect at any time thereafter. The term of the Encina Credit Facility is three years. Advances under the Encina Credit Facility bear interest at a floating rate per annum equal to LIBOR plus 4.0%, with LIBOR having a floor of 0.75%, with customary provisions related to our and Encina’s selection of a replacement benchmark rate. Concurrently with the closing of the Encina Credit Facility, all remaining amounts outstanding on our existing revolving credit facility with Madison Capital Funding, LLC were repaid and the facility was terminated. On January 27, 2023, among other things, the borrowings available under the Encina Credit Facility was increased from up to $50.0 million to up to $65.0 million, the underlying benchmark rate used to compute interest changed from LIBOR to Term SOFR for one-month tenor plus a 0.10% credit spread adjustment; the applicable effective margin rate on borrowings increased from 4.00% to 4.25% and the maturity date was extended from October 4, 2024 to January 27, 2026.

111

We have formed a wholly owned special purpose entity, Saratoga Investment Funding III LLC, a Delaware limited liability company (“SIF III”), for the purpose of entering into a $50.0 million senior secured revolving credit facility with Live Oak Banking Company (“Live Oak”), supported by loans held by SIF III and pledged to Live Oak under the credit facility (the “Live Oak Credit Facility). The Live Oak Credit Facility closed on March 27, 2024. During the first two years following the closing date, SIF III may request an increase in the commitment amount under the Live Oak Credit Facility to up to $150.0 million. The terms of the Live Oak Credit Facility required a minimum drawn amount of $12.5 million at all times during the period ended March 27, 2025, which increased to the greater of $25.0 million or 50% of the facility amount in effect at any time thereafter. The term of the Live Oak Credit Facility is three years. Advances under the Live Oak Credit Facility bear interest at a floating rate per annum equal to Adjusted Term SOFR plus an applicable margin between 3.50% and 4.25% based on the Live Oak Credit Facility’s utilization. On June 14, 2024, the Live Oak Credit Facility was amended to, among other things: (i) increase the borrowings available under the Live Oak Credit Facility from up to $50.0 million to up to $75.0 million, subject to a borrowing base requirement; (ii) add new lenders to the Live Oak Credit Agreement; (iii) replace administrative agent approval with “Required Lender” (as defined in the Live Oak Credit Agreement) approval with respect to certain matters; (iv) replace Required Lender approval with 100% lender approval with respect to certain matters; and (v) change the definition of Required Lender to require the approval of at least two unaffiliated lenders.

On October 26, 2021, we entered into a Limited Liability Company Agreement with TJHA JV I LLC (“TJHA”) to co-manage Saratoga Senior Loan Fund I JV LLC (“SLF JV”). SLF JV is invested in Saratoga Investment Corp Senior Loan Fund 2021-1 Ltd (“SLF 2021”), which is a wholly owned subsidiary of SLF JV. SLF 2021 was formed for the purpose of making investments in a diversified portfolio of broadly syndicated first lien and second lien term loans or bonds in the primary and secondary markets.

On September 30, 2022, SLF 2021 was renamed to Saratoga Investment Corp Senior Loan Fund 2022-1, Ltd. (“SLF 2022”).

We and TJHA have equal voting interest on all material decisions with respect to SLF JV, including those involving its investment portfolio, and equal control of corporate governance. No management fee is charged to SLF JV as control and management of SLF JV is shared equally.

We and TJHA have committed to provide up to a combined $50.0 million of financing to SLF JV through cash contributions, where we provided $43.75 million and TJHA provided $6.25 million, resulting in an 87.5% and 12.5% ownership between the two parties. The financing is issued in the form of an unsecured note and equity. The unsecured note will pay a fixed-rate of 10.0% per annum and is due and payable in full on October 20, 2033. As of August 31, 2025, our and TJHA’s investment in SLF JV consisted of an unsecured note of $17.6 million and $2.5 million, respectively; and membership interest of $17.6 million and $2.5 million, respectively. As of February 28, 2025, our and TJHA’s investment in SLF JV consisted of an unsecured note of $17.6 million and $2.5 million, respectively; and membership interest of $17.6 million and $2.5 million, respectively. As of August 31, 2025 and February 28, 2025, our investment in the unsecured note of SLF JV had a fair value of $16.8 million and $16.5 million, respectively, and our investment in the membership interests of SLF JV had a fair value of $2.9 million and $3.1 million, respectively.

We have determined that SLF JV is an investment company under (“FASB”) Accounting Standards Codification (“ASC”) Topic 946, Financial Services—Investment Companies (“ASC 946”); however, in accordance with such guidance we will generally not consolidate our investment in a company other than a wholly owned investment company subsidiary. SLF JV is not a wholly owned investment company subsidiary as we and TJHA each have an equal 50% voting interest in SLF JV and thus neither party has a controlling financial interest. Furthermore, FASB ASC Topic 810, Consolidation (“ASC 810”), concludes that in a joint venture where both members have equal decision-making authority, it is not appropriate for one member to consolidate the joint venture since neither has control. Accordingly, we do not consolidate SLF JV.

On October 28, 2022, SLF 2022 issued $402.1 million of debt through the JV CLO trust. The 2022 JV CLO Notes were issued pursuant to the JV Indenture, with the Trustee. As part of the transaction, we purchased 87.50% of the Class E Notes from SLF 2022 with a par value of $12.25 million. As of August 31, 2025 and February 28, 2025, the fair value of these Class E Notes were $12.3 million and $12.3 million, respectively.

112

Critical Accounting Policies and Estimates

Basis of Presentation

The preparation of financial statements in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) requires management to make certain estimates and assumptions affecting amounts reported in our consolidated financial statements. We have identified investment valuation, revenue recognition and the recognition of capital gains incentive fee expense as our most critical accounting estimates. We continuously evaluate our estimates, including those related to the matters described below. These estimates are based on the information that is currently available to us and on various other assumptions that we believe to be reasonable under the circumstances. Actual results could differ materially from those estimates under different assumptions or conditions. A discussion of our critical accounting policies and estimates follows.

Investment Valuation

We account for investments at fair value in accordance with the FASB ASC Topic 820, Fair Value Measurement (“ASC 820”). ASC 820 defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the quality of inputs used to measure fair value and enhances disclosure requirements for fair value measurements. Under ASC 820 we are required to assume that its investments are to be sold or its liabilities are to be transferred at the balance sheet date in the principal market to independent market participants, or in the absence of a principal market, in the most advantageous market, which may be a hypothetical market. Market participants are defined as buyers and sellers in the principal or most advantageous market that are independent, knowledgeable, and willing and able to transact.

Investments for which market quotations are readily available are fair valued at such market quotations obtained from independent third-party pricing services and market makers subject to any decision by our board of directors to approve a fair value determination to reflect significant events affecting the value of these investments. We value investments for which market quotations are not readily available at fair value as approved, in good faith, by our board of directors based on input from Saratoga Investment Advisors (the “Manager” or “Saratoga Investment Advisors”), the audit committee of our board of directors and a third-party independent valuation firm. We use multiple techniques for determining fair value based on the nature of the investment and experience with those types of investments and specific portfolio companies. The selections of the valuation techniques and the inputs and assumptions used within those techniques often require subjective judgements and estimates. These techniques include market comparables, discounted cash flows and enterprise value waterfalls. Fair value is best expressed as a range of values from which we determine a single best estimate. The types of inputs and assumptions that may be considered in determining the range of values of our investments include the nature and realizable value of any collateral, the portfolio company’s ability to make payments, market yield trend analysis and volatility in future interest rates, call and put features, the markets in which the portfolio company does business, comparison to publicly traded companies, discounted cash flows and other relevant factors.

We undertake a multi-step valuation process each quarter when valuing investments for which market quotations are not readily available, as described below:

●

each investment is initially valued by the responsible investment professionals of Saratoga Investment Advisors and preliminary valuation conclusions are documented and discussed with our senior management; and

●

an independent valuation firm engaged by our board of directors independently reviews a selection of these preliminary valuations each quarter so that the valuation of each investment for which market quotes are not readily available is reviewed by the independent valuation firm at least once each fiscal year. We use a third-party independent valuation firm to value our investment in the subordinated notes of Saratoga CLO and the Class F-2-R-3 Notes tranche of the Saratoga CLO every quarter.

113

In addition, all our investments are subject to the following valuation process:

●

the audit committee of our board of directors reviews and approves each preliminary valuation and Saratoga Investment Advisors and an independent valuation firm (if applicable) will supplement the preliminary valuation to reflect any comments provided by the audit committee; and

●

our board of directors discusses the valuations and approves the fair value of each investment, in good faith, based on the input of Saratoga Investment Advisors, independent valuation firm (to the extent applicable) and the audit committee of our board of directors.

Our investment in Saratoga CLO is carried at fair value, which is based on a discounted cash flows that utilizes prepayment, re-investment and loss assumptions based on historical experience and projected performance, economic factors, the characteristics of the underlying cash flow, and market comparables for equity interests in collateralized loan obligation funds similar to Saratoga CLO, when available, as determined by Saratoga Investment Advisors and recommended to our board of directors. Specifically, we use Intex cash flows, or an appropriate substitute, to form the basis for the valuation of our investment in Saratoga CLO. The cash flows use a set of inputs including projected default rates, recovery rates, reinvestment rates and prepayment rates in order to arrive at estimated valuations. The inputs are based on available market data and projections provided by third parties as well as management estimates. We use the output from the Intex models (i.e., the estimated cash flows) to perform a discounted cash flow analysis on expected future cash flows to determine a valuation for our investment in Saratoga CLO.

Our investments in CLO BB and CLO BBB debt have been valued using recent actual market trades or an independent pricing service. The valuation methodology of the independent pricing service includes incorporating data comprised of observable market transactions, executable bids, broker quotes from dealers with two sided markets, as well as transaction activity from comparable securities to those being valued. As the independent pricing service contemplates real-time market data and no unobservable inputs or significant judgment has been used by the Manager in the valuation of the Company’s investments in CLO BB and CLO BBB debt, such positions are considered level II assets.

Rule 2a-5 under the 1940 Act (“Rule 2a-5”) establishes a regulatory framework for determining fair value in good faith for purposes of the 1940 Act. Rule 2a-5 permits boards, subject to board oversight and certain other conditions, to designate the investment adviser to perform fair value determinations. Rule 2a-5 also defines when market quotations are “readily available” for purposes of the 1940 Act and the threshold for determining whether a fund must determine the fair value of a security. Rule 31a-4 under the 1940 Act (“Rule 31a-4”) provides the recordkeeping requirements associated with fair value determinations. While our board of directors has not elected to designate Saratoga Investment Advisors as the valuation designee, we have adopted certain revisions to its valuation policies and procedures in order comply with the applicable requirements of Rule 2a-5 and Rule 31a-4.

Revenue Recognition

Income Recognition

Purchases and sales of investments and the related realized gains or losses are recorded on a trade-date basis. Interest income, adjusted for amortization of premium and accretion of discount, is recorded on an accrual basis to the extent that such amounts are expected to be collected. We stop accruing interest on our investments when it is determined that interest is no longer collectible. Discounts and premiums on investments purchased are accreted/amortized over the life of the respective investment using the effective yield method. The amortized cost of investments represents the original cost adjusted for the accretion of discounts and amortization of premiums on investments.

114

Payment-in-Kind Interest

We hold debt and preferred equity investments in our portfolio that contain a payment-in-kind (“PIK”) interest provision. The PIK interest, which represents contractually deferred interest added to the investment balance that is generally due at maturity, is generally recorded on an accrual basis to the extent such amounts are expected to be collected. We stop accruing PIK interest if we do not expect the issuer to be able to pay all principal and interest when due.

Revenues

We generate revenue in the form of interest income and capital gains on the debt investments that we hold and capital gains, if any, on equity interests that we may acquire. We expect our debt investments, whether in the form of leveraged loans or mezzanine debt, to have terms of up to ten years, and to bear interest at either a fixed or floating rate. Interest on debt will be payable generally either quarterly or semi-annually. In some cases, our debt or preferred equity investments may provide for a portion or all of the interest to be PIK. To the extent interest is PIK, it will be payable through the increase of the principal amount of the obligation by the amount of interest due on the then-outstanding aggregate principal amount of such obligation. The principal amount of the debt and any accrued but unpaid interest will generally become due at the maturity date. In addition, we may generate revenue in the form of commitment, origination, structuring, amendment, redemption or diligence fees, fees for providing managerial assistance or investment management services and possibly consulting fees. Any such fees will be generated in connection with our investments and recognized as earned. We may also invest in preferred equity or common equity securities that pay dividends on a current basis.

On January 22, 2008, we entered into a collateral management agreement with Saratoga CLO, pursuant to which we act as its collateral manager. The Saratoga CLO was refinanced in October 2013 and November 2016 with its reinvestment period extended to October 2016 and October 2018, respectively.

On December 14, 2018, we completed a third refinancing and upsize of the Saratoga CLO. The third Saratoga CLO refinancing, among other things, extended its reinvestment period to January 2021, and extended its legal maturity date to January 2030, and added a non-call period of January 2020. Following this refinancing, the Saratoga CLO portfolio increased its aggregate principal amount from approximately $300.0 million to approximately $500.0 million of predominantly senior secured first lien term loans. In addition to refinancing its liabilities, we invested an additional $13.8 million in all of the newly issued subordinated notes of the Saratoga CLO and also purchased $2.5 million in aggregate principal amount of the Class F-R-2 and $7.5 million aggregate principal amount of the Class G-R-2 notes tranches at par, with a coupon of 3M USD LIBOR plus 8.75% and 3M USD LIBOR plus 10.00%, respectively. As part of this refinancing, we also redeemed our existing $4.5 million aggregate amount of the Class F notes tranche at par and the $20.0 million CLO 2013-1 Warehouse Loan was repaid.

On February 11, 2020, we entered into an unsecured loan agreement (“CLO 2013-1 Warehouse 2 Loan”) with Saratoga Investment Corp. CLO 2013-1 Warehouse 2, Ltd (“CLO 2013-1 Warehouse 2”), a wholly owned subsidiary of Saratoga CLO, which was fully repaid during the fourth quarter ended February 28, 2021.

On February 26, 2021, we completed the fourth refinancing of the Saratoga CLO. This refinancing, among other things, extended the Saratoga CLO reinvestment period to April 2024, extended its legal maturity to April 2033, and added a non-call period of February 2022. In addition, and as part of the refinancing, the Saratoga CLO was upsized from $500 million in assets to approximately $650 million. As part of this refinancing and upsizing, we invested an additional $14.0 million in all of the newly issued subordinated notes of the Saratoga CLO, and purchased $17.9 million in aggregate principal amount of the Class F-R-3 Notes tranche at par. Concurrently with the fourth refinancing of the Saratoga CLO, the existing $2.5 million of Class F-R-2 Notes, $7.5 million of Class G-R-2 Notes and $25.0 million of the CLO 2013-1 Warehouse 2 Loan were repaid. We also paid $2.6 million of transaction costs related to the refinancing and upsizing on behalf of the Saratoga CLO, to be reimbursed from future equity distributions. At August 31, 2021, the outstanding receivable of $2.6 million was repaid in full.

115

On August 9, 2021, we exchanged our existing $17.9 million Class F-R-3 Notes for $8.5 million Class F-1-R-3 Notes and $9.4 million Class F-2-R-3 Notes at par. On August 11, 2021, we sold our Class F-1-R-3 Notes to third parties, resulting in a realized loss of $0.1 million.

On June 10, 2024, we completed our fifth refinancing of the Saratoga CLO, which adjusted the interest rate of two of the existing Notes. Saratoga CLO issued $422.5 million notes (the “2013-1 2024 Reset CLO Notes”), consisting of Class A-1-R-4 and Class A-2-R-4. The 2013-1 2024 Reset CLO Notes were issued pursuant to the indenture with the same trustee. Proceeds of the issuance of the 2013-1 2024 Reset CLO Notes were used along with existing assets of the Saratoga CLO to redeem the existing Class A-1-R-3 and Class A-2-R-3 Notes. No other Notes were refinanced as part of this refinancing. The Saratoga CLO paid $0.5 million of transaction costs related to the refinancing.

The Saratoga CLO remains effectively 100% owned and managed by Saratoga Investment Corp. We receive a base management fee of 0.10% per annum and a subordinated management fee of 0.40% per annum of the outstanding principal amount of Saratoga CLO’s assets, paid quarterly to the extent of available proceeds.

Following the third refinancing and the issuance of the 2013-1 Reset CLO Notes on December 14, 2018, we are no longer entitled to an incentive management fee equal to 20.0% of excess cash flow to the extent the Saratoga CLO subordinated notes receive an internal rate of return paid in cash equal to or greater than 12.0%.

Interest income on our investment in Saratoga CLO is recorded using the effective interest method in accordance with the provisions of FASB ASC Topic 325-40, Investments—Other, Beneficial Interests in Securitized Financial Assets, based on the anticipated yield and the estimated cash flows over the projected life of the investment. Yields are revised when there are changes in actual or estimated cash flows due to changes in prepayments and/or re-investments, credit losses or asset pricing. Changes in estimated yield are recognized as an adjustment to the estimated yield over the remaining life of the investment from the date the estimated yield was changed.

On October 26, 2021, we and TJHA entered into the LLC Agreement to co-manage SLF JV. SLF JV is invested in Saratoga Investment Corp Senior Loan Fund 2022-1, Ltd (“SLF 2021”), which is a wholly owned subsidiary of SLF JV. SLF 2021 was formed for the purpose of making investments in a diversified portfolio of broadly syndicated first lien and second lien term loans or bonds in the primary and secondary markets.

We and TJHA have committed to provide up to a combined $50.0 million of financing to SLF JV through cash contributions, with us providing $43.75 million and TJHA providing $6.25 million, resulting in 87.5% and 12.5% ownership between the two parties. The financing is issued in the form of an unsecured note and equity. The unsecured note pays a fixed-rate of 10% per annum and is due and payable in full on October 20, 2033.

We record interest income from its investment in an unsecured loan with SLF JV on an accrual basis and records dividend income from its membership interest when earned. All operating decisions are shared with a 50% voting interest in SLF JV

116

Expenses

Our primary operating expenses include the payment of investment advisory and management fees, professional fees, directors and officers insurance, fees paid to directors who are not “interested persons” (as defined in Section 2(a)(19) of the 1940 Act) of the Company (“independent directors”) and administrator expenses, including our allocable portion of our administrator’s overhead. Our investment advisory and management fees compensate our Manager for its work in identifying, evaluating, negotiating, closing and monitoring our investments. We bear all other costs and expenses of our operations and transactions, including those relating to:

●

organization;

●

calculating our net asset value (“NAV”) (including the cost and expenses of any independent valuation firm);

●

expenses incurred by our Manager payable to third parties, including agents, consultants or other advisers, in monitoring our financial and legal affairs and in monitoring our investments and performing due diligence on our prospective portfolio companies;

●

expenses incurred by our Manager payable for travel and due diligence on our prospective portfolio companies;

●

interest payable on debt, if any, incurred to finance our investments;

●

offerings of our common stock and other securities;

●

investment advisory and management fees;

●

fees payable to third parties, including agents, consultants or other advisers, relating to, or associated with, evaluating and making investments;

●

transfer agent and custodial fees;

●

federal and state registration fees;

●

all costs of registration and listing our common stock on any securities exchange;

●

U.S. federal, state and local taxes;

●

independent directors fees and expenses;

●

costs of preparing and filing reports or other documents required by governmental bodies (including the SEC and the SBA);

●

costs of any reports, proxy statements or other notices to common stockholders including printing costs;

●

our fidelity bond, directors and officers errors and omissions liability insurance, and any other insurance premiums;

●

direct costs and expenses of administration, including printing, mailing, long distance telephone, copying, secretarial and other staff, independent auditors and outside legal costs; and

●

administration fees and all other expenses incurred by us or, if applicable, the administrator in connection with administering our business (including payments under the Administration Agreement based upon our allocable portion of the administrator’s overhead in performing its obligations under an Administration Agreement, including rent and the allocable portion of the cost of our officers and their respective staffs (including travel expenses)).

117

The terms of the investment advisory and management agreement with Saratoga Investment Advisors, our current investment adviser, are substantially similar to the terms of the investment advisory and management agreement we had entered into with GSCP (NJ), L.P., our former investment adviser, except for the following material distinctions in the fee terms:

●

The capital gains portion of the incentive fee was reset with respect to gains and losses from May 31, 2010, and therefore losses and gains incurred prior to such time will not be taken into account when calculating the capital gains fee payable to Saratoga Investment Advisors and, as a result, Saratoga Investment Advisors will be entitled to 20.0% of net gains that arise after May 31, 2010. In addition, the cost basis for computing realized gains and losses on investments held by us as of May 31, 2010 equal the fair value of such investment as of such date. Under the investment advisory and management agreement with our former investment adviser, GSCP (NJ), L.P., the capital gains fee was calculated from March 21, 2007, and the gains were substantially outweighed by losses.

●

Under the “catch up” provision, 100.0% of our pre-incentive fee net investment income with respect to that portion of such pre-incentive fee net investment income that exceeds 1.875% but is less than or equal to 2.344% in any fiscal quarter is payable to Saratoga Investment Advisors. This will enable Saratoga Investment Advisors to receive 20.0% of all net investment income as such amount approaches 2.344% in any quarter, and Saratoga Investment Advisors will receive 20.0% of any additional net investment income. Under the investment advisory and management agreement with our former investment adviser, GSCP (NJ), L.P. only received 20.0% of the excess net investment income over 1.875%.

●

We will no longer have deferral rights regarding incentive fees in the event that the distributions to stockholders and change in net assets is less than 7.5% for the preceding four fiscal quarters.

Capital Gains Incentive Fee

We record an expense accrual relating to the capital gains incentive fee payable by us to the Manager when the unrealized gains on its investments exceed all realized capital losses on its investments given the fact that a capital gains incentive fee would be owed to the Manager if we were to liquidate our investment portfolio at such time. The actual incentive fee payable to our Manager related to capital gains will be determined and payable in arrears at the end of each fiscal year and will include only realized capital gains for the period.

Recent Accounting Pronouncements

In December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures (“ASU 2023-09”), which requires additional disaggregated information on income taxes paid. This amended guidance is effective for annual periods beginning after December 15, 2024. Early adoption is permitted, however the Company has not elected to early adopt this provision as of the date of the financial statements contained in this report. The Company is currently evaluating the impact of the new guidance on the Company’s consolidated financial statements and related disclosures.

In November 2024, the FASB issued ASU 2024-03, Disaggregation of Income Statement Expenses, which requires additional disclosure of the nature of expenses included in the income statement in response to requests from investors for more information about an entity’s expenses. The new standard requires disaggregation of certain expense captions into specified categories in disclosures within the footnotes to the financial statements. The new guidance is effective for annual periods beginning after December 15, 2026, and interim periods within the annual reporting periods beginning after December 15, 2027. Early adoption permitted. We are currently evaluating the impact of the new standard on our consolidated financial statements and related disclosures and do not believe it will have a material impact on its consolidated financial statements or its disclosures.

118

Portfolio and Investment Activity

Investment Portfolio Overview

	August 31, 2025			February 28, 2025
	($ in millions)
Number of investments(1)		101			135
Number of portfolio companies(2)		44			48
Average investment per portfolio company(2)	$	20.6		$	20.1
Average investment size(1)	$	9.2		$	7.2
Weighted average maturity(3)		2.4 yrs			2.2 yrs
Number of industries (5)		39			41
Non-performing or delinquent investments (fair value)	$	1.8		$	2.6
Fixed rate debt (% of interest earning portfolio)(3)	$	9.8(1.2	)%	$	26.1(3.0	)%
Fixed rate debt (weighted average current coupon)(3)		8.3	%		7.4	%
Floating rate debt (% of interest earning portfolio)(3)	$	836.5(98.8	)%	$	850.5(97.0	)%
Floating rate debt (weighted average current spread over SOFR)(3)(4)		6.9	%		7.2	%

(1)	Excludes our investment in the subordinated notes of Saratoga CLO, and our investments in BBB and BB CLO Debt.
(2)	Excludes our investment in the subordinated notes of Saratoga CLO and Class F-2-R-3 Notes tranche, as well as the unsecured notes and equity interests in the SLF JV, the Class E Note tranche of the SLF 2022 and our investments in BB and BBB CLO debt.
(3)	Excludes our investment in the subordinated notes of Saratoga CLO and equity interests, as well as the unsecured notes and equity interests in SLF JV, the Class E Note tranche of the SLF 2022 and our investments in BB and BBB CLO debt.
(4)	Calculation uses either 1-month or 3-month SOFR, depending on the contractual terms, and after factoring in any existing SOFR floors.
(5)	Our investment in the subordinated notes of Saratoga CLO and Class F-R-3 Note tranche, the unsecured notes and equity interests in the SLF JV, the Class E Note tranche of the SLF 2022 and the BB and BBB CLO debt securities are included in Structured Finance Securities industry.

During the three months ended August 31, 2025, we invested $52.2 million in new and existing portfolio companies and had $29.8 million in aggregate amount of exits and repayments resulting in net investments of $22.4 million for the period. During the three months ended August 31, 2024, we invested $2.6 million in new and existing portfolio companies and had $60.1 million in aggregate amount of exits and repayments resulting in net repayments of $(57.5) million for the period.

During the six months ended August 31, 2025, we invested $102.3 million in new and existing portfolio companies and had $94.9 million in aggregate amount of exits and repayments resulting in net investments of $7.4 million for the period. During the six months ended August 31, 2024, we invested $41.9 million in new and existing portfolio companies and had $135.8 million in aggregate amount of exits and repayments resulting in net repayments of $(93.9) million for the period.

119

Portfolio Composition

Our portfolio composition at August 31, 2025: and February 28, 2025: at fair value was as follows:

	August 31, 2025						February 28, 2025
	Percentage of Total Portfolio			Weighted Average Current Yield			Percentage of Total Portfolio			Weighted Average Current Yield
First lien term loans		84.3	%		11.0	%		88.7	%		11.3	%
Second lien term loans		0.7			16.9			0.7			16.7
Unsecured term loans		1.7			10.5			1.7			10.7
Structured finance securities		5.4			12.2			1.5			19.9
Equity interests		7.9			-			7.4			-
Total		100.0	%		10.4	%		100.0	%		10.8	%

At August 31, 2025, our investment in the subordinated notes of Saratoga CLO, a collateralized loan obligation fund, had a fair value of $0.1 million and constituted 0.01% of our portfolio. This investment constitutes a first loss position in a portfolio that, as of August 31, 2025 and February 28, 2025, was composed of $462.9 million and $527.1 million, respectively, in aggregate principal amount of primarily senior secured first lien term loans. In addition, as of August 31, 2025, we also own $9.4 million in aggregate principal of the F-2-R-3 Notes in the Saratoga CLO, which only rank senior to the subordinated notes.

This investment is subject to unique risks. (See Part 1. Item 1A. Risk Factors—“Our investment in Saratoga CLO constitutes a leveraged investment in a portfolio of subordinated notes representing the lowest-rated securities issued by a pool of predominantly senior secured first lien term loans and is subject to additional risks and volatility. All losses in the pool of loans will be borne by our subordinated notes and only after the value of our subordinated notes is reduced to zero will the higher-rated notes issued by the pool bear any losses.” in our Annual Report on Form 10-K for the fiscal year ended February 28, 2025).

We do not consolidate the Saratoga CLO portfolio in our consolidated financial statements. Accordingly, the metrics below do not include the underlying Saratoga CLO portfolio investments. However, at August 31, 2025, $415.4 million or 96.7% of the Saratoga CLO portfolio investments in terms of market value had a CMR (as defined below) color rating of green or yellow and 10 Saratoga CLO portfolio investments were in default with a fair value of $11.5 million. At February 28, 2025, $484.3 million or 98.4% of the Saratoga CLO portfolio investments in terms of market value had a CMR color rating of green or yellow and eight of the Saratoga CLO portfolio investments were in default with a fair value of $4.4 million. For more information relating to the Saratoga CLO, see the audited financial statements for Saratoga in our Annual Report on Form 10-K for the fiscal year ended February 28, 2025.

Saratoga Investment Advisors normally grades all of our investments using a credit and monitoring rating system (“CMR”). The CMR consists of a single component: a color rating. The color rating is based on several criteria, including financial and operating strength, probability of default, and restructuring risk. The color ratings are characterized as follows: (Green)—performing credit; (Yellow)—underperforming credit; (Red)—in principal payment default and/or expected loss of principal.

120

Portfolio CMR distribution

The CMR distribution for our investments at August 31, 2025 and February 28, 2025 was as follows:

Saratoga Investment Corp.

	August 31, 2025					February 28, 2025
Color Score	Investments at Fair Value		Percentage of Total Portfolio			Investments at Fair Value		Percentage of Total Portfolio
	($ in thousands)
Green	$	900,920		90.5	%	$	890,437		91.0	%
Yellow		1,303		0.1			1,086		0.1
Red		1,847		0.2			1,547		0.2
N/A(1)		91,226		9.2			85,008		8.7
Total	$	995,295		100.0	%	$	978,078		100.0	%

(1)	Comprised of our investment in the subordinated notes of Saratoga CLO, equity interests, and BB and BBB CLO debt securities.

The CMR distribution of Saratoga CLO investments at August 31, 2025 and February 28, 2025 was as follows:

Saratoga CLO

	August 31, 2025					February 28, 2025
Color Score	Investments at Fair Value		Percentage of Total Portfolio			Investments at Fair Value		Percentage of Total Portfolio
	($ in thousands)
Green	$	393,775		91.7	%	$	446,859		90.8	%
Yellow		21,644		5.0			37,453		7.6
Red		11,499		2.7			6,198		1.3
N/A(1)		2,574		0.6			1,685		0.3
Total	$	429,492		100.0	%	$	492,195		100.0	%

(1)	Comprised of Saratoga CLO’s equity interests.

121

Portfolio composition by industry grouping at fair value

The following table shows our portfolio composition by industry grouping at fair value at August 31, 2025 and February 28, 2025:

Saratoga Investment Corp.

	August 31, 2025					February 28, 2025
	Investments At Fair Value		Percentage of Total Portfolio			Investments At Fair Value		Percentage of Total Portfolio
	($ in thousands)
Healthcare Services	$	96,671		9.7	%	$	85,149		8.5	%
Structured Finance Securities(1)		73,026		7.3			34,387		3.5
Consumer Services		59,257		6.0			59,439		6.1
HVAC Services and Sales		53,325		5.4			57,458		5.9
Real Estate Services		51,875		5.2			51,750		5.3
Healthcare Software		45,884		4.6			45,986		4.7
Research Software		36,940		3.7			26,280		2.7
Mental Healthcare Services		32,562		3.3			32,405		3.3
Education Services		32,189		3.2			27,533		2.8
Education Software		32,000		3.2			41,595		4.3
Custom Millwork Software		31,898		3.2			31,722		3.2
Restaurant		31,740		3.2			31,600		3.2
Dental Practice Management		31,196		3.1			35,159		3.6
Municipal Government Software		30,340		3.0			29,720		3.0
Employee Collaboration Software		28,082		2.8			27,179		2.8
Talent Acquisition Software		27,392		2.8			27,334		2.8
Financial Services		26,294		2.7			26,302		2.7
Architecture & Engineering Software		25,253		2.6			25,293		2.6
Health/Fitness Franchisor		24,957		2.5			28,453		2.9
Direct Selling Software		23,852		2.4			24,064		2.5
Mentoring Software		21,061		2.1			22,027		2.3
Insurance Software		20,983		2.1			20,345		2.1
IT Services		19,365		1.9			18,810		1.9
Marketing Orchestration Software		18,311		1.8			18,444		1.9
Fire Inspection Business Software		18,047		1.8			10,178		1.0
Corporate Education Software		17,763		1.8			17,346		1.8
Alternative Investment Management Software		14,323		1.5			11,576		1.2
Veterinary Services		13,358		1.3			12,667		1.3
Lead Management Software		11,526		1.2			11,641		1.2
HVAC Monitoring Devices		10,940		1.1			-		0.0
Supply Chain Planning Software		10,113		1.0			-		0.0
Industrial Products		9,564		1.0			9,404		1.0
Office Supplies		5,339		0.5			5,339		0.5
Cyber Security		3,857		0.4			3,517		0.4
Staffing Services		2,403		0.2			3,426		0.4
Specialty Food Retailer		1,847		0.2			1,546		0.2
Association Management Software		1,762		0.2			24,850		2.5
Non-profit Services		-		0.0			16,470		1.7
Financial Services Software		-		0.0			9,933		1.0
Field Service Management		-		0.0			11,751		1.2
Total	$	995,295		100.0	%	$	978,078		100.0	%

(1)	As of August 31, 2025 and February 28, 2025, the foregoing comprised of our investment in the subordinated notes and F-2-R-3 Notes of Saratoga CLO, the unsecured notes and equity interests in the SLF JV, E-Notes of SLF 2022, and BB and BBB CLO debt securities.

122

The following table shows Saratoga CLO’s portfolio composition by industry grouping at fair value at August 31, 2025 and February 28, 2025:

Saratoga CLO

	August 31, 2025					February 28, 2025
	Investments at Fair Value		Percentage of Total Portfolio			Investments at Fair Value		Percentage of Total Portfolio
	($ in thousands)
Banking, Finance, Insurance & Real Estate	$	80,073		18.6	%	$	101,194		20.9	%
Services: Business		41,872		9.7			46,915		9.5
High Tech Industries		34,570		8.0			39,950		8.1
Services: Consumer		23,994		5.6			26,923		5.5
Chemicals, Plastics, & Rubber		22,475		5.2			25,268		5.1
Healthcare & Pharmaceuticals		21,984		5.1			26,032		5.3
Retail		21,807		5.1			22,306		4.5
Hotel, Gaming & Leisure		16,762		3.9			16,900		3.4
Media: Advertising, Printing & Publishing		14,361		3.3			17,309		3.4
Consumer Goods: Durable		14,344		3.3			14,008		2.7
Automotive		13,747		3.2			16,730		3.4
Telecommunications		13,656		3.2			19,475		4.0
Beverage, Food & Tobacco		12,574		2.9			12,920		2.6
Construction & Building		12,215		2.8			13,129		2.7
Containers, Packaging & Glass		10,975		2.6			13,522		2.7
Consumer goods: Non-durable		9,822		2.3			10,571		2.1
Aerospace & Defense		7,950		1.9			8,353		1.7
Wholesale		7,590		1.8			8,061		1.6
Transportation: Cargo		6,599		1.5			7,153		1.5
Utilities: Oil & Gas		6,381		1.6			6,417		1.3
Media: Broadcasting & Subscription		6,349		1.6			7,069		1.4
Capital Equipment		4,712		1.1			4,739		1.0
Media: Diversified & Production		4,426		1.0			6,286		1.3
Forest Products & Paper		4,066		0.9			4,408		0.9
Transportation: Consumer		3,673		0.9			3,727		0.8
Energy: Electricity		3,296		0.8			3,306		0.7
Energy: Oil & Gas		3,028		0.7			3,012		0.6
Environmental Industries		2,307		0.5			2,588		0.5
Utilities: Electric		1,988		0.5			1,988		0.4
Metals & Mining		1,897		0.4			1,936		0.4
Total	$	429,493		100.0	%	$	492,195		100.0	%

Portfolio composition by geographic location at fair value

The following table shows our portfolio composition by geographic location at fair value at August 31, 2025 and February 28, 2025. The geographic composition is determined by the location of the corporate headquarters of the portfolio company.

	August 31, 2025					February 28, 2025
	Investments at Fair Value		Percentage of Total Portfolio			Investments at Fair Value		Percentage of Total Portfolio
	($ in thousands)
Midwest	$	359,902		36.2	%	$	364,944		37.3	%
Southeast		206,361		20.7			234,144		23.9
Northeast		127,614		12.8			128,787		13.2
West		116,047		11.7			120,361		12.3
Southwest		79,247		8.0			63,278		6.5
International/Other		19,365		1.9			18,810		1.9
Other(1)		86,759		8.7			47,754		4.9
Total	$	995,295		100.0	%	$	978,078		100.0	%

(1)	Comprised of our investments in the subordinated notes, F-2-R-3 Notes of Saratoga CLO, as well as the unsecured notes and equity interests in the SLF JV, foreign investments the BB and BBB CLO debt securities.

123

Results of operations

Operating results for the three and six months ended August 31, 2025 and August 31, 2024 was as follows:

	For the three months ended					For the six months ended
	August 31, 2025		August 31, 2024			August 31, 2025		August 31, 2024
	($ in thousands)
Total investment income	$	30,626	$	43,003		$	62,944	$	81,682
Total operating expenses		21,545		24,806			43,722		49,149
Net investment income		9,081		18,197			19,222		32,533
Net realized gain (loss) from investments		53		(33,449	)		2,954		(54,644	)
Net change in unrealized appreciation (depreciation) on investments		3,727		28,728			4,672		42,660
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments		424		(158	)		369		(621	)
Net increase (decrease) in net assets resulting from operations	$	13,285	$	13,318		$	27,217	$	19,928

Investment income

The composition of our investment income for three and six months ended August 31, 2025 and August 31, 2024 was as follows:

	For the three months ended					For the six months ended
	August 31, 2025			August 31, 2024		August 31, 2025		August 31, 2024
	($ in thousands)
Interest from investments	$	26,377		$	39,365	$	54,381	$	73,672
Interest from cash and cash equivalents		2,360			1,671		4,388		2,296
Management fee income		664			792		1,369		1,597
Dividend Income		1,031			1,078		2,030		2,625
Structuring and advisory fee income		222			35		486		446
Other income		(28	)		62		291		1,047
Total investment income	$	30,626		$	43,003	$	62,945	$	81,683

For the three months ended August 31, 2025, total investment income decreased $12.4 million, or 28.8%, to $30.6 million from $43.0 million for the three months ended August 31, 2024. Interest income from investments decreased $13.0 million, or 33.0%, to $26.4 million for the three months ended August 31, 2025 from $39.4 million for the three months ended August 31, 2024. Interest income from investments decreased due to the (i) non-recurrence of $7.9 million interest income related to our Knowland investment recognized last year that was previously on non-accrual, and (ii) decrease of $45.4 million, or 4.4%, in total investments at August 31, 2025 from $1,040.7 million at August 31, 2024 to $995.3 million as of August 31, 2025, combined with the decrease in the weighted average current yield on investments to 10.4%, down from 11.5% at August 31, 2024, primarily due to the reduction in SOFR base rates during this period.

For the six months ended August 31, 2025, total investment income decreased $18.7 million, or 22.9%, to $62.9 million from $81.7 million for the six months ended August 31, 2024. Interest income from investments decreased $19.3 million, or 26.2%, to $54.4 million for the six months ended August 31, 2025 from $73.7 million for the six months ended August 31, 2024. Interest income from investments decreased due to the (i) non-recurrence of $7.9 million interest income related to our Knowland investment recognized last year that was previously on non-accrual, and (ii) decrease of the weighted average current yield on investments to 10.4% as of August 31, 2025, down from 11.5% at August 31, 2024, primarily due to the reduction in SOFR base rates during this period.

For the three and six months ended August 31, 2025 and August 31, 2024, total PIK income was $0.8 million and $1.6 million, respectively and $1.9 million and $2.5 million, respectively.

For the three months ended August 31, 2025 and August 31, 2024, interest from cash and cash equivalents was $2.4 million and $1.7 million, respectively. The increase of $0.7 million was due to increased cash and cash equivalents balances during this period as compared to last year, reflecting the significant levels of repayments experienced during this period.

For the six months ended August 31, 2025 and August 31, 2024, interest from cash and cash equivalents was $4.4 million and $2.3 million, respectively. The increase of $2.1 million was due to increased cash and cash equivalents balances during this period as compared to last year, reflecting the significant levels of repayments experienced during this period.

124

Management fee income reflects the fee income received for managing the Saratoga CLO. For the three months ended August 31, 2025 and August 31, 2024, total management fee income was $0.7 million and $0.8 million, respectively. For the six months ended August 31, 2025 and 2024, total management fee income was $1.4 million and $1.6 million, respectively.

For the three and six months ended August 31, 2025 and August 31, 2024, total dividend income was $1.0 million and $1.1 million, respectively and $2.0 million and $2.6 million. Dividends received are recorded in the consolidated statements of operations when earned, and the decrease primarily reflects lower dividend income of $0.9 million and $1.3 million, respectively, received on our membership interest in SLF JV during the three and six months ended August 31, 2025 as compared to the three and six months ended August 31, 2024.

For the three and six months ended August 31, 2025 and August 31, 2024, total structuring and advisory fee income was $0.2 million and $0.0 million, respectively and $0.5 million and $0.4 million. Structuring and advisory fee income represents fee income earned and received performing certain investment and advisory activities during the closing of new investments.

For the three and six months ended August 31, 2025 and August 31, 2024, other income was $0.0 million and $0.1 million, respectively and $0.3 million and $1.0 million, respectively. Other income includes origination fees, monitoring and amendment fees and prepayment fees and is recorded in the consolidated statements of operations when earned.

Operating expenses

The composition of our operating expenses for the three and six months ended August 31, 2025 and August 31, 2024 was as follows:

	For the three months ended					For the six months ended
	August 31, 2025			August 31, 2024		August 31, 2025		August 31, 2024
	($ in thousands)
Interest and debt financing expenses	$	12,372		$	13,129	$	24,824	$	26,091
Base management fees		4,374			4,766		8,708		9,749
Incentive management fees expense (benefit)		2,271			4,550		4,808		8,135
Professional fees		650			126		1,349		1,125
Administrator expenses		1,283			1,133		2,533		2,208
Insurance		74			78		149		155
Directors fees and expenses		119			80		250		193
General & administrative and other expenses		413			822		1,058		1,431
Income tax expense (benefit)		(11	)		122		43		62
Total operating expenses	$	21,545		$	24,806	$	43,722	$	49,149

For the three months ended August 31, 2025, total operating expenses decreased $3.3 million, or 13.2%, compared to the three months ended August 31, 2024. For the six months ended August 31, 2025, total operating expenses decreased $5.4, or 11.0%, compared to the six months ended August 31, 2024.

For the three months ended August 31, 2025, interest and debt financing expenses decreased $0.8 million, or 5.8%, compared to the three months ended August 31, 2024. The decrease is primarily attributable to a decrease of 5.8% in average outstanding debt from $836.9 million for the three months ended August 31, 2024 to $788.4 million for the three months ended August 31, 2025. For the six months ended August 31, 2025, interest and debt financing expenses decreased $1.3 million, or 3.9% compared to the six months ended August 31, 2024. The decrease is primarily attributable to a decrease of 5.3% in average outstanding debt from $835.0 million for the six months ended August 31, 2024 to $790.6 million for the six months ended August 31, 2025.

For the three and six months ended August 31, 2025 and August 31, 2024, the weighted average interest rate on our outstanding indebtedness was 5.57% and 6.06%, respectively and 5.58% and 6.06%, respectively.

As of August 31, 2025 and February 28, 2025, the SBA debentures represented 21.6% and 21.4% of overall debt, respectively.

For the three months ended August 31, 2025, base management fees decreased $0.4 million, or 8.2%, from $4.8 million to $4.4 million compared to the three months ended August 31, 2024. The decrease in base management fees results from the 8.2 % decrease in the average value of our total assets, less cash and cash equivalents, from $1,080.6 million for the three months ended August 31, 2024 to $991.7 million for the three months ended August 31, 2025.

125

For the six months ended August 31, 2025, base management fees decreased $1.0 million, or 10.7%, from $9.7 million to $8.7 million compared to the six months ended August 31, 2024. The decrease in base management fees results from the 10.7% decrease in the average value of our total assets, less cash and cash equivalents, from $1,105.1 million for the six months ended August 31, 2024 to $987.0 million for the six months ended August 31, 2025.

For the three months ended August 31, 2025, incentive management fees decreased $2.3 million to $2.3 million, or 50.4%, compared to $4.6 million the three months ended August 31, 2024. The incentive fee on income decreased from $4.6 million to $2.3 million for the three months ended August 31, 2024 and 2025, respectively, reflecting the decrease in net investment income during the three months ended August 31, 2025 as compared to the three months ended August 31, 2024. The incentive fee on capital gains remained unchanged at $0.8 million for both the three months ended August 31, 2024 and August 31, 2025, reflecting no incentive fee on net realized and unrealized depreciation recognized during both these periods, with the liability floor capped at zero.

For the six months ended August 31, 2025, incentive management fees decreased $3.3 million to $4.8 million, or 41.1%, compared to $8.1 million the six months ended August 31, 2024. The incentive fee on income decreased from $8.1 million to $4.8 million for the six months ended August 31, 2024 and 2025, respectively, reflecting the decrease in net investment income during the six months ended August 31, 2025 as compared to the six months ended August 31, 2024. The incentive fee on capital gains remained unchanged at $0.0 million for both the six months ended August 31, 2024 and August 31, 2025, reflecting no incentive fee on net realized and unrealized depreciation recognized during both these periods, with the liability floor capped at zero.

For the three months ended August 31, 2025, professional fees increased $0.5 million, or 416.3% compared to the three months ended August 31, 2024.

For the six months ended August 31, 2025, professional fees increased $0.2 million, or 19.9% compared to the six months ended August 31, 2024.

For the three months ended August 31, 2025, administrator expenses increased $0.2 million, or 13.2% compared to the three months ended August 31, 2024, reflecting the contractual changes to the administrator agreement cap.

For the six months ended August 31, 2025, administrator expenses increased $0.3 million, or 14.7% compared to the six months ended August 31, 2024, reflecting the contractual changes to the administrator agreement cap.

For the three months ended August 31, 2025, general and administrative expenses decreased $0.4 million, or 49.8% compared to the three months ended August 31, 2024.

For the six months ended August 31, 2025, general and administrative expenses increased $0.4 million, or 26.0% compared to the six months ended August 31, 2024.

As discussed above, the decrease in interest and debt financing expenses for the three months ended August 31, 2025 compared to the three months ended August 31, 2024 is primarily attributable to a decrease in the overall average dollar amount of outstanding debt. For the three months ended August 31, 2025 and August 31, 2024, the average borrowings outstanding under the Encina Credit Facility was $32.5 million and $32.5 million, respectively, and the average weighted average interest rate on the outstanding borrowing under the Encina Credit Facility was 8.9% and 9.9%, respectively. For the three months ended August 31, 2025 and August 31, 2024, the average borrowings outstanding under the Live Oak Credit Facility was $37.5 million and $19.0 million, respectively, and the average weighted average interest rate on the outstanding borrowing under the Live Oak Credit Facility was 8.5% and 9.6%, respectively. For the three months ended August 31, 2025 and August 31, 2024, the average borrowings outstanding of SBA debentures was $170.0 million and $214.0 million, respectively. For the three months ended August 31, 2025 and August 31, 2024, the weighted average interest rate on the outstanding borrowings of the SBA debentures was 3.0% and 3.3%, respectively. For the three months ended August 31, 2025 and August 31, 2024, the average borrowings outstanding of our Notes Payable was $546.4 million and $571.4 million, respectively. For the three months ended August 31, 2025 and August 31, 2024, the weighted average interest rate on the Notes Payable was 5.96% and 6.06%, respectively.

As discussed above, the decrease in interest and debt financing expenses for the six months ended August 31, 2025 compared to the six months ended August 31, 2024 is primarily attributable to a decrease in the overall average dollar amount of outstanding debt. For the six months ended August 31, 2025 and August 31, 2024, the average borrowings outstanding under the Encina Credit Facility was $32.5 million and $33.6 million, respectively, and the average weighted average interest rate on the outstanding borrowing under the Encina Credit Facility was 8.9% and 9.9%, respectively. For the six months ended August 31, 2025 and August 31, 2024, the average borrowings outstanding under the Live Oak Credit Facility was $35.0 million and $16.0 million, respectively, and the average weighted average interest rate on the outstanding borrowing under the Live Oak Credit Facility was 8.5% and 9.5%, respectively. For the six months ended August 31, 2025 and August 31, 2024, the average borrowings outstanding of SBA debentures was $170.0 million and $214.0 million, respectively. For the six months ended August 31, 2025 and August 31, 2024, the weighted average interest rate on the outstanding borrowings of the SBA debentures was 3.0% and 3.4%, respectively. For the six months ended August 31, 2025 and August 31, 2024, the average borrowings outstanding of our Notes Payable was $546.4 million and $571.4 million, respectively. For the six months ended August 31, 2025 and August 31, 2024, the weighted average interest rate on the Notes Payable was 6.0% and 6.1%, respectively.

126

The weighted average dollar amount of our unsecured notes for the three and six months ended August 31, 2025 and August 31, 2024 was as follows:

	For the three months ended				For the six months ended
	August 31, 2025		August 31, 2024		August 31, 2025		August 31, 2024
	($ in thousands)
7.75% 2025 Notes	$	-	$	5.0	$	5.0	$	5.0
6.25% 2027 Notes		15.0		15.0		15.0		15.0
4.375% 2026 Notes		175.0		175.0		175.0		175.0
4.35% 2027 Notes		75.0		75.0		75.0		75.0
6.00% 2027 Notes		105.5		105.5		105.5		105.5
7.00% 2025 Notes		12.0		12.0		12.0		12.0
8.00% 2027 Notes		46.0		46.0		46.0		46.0
8.125% 2027 Notes		60.4		60.4		60.4		60.4
8.75% 2024 Notes		-		20.0		0.0		20.0
8.50% 2028 Notes		57.5		57.5		57.5		57.5

For the three and six months ended August 31, 2025 and August 31, 2024, there were income tax expense (benefits) of ($.01) million and $0.1 million, respectively and $.04 million and $0.1 million This relates to net deferred federal and state income tax expense (benefit) with respect to operating gains and losses and income derived from equity investments held in entities that are treated as corporations for U.S. federal income tax purposes, as well as current U.S. federal and state income taxes on those operating gains and losses when realized.

Net realized gains (losses) on sales of investments

For the three months ended August 31, 2025, we had $29.8 million of sales, repayments, exits or restructurings resulting in $0.05 million of net realized gains. For the six months ended August 31, 2025, we had $94.9 million of sales, repayments, exits or restructurings resulting in $3.0 million of net realized gains.

The most significant cumulative net change in realized gains (losses) for the six months ended August 31, 2025 were the following (dollars in thousands):

Six Months ended August 31, 2025

Issuer	Asset Type	Gross Proceeds			Cost			Net Realized Gain (Loss)
HemaTerra Holdings Company, LLC	First Lien Term Loan & Equity Interests	$	-		$	(97	)	$	97
Identity Automation Systems	First Lien Term Loan & Equity Interests		(2,570	)		(4,735	)		2,166
Netreo Holdings, LLC	First Lien Term Loan & Equity Interests		-			(638	)		638

We received escrow payments from the prior sales of our investments in HemaTerra Holdings Company, LLC and Netreo Holdings, LLC.

The $2.2 million of net realized gains was from the sale of the equity positions in our Identity Automation Systems investment.

For the three months ended August 31, 2024, we had $60.1 million of sales, repayments, exits or restructurings resulting in $33.4 million of net realized losses. For the six months ended August 31, 2024, we had $135.8 million of sales, repayments, exits or restructurings resulting in $54.6 million of net realized losses.

127

The most significant cumulative net change in realized gains (losses) for the six months ended August 31, 2024 were the following (dollars in thousands):

Six Months ended August 31, 2024

Issuer	Asset Type	Gross Proceeds		Cost		Net Realized Gain (Loss)
Zollege PBC	First Lien Term Loan & Equity Interests	$	3,205	$	18,316	$	(15,111	)
Netreo Holdings, LLC	Equity Interests		2,260		8,344		(6,084	)
Book4Time, Inc.	First Lien Term Loan, Second Lien Term Loan & Equity Interests		707		157		550
Pepper Palace, Inc.	First Lien Term Loan & Equity Interests		-		-		(34,007	)

The $15.1 million of net realized losses was from the restructuring of our Zollege PBC investment.

The $6.1 million of net realized losses was from the sale of the equity position in our Netreo Holdings, LLC investment.

The $0.6 million of net realized gains was from the sale of the equity position in our Book4Time, Inc. investment.

The $34.0 million of net realized losses was from the restructuring of our Pepper Palace, Inc. investment.

Net change in unrealized appreciation (depreciation) on investments

For the six months ended August 31, 2025, our investments had a net change in unrealized appreciation of $4.7 million compared to a net change in unrealized depreciation of $42.7 million for the six months ended August 31, 2024.

The most significant cumulative net change in unrealized appreciation (depreciation) for the six months ended August 31, 2025 were the following (dollars in thousands):

Six Months ended August 31, 2025

Issuer	Asset Type	Cost		Fair Value		Total Unrealized Appreciation (Depreciation)		YTD Change in Unrealized Appreciation (Depreciation)
Zollege PBC	First Lien Term Loan & Equity Interests	$	2,098	$	8,610	$	6,512	$	4,595
Identity Automation Systems	First Lien Term Loan & Equity Interests		-		-		-		(1,108	)
Avionte Holdings	Equity Interests		100		2,403		2,303		(1,024	)

The $4.6 million net change in unrealized appreciation in our investment in Zollege PBC was driven by improved Company performance.

The $1.1 million net change in unrealized depreciation in our investment in Identity Automation Systems was driven by the sale of the equity position, resulting in a reversal of previously recognized unrealized appreciation reclassified to realized gain.

The $1.1 million net change in unrealized depreciation in our investment in Avionte Holdings was driven by a change in the industry multiple.

128

The most significant cumulative net change in unrealized appreciation (depreciation) for the six months ended August 31, 2024 were the following (dollars in thousands):

Six Months ended August 31, 2024

Issuer	Asset Type	Cost		Fair Value		Total Unrealized Appreciation (Depreciation)			YTD Change in Unrealized Appreciation (Depreciation)
Pepper Palace, Inc.	First Lien Term Loan & Equity Interests	$	2,686	$	1,461	$	(1,225	)	$	31,724
Zollege PBC	First Lien Term Loan & Equity Interests		2,016		2,177		161			14,325
Artemis Wax Corp	First Lien Term Loan & Equity Interests		60,485		60,276		(209	)		(4,690	)
Saratoga Senior Loan Fund I JV, LLC	Equity Interests		35,202		21,407		(13,795	)		(3,815	)
Netreo Holdings, LLC	First Lien Term Loan & Equity Interests		-		-		-			3,803
Saratoga Investment Corp. CLO 2013-1, Ltd.	Structured Finance Securities		9,375		5,273		(4,102	)		(3,602	)
ARC Health OpCo LLC	First Lien Term Loan & Equity Interests		37,519		33,807		(3,712	)		(3,577	)
Invita (fka HemaTerra Holding Company, LLC)	First Lien Term Loan, Second Lien Term Loan & Equity Interests		69,960		75,728		5,768			2,675
Axero Holdings, LLC	First Lien Term Loan, Revolving Credit & Equity Interests		10,678		16,136		5,458			1,981
ETU Holdings, Inc.	First Lien Term Loan, Second Lien Term Loan & Equity Interests		16,519		13,057		(3,462	)		(1,026	)

The $31.8 million net change in unrealized appreciation in our investment in Pepper Palace, Inc. was driven by the restructuring of the investment, resulting in a reversal of previously recognized unrealized depreciation reclassified to realized loss.

The $14.3 million net change in unrealized appreciation in our investment in Zollege PBC was driven by the restructuring of the investment, resulting in a reversal of previously recognized unrealized depreciation reclassified to realized loss.

The $4.7 million of net change in unrealized depreciation in our investment in Artemis Wax Corp. was driven by a decline in company performance, overall market conditions and capital structure changes.

The $3.8 million net change in unrealized depreciation in our investment in Saratoga Senior Loan Fund I, JV, LLC was driven by the impact of overall market conditions.

The $3.8 million net change in unrealized appreciation in our investment in Netreo Holdings, LLC was driven by the sale of the equity position, resulting in a reversal of previously recognized unrealized depreciation reclassified to realized loss.

The $3.6 million net change in unrealized depreciation in our investment in Saratoga Investment Corp. CLO 2013-1, Ltd. was driven by the quarterly cash distribution, as well as a reduction in the carrying value of certain defaulted loans in the portfolio, as well as overall market conditions.

The $3.5 million of net change in unrealized depreciation in our investment in ARC Health OpCo LLC was driven by declines in company performance and capital structure changes.

The $2.7 million net change in unrealized depreciation in our investment in Invita (fka HemaTerra Holding Company, LLC) was driven by strong financial results and market factors.

The $2.0 million net change in unrealized appreciation in our investment in Axero Holdings, LLC was driven by strong financial performance.

The $1.0 million of net change in unrealized depreciation in our investment in ETU Holdings, Inc. was driven by a decline in company performance and overall market conditions.

129

Changes in net assets resulting from operations

For the three months ended August 31, 2025, we recorded a net increase in net assets resulting from operations of $13.3 million. Based on 15,775,387 weighted average common shares outstanding as of August 31, 2025, our per share net increase in net assets resulting from operations was $0.84 for the three months ended August 31, 2025. For the three months ended August 31, 2024, we recorded a net increase in net assets resulting from operations of $13.3 million. Based on 13,726,142 weighted average common shares outstanding as of August 31, 2024, our per share net increase in net assets resulting from operations was $0.97 for the three months ended August 31, 2024.

For the six months ended August 31, 2025, we recorded a net increase in net assets resulting from operations of $27.2 million. Based on 15,560,114 weighted average common shares outstanding as of August 31, 2025, our per share net increase in net assets resulting from operations was $1.75 for the six months ended August 31, 2025. For the six months ended August 31, 2024, we recorded a net increase in net assets resulting from operations of $19.9 million. Based on 13,704,759 weighted average common shares outstanding as of August 31, 2024, our per share net increase in net assets resulting from operations was $1.45 for the six months ended August 31, 2024.

FINANCIAL CONDITION, LIQUIDITY AND CAPITAL RESOURCES

We intend to continue to generate cash primarily from cash flows from operations, including interest earned from our investments in debt in middle-market companies, interest earned from the temporary investment of cash in U.S. government securities and other high-quality debt investments that mature in one year or less, the Encina Credit Facility and the Live Oak Credit Facility, our continued access to the SBA debentures future borrowings and future offerings of debt and equity securities.

Although we expect to fund the growth of our investment portfolio through the net proceeds from future equity offerings, including our dividend reinvestment plan (“DRIP”), our equity ATM Program (as defined below), and issuances of senior securities or future borrowings, to the extent permitted by the 1940 Act, we cannot assure you that our plans to raise capital will be successful. In this regard, because our common stock has historically traded at a price below our current NAV per share and we are limited in our ability to sell our common stock at a price below NAV per share, we have been and may continue to be limited in our ability to raise equity capital.

In addition, we intend to distribute to our stockholders substantially all of our operating taxable income in order to satisfy the distribution requirement applicable to RICs under the Code. In satisfying this distribution requirement, in accordance with certain applicable provisions of the Code and the Treasury regulations and a revenue procedure issued by the Internal Revenue Service (“IRS”), a RIC may treat a distribution of its own stock as fulfilling its RIC distribution requirements if each stockholder may elect to receive his or her entire distribution in either cash or stock of the RIC subject to a limitation that the aggregate amount of cash to be distributed to all stockholders must be at least 20% of the aggregate declared distribution. We may rely on the revenue procedure in future periods to satisfy our RIC distribution requirement.

Also, as a BDC, we generally are required to meet a coverage ratio of total assets, less liabilities and indebtedness not represented by senior securities, to total senior securities, which include all of our borrowings and any outstanding preferred stock, of at least 200%, reduced to 150% effective April 16, 2019 following the approval received from our board of directors, including a majority of our independent directors, on April 16, 2018. This requirement limits the amount that we may borrow. Our asset coverage ratio, as defined in the 1940 Act, was 166.6% as of August 31, 2025 and 162.9% as of February 28, 2025. To fund growth in our investment portfolio in the future, we anticipate needing to raise additional capital from various sources, including the equity markets and other public and private debt-related markets, which may or may not be available on favorable terms, if at all.

Consequently, we may not have the funds or the ability to fund new investments, to make additional investments in our portfolio companies, to fund our unfunded commitments to portfolio companies, to pay dividends or to repay borrowings. Also, the illiquidity of our portfolio investments may make it difficult for us to sell these investments when desired and, if we are required to sell these investments, we may realize significantly less than their recorded value.

Due to the diverse capital sources available to us at this time, we believe we have adequate liquidity to support our near-term capital requirements.

Encina Credit Facility

Below is a summary of the terms of the senior secured revolving credit facility we entered into with Encina Lender Finance, LLC on October 4, 2021.

Commitment. We entered into the Credit and Security Agreement (the “Encina Credit Agreement”) relating to the Encina Credit Facility in the initial facility amount of $50.0 million (the “Encina Facility Amount”).

130

Availability. We can draw up to the lesser of (i) the Encina Facility Amount and (ii) the borrowing base. The borrowing base is an amount equal to (i) the difference of (A) the product of the applicable advance rate which varies from 50.0% to 75.0% depending on the type of loan asset (Defaulted Loans being excluded in that they carry an advance rate of 0%) and the value, determined in accordance with the Encina Credit Facility (the “Adjusted Borrowing Value”), of certain “eligible” loan assets pledged as security for the loan (the “Borrowing Base Value”) and (B) the Excess Concentration Amount, as calculated in accordance with the Encina Credit Facility, plus (ii) any amounts held in the Prefunding Account and, without duplication, Excess Cash held in the Collection Account, less (iii) the product of (a) the amount of any undrawn funding commitments we have under any loan asset and (b) the Unfunded Exposure Haircut Percentage, and less (iv) $100,000. Each loan asset we held as of the date on which the Encina Credit Facility was closed was valued as of that date and each loan asset that we acquire after such date will be valued at the lowest of its fair value, its face value (excluding accrued interest) and the purchase price paid for such loan asset. Adjustments to the value of a loan asset will be made to reflect, among other things and under certain circumstances, changes in its fair value, a default by the obligor on the loan asset, insolvency of the obligor, acceleration of the loan asset, and certain modifications to the terms of the loan asset.

The Encina Credit Facility contains limitations on the type of loan assets that are “eligible” to be included in the borrowing base and as to the concentration level of certain categories of loan assets in the borrowing base such as restrictions on geographic and industry concentrations, asset size and quality, payment frequency, status and terms, average life, and collateral interests. In addition, if an asset is to remain an “eligible” loan asset, we may not make changes to the payment, amortization, collateral and certain other terms of the loan assets without the consent of the administrative agent that will either result in subordination of the loan asset or be materially adverse to the lenders.

The Encina Credit Facility requires certain minimum drawn amounts. For the period beginning on the closing date and ending April 4, 2022, the minimum funding amount was $12.5 million. For the period beginning on April 5, 2022 through maturity, the minimum funding amount is the greater of $25.0 million and 50% of the Encina Facility Amount in effect from time to time.

Collateral. The Encina Credit Facility is secured by assets of Saratoga Investment Funding II LLC (“SIF II”) and pledged to Encina under the Encina Credit Facility. SIF II is a wholly owned special purpose entity formed for the purpose of entering into the Encina Credit Facility.

Interest Rate and Fees. Under the Encina Credit Facility, funds were borrowed from or through certain lenders at the greater of the prevailing LIBOR rate and 0.75%, plus an applicable margin of 4.00%. The Encina Credit Agreement includes benchmark replacement provisions which permit the Administrative Agent and the borrower to select a replacement rate upon the unavailability of LIBOR. In addition, we pay the lenders a commitment fee of 0.75% per year (or 0.50% if the ratio of advances outstanding to aggregate commitments is greater than or equal to 50%) on the unused amount of the Encina Credit Facility for the duration of the term of the Encina Credit Facility. Accrued interest and commitment fees are payable monthly in arrears. We were also obligated to pay certain other fees to the lenders in connection with the closing of the Encina Credit Facility.

Collateral Tests. It is a condition precedent to any borrowing under the Encina Credit Facility that the principal amount outstanding under the Encina Credit Facility, after giving effect to the proposed borrowings, not exceed the borrowing base (the “Borrowing Base Test”). In addition to satisfying the Borrowing Base Test, the following tests must also be satisfied (together with Borrowing Base Test, the “Collateral Tests”):

●

Interest Coverage Ratio. The ratio (expressed as a percentage) of interest collections with respect to pledged loan assets, less certain fees and expenses relating to the Encina Credit Facility, to accrued interest and commitment fees payable to the lenders under the Encina Credit Facility for the last 6 payment periods must equal at least 175.0%.

●

Overcollateralization Ratio. The ratio (expressed as a percentage) of the aggregate Adjusted Borrowing Value of “eligible” pledged loan assets plus the fair value of certain ineligible pledged loan assets (in each case, subject to certain adjustments) to outstanding borrowings under the Encina Credit Facility plus the Unfunded Exposure Amount must equal at least 200.0%.

The Encina Credit Facility also may require payment of outstanding borrowings or replacement of pledged loan assets upon our breach of our representation and warranty that pledged loan assets included in the borrowing base are “eligible” loan assets. Such ineligible collateral loans will be excluded from the calculation of the borrowing base and may lead to a Borrowing Base Deficiency, which may be cured by effecting one or more (or any combination thereof) of the following actions: (A) deposit into or credit to the collection account cash and eligible investments, (B) repay outstanding borrowings (together with certain costs and expenses), (C) sell or substitute loan assets in accordance with the Encina Credit Facility, or (D) pledge additional loan assets as collateral. Compliance with the Collateral Tests is also a condition to the discretionary sale of pledged loan assets by us.

131

Priority of Payments. The priority of payments provisions of the Encina Credit Facility require, after payment of specified fees and expenses, that collections of interest from the loan assets and, to the extent that these are insufficient, collections of principal from the loan assets, be applied on each payment date to payment of outstanding borrowings if the Borrowing Base Test, the Overcollateralization Ratio and the Interest Coverage Ratio would not otherwise be met.

Operating Expenses. The priority of payments provision of the Encina Credit Facility provides for the payment of certain of our operating expenses out of collections on interest and principal in accordance with the priority established in such provision. The operating expenses payable pursuant to the priority of payment provisions is limited to $200,000 per annum.

Covenants; Representations and Warranties; Events of Default. The Encina Credit Agreement contains customary representations and warranties, affirmative covenants, negative covenants and events of default. The Encina Credit Agreement does not contain grace periods for breach by us of any negative covenants or of certain of the affirmative covenants, including, without limitation, those related to preservation of the existence and separateness of the Company. Other events of default under the Encina Credit Agreement include, among other things, the following:

●

our failure to maintain an Interest Coverage Ratio of less than 175%;

●

our failure to maintain an Overcollateralization Ratio of less than 200%;

●

the filing of certain ERISA or tax liens on our assets or the Equity holder;

●

failure by Specified Holders to collectively, directly or indirectly, own and control at least 51% of the outstanding equity interests of Saratoga Investment Advisor, or (y) possess the right to elect (through contract, ownership of voting securities or otherwise) at all times a majority of the board of directors (or similar governing body) of Saratoga Investment Advisor and to direct the management policies and decisions of Saratoga Investment Advisor, or (ii) the dissolution, termination or liquidation in whole or in part, transfer or other disposition, in each case, of all or substantially all of the assets of, Saratoga Investment Advisor;

●

indictment or conviction of Saratoga Investment Advisors or any “key person” for a felony offense, or any fraud, embezzlement or misappropriation of funds by Saratoga Investment Advisors or any “key person” and, in the case of “key persons,” without a reputable, experienced individual reasonably satisfactory to Encina Lender Finance appointed to replace such key person within 30 days;

●

resignation, termination, disability or death of a “key person” or failure of any “key person” to provide active participation in Saratoga Investment Advisors’ daily activities, all without a reputable, experienced individual reasonably satisfactory to Encina Lender Finance appointed within 30 days.

Fees and Expenses. We paid certain fees and reimbursed Encina Lender Finance, LLC for the aggregate amount of all documented, out-of-pocket costs and expenses, including the reasonable fees and expenses of lawyers, incurred by Encina Lender Finance, LLC in connection with the Encina Credit Facility and the carrying out of any and all acts contemplated thereunder up to and as of the date of closing. These amounts totaled $1.4 million.

On January 27, 2023, we entered into the first amendment to the Encina Credit Agreement to, among other things:

●

increased the borrowings available under the Encina Credit Facility from up to $50.0 million to up to $65.0 million;

●

changed the underlying benchmark used to compute interest under the Encina Credit Agreement from LIBOR to Term SOFR for a one-month tenor plus a 0.10% credit spread adjustment;

●

increased the applicable effective margin rate on borrowings from 4.00% to 4.25%;

●

extended the revolving period from October 4, 2024 to January 27, 2026;

132

●

revised the eligibility criteria for eligible collateral loans to exclude certain industries in which an obligor or related guarantor may be involved; and

●

As of August 31, 2025, we had $32.5 million outstanding borrowings under the Encina Credit Facility. Our borrowing base under the Encina Credit Facility at August 31, 2025 was $78.4 million.

Live Oak Credit Facility

Below is a summary of the terms of the senior secured revolving credit facility we entered into with Live Oak Banking Company on March 27, 2024.

Commitment. We entered into the Credit and Security Agreement (the “Live Oak Credit Agreement”) relating to the Live Oak Credit Facility in the initial facility amount of $50.0 million (the “Live Oak Facility Amount”).

Availability. We can draw up to the lesser of (i) the Live Oak Facility Amount and (ii) the borrowing base. The borrowing base is an amount equal to (i) the difference of (A) the product of the applicable advance rate which varies from 50.0% to 75.0% depending on the type of loan asset (Defaulted Loans being excluded in that they carry an advance rate of 0%) and the value, determined in accordance with the Encina Credit Facility (the “Adjusted Borrowing Value”), of certain “eligible” loan assets pledged as security for the loan (the “Borrowing Base Value”) and (B) the Excess Concentration Amount, as calculated in accordance with the Encina Credit Facility, plus (ii) any amounts held in the Prefunding Account and, without duplication, Excess Cash held in the Collection Account, less (iii) the product of (a) the amount of any undrawn funding commitments we have under any loan asset and (b) the Unfunded Exposure Haircut Percentage, and less (iv) $100,000. Each loan asset we held as of the date on which the Live Oak Credit Facility was closed was valued as of that date and each loan asset that we acquire after such date will be valued at the lowest of its fair value, its face value (excluding accrued interest) and the purchase price paid for such loan asset. Adjustments to the value of a loan asset will be made to reflect, among other things and under certain circumstances, changes in its fair value, a default by the obligor on the loan asset, insolvency of the obligor, acceleration of the loan asset, and certain modifications to the terms of the loan asset.

The Live Oak Credit Facility contains limitations on the type of loan assets that are “eligible” to be included in the borrowing base and as to the concentration level of certain categories of loan assets in the borrowing base such as restrictions on geographic and industry concentrations, asset size and quality, payment frequency, status and terms, average life, and collateral interests. In addition, if an asset is to remain an “eligible” loan asset, we may not make changes to the payment, amortization, collateral and certain other terms of the loan assets without the consent of the administrative agent that will either result in subordination of the loan asset or be materially averse to the lenders.

133

The Live Oak Credit Facility requires certain minimum drawn amounts. For the period beginning on the closing date of March 27, 2025, and ending March 27, 2027, the minimum funding amount was $12.5 million. For the period beginning on March 28, 2025, through maturity, the minimum funding amount is the greater of $25.0 million and 50% of the Live Oak Facility Amount in effect from time to time.

Collateral. The Live Oak Credit Facility is secured by assets of Saratoga Investment Funding III LLC (“SIF III”) and pledged to Live Oak under the Live Oak Credit Facility. SIF III is a wholly owned special purpose entity formed for the purpose of entering into the Live Oak Credit Facility.

Interest Rate and Fees. Advances under the Live Oak Credit Facility bear interest at a floating rate per annum equal to the greater of the prevailing Adjusted Term SOFR and 0.75%, plus an applicable margin between 3.50% and 4.25% based on the Live Oak Credit Facility’s utilization. In addition, we pay the lenders a commitment fee of 0.50% per year on the unused amount of the Live Oak Credit Facility for the duration of the term of the Live Oak Credit Facility. Accrued interest and commitment fees are payable monthly in arrears. We were also obligated to pay certain other fees to the lenders in connection with the closing of the Live Oak Credit Facility.

Collateral Tests. It is a condition precedent to any borrowing under the Live Oak Credit Facility that the principal amount outstanding under the Live Oak Credit Facility, after giving effect to the proposed borrowings, not exceed the borrowing base (the “Borrowing Base Test”). In addition to satisfying the Borrowing Base Test, the following tests must also be satisfied (together with Borrowing Base Test, the “Collateral Tests”):

●

Interest Coverage Ratio. The ratio (expressed as a percentage) of interest collections with respect to pledged loan assets, less certain fees and expenses relating to the Live Oak Credit Facility, to accrued interest and commitment fees payable to the lenders under the Live Oak Credit Facility for the last 6 payment periods must equal at least 175.0%.

●

Overcollateralization Ratio. The ratio (expressed as a percentage) of the aggregate Adjusted Borrowing Value of “eligible” pledged loan assets plus the fair value of certain ineligible pledged loan assets (in each case, subject to certain adjustments) to outstanding borrowings under the Live Oak Credit Facility plus the Unfunded Exposure Amount must equal at least 200.0%.

The Live Oak Credit Facility also may require payment of outstanding borrowings or replacement of pledged loan assets upon our breach of our representation and warranty that pledged loan assets included in the borrowing base are “eligible” loan assets. Such ineligible collateral loans will be excluded from the calculation of the borrowing base and may lead to a Borrowing Base Deficiency, which may be cured by effecting one or more (or any combination thereof) of the following actions: (A) deposit into or credit to the Collection Account cash and Eligible Investments, (B) repay Advances (together with all accrued and unpaid costs and expenses of the Agents, Custodian, Collateral Administrator, Securities Intermediary and the Lenders), (C) sell or substitute Collateral Loans in accordance with Article X, or (D) pledge additional Collateral Loans as Collateral.

Priority of Payments. The priority of payments provisions of the Live Oak Credit Facility require, after payment of specified fees and expenses, that collections of interest from the loan assets and, to the extent that these are insufficient, collections of principal from the loan assets, be applied on each payment date to payment of outstanding borrowings if the Borrowing Base Test, the Overcollateralization Ratio and the Interest Coverage Ratio would not otherwise be met.

Operating Expenses. The priority of payments provision of the Live Oak Credit Facility provides for the payment of certain of our operating expenses out of collections on interest and principal in accordance with the priority established in such provision. The operating expenses payable pursuant to the priority of payment provisions is limited to $200,000 per annum.

134

Covenants; Representations and Warranties; Events of Default. The Live Oak Credit Agreement contains customary representations and warranties, affirmative covenants, negative covenants and events of default. The Live Oak Credit Agreement does not contain grace periods for breach by us of any negative covenants or of certain of the affirmative covenants, including, without limitation, those related to preservation of the existence and separateness of the Company. Other events of default under the Live Oak Credit Agreement include, among other things, the following:

●

our failure to maintain an Interest Coverage Ratio of less than 175%;

●

our failure to maintain an Overcollateralization Ratio of less than 200%;

●

the filing of certain ERISA or tax liens on our assets or the Equity holder;

●

indictment or conviction of Saratoga Investment Advisors or any “key person” for a felony offense, or any fraud, embezzlement or misappropriation of funds by Saratoga Investment Advisors or any “key person” and, in the case of “key persons,” without a reputable, experienced individual reasonably satisfactory to Live Oak Lender Finance appointed to replace such key person within 30 days;

●

Fees and Expenses. We paid certain fees and reimbursed Live Oak Lender Finance, LLC for the aggregate amount of all documented, out-of-pocket costs and expenses, including the reasonable fees and expenses of lawyers, incurred by Live Oak Banking Company in connection with the Live Oak Credit Facility and the carrying out of any and all acts contemplated thereunder up to and as of the date of closing. These amounts totaled $0.8 million.

As of August 31, 2025 there was $37.5 million in outstanding borrowings under the Live Oak Credit Facility. During the applicable period, we were in compliance with all of the limitations and requirements under the Live Oak Credit Agreement. Our borrowing base under the Live Oak Credit Facility at August 31, 2025 was $77.3 million

SBA-guaranteed debentures

In addition, we, through two current wholly owned subsidiaries, sought and obtained licenses from the SBA to operate an SBIC. In this regard, our wholly owned subsidiaries, SBIC II LP, and SBIC III LP, received an SBIC license from the SBA on August 14, 2019, and September 29, 2022, respectively. SBICs are designated to stimulate the flow of private equity capital to eligible small businesses. Under SBA regulations, SBICs may make loans to eligible small businesses and invest in the equity securities of small businesses. Our wholly owned subsidiary SBIC LP fully repaid its outstanding debentures and subsequently surrendered its license to the SBA on January 3, 2023, and SBIC LP subsequently merged with and into the Company.

The SBIC license allows our SBIC Subsidiaries to obtain leverage by issuing SBA-guaranteed debentures. SBA-guaranteed debentures are non-recourse, interest only debentures with interest payable semi-annually and have a ten-year maturity. The principal amount of SBA-guaranteed debentures is not required to be paid prior to maturity but may be prepaid at any time without penalty. The interest rate of SBA-guaranteed debentures is fixed on a semi-annual basis at a market-driven spread over U.S. Treasury Notes with 10-year maturities.

The SBIC Subsidiaries are regulated by the SBA. SBA regulations currently limit the amount that our SBIC Subsidiaries may individually borrow up to a maximum of $175.0 million of SBA debentures if the SBIC Subsidiary has at least $87.5 million in regulatory capital, subject to the SBA’s approval. Under current SBIC regulations, for two or more SBICs under common control, the maximum amount of outstanding SBA debentures cannot exceed $350.0 million. The SBIC Subsidiaries are able to borrow funds from the SBA against regulatory capital (which generally approximates equity capital in the respective SBIC) and is subject to customary regulatory requirements, including, but not limited to, periodic examination by the SBA.

135

We received exemptive relief from the SEC to permit us to exclude the debt of our SBIC Subsidiaries guaranteed by the SBA from the definition of senior securities in the asset coverage test under the 1940 Act. This allows us increased flexibility under the asset coverage test by permitting us to borrow up to $350.0 million more than we would otherwise be able to absent the receipt of this exemptive relief. On April 16, 2018, as permitted by the Small Business Credit Availability Act, which was signed into law on March 23, 2018, our board of directors, including a majority of our independent directors, approved of our becoming subject to a minimum asset coverage ratio of 150% from 200% under Sections 18(a)(1) and 18(a)(2) of the Investment Company Act, as amended. The 150% asset coverage ratio became effective on April 16, 2019.

As of August 31, 2025 SBIC II LP had $87.5 million in regulatory capital and $131.0 million in SBA-guaranteed debentures outstanding and SBIC III LP had $87.5 million in regulatory capital and $39.0 million in SBA-guaranteed debentures outstanding.

Unsecured notes

7.75% 2025 Notes

On July 9, 2020, we issued $5.0 million in aggregate principal amount of our 7.75% fixed-rate notes due in 2025 (the “7.75% 2025 Notes”) for net proceeds of $4.8 million after deducting underwriting commissions of approximately $0.2 million. Offering costs incurred were approximately $0.1 million. Interest on the 7.75% 2025 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 7.75% per year. The 7.75% 2025 Notes mature on July 9, 2025 and may be redeemed in whole or in part at any time or from time to time at our option, subject to a fee depending on the date of repayment. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $0.3 million related to the 7.75% 2025 Notes have been capitalized and are being amortized over the term of the Notes. The 7.75% 2025 Notes are not listed and have a par value of $25.00 per note. On July 9, 2025, we repaid $5.0 million in aggregate principal amount of the issued and outstanding 7.75% 2025 Notes.

6.25% 2027 Notes

On December 29, 2020, we issued $5.0 million in aggregate principal amount of our 6.25% fixed-rate notes due in 2027 (the “6.25% 2027 Notes”). Offering costs incurred were approximately $0.1 million. Interest on the 6.25% 2027 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 6.25% per year. The 6.25% 2027 Notes mature on December 29, 2027 and may be redeemed in whole or in part at any time or from time to time at our option, on or after December 29, 2024. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $0.1 million related to the 6.25% 2027 Notes have been capitalized and are being amortized over the term of the Notes.

On January 28, 2021, we issued an additional $10.0 million in aggregate principal amount of the 6.25% 2027 Notes for net proceeds of $9.7 million after deducting underwriting commissions of approximately $0.3 million (the “Additional 6.25% 2027 Notes”). The Additional 6.25% 2027 Notes are treated as a single series with the existing 6.25% 2027 Notes under the indenture and have the same terms as the existing 6.25% 2027 Notes. Offering costs incurred were approximately $0.1 million. Interest on the 6.25% 2027 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 6.25% per year. The 6.25% 2027 Notes mature on January 28, 2027 and commencing January 28, 2023, may be redeemed in whole or in part at any time or from time to time at our option. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $0.4 million related to the 6.25% 2027 Notes have been capitalized and are being amortized over the term of the 6.25% 2027 Notes. The 6.25% 2027 Notes are not listed and have a par value of $25.00 per note.

At August 31, 2025, the total amount of 6.25% 2027 Notes outstanding was $15.0 million.

4.375% 2026 Notes

On March 10, 2021, we issued $50.0 million in aggregate principal amount of the 4.375% notes due 2026 (the “4.375% 2026 Notes”) for net proceeds of $49.0 million after deducting underwriting commissions of approximately $1.0 million. Offering costs incurred were approximately $0.3 million. Interest on the 4.375% 2026 Notes is paid semi-annually in arrears on February 28 and August 28, at a rate of 4.375% per year. The 4.375% 2026 Notes mature on February 28, 2026 and may be redeemed in whole or in part at any time on or after November 28, 2025 at par plus a “make-whole” premium, and thereafter at par. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $1.3 million related to the 4.375% 2026 Notes have been capitalized and are being amortized over the term of the 4.375% 2026 Notes.

136

On July 15, 2021, we issued an additional $125.0 million in aggregate principal amount of the 4.375% 2026 Notes (the “Additional 4.375% 2026 Notes”) for net proceeds for approximately $123.5 million, based on the public offering price of 101.00% of the aggregate principal amount of the Additional 4.375% 2026 Notes, after deducting the underwriting discount of $2.5 million and the offering expenses of approximately $0.2 million payable by us. The net proceeds from the offering were used to redeem all of the outstanding 6.25% 2025 Notes (as described above), and for general corporate purposes in accordance with our investment objective and strategies. The Additional 4.375% 2026 Notes are treated as a single series with the existing 4.375% 2026 Notes under the indenture and have the same terms as the existing 4.375% 2026 Notes.

At August 31, 2025, the total amount of 4.375% 2026 Notes outstanding was $175.0 million.

4.35% 2027 Notes

On January 19, 2022, we issued $75.0 million in aggregate principal amount of our 4.35% fixed-rate Notes due in 2027 (the “4.35% 2027 Notes”) for net proceeds of $73.0 million, based on the public offering price of 99.317% of the aggregate principal amount of the 4.35% 2027 Notes, after deducting the underwriting commissions of approximately $1.5 million. Offering costs incurred were approximately $0.3 million. Interest on the 4.35% 2027 Notes is paid semi-annually in arrears on February 28 and August 28, at a rate of 4.35% per year. The 4.35% 2027 Notes mature on February 28, 2027 and may be redeemed in whole or in part at our option at any time prior to November 28, 2026, at par plus a “make-whole” premium, and thereafter at par. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $1.8 million related to the 4.35% 2027 Notes have been capitalized and are being amortized over the term of the 4.35% 2027 Notes.

At August 31, 2025 the total amount of 4.35% 2027 Notes outstanding was $75.0 million.

6.00% 2027 Notes

On April 27, 2022, we issued $87.5 million in aggregate principal amount of 6.00% fixed-rate notes due 2027 (the “6.00% 2027 Notes”) for net proceeds of $84.8 million after deducting underwriting commissions of approximately $2.7 million. Offering costs incurred were approximately $0.1 million. On May 10, 2022, the underwriters partially exercised their option to purchase an additional $10.0 million in aggregate principal amount of the 6.00% 2027 Notes. Net proceeds were $9.7 million after deducting underwriting commissions of approximately $0.3 million. Interest on the 6.00% 2027 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 6.00% per year. The 6.00% 2027 Notes mature on April 30, 2027 and commencing April 27, 2024, may be redeemed in whole or in part at any time or from time to time at our option. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $3.3 million related to the 6.00% 2027 Notes have been capitalized and are being amortized over the term of the 6.00% 2027 Notes. The 6.00% 2027 Notes are listed on the NYSE under the trading symbol “SAT” with a par value of $25.00 per note.

On August 15, 2022, we issued an additional $8.0 million in aggregate principal amount of the 6.00% 2027 Notes (the “Additional 6.00% 2027 Notes”) for net proceeds of $7.8 million, based on the public offering price of 97.80% of the aggregate principal amount of the 6.00% 2027 Notes. The Additional 6.00% 2027 Notes are treated as a single series with the existing 6.00% 2027 Notes under the indenture and have the same terms as the existing 6.00% 2027 Notes. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Additional offering costs incurred were approximately $0.02 million. Additional financing costs of $0.03 million related to the 6.00% 2027 Notes have been capitalized and are being amortized over the term of the 6.00% 2027 Notes.

At August 31, 2025 the total amount of 6.00% 2027 Notes outstanding was $105.5 million.

7.00% 2025 Notes

On September 8, 2022, we issued $12.0 million in aggregate principal amount of 7.00% fixed-rate notes due 2025 (the “7.00% 2025 Notes”) for net proceeds of $11.6 million after deducting underwriting discounts of approximately $0.4 million. Interest on the 7.00% 2025 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 7.00% per year. The 7.00% 2025 Notes mature on September 8, 2025 and commencing September 8, 2024, may be redeemed in whole or in part at any time or from time to time at our option. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $0.05 million related to the 7.00% 2025 Notes have been capitalized and are being amortized over the term of the 7.00% 2025 Notes.

137

At August 31, 2025 the total amount of 7.00% 2025 Notes outstanding was $12.0 million.

8.00% 2027 Notes

On October 27, 2022, we issued $40.0 million in aggregate principal amount of our 8.00% fixed-rate notes due 2027 (the “8.00% 2027 Notes”) for net proceeds of $38.7 million after deducting underwriting commissions of approximately $1.3 million. Offering costs incurred were approximately $0.2 million. On November 10, 2022, the underwriters partially exercised their option to purchase an additional $6.0 million in aggregate principal amount of the 8.00% 2027 Notes. Net proceeds were $5.8 million after deducting underwriting commissions of approximately $0.2 million. Interest on the 8.00% 2027 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 8.00% per year. The 8.00% 2027 Notes mature on October 31, 2027 and commencing October 27, 2024, may be redeemed in whole or in part at any time or from time to time at our option. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $1.73 million related to the 8.00% 2027 Notes have been capitalized and are being amortized over the term of the 8.00% 2027 Notes. The 8.00% 2027 Notes are listed on the NYSE under the trading symbol “SAJ” with a par value of $25.00 per note.

At August 31, 2025 the total amount of 8.00% 2027 Notes outstanding was $46.0 million.

8.125% 2027 Notes

On December 13, 2022, we issued $52.5 million in aggregate principal amount of 8.125% fixed-rate notes due 2027 (the “8.125% 2027 Notes”) for net proceeds of $50.8 million after deducting underwriting commissions of approximately $1.6 million. Offering costs incurred were approximately $0.1 million. On December 21, 2022, the underwriters fully exercised their option to purchase an additional $7.875 million in aggregate principal amount of the 8.125% 2027 Notes. Net proceeds were $7.6 million after deducting underwriting commissions of approximately $0.2 million. Interest on the 8.125% 2027 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 8.125% per year. The 8.125% 2027 Notes mature on December 31, 2027 and commencing December 13, 2024, may be redeemed in whole or in part at any time or from time to time at our option. The net proceeds from this offering were used to make investments in middle-market companies (including investments made through our SBIC subsidiaries) in accordance with our investment objective and strategies and for general corporate purposes. Financing costs of $2.0 million related to the 8.125% 2027 Notes have been capitalized and are being amortized over the term of the 8.125% 2027 Notes. The 8.125% 2027 Notes are listed on the NYSE under the trading symbol “SAY” with a par value of $25.00 per note.

At August 31, 2025, the total amount of 8.125% 2027 Notes outstanding was $60.4 million.

8.75% 2025 Notes

On March 31, 2023, we issued $10.0 million in aggregate principal amount of 8.75% fixed-rate notes due 2024 (the “8.75% 2025 Notes”) for net proceeds of $9.7 million after deducting underwriting discounts of approximately $0.4 million. On May 1, 2023, we issued an additional $10.0 million in aggregate principal amount of the 8.75% 2024 Notes for net proceeds of $9.7 million after deducting underwriting discounts of approximately $0.4 million. Offering costs incurred were approximately $0.03 million. Interest on the 8.75% 2025 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 8.75% per year. On February 2, 2024, pursuant to the terms of the indenture governing the 8.75% 2025 Notes, we elected to exercise our option to extend the maturity date of the 8.75% 2025 Notes from March 31, 2024 to March 31, 2025. Net proceeds from this offering were used to make investments in middle-market companies (including investments made through our SBIC Subsidiaries) in accordance with our investment objective and strategies and general corporate purposes. Financing costs and discounts of $0.7 million related to the 8.75% 2025 Notes have been capitalized and are being amortized over the term of the 8.75% 2025 Notes. On March 31, 2025, we repaid $20.0 million in aggregate principal amount of the issued and outstanding 8.75% 2025 Notes.

8.50% 2028 Notes

On April 14, 2023, we issued $50.0 million in aggregate principal amount of 8.50% fixed-rate notes due 2028 (the “8.50% 2028 Notes”) for net proceeds of $48.4 million after deducting underwriting commissions of approximately $1.6 million. Offering costs incurred were approximately $0.03 million. On April 26, 2023, the underwriters fully exercised their option to purchase an additional $7.5 million in aggregate principal amount of the 8.50% 2028 Notes. Net proceeds were $7.3 million after deducting underwriting commissions of approximately $0.2 million. Interest on the 8.50% 2028 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 8.50% per year. The 8.50% 2028 Notes mature on April 15, 2028, and commencing April 14, 2025, may be redeemed in whole or in part at any time or from time to time at our option. Net proceeds from this offering were used to repay a portion of the outstanding indebtedness under the Encina Credit Facility, make investments in middle-market companies (including investments made through our SBIC Subsidiaries) in accordance with our investment objective and strategies and for general corporate purposes. Financing costs of $2.0 million related to the 8.50% 2028 Notes have been capitalized and are being amortized over the term of the 8.50% 2028 Notes. The 8.50% 2028 Notes are listed on the NYSE under the trading symbol “SAZ” with a par value of $25.00 per note.

138

At August 31, 2025, the total amount of 8.50% 2028 Notes outstanding was $57.5 million.

At August 31, 2025 and February 28, 2025, the fair value of investments, cash and cash equivalents and cash and cash equivalents, reserve accounts were as follows:

	August 31, 2025					February 28, 2025
	Fair Value		Percentage of Total			Fair Value		Percentage of Total
	($ in thousands)
Cash and cash equivalents	$	105,660		8.8	%	$	148,218		12.6	%
Cash and cash equivalents, reserve accounts		95,145		8.0			56,505		4.8
First lien term loans		839,483		70.1			867,866		73.4
Second lien term loans		6,826		0.6			6,388		0.5
Structured finance securities		16,790		1.4			14,772		1.2
Unsecured loan		53,351		4.5			16,534		1.4
Equity interests		78,845		6.6			72,518		6.1
Total	$	1,196,100		100.0	%	$	1,182,801		100.0	%

Equity Capital Activities

Share Repurchases

On September 24, 2014, we announced the approval of the Share Repurchase Plan. Since September 24, 2014, the Share Repurchase Plan has been extended annually, and we have periodically increased the amount of shares of common stock that may be purchased under the Share Repurchase Plan. Most recently, on January 7, 2025, our board of directors extended the Share Repurchase Plan for another year to January 15, 2026, which currently permits up to 1.7 million shares of common stock to be repurchased under the Share Repurchase Plan. As of August 31, 2025, we purchased 1,035,203 shares of common stock, at the average price of $22.05 for approximately $22.8 million pursuant to the Share Repurchase Plan. During the three and six months ended August 31, 2025, we did not purchase any shares pursuant to the Share Repurchase Plan.

Public Equity Offering

On July 13, 2018, we issued 1,150,000 shares of common stock priced at $25.00 per share (par value $0.001 per share) at an aggregate total of $28.75 million. The net proceeds, after deducting underwriting commissions of $1.15 million and offering costs of approximately $0.2 million, amounted to approximately $27.4 million. We also granted the underwriters a 30-day option to purchase up to an additional 172,500 shares of common stock, which was not exercised.

Equity ATM Program

On March 16, 2017, we entered into an equity distribution agreement with Ladenburg Thalmann & Co. Inc. (“Ladenburg”), through which we may offer for sale, from time to time, up to $30.0 million of our common stock through an ATM offering. Subsequent to this, we amended our equity distribution agreement to add BB&T Capital Markets and B. Riley FBR, Inc. as sales agents in our ATM offering. On July 11, 2019, the amount of the common stock to be offered was increased to $70.0 million, and on October 8, 2019, the amount of the common stock to be offered was increased to $130.0 million. This agreement was terminated as of July 29, 2021, and as of that date, we had sold 3,922,018 shares for gross proceeds of $97.1 million at an average price of $24.77 for aggregate net proceeds of $95.9 million (net of transaction costs).

On July 30, 2021, we entered into an equity distribution agreement (the “Equity Distribution Agreement”) with Ladenburg and Compass Point Research and Trading, LLC (“Compass Point”), each as distribution agents, through which we may offer for sale, from time to time, up to $150.0 million of our common stock through the Agents (as defined below), or to them, as principal for their account (the “ATM Program”).

On July 6, 2023, we amended the Equity Distribution Agreement to increase the maximum amount of shares of our common stock to be sold through the ATM Program to $300.0 million from $150.0 million On July 19, 2023, we amended the Equity Distribution Agreement to add an additional distribution agent, Raymond James & Associates, Inc. (“Raymond James”). On May 15, 2024, we amended the Equity Distribution Agreement to add an additional distribution agent, Lucid Capital Markets, LLC (“Lucid” and together with Ladenburg, Compass Point, and Raymond James, the “Agents”). The sales price per share of our common stock offered under the ATM Program, less the Agents’ commission, will not be less than the NAV per share of our common stock at the time of such a sale. Consistent with the terms of the ATM Program, the Manager may, from time to time and in its sole discretion, contribute proceeds necessary to ensure that no sales are made at a price below the then-current NAV per share.

139

As of August 31, 2025, we sold 8,532,953 shares for gross proceeds of $225.7 million at an average price of $26.37 for aggregate net proceeds of $224.0 million (net of transaction costs). During the three months ended August 31, 2025, we sold 443,406 shares for gross proceeds of $11.4 million at an average price of $25.61 for aggregate net proceeds of $11.4 million (net of transaction costs). During the six months ended August 31, 2025, we sold 688,237 shares for gross proceeds of $17.8 million at an average price of $25.86 for aggregate net proceeds of $17.8 million (net of transaction costs).

Dividend Distributions

We have distributed or intend to distribute sufficient dividends to eliminate taxable income for our completed tax years. If we fail to satisfy the 90% distribution requirement or otherwise fail to qualify as a RIC in any tax year, we would be subject to U.S. federal income tax in that year on all of our taxable income imposed at corporate rates, regardless of whether we made any distributions to our shareholders. Shareholders have the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the DRIP. Our distributions from August 31, 2025 to inception were as follows:

Payment date	Cash Dividend
Tax Year Ended February 28, 2026
September 24, 2025		0.25	⁽⁵⁵⁾
August 21, 2025		0.25	⁽⁵⁴⁾
July 24, 2025		0.25	⁽⁵³⁾
June 24, 2025		0.25	⁽⁵²⁾
May 22, 2025		0.25	⁽⁵¹⁾
April 24, 2025		0.25	⁽⁵⁰⁾
March 25, 2025		0.74	⁽⁴⁹⁾
	$	2.24
Tax Year Ended February 28, 2025
December 19, 2024	$	1.09	⁽⁴⁸⁾
September 26, 2024		0.74	⁽⁴⁷⁾
June 27, 2024		0.74	⁽⁴⁶⁾
March 28, 2024		0.73	⁽⁴⁵⁾
	$	3.30
Tax Year Ended February 29, 2024
December 28, 2023	$	0.72	⁽⁴⁴⁾
September 28, 2023		0.71	⁽⁴³⁾
June 29, 2023		0.70	⁽⁴²⁾
March 30, 2023		0.69	⁽¹⁾
	$	2.82
Tax Year Ended February 28, 2023
January 4, 2023	$	0.68	⁽²⁾
September 29, 2022		0.54	⁽³⁾
June 29, 2022		0.53	⁽⁴⁾
March 28, 2022		0.53	⁽⁵⁾
	$	2.28
Tax Year Ended February 28, 2022
January 19, 2022	$	0.53	⁽⁶⁾
September 28, 2021		0.52	⁽⁷⁾
June 29, 2021		0.44	⁽⁸⁾
April 22, 2021		0.43	⁽⁹⁾
	$	1.92
Tax Year Ended February 28, 2021
February 10, 2021	$	0.42	⁽¹⁰⁾
November 10, 2020		0.41	⁽¹¹⁾
August 12, 2020		0.40	⁽¹²⁾
	$	1.23
Tax Year Ended February 29, 2020
February 6, 2020	$	0.56	⁽¹³⁾
September 26, 2019		0.56	⁽¹⁴⁾
June 27, 2019		0.55	⁽¹⁵⁾
March 28, 2019		0.54	⁽¹⁶⁾
	$	2.21

140

Payment date	Cash Dividend
Tax Year Ended February 28, 2019
January 2, 2019	$	0.53	⁽¹⁷⁾
September 27, 2018		0.52	⁽¹⁸⁾
June 27, 2018		0.51	⁽¹⁹⁾
March 26, 2018		0.50	⁽²⁰⁾
	$	2.06
Tax Year Ended February 28, 2018
December 27, 2017	$	0.49	⁽²¹⁾
September 26, 2017		0.48	⁽²²⁾
June 27, 2017		0.47	⁽²³⁾
March 28, 2017		0.46	⁽²⁴⁾
	$	1.90
Tax Year Ended February 28, 2017
February 9, 2017	$	0.45	⁽²⁵⁾
November 9, 2016		0.44	⁽²⁶⁾
September 5, 2016		0.20	⁽²⁷⁾
August 9, 2016		0.43	⁽²⁸⁾
April 27, 2016		0.41	⁽²⁹⁾
	$	1.93
Tax Year Ended February 29, 2016
February 29, 2016	$	0.40	⁽³⁰⁾
November 30, 2015		0.36	⁽³¹⁾
August 31, 2015		0.33	⁽³²⁾
June 5, 2015		1.00	⁽³³⁾
May 29. 2015		0.27	⁽³⁴⁾
	$	2.36
Tax Year Ended February 28, 2015
February 27, 2015	$	0.22	⁽³⁵⁾
November 28, 2014		0.18	⁽³⁶⁾
	$	0.40
Tax Year Ended February 28. 2014
December 27, 2013	$	2.65	⁽³⁷⁾
	$	2.65
Tax Year Ended February 28, 2013
December 31, 2012	$	4.25	⁽³⁸⁾
	$	4.25
Tax Year Ended February 29, 2012
December 30, 2011	$	3.00	⁽³⁹⁾
	$	3.00
Tax Year Ended February 28, 2011
December 29, 2010	$	4.40	⁽⁴⁰⁾
	$	4.40
Tax Year Ended February 28, 2010
December 31, 2009	$	18.25	⁽⁴¹⁾
	$	18.25

(1)

Based on shareholder elections, the dividend consisted of approximately $7.1 million in cash and 45,818 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $23.11 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on March 17, 20, 21, 22, 23, 24, 27, 28, 29, and 30, 2023.

(2)

Based on shareholder elections, the dividend consisted of approximately $6.8 million in cash and 53,615 newly issued shares of common stock, or 0.5% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $24.26 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on December 20, 21, 22, 23, 27, 28, 29 and 30 2022 and January 3 and 4, 2023.

141

(3)	Based on shareholder elections, the dividend consisted of approximately $5.3 million in cash and 52,312 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $22.00 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on September 16, 19, 20, 21, 22, 23, 26, 27, 28 and 29, 2022.
(4)	Based on shareholder elections, the dividend consisted of approximately $5.1 million in cash and 48,590 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $22.40 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on June 15, 16, 17, 21, 22, 23, 24, 27, 28 and 29, 2022.
(5)	Based on shareholder elections, the dividend consisted of approximately $5.3 million in cash and 42,825 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $25.89 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on March 15, 16, 17, 18, 21, 22, 23, 24, 25 and 28, 2022.
(6)	Based on shareholder elections, the dividend consisted of approximately $5.3 million in cash and 41,520 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $26.85 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on January 5, 6, 7, 10, 11, 12, 13, 14, 18 and 19, 2022.

(7)

Based on shareholder elections, the dividend consisted of approximately $4.9 million in cash and 38,016 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $26.77 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on September 15, 16, 17, 20, 21, 22, 23, 24, 27 and 28, 2021.

(8)

Based on shareholder elections, the dividend consisted of approximately $4.1 million in cash and 33,100 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $25.03 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on June 16, 17, 18, 21, 22, 23, 24, 25, 28 and 29, 2021.

(9)

Based on shareholder elections, the dividend consisted of approximately $3.9 million in cash and 38,580 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $23.69 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on April 9,12, 13, 14, 15, 16, 19, 20, 21 and 22, 2021.

(10)

Based on shareholder elections, the dividend consisted of approximately $3.8 million in cash and 41,388 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $21.75 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on January 28, 29 and February 1, 2, 3, 4, 5, 8, 9 and 10, 2021.

(11)

Based on shareholder elections, the dividend consisted of approximately $3.8 million in cash and 45,706 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $17.63 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on October 28, 29, 30 and November 2, 3, 4, 5, 6, 9 and 10, 2020.

(12)

Based on shareholder elections, the dividend consisted of approximately $3.7 million in cash and 47,098 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $16.45 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on July 30, 31 and August 3, 4, 5, 6, 7, 10, 11 and 12, 2020.

(13)

Based on shareholder elections, the dividend consisted of approximately $5.4 million in cash and 35,682 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $25.44 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on January 24, 27, 28, 29, 30, 31 and February 3, 4, 5 and 6, 2020.

142

(14)

Based on shareholder elections, the dividend consisted of approximately $4.5 million in cash and 34,575 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $23.34 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on September 13, 16, 17, 18, 19, 20, 23, 24, 25 and 26, 2019.

(15)

Based on shareholder elections, the dividend consisted of approximately $3.6 million in cash and 31,545 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $22.65 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on June 14, 17, 18, 19, 20, 21, 24, 25, 26 and 27, 2019.

(16)

Based on shareholder elections, the dividend consisted of approximately $3.5 million in cash and 31,240 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $21.36 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on March 15, 18, 19, 20, 21, 22, 25, 26, 27 and 28, 2019.

(17)

Based on shareholder elections, the dividend consisted of approximately $3.4 million in cash and 30,796 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $18.88 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on December 18, 19, 20, 21, 24, 26, 27, 28, 31, 2018 and January 2, 2019.

(18)

Based on shareholder elections, the dividend consisted of approximately $3.3 million in cash and 25,862 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $22.35 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on September 14, 17, 18, 19, 20, 21, 24, 25, 26 and 27, 2018.

(19)

Based on shareholder elections, the dividend consisted of approximately $2.7 million in cash and 21,562 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $23.72 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on June 14, 15, 18, 19, 20, 21, 22, 25, 26 and 27, 2018.

(20)

Based on shareholder elections, the dividend consisted of approximately $2.6 million in cash and 25,354 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $19.91 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on March 13, 14, 15, 16, 19, 20, 21, 22, 23 and 26, 2018.

(21)	Based on shareholder elections, the dividend consisted of approximately $2.5 million in cash and 25,435 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $21.14 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on December 13, 14, 15, 18, 19, 20, 21, 22, 26 and 27, 2017.
(22)	Based on shareholder elections, the dividend consisted of approximately $2.2 million in cash and 33,551 newly issued shares of common stock, or 0.6% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $20.19 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on September 13, 14, 15, 18, 19, 20, 21, 22, 25 and 26, 2017.
(23)	Based on shareholder elections, the dividend consisted of approximately $2.3 million in cash and 26,222 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $20.04 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on June 14, 15, 16, 19, 20, 21, 22, 23, 26 and 27, 2017.

(24)

Based on shareholder elections, the dividend consisted of approximately $2.0 million in cash and 29,096 newly issued shares of common stock, or 0.5% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $21.38 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on March 15, 16, 17, 20, 21, 22, 23, 24, 27 and 28, 2017.

(25)

Based on shareholder elections, the dividend consisted of approximately $1.6 million in cash and 50,453 newly issued shares of common stock, or 0.9% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $20.25 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on January 27, 30, 31 and February 1, 2, 3, 6, 7, 8 and 9, 2017.

143

(26)	Based on shareholder elections, the dividend consisted of approximately $1.5 million in cash and 58,548 newly issued shares of common stock, or 1.0% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $17.12 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on October 27, 28, 31 and November 1, 2, 3, 4, 7, 8 and 9, 2016.
(27)	Based on shareholder elections, the dividend consisted of approximately $0.7 million in cash and 24,786 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $17.06 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on August 22, 23, 24, 25, 26, 29, 30, 31 and September 1 and 2, 2016.
(28)	Based on shareholder elections, the dividend consisted of approximately $1.5 million in cash and 58,167 newly issued shares of common stock, or 1.0% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $16.32 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on July 27, 28, 29 and August 1, 2, 3, 4, 5, 8 and 9, 2016.
(29)	Based on shareholder elections, the dividend consisted of approximately $1.5 million in cash and 56,728 newly issued shares of common stock, or 1.0% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.43 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on April 14, 15, 18, 19, 20, 21, 22, 25, 26 and 27, 2016.
(30)	Based on shareholder elections, the dividend consisted of approximately $1.4 million in cash and 66,765 newly issued shares of common stock, or 1.2% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $13.11 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on February 16, 17, 18, 19, 22, 23, 24, 25, 26 and 29, 2016.

(31)	Based on shareholder elections, the dividend consisted of approximately $1.1 million in cash and 61,029 newly issued shares of common stock, or 1.1% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $14.53 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on November 16, 17, 18, 19, 20, 23, 24, 25, 27 and 30, 2015.
(32)	Based on shareholder elections, the dividend consisted of approximately $1.1 million in cash and 47,861 newly issued shares of common stock, or 0.9% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.28 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on August 18, 19, 20, 21, 24, 25, 26, 27, 28 and 31, 2015.
(33)	Based on shareholder elections, the dividend consisted of approximately $3.4 million in cash and 126,230 newly issued shares of common stock, or 2.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $16.47 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on May 22, 26, 27, 28, 29 and June 1, 2, 3, 4, and 5, 2015.
(34)	Based on shareholder elections, the dividend consisted of approximately $0.9 million in cash and 33,766 newly issued shares of common stock, or 0.6% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $16.78 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on May 15, 18, 19, 20, 21, 22, 26, 27, 28 and 29, 2015.
(35)	Based on shareholder elections, the dividend consisted of approximately $0.8 million in cash and 26,858 newly issued shares of common stock, or 0.5% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $14.97 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on February 13, 17, 18, 19, 20, 23, 24, 25, 26 and 27, 2015.
(36)	Based on shareholder elections, the dividend consisted of approximately $0.6 million in cash and 22,283 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $14.37 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on November 14, 17, 18, 19, 20, 21, 24, 25, 26 and 28, 2014.

144

(37)	Based on shareholder elections, the dividend consisted of approximately $2.5 million in cash and 649,500 shares of common stock, or 13.7% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.439 per share, which equaled the volume weighted average trading price per share of the common stock on December 11, 13 and 16, 2013.
(38)	Based on shareholder elections, the dividend consisted of $3.3 million in cash and 853,455 shares of common stock, or 22.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.444 per share, which equaled the volume weighted average trading price per share of the common stock on December 14, 17 and 19, 2012.
(39)	Based on shareholder elections, the dividend consisted of $2.0 million in cash and 599,584 shares of common stock, or 18.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $13.117067 per share, which equaled the volume weighted average trading price per share of the common stock on December 20, 21 and 22, 2011.
(40)	Based on shareholder elections, the dividend consisted of $1.2 million in cash and 596,235 shares of common stock, or 22.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 10.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $17.8049 per share, which equaled the volume weighted average trading price per share of the common stock on December 20, 21 and 22, 2010.
(41)	Based on shareholder elections, the dividend consisted of $2.1 million in cash and 864,872 shares of common stock, or 104.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 13.7% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $1.5099 per share, which equaled the volume weighted average trading price per share of the common stock on December 24 and 28, 2009.

(42)	Based on shareholder elections, the dividend consisted of approximately $7.6 million in cash and 29,627 newly issued shares of common stock, or 0.2% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $25.29 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on June 15, 16, 20, 21, 22, 23, 26, 27, 28, and 29, 2023.
(43)	Based on shareholder elections, the dividend consisted of approximately $8.4 million in cash and 35,196 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $24.41 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on September 15, 18, 19, 20, 21, 22, 25, 26, 27, and 28, 2023.
(44)	Based on shareholder elections, the dividend consisted of approximately $8.9 million in cash and 37,394 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $24.47 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on December 14, 15, 18, 19, 20, 21, 22, 26, 27, and 28, 2023.

145

(45)	Based on shareholder elections, the dividend consisted of approximately $9.0 million in cash and 45,490 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $22.85 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on March 15, 18, 19, 20, 21, 22, 25, 26, 27, and 28, 2024.
(46)	Based on shareholder elections, the dividend consisted of approximately $9.1 million in cash and 46,803 newly issued shares of common stock, or 10.0% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $21.76 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on June 13, 14, 17, 18, 20, 21, 24, 25, 26, and 27, 2024.
(47)	Based on shareholder elections, the dividend consisted of approximately $9.0 million in cash and 54,999 newly issued shares of common stock, or 10.0% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $22.08 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on September 13, 16, 17, 18, 19, 20, 23, 24, 25, and 26, 2024.
(48)	Based on shareholder elections, the dividend consisted of approximately $13.7 million in cash and 81,471 newly issued shares of common stock, or 11.9% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $22.80 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on December 6, 9, 10, 11, 12, 13, 16, 17, 18, and 19, 2024.
(49)	Based on shareholder elections, the dividend consisted of approximately $9.9 million in cash and 60,611 newly issued shares of common stock, or 12.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $22.96 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on March 12, 13, 14, 17, 18, 19, 20, 21, 24, and 25, 2025.
(50)	Based on shareholder elections, the dividend consisted of approximately $3.4 million in cash and 20,086 newly issued shares of common stock, or 11.5% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $22.02 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on April 10, 11, 14, 15, 16, 17, 21, 22, 23, and 24, 2025.

(51)	Based on shareholder elections, the dividend consisted of approximately $3.4 million in cash and 20,784 newly issued shares of common stock, or 12.5% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $23.02 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on May 9, 12, 13, 14, 15, 16, 19, 20, 21, and 22, 2025.
(52)	Based on shareholder elections, the dividend consisted of approximately $3.4 million in cash and 19,750 newly issued shares of common stock, or 11.7% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $23.09 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on June 10, 11, 12, 13, 16, 17, 18, 20, 23, and 24, 2025.
(53)	Based on shareholder elections, the dividend consisted of approximately $3.5 million in cash and 17,443 newly issued shares of common stock, or 10.6% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $23.86 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on July 11, 14, 15, 16, 17, 18, 21, 22, 23 and 24, 2025.
(54)	Based on shareholder elections, the dividend consisted of approximately $3.6 million in cash and 17,320 newly issued shares of common stock, or 10.5% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $24.11 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on August 8, 11, 12, 13, 14, 15, 18, 19, 20 and 21, 2025.
(55)	Based on shareholder elections, the dividend consisted of approximately $3.6 million in cash and 17,673 newly issued shares of common stock, or 10.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $23.32 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on September 11, 12, 15, 16, 17, 18, 19, 22, 23 and 24, 2025.

We cannot provide any assurance that these measures will provide sufficient sources of liquidity to support our operations and growth.

Our asset coverage ratio, as defined in the 1940 Act, was 166.6% as of August 31, 2025 and 162.9% as of February 28, 2025.

146

Subsequent Events

Month	Amount per Share		Record Date	Payment Date
September 2025	$	0.25	October 7, 2025	October 23, 2025
October 2025	$	0.25	November 4, 2025	November 20, 2025
November 2025	$	0.25	December 2, 2025	December 18, 2025

Contractual obligations

The following table shows our payment obligations for repayment of debt and other contractual obligations at August 31, 2025:

			Payment Due by Period
Long-Term Debt Obligations	Total		Less Than 1 Year		1 - 3 Years		3 - 5 Years		More Than 5 Years
	($ in thousands)
Revolving credit facility	$	32,500	$	32,500	$	-	$	-	$	-
Live Oak credit facility		37,500		-		37,500		-		-
SBA debentures		170,000		-		-		20,000		150,000
7.00% 2025 Notes		12,000		12,000		-		-		-
4.375% 2026 Notes		175,000		175,000		-		-		-
4.35% 2027 Notes		75,000		-		75,000		-		-
6.25% 2027 Notes		15,000		-		15,000		-		-
6.00% 2027 Notes		105,500		-		105,500		-		-
8.00% 2027 Notes		46,000		-		46,000		-		-
8.125% 2027 Notes		60,375		-		60,375		-		-
8.5% 2028 Notes		57,500		-		57,500		-		-
Total Long-Term Debt Obligations	$	786,375	$	219,500	$	396,875	$	20,000	$	150,000

Off-balance sheet arrangements

As of August 31, 2025 and February 28, 2025, our off-balance sheet arrangements consisted of $96.2 million and $126.7 million, respectively, of unfunded commitments outstanding to provide debt financing to its portfolio companies or to fund limited partnership interests. Such commitments are generally up to our discretion to approve, or the satisfaction of certain financial and nonfinancial covenants and involve, to varying degrees, elements of credit risk in excess of the amount recognized in our consolidated statements of assets and liabilities and are not reflected in our consolidated statements of assets and liabilities.

147

A summary of the unfunded commitments outstanding as of August 31, 2025 and February 28, 2025 is shown in the table below (dollars in thousands):

	August 31, 2025		February 28, 2025
At Company’s discretion
ActiveProspect, Inc.	$	10,000	$	10,000
Artemis Wax Corp.		-		23,500
Ascend Software, LLC		-		5,000
C2 Educational Systems		-		2,000
Davisware, LLC		-		1,000
JDXpert		4,500		4,500
Lee’s Famous Recipe Chicken		10,000		10,000
Pepper Palace, Inc.		1,200		1,200
Procurement Partners, LLC		-		-
Saratoga Senior Loan Fund I JV, LLC		8,548		8,548
VetnCare MSO, LLC		10,000		10,000
StockIQ Technologies, LLC		5,000		-
Total	$	49,248	$	75,748

At portfolio company’s discretion - satisfaction of certain financial and nonfinancial covenants required
Axero Holdings, LLC - Revolver		500		500
Axiom Medical Consulting, LLC		1,000		1,500
BQE Software, Inc.		250		2,250
Cloudpermit Intermediate Holding Company		5,000		5,000
Davisware, LLC		-		1,750
Exigo, LLC - Revolver		625		625
Gen4 Dental Partners Holdings, LLC		2,381		2,857
Granite Comfort, LP		-		11,637
Innergy, Inc.		5,000		5,000
Inspect Point Holding, LLC		2,000		1,500
Modis Dental Partners OpCo, LLC		4,500		8,900
Pepper Palace, Inc. - Revolver		-		600
Stretch Zone Franchising, LLC		-		1,500
VetnCare MSO, LLC		6,709		7,319
StockIQ Technologies, LLC		2,000		-
SmartAC.com, Inc.		17,000		-
		46,965		50,938
Total	$	96,213	$	126,686

We believe our assets will provide adequate coverage to satisfy these unfunded commitments. As of August 31, 2025, we had cash and cash equivalents of $105.7 million and $32.5 million in available borrowings under the Encina Credit Facility, and $37.5 million in available borrowings under the Live Oak Credit Facility.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Our business activities contain elements of market risk. We consider the fluctuation in interest rates to be our principal market risk. Managing this risk is essential to our business. Accordingly, we have systems and procedures designed to identify and analyze our risks, to establish appropriate policies and thresholds and to continually monitor this risk and thresholds by means of administrative and information technology systems and other policies and processes.

Interest rate risk is defined as the sensitivity of our current and future earnings to interest rate volatility, including relative changes in different interest rates, variability of spread relationships, the difference in re-pricing intervals between our assets and liabilities and the effect that interest rates may have on our cash flows. Changes in the general level of interest rates can affect our net interest income, which is the difference between the interest income earned on interest earning assets and our interest expense incurred in connection with our interest-bearing debt and liabilities. Changes in interest rates can also affect, among other things, our ability to acquire leveraged loans, high yield bonds and other debt investments and the value of our investment portfolio.

148

Our investment income is affected by fluctuations in various interest rates, including SOFR and the prime rate. Substantially all of our portfolio is, and we expect will continue to be, comprised of floating rate investments that utilize SOFR or an alternate rate. The Federal Reserve cut interest rates in the third quarter of 2025, after holding rates steady in the first and second quarters of 2025. The Federal Reserve has indicated that there may be additional rate cuts in the future; however, future reductions to benchmark rates are not certain. In an elevated interest rate environment, our cost of funds would increase, which could reduce our net investment income if there was not a corresponding increase in interest income generated by our investment portfolio. It is possible that the Federal Reserve’s tightening cycle could result in a recession in the United States, which would likely decrease interest rates. A prolonged reduction in interest rates will reduce our gross investment income and could result in a decrease in our net investment income if such decreases in base rates, such as SOFR, are not offset by corresponding increases in the spread over such base rates that we earn on any portfolio investments, a decrease in in our operating expenses, including with respect to our income incentive fee, or a decrease in the interest rate of our floating interest rate liabilities. Our interest expense is affected by fluctuations in SOFR on our Encina and Live Oak Credit Facilities.

At August 31, 2025, we had $786.4 million of borrowings outstanding. This includes $32.5 million borrowings outstanding under the Encina Credit Facility and $37.5 million borrowings outstanding under the Live Oak Credit Facility as of August 31, 2025. As of August 31, 2025, on a fair value basis, approximately 1.2% of our debt investments bear interest at a fixed-rate and approximately 98.8% of our debt investments bear interest at a floating rate. As of August 31, 2025, 100% of our floating rate debt investments are subject to interest rate floors. Additionally, both the Encina Credit Facility and the Live Oak Credit Facility are subject to a floating interest rate and is currently paid based on floating Term SOFR rate.

We have analyzed the potential impact of changes in interest rates on interest income from investments. Assuming that our investments as of August 31, 2025 were to remain constant for a full fiscal year and no actions were taken to alter the existing interest rate terms, a hypothetical change of a 1.0% increase in interest rates would cause a corresponding increase of approximately $8.8 million to our interest income. Conversely, a hypothetical change of a 1.0% decrease in interest rates would cause a corresponding decrease of approximately $8.8 million to our interest income.

Changes in interest rates would have no impact to our current interest and debt financing expenses, except for our borrowings under our Encina and Live Oak credit facilities. All of our remaining borrowings are fixed-rate borrowings. Assuming that our Encina and Live Oak borrowings as of August 31, 2025 were to remain constant for a full fiscal year and no actions were taken to alter the existing interest rate terms, a hypothetical change of a 1.0% increase in interest rates would cause a corresponding increase of approximately $0.7 million to our interest expense. Conversely, a hypothetical change of a 1.0% decrease in interest rates would cause a corresponding decrease of approximately $0.7 million to our interest expense.

Although management believes that this measure is indicative of our sensitivity to interest rate changes, it does not adjust for potential changes in credit quality, size and composition of the assets on the statements of assets and liabilities and other business developments that could magnify or diminish our sensitivity to interest rate changes, nor does it account for divergences in SOFR and the commercial paper rate, which have historically moved in tandem but, in times of unusual credit dislocations, have experienced periods of divergence. Accordingly, no assurances can be given that actual results would not materially differ from the potential outcome simulated by this estimate.

149

For further information, the following table shows the approximate annualized increase or decrease in the components of net investment income due to hypothetical base rate changes in interest rates, assuming no changes in our investments and borrowings as of August 31, 2025.

	Increase			(Increase)			Increase			Increase			Increase
Basis	(Decrease)			Decrease			(Decrease) in Net			(Decrease) in Net			(Decrease) in Net
Point	in Interest			in Interest			Interest			Interest			Investment
Change	Income			Expense			Income			Income*			Income per Share
	($ in thousands)
-400	$	(27,195	)	$	2,536		$	(24,659	)	$	(19,727	)	$	(1.23	)
-300		(24,187	)		2,100			(22,087	)		(17,670	)		(1.10	)
-200		(17,590	)		1,400			(16,190	)		(12,952	)		(0.81	)
-100		(8,828	)		700			(8,128	)		(6,502	)		(0.41	)
-50		(4,414	)		350			(4,064	)		(3,251	)		(0.20	)
-25		(2,207	)		175			(2,032	)		(1,626	)		(0.10	)
25		2,220			(175	)		2,045			1,636			0.10
50		4,441			(350	)		4,091			3,273			0.20
100		8,881			(700	)		8,181			6,545			0.41
200		17,762			(1,400	)		16,362			13,090			0.82
300		26,644			(2,100	)		24,544			19,635			1.23
400		35,525			(2,800	)		32,725			26,180			1.63

*	Adjusts Net Interest Income for the impact of the first incentive fee on Net Investment Income

ITEM 4. CONTROLS AND PROCEDURES

(a)

As of the end of the period covered by this report, we carried out an evaluation, under the supervision and with the participation of our management, including our chief executive officer and our chief financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)). Based on that evaluation, our chief executive officer and our chief financial officer have concluded that our current disclosure controls and procedures are effective in facilitating timely decisions regarding required disclosure of any material information relating to us that is required to be disclosed by us in the reports we file or submit under the Exchange Act. However, in evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

(b)

There have been no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) of the Exchange Act) that occurred during the quarter ended August 31, 2025 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

150

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

Neither we nor our wholly owned subsidiaries, Saratoga Investment Funding LLC, Saratoga Investment Funding II, LLC, Saratoga Investment Corp. SBIC II LP, or Saratoga Investment Corp. SBIC III LP, are currently subject to any material legal proceedings.

Item 1A. Risk Factors

In addition to information set forth in this report, you should carefully consider the “Risk Factors” discussed in our most recent Annual Report on Form 10-K filed with the SEC, which could materially affect our business, financial condition and/or operating results. There have been no material changes during the six months ended August 31, 2025 to the risk factors discussed in “Item 1A. Risk Factors” of our Annual Report on Form 10-K for the fiscal year ended February 28, 2025. Additional risks or uncertainties not currently known to us or that we currently deem to be immaterial also may materially affect our business, financial condition and/or operating results.

We are subject to risks to the extent we invest in covenant-lite loans.

On occasion, the Company may invest in “covenant-lite” loans. Covenant-lite loans contain fewer maintenance covenants than other loans, or no maintenance covenants, and do not always include terms that allow the lender to monitor the performance of the borrower and declare a default if certain criteria are breached. Covenant-lite loans can carry more risk than traditional loans as they allow borrowers to engage in activities that would otherwise be difficult or not permitted under loan agreements with a full package of covenants. In an event of default, covenant-lite loans could result in diminished recovery values where the lender did not have the opportunity to negotiate with the borrower or to restructure the loan prior to default. Accordingly, to the extent the Company invests in covenant-lite loans, the Company may have fewer rights against a borrower and may have a greater risk of loss on such investments as compared to investments in or exposure to loans with financial maintenance covenants.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Issuer Purchases of Equity Securities

On September 24, 2014, we announced the approval of an open market share repurchase plan that originally allowed it to repurchase up to 200,000 shares of its common stock at prices below its NAV as reported in its then most recently published consolidated financial statements (the “Share Repurchase Plan”). Since September 24, 2014, the Share Repurchase Plan has been extended annually, and we have periodically increased the amount of shares of common stock that may be purchased under the Share Repurchase Plan, most recently to 1.7 million shares of common stock. On January 7, 2025, our board of directors extended the Share Repurchase Plan for another year to January 15, 2026. As of August 31, 2025, we had purchased 1,035,203 shares of common stock, at the average price of $22.05 for approximately $22.8 million pursuant to the Share Repurchase Plan. During the three and six months ended August 31, 2025, we did not purchase any shares of common stock pursuant to the Share Repurchase Plan.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

(a)

None.

(b)

None.

(c)

For the period covered by this Quarterly Report on Form 10-Q, no director or officer of the Company has entered into (i) any contract, instruction or written plan for the purchase or sale of securities of the Company intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act or (ii) any non-Rule 10b5-1 trading arrangement.

151

Item 6. Exhibits

The following exhibits are filed as part of this report or hereby incorporated by reference to exhibits previously filed with the SEC:

EXHIBIT INDEX

Exhibit Number		Description

3.1(a)		Articles of Incorporation of Saratoga Investment Corp. (f/k/a GSC Investment Corp.) (incorporated by reference to Saratoga Investment Corp.’s Form 10-Q for the quarterly period ended May 31, 2007).

3.1(b)		Articles of Amendment of Saratoga Investment Corp. (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed August 3, 2010).

3.1(c)		Articles of Amendment of Saratoga Investment Corp. (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed August 13, 2010).

3.2		Third Amended and Restated Bylaws of Saratoga Investment Corp. (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 10-Q filed January 6, 2021)

4.1		Specimen certificate of Saratoga Investment Corp.’s common stock, par value $0.001 per share. (incorporated by reference to Saratoga Investment Corp.’s Registration Statement on Form N-2, File No. 333-169135, filed on September 1, 2010).

4.2		Registration Rights Agreement dated July 30, 2010 between GSC Investment Corp., GSC CDO III L.L.C., and the investors party thereto (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on August 3, 2010).

4.3		Dividend Reinvestment Plan (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on September 24, 2014).

4.4		Form of Indenture by and between the Company and U.S. Bank National Association, as trustee (incorporated by reference to Saratoga Investment Corp.’s Pre-Effective Amendment No. 2 to the Registration Statement on Form N-2, File No. 333-186323 filed April 30, 2013).

4.5		Form of Articles Supplementary Establishing and Fixing the Rights and Preferences of Preferred Stock (incorporated by reference to Saratoga Investment Corp.’s registration statement on Form N-2 Pre-Effective Amendment No. 1, File No. 333-196526, filed on December 5, 2014).

4.6		Fifth Supplemental Indenture between Saratoga Investment Corp. and U.S. Bank National Association, as trustee, relating to 7.75% Notes due 2025 (incorporated by reference to Saratoga Investment Corp.’s Quarterly Report on Form 10-Q, filed on January 10, 2023).

4.7		Seventh Supplemental Indenture between Saratoga Investment Corp. and U.S. Bank National Association, as trustee, relating to 6.25% Notes due 2027 (incorporated by reference to Saratoga Investment Corp.’s Quarterly Report on Form 10-Q, filed on January 10, 2023).

4.8		Eighth Supplemental Indenture between the Saratoga Investment Corp. and U.S. Bank National Association, as trustee, relating to the 4.375% Note due 2026 (incorporated by reference to Exhibit 4.2 to the Registrant’s Current Report on Form 8-K (File No. 814-00732) filed on March 10, 2021).

4.9		Ninth Supplemental Indenture between Saratoga Investment Corp. and U.S. Bank National Association, as trustee, relating to the 4.375% Note due 2027 (incorporated by reference to the Registrant’s Current Report on Form 8-K (File No. 814-00732) filed on January 19, 2022).

4.10		Tenth Supplemental Indenture between Saratoga Investment Corp. and U.S. Bank National Association, as trustee, relating to the 6.00% Note due 2027 (incorporated by reference to the Registrant’s Current Report on Form 8-K (File No. 814-00732) filed on April 27, 2022).

4.11		Eleventh Supplemental Indenture between Saratoga Investment Corp. and U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), as trustee, relating to the 7.00% Notes due 2025 (incorporated by reference to the Registrant’s Quarterly Report on Form 10-Q, filed on January 10, 2023).

4.12		Twelfth Supplemental Indenture between Saratoga Investment Corp. and U.S. Bank Trust Company, National Association, as trustee, relating to the 8.00% Notes due 2027 (incorporated by reference to the Saratoga Investment Corp.’s Current Report on Form 8-K (File No. 813-00732) filed on October 27, 2022).

4.13		Thirteenth Supplemental Indenture between Saratoga Investment Corp. and U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), as trustee, relating to the 8.125% Notes due 2027 (incorporated by reference to the Registrant’s Current Report on Form 8-K, filed on December 13, 2022).

152

4.14		Fifteenth Supplemental Indenture between Saratoga Investment Corp. and U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), as trustee, relating to the 8.50% Notes due 2028 (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on April 14, 2023).

4.15		Form of 7.75% Notes due 2025 (incorporated by reference to Exhibit 4.6 hereto).

4.16		Form of 6.25% Notes due 2027 (incorporated by reference to Exhibit 4.7 hereto).

4.17		Form of 4.375% Notes due 2026 (incorporated by reference to Exhibit 4.8 hereto).

4.18		Form of 4.35% Notes due 2027 (incorporated by reference to Exhibit 4.9 hereto).

4.19		Form of 6.00% Notes due 2027 (incorporated by reference to Exhibit 4.10 hereto).

4.20		Form of 7.00% Notes due 2025 (incorporated by reference to Exhibit 4.11 hereto).

4.21		Form of 8.00% Notes due 2027 (incorporated by reference to Exhibit 4.12 hereto).

4.22		Form of 8.125% Notes due 2027 (incorporated by reference to Exhibit 4.13 hereto).

4.23		Form of 8.50% Notes due 2028 (incorporated by reference to Exhibit 4.14 hereto).

31.1*		Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934

31.2*		Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934

32.1*		Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C.1350)

32.2*		Certification of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350)

101.INS		Inline XBRL Instance Document.

101.SCH		Inline XBRL Taxonomy Extension Schema Document.

101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document.

101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document.

101.LAB		Inline XBRL Taxonomy Extension Label Linkbase Document.

101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document.

104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

*	Filed herewith

ITEM 16. FORM 10-K SUMMARY

None.

153

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	SARATOGA INVESTMENT CORP.

Date: October 7, 2025	By:	/s/ CHRISTIAN L. OBERBECK
		Christian L. Oberbeck
		Chief Executive Officer

	By:	/s/ HENRI J. STEENKAMP
		Henri J. Steenkamp
		Chief Financial Officer and Chief Compliance Officer

154

2025-06-30 2027-08-09 2025-07-09 0.1142 Represents an investment that is not a “qualifying asset” under Section 55(a) of the Investment Company Act of 1940, as amended (the 1940 Act”). As of February 28, 2025, non-qualifying assets represent 4.0% of the Company’s portfolio at fair value. As a BDC, the Company generally has to invest at least 70% of its total assets in qualifying assets. Percentages are based on net assets of $392,665,468 as of February 28, 2025. Because there is no “readily available market quotations” (as defined in the 1940 Act) for these investments, the fair values of these investments were determined using significant unobservable inputs and approved in good faith by our board of directors. These investments have been included as Level 3 in the Fair Value Hierarchy (see Note 3 to the consolidated financial statements). As defined in the 1940 Act, this portfolio company is an “affiliate” as we own between 5.0% and 25.0% of the outstanding voting securities. Transactions during the year ended February 28, 2025 in which the issuer was an affiliate are as follows: As defined in the 1940 Act, we “control” this portfolio company because we own more than 25% of the portfolio company’s outstanding voting securities. Transactions during the year ended February 28, 2025 in which the issuer was both an affiliate and a portfolio company that we control are as follows: Non-income producing at February 28, 2025. All or a portion of this investment has an unfunded commitment as of February 28, 2025. (See Note 9 to the consolidated financial statements). As of February 28, 2025, the investment was on non-accrual status. The fair value of these investments was approximately $2.6 million, which represented 0.3% of the Company’s portfolio (see Note 2 to the consolidated financial statements). This investment elected to PIK 20% of accrued interest, with 80% of accrued interest payable in cash. http://fasb.org/srt/2025#ChiefOperatingOfficerMember Included within cash and cash equivalents in Saratoga CLO's Statements of Assets and Liabilities as of August 31, 2025. Included within cash and cash equivalents in Saratoga CLO’s Statements of Assets and Liabilities as of February 28, 2025. As of August 31, 2025, the investment was in default and on non-accrual status. Investments include Payment-in-Kind Interest. 0001377936 false 2026 Q2 --02-28 0001377936 2025-03-01 2025-08-31 0001377936 us-gaap:CommonStockMember 2025-03-01 2025-08-31 0001377936 sar:SixPointZeroTwoTHousandTwentySevenNotesMember 2025-03-01 2025-08-31 0001377936 sar:EightPointZeroZeroTwoThousandTwentySevenNotesMember 2025-03-01 2025-08-31 0001377936 sar:EightPointOneTwentyFiveTwoThousandTwentySevenNotesMember 2025-03-01 2025-08-31 0001377936 sar:NotesPayableFourMember 2025-03-01 2025-08-31 0001377936 2025-10-07 0001377936 us-gaap:InvestmentUnaffiliatedIssuerMember 2025-08-31 0001377936 us-gaap:InvestmentUnaffiliatedIssuerMember 2025-02-28 0001377936 us-gaap:InvestmentAffiliatedIssuerNoncontrolledMember 2025-08-31 0001377936 us-gaap:InvestmentAffiliatedIssuerNoncontrolledMember 2025-02-28 0001377936 us-gaap:InvestmentAffiliatedIssuerMember 2025-08-31 0001377936 us-gaap:InvestmentAffiliatedIssuerMember 2025-02-28 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember 2025-08-31 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember 2025-02-28 0001377936 2025-08-31 0001377936 2025-02-28 0001377936 us-gaap:RevolvingCreditFacilityMember 2025-08-31 0001377936 us-gaap:RevolvingCreditFacilityMember 2025-02-28 0001377936 sar:SBADebenturesMember 2025-08-31 0001377936 sar:SBADebenturesMember 2025-02-28 0001377936 sar:TwoThousandAndTwentyFiveNotes1Member 2025-08-31 0001377936 sar:TwoThousandAndTwentyFiveNotes1Member 2025-02-28 0001377936 sar:SevenPointZeroPercentageTwoThousandTwentyFiveNotesMember 2025-08-31 0001377936 sar:SevenPointZeroPercentageTwoThousandTwentyFiveNotesMember 2025-02-28 0001377936 sar:SevenPointSeventyFivePercentageTwoThousandTwentyFiveNotesMember 2025-02-28 0001377936 sar:SevenPointSeventyFivePercentageTwoThousandTwentyFiveNotesMember 2025-08-31 0001377936 sar:FourPointThreeHunderendSeventyFiveTwoThousandTwintySixNotesMember 2025-08-31 0001377936 sar:FourPointThreeHunderendSeventyFiveTwoThousandTwintySixNotesMember 2025-02-28 0001377936 sar:FourPointThirtyFiveTwoThousandTwentySevenNotesMember 2025-08-31 0001377936 sar:FourPointThirtyFiveTwoThousandTwentySevenNotesMember 2025-02-28 0001377936 sar:SixPointTwentyFiveTwoThousandTwentySevenNotesMember 2025-08-31 0001377936 sar:SixPointTwentyFiveTwoThousandTwentySevenNotesMember 2025-02-28 0001377936 sar:SixPointZeroTwoTHousandTwentySevenNotesMember 2025-08-31 0001377936 sar:SixPointZeroTwoTHousandTwentySevenNotesMember 2025-02-28 0001377936 sar:EightPointZeroZeroTwoThousandTwentySevenNotesMember 2025-08-31 0001377936 sar:EightPointZeroZeroTwoThousandTwentySevenNotesMember 2025-02-28 0001377936 sar:EightPointOneTwentyFiveTwoThousandTwentySevenNotesMember 2025-08-31 0001377936 sar:EightPointOneTwentyFiveTwoThousandTwentySevenNotesMember 2025-02-28 0001377936 sar:EightPointFiftyPercentageTwoThosandTwentyEightNotesMember 2025-08-31 0001377936 sar:EightPointFiftyPercentageTwoThosandTwentyEightNotesMember 2025-02-28 0001377936 us-gaap:InvestmentUnaffiliatedIssuerMember 2025-06-01 2025-08-31 0001377936 us-gaap:InvestmentUnaffiliatedIssuerMember 2024-06-01 2024-08-31 0001377936 us-gaap:InvestmentUnaffiliatedIssuerMember 2025-03-01 2025-08-31 0001377936 us-gaap:InvestmentUnaffiliatedIssuerMember 2024-03-01 2024-08-31 0001377936 us-gaap:InvestmentAffiliatedIssuerMember 2025-06-01 2025-08-31 0001377936 us-gaap:InvestmentAffiliatedIssuerMember 2024-06-01 2024-08-31 0001377936 us-gaap:InvestmentAffiliatedIssuerMember 2025-03-01 2025-08-31 0001377936 us-gaap:InvestmentAffiliatedIssuerMember 2024-03-01 2024-08-31 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember 2025-06-01 2025-08-31 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember 2024-06-01 2024-08-31 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember 2025-03-01 2025-08-31 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember 2024-03-01 2024-08-31 0001377936 2025-06-01 2025-08-31 0001377936 2024-06-01 2024-08-31 0001377936 2024-03-01 2024-08-31 0001377936 2024-02-29 0001377936 2024-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Altvia MidCo, LLC. - Alternative Investment Management Software - First Lien Term Loan (6M USD TERM SOFR+8.08%), 12.46% Cash, 7/18/2027

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Altvia MidCo, LLC. - Alternative Investment Management Software - First Lien Term Loan (6M USD TERM SOFR+8.08%), 12.46% Cash, 7/18/2027

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Altvia MidCo, LLC. - Alternative Investment Management Software - Series A-1 Preferred Shares

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Altvia MidCo, LLC. - Alternative Investment Management Software - Series A-1 Preferred Shares

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Alternative Investment Management Software

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Architecture & Engineering Software - First Lien Term Loan (3M USD TERM SOFR+5.50%), 9.67% Cash, 4/13/2028

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Architecture & Engineering Software - First Lien Term Loan (3M USD TERM SOFR+5.50%), 9.67% Cash, 4/13/2028

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - BQE Software, Inc. - Architecture & Engineering Software - Delayed Draw Term Loan (3M USD TERM SOFR+5.50%), 9.67% Cash, 4/13/2028

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - BQE Software, Inc. - Architecture & Engineering Software - Delayed Draw Term Loan (3M USD TERM SOFR+5.50%), 9.67% Cash, 4/13/2028

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Architecture & Engineering Software

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Golden TopCo LP - Association Management Software - Class A-2 Common Units

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Golden TopCo LP - Association Management Software - Class A-2 Common Units

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Association Management Software

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Artemis Wax Corp. - Consumer Services - Delayed Draw Term Loan (1M USD TERM SOFR+6.75%), 11.02% Cash, 5/20/2026

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Artemis Wax Corp. - Consumer Services - Delayed Draw Term Loan (1M USD TERM SOFR+6.75%), 11.02% Cash, 5/20/2026

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Artemis Wax Corp. - Consumer Services - Series B-1 Preferred Stock

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Artemis Wax Corp. - Consumer Services - Series B-1 Preferred Stock

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Artemis Wax Corp. - Consumer Services - Series D Preferred Stock

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Artemis Wax Corp. - Consumer Services - Series D Preferred Stock

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Consumer Services

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Schoox, Inc. - Corporate Education Software - Series 1 Membership Interest

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Schoox, Inc. - Corporate Education Software - Series 1 Membership Interest

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Corporate Education Software

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Innergy, Inc. - First Lien Term Loan - (3M USD TERM SOFR+5.50%), 9.67% Cash, 2/20/2030

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Innergy, Inc. - First Lien Term Loan - (3M USD TERM SOFR+5.50%), 9.67% Cash, 2/20/2030

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Innergy, Inc. - Custom Millwork Software - Delayed Draw Term Loan - (3M USD TERM SOFR+5.50%), 9.67% Cash, 2/20/2030

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Innergy, Inc. - Custom Millwork Software - Delayed Draw Term Loan - (3M USD TERM SOFR+5.50%), 9.67% Cash, 2/20/2030

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Custom Millwork Software

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - GreyHeller LLC - Cyber Security - Common Stock

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - GreyHeller LLC - Cyber Security - Common Stock

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Cyber Security

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Gen4 Dental Partners Holdings, LLC - Dental Practice Management - First Lien Term Loan - (1M USD TERM SOFR+5.75%), 10.02% Cash, 5/13/2030

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Gen4 Dental Partners Holdings, LLC - Dental Practice Management - First Lien Term Loan - (1M USD TERM SOFR+5.75%), 10.02% Cash, 5/13/2030

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Gen4 Dental Partners Holdings, LLC - Dental Practice Management - Delayed Draw Term Loan - (1M USD TERM SOFR+5.75%), 10.02% Cash, 5/13/2030

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Gen4 Dental Partners Holdings, LLC - Dental Practice Management - Delayed Draw Term Loan - (1M USD TERM SOFR+5.75%), 10.02% Cash, 5/13/2030

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Gen4 Dental Partners Holdings, LLC - Dental Practice Management - Revolving Credit Facility (1M USD TERM SOFR+5.75%), 10.02% Cash, 5/13/2030

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Gen4 Dental Partners Holdings, LLC - Dental Practice Management - Revolving Credit Facility (1M USD TERM SOFR+5.75%), 10.02% Cash, 5/13/2030

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Gen4 Dental Partners Holdings, LLC - Dental Practice Management - Series A Preferred Units

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Gen4 Dental Partners Holdings, LLC - Dental Practice Management - Series A Preferred Units

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Modis Dental Partners OpCo, LLC - Dental Practice Management - First Lien Term Loan (1M USD TERM SOFR+9.42%), 13.69% Cash, 4/18/2028

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Modis Dental Partners OpCo, LLC - Dental Practice Management - First Lien Term Loan (1M USD TERM SOFR+9.42%), 13.69% Cash, 4/18/2028

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Modis Dental Partners OpCo, LLC - Dental Practice Management - Delayed Draw Term Loan (1M USD TERM SOFR+9.42%), 13.69% Cash, 4/18/2028

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Modis Dental Partners OpCo, LLC - Dental Practice Management - Delayed Draw Term Loan (1M USD TERM SOFR+9.42%), 13.69% Cash, 4/18/2028

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Modis Dental Partners OpCo, LLC - Dental Practice Management - Class A Preferred Units

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Modis Dental Partners OpCo, LLC - Dental Practice Management - Class A Preferred Units

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Dental Practice Management

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Exigo, LLC - Direct Selling Software - First Lien Term Loan - (1M USD TERM SOFR+6.25%), 10.62% Cash, 3/16/2027

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Exigo, LLC - Direct Selling Software - First Lien Term Loan - (1M USD TERM SOFR+6.25%), 10.62% Cash, 3/16/2027

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Exigo, LLC - Direct Selling Software - Revolving Credit Facility (1M USD TERM SOFR+6.25%), 10.62% Cash, 3/16/2027

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Exigo, LLC - Direct Selling Software - Revolving Credit Facility (1M USD TERM SOFR+6.25%), 10.62% Cash, 3/16/2027

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Exigo, LLC - Direct Selling Software - Common Units

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Exigo, LLC - Direct Selling Software - Common Units

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Direct Selling Software

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - C2 Educational Systems, Inc. - Education Services - First Lien Term Loan (3M USD TERM SOFR+8.50%), 12.67% Cash, 11/30/2026

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - C2 Educational Systems, Inc. - Education Services - First Lien Term Loan (3M USD TERM SOFR+8.50%), 12.67% Cash, 11/30/2026

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - C2 Education Systems, Inc. - Education Services - Series A-1 Preferred Stock

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - C2 Education Systems, Inc. - Education Services - Series A-1 Preferred Stock

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Ready Education - Education Software - First Lien Term Loan (3M USD TERM SOFR+7.00%), 11.32% Cash, 8/5/2027

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Ready Education - Education Software - First Lien Term Loan (3M USD TERM SOFR+7.00%), 11.32% Cash, 8/5/2027

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Education Software

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - TG Pressure Washing Holdings, LLC - Facilities Maintenance - Preferred Equity

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - TG Pressure Washing Holdings, LLC - Facilities Maintenance - Preferred Equity

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Facilities Maintenance

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Ascend Software, LLC - Financial Services Software - First Lien Term Loan (3M USD TERM SOFR+7.00%), 11.17% Cash, 12/30/2026

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Ascend Software, LLC - Financial Services Software - First Lien Term Loan (3M USD TERM SOFR+7.00%), 11.17% Cash, 12/30/2026

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Ascend Software, LLC - Financial Services Software - First Lien Term Loan (3M USD TERM SOFR+7.50%), 12.09% Cash, 12/15/2026

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Omatic Software, LLC - Non-profit Services - First Lien Term Loan (3M USD TERM SOFR+7.00%), 11.17% Cash, 12/30/2026

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Omatic Software, LLC - Non-profit Services - First Lien Term Loan (3M USD TERM SOFR+7.00%), 11.17% Cash, 12/30/2026

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - GDS Software Holdings, LLC - Financial Services - Common Stock Class A Units

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - GDS Software Holdings, LLC - Financial Services - Common Stock Class A Units

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Non-profit Services

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Inspect Point Holdings, LLC - Fire Inspection Business Software - First Lien Term Loan (1M USD TERM SOFR+5.50%), 9.77% Cash, 07/19/2029

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Inspect Point Holdings, LLC - Fire Inspection Business Software - First Lien Term Loan (1M USD TERM SOFR+5.50%), 9.77% Cash, 07/19/2029

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Inspect Point Holdings, LLC - Fire Inspection Business Software - Delayed Draw Term Loan (1M USD TERM SOFR+5.50%), 9.77% Cash, 07/19/2029

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Inspect Point Holdings, LLC - Fire Inspection Business Software - Delayed Draw Term Loan (1M USD TERM SOFR+5.50%), 9.77% Cash, 07/19/2029

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Fire Inspection Business Software

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Stretch Zone Franchising, LLC - Health/Fitness Franchisor - First Lien Term Loan - (3M USD TERM SOFR+7.00%), 11.17% Cash, 3/31/2028

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Stretch Zone Franchising, LLC - Health/Fitness Franchisor - First Lien Term Loan - (3M USD TERM SOFR+7.00%), 11.17% Cash, 3/31/2028

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Stretch Zone Franchising, LLC - Health/Fitness Franchisor - First Lien Term Loan - (3M USD TERM SOFR+7.00%), 11.17% Cash, 3/31/2028 - One

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Stretch Zone Franchising, LLC - Health/Fitness Franchisor - First Lien Term Loan - (3M USD TERM SOFR+7.00%), 11.17% Cash, 3/31/2028 - One

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Stretch Zone Franchising, LLC - Health/Fitness Franchisor - Class A Units

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Stretch Zone Franchising, LLC - Health/Fitness Franchisor - Class A Units

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Health/Fitness Franchisor

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Alpha Aesthetics Partners OpCo, LLC - Healthcare Services - First Lien Term Loan (1M USD TERM SOFR+9.88%), 14.15% Cash, 3/20/2028

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Alpha Aesthetics Partners OpCo, LLC - Healthcare Services - First Lien Term Loan (1M USD TERM SOFR+9.88%), 14.15% Cash, 3/20/2028

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Alpha Aesthetics Partners OpCo, LLC - Healthcare Services - Delayed Draw Term Loan (1M USD TERM SOFR+9.88%), 14.15% Cash, 3/20/2028

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Alpha Aesthetics Partners OpCo, LLC - Healthcare Services - Delayed Draw Term Loan (1M USD TERM SOFR+9.88%), 14.15% Cash, 3/20/2028

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Alpha Aesthetics Partners OpCo, LLC - Healthcare Services - Class A Preferred Units

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Alpha Aesthetics Partners OpCo, LLC - Healthcare Services - Class A Preferred Units

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Axiom Medical Consulting, LLC - Healthcare Services - First Lien Term Loan (3M USD TERM SOFR+6.00%), 10.17% Cash, 9/11/2028

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Axiom Medical Consulting, LLC - Healthcare Services - First Lien Term Loan (3M USD TERM SOFR+6.00%), 10.17% Cash, 9/11/2028

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Axiom Medical Consulting, LLC - Healthcare Services - Delayed Draw Term Loan - (3M USD TERM SOFR+6.00%), 10.17% Cash, 9/11/2028

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Axiom Medical Consulting, LLC - Healthcare Services - Delayed Draw Term Loan - (3M USD TERM SOFR+6.00%), 10.17% Cash, 9/11/2028

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Axiom Parent Holdings, LLC - Healthcare Services - Class A Preferred Units

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Axiom Parent Holdings, LLC - Healthcare Services - Class A Preferred Units

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - ComForCare Health Care - Healthcare Services - First Lien Term Loan (3M USD TERM SOFR+6.25%), 10.42% Cash, 12/31/2028

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - ComForCare Health Care - Healthcare Services - First Lien Term Loan (3M USD TERM SOFR+6.25%), 10.42% Cash, 12/31/2028

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Healthcare Services

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Procurement Partners, LLC - Healthcare Software - First Lien Term Loan (3M USD TERM SOFR+6.50%), 10.67% Cash, 5/12/2026

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Procurement Partners, LLC - Healthcare Software - First Lien Term Loan (3M USD TERM SOFR+6.50%), 10.67% Cash, 5/12/2026

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Procurement Partners, LLC - Healthcare Software - First Lien Term Loan (3M USD TERM SOFR+6.50%), 10.67% Cash, 5/12/2026 - One

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Procurement Partners, LLC - Healthcare Software - First Lien Term Loan (3M USD TERM SOFR+6.50%), 10.67% Cash, 5/12/2026 - One

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Procurement Partners Holdings LLC - Healthcare Software - Class A Units

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Procurement Partners Holdings LLC - Healthcare Software - Class A Units

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Procurement Partners Holdings LLC - Healthcare Software - Class AA Units

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Procurement Partners Holdings LLC - Healthcare Software - Class AA Units

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Healthcare Software

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Roscoe Medical, Inc. - Healthcare Supply - Common Stock

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Roscoe Medical, Inc. - Healthcare Supply - Common Stock

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Healthcare Supply

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Granite Comfort, LP - HVAC Services and Sales - First Lien Term Loan (3M USD TERM SOFR+7.40%), 11.57% Cash, 5/16/2027

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Granite Comfort, LP - HVAC Services and Sales - First Lien Term Loan (3M USD TERM SOFR+7.40%), 11.57% Cash, 5/16/2027

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Granite Comfort, LP - HVAC Services and Sales - Delayed Draw Term Loan (3M USD TERM SOFR+7.40%), 11.57% Cash, 5/16/2027

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Granite Comfort, LP - HVAC Services and Sales - Delayed Draw Term Loan (3M USD TERM SOFR+7.40%), 11.57% Cash, 5/16/2027

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - HVAC Services and Sales

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Vector Controls Holding Co., LLC - Industrial Products - Warrants to Purchase Limited Liability Company Interests, Expires 11/30/2027

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Vector Controls Holding Co., LLC - Industrial Products - Warrants to Purchase Limited Liability Company Interests, Expires 11/30/2027

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Industrial Products

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - AgencyBloc, LLC - Insurance Software - First Lien Term Loan (1M USD TERM SOFR+7.76%), 12.03% Cash, 10/1/2026

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - AgencyBloc, LLC - Insurance Software - First Lien Term Loan (1M USD TERM SOFR+7.76%), 12.03% Cash, 10/1/2026

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Panther ParentCo LLC - Insurance Software - Class A Units

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Panther ParentCo LLC - Insurance Software - Class A Units

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Insurance Software

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Avantra - IT Services - First Lien Term Loan (3M USD TERM SOFR+7.97%), 12.14% Cash, 9/20/2029

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Avantra - IT Services - First Lien Term Loan (3M USD TERM SOFR+7.97%), 12.14% Cash, 9/20/2029

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Maple Holdings Midco Limited - IT Services - Class A Common Units

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Maple Holdings Midco Limited - IT Services - Class A Common Units

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - IT Services

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - ActiveProspect, Inc. - Lead Management Software - First Lien Term Loan (3M USD TERM SOFR+6.00%), 10.37% Cash, 8/8/2027

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - ActiveProspect, Inc. - Lead Management Software - First Lien Term Loan (3M USD TERM SOFR+6.00%), 10.37% Cash, 8/8/2027

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - ActiveProspect, Inc. - Lead Management Software - Delayed Draw Term Loan (3M USD TERM SOFR+6.00%), 10.37% Cash, 8/8/2027

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - ActiveProspect, Inc. - Lead Management Software - Delayed Draw Term Loan (3M USD TERM SOFR+6.00%), 10.37% Cash, 8/8/2027

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Lead Management Software

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Madison Logic, Inc. - Marketing Orchestration Software - First Lien Term Loan (1M USD TERM SOFR+7.00%), 11.37% Cash, 12/30/2028

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Madison Logic, Inc. - Marketing Orchestration Software - First Lien Term Loan (1M USD TERM SOFR+7.00%), 11.37% Cash, 12/30/2028

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Marketing Orchestration Software

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - ARC Health OpCo LLC - Mental Healthcare Services - First Lien Term Loan (3M USD TERM SOFR+8.33%), 12.52% Cash, 8/5/2027

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - ARC Health OpCo LLC - Mental Healthcare Services - First Lien Term Loan (3M USD TERM SOFR+8.33%), 12.52% Cash, 8/5/2027

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - ARC Health OpCo LLC - Mental Healthcare Services - Delayed Draw Term Loan (3M USD TERM SOFR+8.33%), 12.52% Cash, 8/5/2027

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - ARC Health OpCo LLC - Mental Healthcare Services - Delayed Draw Term Loan (3M USD TERM SOFR+8.33%), 12.52% Cash, 8/5/2027

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - ARC Health OpCo LLC - Mental Healthcare Services - Class A Preferred Units

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - ARC Health OpCo LLC - Mental Healthcare Services - Class A Preferred Units

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Mental Healthcare Services

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Chronus LLC - Mentoring Software - First Lien Term Loan (3M USD TERM SOFR+5.25%), 9.57% Cash, 8/26/2026

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Chronus LLC - Mentoring Software - First Lien Term Loan (3M USD TERM SOFR+5.25%), 9.57% Cash, 8/26/2026

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Chronus LLC - Mentoring Software - First Lien Term Loan (3M USD TERM SOFR+5.25%), 9.57% Cash, 8/26/2026 - One

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Chronus LLC - Mentoring Software - First Lien Term Loan (3M USD TERM SOFR+5.25%), 9.57% Cash, 8/26/2026 - One

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Chronus LLC - Mentoring Software - Series A Preferred Stock

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Chronus LLC - Mentoring Software - Series A Preferred Stock

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Mentoring Software

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Cloudpermit - Municipal Government Software - First Lien Term Loan (3M USD TERM SOFR+5.75%), 9.92% Cash, 9/5/2029

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Cloudpermit - Municipal Government Software - First Lien Term Loan (3M USD TERM SOFR+5.75%), 9.92% Cash, 9/5/2029

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Cloudpermit - Municipal Government Software - Delayed Draw Term Loan (3M USD TERM SOFR+5.75%), 9.92% Cash, 9/5/2029

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Cloudpermit - Municipal Government Software - Delayed Draw Term Loan (3M USD TERM SOFR+5.75%), 9.92% Cash, 9/5/2029

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Cloudpermit - Municipal Government Software - Limited Partner Interests

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Cloudpermit - Municipal Government Software - Limited Partner Interests

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Municipal Government Software

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Emily Street Enterprises, L.L.C. - Office Supplies - Senior Secured Note (3M USD TERM SOFR+6.75%), 11.00% Cash, 12/31/2028

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Emily Street Enterprises, L.L.C. - Office Supplies - Senior Secured Note (3M USD TERM SOFR+6.75%), 11.00% Cash, 12/31/2028

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Office Supplies

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Buildout, Inc. - Real Estate Services - First Lien Term Loan (3M USD TERM SOFR+7.00%), 11.27% Cash, 9/30/2025

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Buildout, Inc. - Real Estate Services - First Lien Term Loan (3M USD TERM SOFR+7.00%), 11.27% Cash, 9/30/2025

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Buildout, Inc. - Real Estate Services - Delayed Draw Term Loan (3M USD TERM SOFR+7.00%), 11.27% Cash, 9/30/2025

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Buildout, Inc. - Real Estate Services - Delayed Draw Term Loan (3M USD TERM SOFR+7.00%), 11.27% Cash, 9/30/2025

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Buildout, Inc. - Real Estate Services - Limited Partner Interests

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Buildout, Inc. - Real Estate Services - Limited Partner Interests

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Real Estate Services

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Wellspring Worldwide Inc. - Research Software - First Lien Term Loan (3M USD TERM SOFR+8.42%), 12.59% Cash, 2/28/2029

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Wellspring Worldwide Inc. - Research Software - First Lien Term Loan (3M USD TERM SOFR+8.42%), 12.59% Cash, 2/28/2029

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Wellspring Worldwide Inc. - Research Software - Delayed DrawTerm Loan (3M USD TERM SOFR+8.42%), 12.59% Cash, 2/28/2029

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Wellspring Worldwide Inc. - Research Software - Delayed DrawTerm Loan (3M USD TERM SOFR+8.42%), 12.59% Cash, 2/28/2029

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Archimedes Parent LLC - Research Software - Class A Common Units

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Archimedes Parent LLC - Research Software - Class A Common Units

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Research Software

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - LFR Chicken LLC - Restaurant - First Lien Term Loan (1M USD TERM SOFR+7.00%), 11.27% Cash, 11/19/2026

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - LFR Chicken LLC - Restaurant - First Lien Term Loan (1M USD TERM SOFR+7.00%), 11.27% Cash, 11/19/2026

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - LFR Chicken LLC - Restaurant - Delayed Draw Term Loan (1M USD TERM SOFR+7.00%), 11.27% Cash, 11/19/2026

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - LFR Chicken LLC - Restaurant - Delayed Draw Term Loan (1M USD TERM SOFR+7.00%), 11.27% Cash, 11/19/2026

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - LFR Chicken LLC - Restaurant - Series B Preferred Units

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - LFR Chicken LLC - Restaurant - Series B Preferred Units

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Restaurant

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Avionte Holdings, LLC - Staffing Services - Class A Units

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Avionte Holdings, LLC - Staffing Services - Class A Units

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Staffing Services

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - AIMCO 2025-24A E - Structured Finance Securities - First Lien Term Loan (3M USD TERM SOFR+5.15%), 9.32% Cash, 7/26/2038

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - AIMCO 2025-24A E - Structured Finance Securities - First Lien Term Loan (3M USD TERM SOFR+5.15%), 9.32% Cash, 7/26/2038

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - APID 2023-45A ER - Structured Finance Securities - First Lien Term Loan (3M USD TERM SOFR+5.15%), 9.32% Cash, 7/26/2038

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - APID 2023-45A ER - Structured Finance Securities - First Lien Term Loan (3M USD TERM SOFR+5.15%), 9.32% Cash, 7/26/2038

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - APID 2023-45A ER - Structured Finance Securities -

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - APID 2023-45A ER - Structured Finance Securities - First Lien Term Loan (3M USD TERM SOFR+5.00%), 9.17% Cash, 10/20/2038

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - APID 2023-45A ER - Structured Finance Securities - First Lien Term Loan (3M USD TERM SOFR+5.00%), 9.17% Cash, 10/20/2038

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - BGCLO 2025-13A D2 - Structured Finance Securities - First Lien Term Loan (3M USD TERM SOFR+4.05%), 8.22% Cash, 10/23/2038

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - BGCLO 2025-13A D2 - Structured Finance Securities - First Lien Term Loan (3M USD TERM SOFR+4.05%), 8.22% Cash, 10/23/2038

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - BSP 2025-40A E - Structured Finance Securities - First Lien Term Loan (3M USD TERM SOFR+5.25%), 9.42% Cash, 7/25/2038

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - BSP 2025-40A E - Structured Finance Securities - First Lien Term Loan (3M USD TERM SOFR+5.25%), 9.42% Cash, 7/25/2038

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - BSP 2016-10A C2R3 - Structured Finance Securities - First Lien Term Loan (3M USD TERM SOFR+4.10%), 8.27% Cash, 7/20/2038

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - BSP 2016-10A C2R3 - Structured Finance Securities - First Lien Term Loan (3M USD TERM SOFR+4.10%), 8.27% Cash, 7/20/2038

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - HLM 2025-26A D2 - Structured Finance Securities - First Lien Term Loan (3M USD TERM SOFR+4.10%), 8.27% Cash, 7/20/2038

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - HLM 2025-26A D2 - Structured Finance Securities - First Lien Term Loan (3M USD TERM SOFR+4.10%), 8.27% Cash, 7/20/2038

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - NMC CLO-4A ER - Structured Finance Securities - First Lien Term Loan (3M USD TERM SOFR+6.91%), 11.08% Cash, 3/20/2038

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - NMC CLO-4A ER - Structured Finance Securities - First Lien Term Loan (3M USD TERM SOFR+6.91%), 11.08% Cash, 3/20/2038

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - NMC CLO-7A E - Structured Finance Securities - First Lien Term Loan (3M USD TERM SOFR+5.00%), 9.17% Cash, 3/31/2038

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - NMC CLO-7A E - Structured Finance Securities - First Lien Term Loan (3M USD TERM SOFR+5.00%), 9.17% Cash, 3/31/2038

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - NMC CLO-5A ER - Structured Finance Securities - First Lien Term Loan - (3M USD TERM SOFR+5.85%), 10.02% Cash, 7/20/2036

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - NMC CLO-5A ER - Structured Finance Securities - First Lien Term Loan - (3M USD TERM SOFR+5.85%), 10.02% Cash, 7/20/2036

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% NMC - CLO-3A D2R - Structured Finance Securities - First Lien Term Loan (3M USD TERM SOFR+4.10%), 8.27% Cash, 10/20/2034

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% NMC - CLO-3A D2R - Structured Finance Securities - First Lien Term Loan (3M USD TERM SOFR+4.10%), 8.27% Cash, 10/20/2034

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - OAKC 2016-13A ER2 - Structured Finance Securities - First Lien Term Loan (3M USD TERM SOFR+5.75%), 9.92% Cash, 10/21/2037

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - OAKC 2016-13A ER2 - Structured Finance Securities - First Lien Term Loan (3M USD TERM SOFR+5.75%), 9.92% Cash, 10/21/2037

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - OAKC 2025-22A E - Structured Finance Securities - First Lien Term Loan (3M USD TERM SOFR+5.55%), 9.72% Cash, 7/20/2038

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - OAKC 2025-22A E - Structured Finance Securities - First Lien Term Loan (3M USD TERM SOFR+5.55%), 9.72% Cash, 7/20/2038

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - OAKC 2020-7A D2R2 - Structured Finance Securities - First Lien Term Loan (3M USD TERM SOFR+4.05%), 8.22% Cash, 7/19/2038

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - OAKC 2020-7A D2R2 - Structured Finance Securities - First Lien Term Loan (3M USD TERM SOFR+4.05%), 8.22% Cash, 7/19/2038

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - OCP 2025-43A E - Structured Finance Securities - First Lien Term Loan (3M USD TERM SOFR+6.50%), 10.67% Cash, 7/20/2038

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - OCP 2025-43A E - Structured Finance Securities - First Lien Term Loan (3M USD TERM SOFR+6.50%), 10.67% Cash, 7/20/2038

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - OCP 2023-28A - Structured Finance Securities - First Lien Term Loan (3M USD TERM SOFR+5.25%), 9.42% Cash, 7/16/2038

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - OCP 2023-28A - Structured Finance Securities - First Lien Term Loan (3M USD TERM SOFR+5.25%), 9.42% Cash, 7/16/2038

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - OCP 2016-11A D2R3 - Structured Finance Securities - First Lien Term Loan (3M USD TERM SOFR+4.10%), 8.27% Cash, 7/26/2038

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - OCP 2016-11A D2R3 - Structured Finance Securities - First Lien Term Loan (3M USD TERM SOFR+4.10%), 8.27% Cash, 7/26/2038

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - TREST 2017-1A ERR - Structured Finance Securities - First Lien Term Loan (3M USD TERM SOFR+5.95%), 10.12% Cash, 7/25/2037

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - TREST 2017-1A ERR - Structured Finance Securities - First Lien Term Loan (3M USD TERM SOFR+5.95%), 10.12% Cash, 7/25/2037

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - WBOX 2023-4A ER - Structured Finance Securities - First Lien Term Loan (3M USD TERM SOFR+6.48%), 10.65% Cash, 4/20/2036

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - WBOX 2023-4A ER - Structured Finance Securities - First Lien Term Loan (3M USD TERM SOFR+6.48%), 10.65% Cash, 4/20/2036

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - WBOX 2025-5A D2 - Structured Finance Securities - First Lien Term Loan (3M USD TERM SOFR+4.10%), 8.27% Cash, 7/20/2038

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - WBOX 2025-5A D2 - Structured Finance Securities - First Lien Term Loan (3M USD TERM SOFR+4.10%), 8.27% Cash, 7/20/2038

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Structured Finance Securities

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - StockIQ Technologies, LLC - Supply Chain Planning Software - First Lien Term Loan (3M USD TERM SOFR+5.25%), 9.42% Cash, 3/26/2030

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - StockIQ Technologies, LLC - Supply Chain Planning Software - First Lien Term Loan (3M USD TERM SOFR+5.25%), 9.42% Cash, 3/26/2030

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - StockIQ Technologies, LLC - Supply Chain Planning Software - Delayed Draw Term Loan (3M USD TERM SOFR+5.25%), 9.42% Cash, 3/26/2030

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - StockIQ Technologies, LLC - Supply Chain Planning Software - Delayed Draw Term Loan (3M USD TERM SOFR+5.25%), 9.42% Cash, 3/26/2030

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - StockIQ Technologies, LLC - Supply Chain Planning Software - Class A Units

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - StockIQ Technologies, LLC - Supply Chain Planning Software - Class A Units

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% -Supply Chain Planning Software

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - JDXpert - Talent Acquisition Software - First Lien Term Loan (3M USD TERM SOFR+8.50%), 12.93% Cash, 5/2/2027

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - JDXpert - Talent Acquisition Software - First Lien Term Loan (3M USD TERM SOFR+8.50%), 12.93% Cash, 5/2/2027

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - JDXpert - Talent Acquisition Software - Delayed Draw Term Loan (3M USD TERM SOFR+8.50%), 12.93% Cash, 5/2/2027

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - JDXpert - Talent Acquisition Software - Delayed Draw Term Loan (3M USD TERM SOFR+8.50%), 12.93% Cash, 5/2/2027

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - JDXpert - Talent Acquisition Software - Delayed Draw Term Loan (3M USD TERM SOFR+8.50%), 12.93% Cash, 5/2/2027 - One

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - JDXpert - Talent Acquisition Software - Delayed Draw Term Loan (3M USD TERM SOFR+8.50%), 12.93% Cash, 5/2/2027 - One

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Jobvite, Inc. - Talent Acquisition Software - First Lien Term Loan (3M USD TERM SOFR+7.50%), 11.67% Cash, 8/5/2028

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Jobvite, Inc. - Talent Acquisition Software - First Lien Term Loan (3M USD TERM SOFR+7.50%), 11.67% Cash, 8/5/2028

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Talent Acquisition Software

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - VetnCare MSO, LLC - Veterinary Services - Delayed Draw Term Loan (3M USD TERM SOFR+5.75%), 9.92% Cash, 5/12/2023

2025-03-01 2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - VetnCare MSO, LLC - Veterinary Services - Delayed Draw Term Loan (3M USD TERM SOFR+5.75%), 9.92% Cash, 5/12/2023

2025-08-31 0001377936

Non-control/Non-affiliate investments - 219.0% - Veterinary Services

2025-08-31 0001377936

Sub Total Non-control/Non-affiliate investments

2025-08-31 0001377936

Affiliate investments - 12.9% - ETU Holdings, Inc. - Corporate Education Software - First Lien Term Loan (3M USD TERM SOFR+9.00%), 13.32% Cash, 2/18/2028

2025-03-01 2025-08-31 0001377936

Affiliate investments - 12.9% - ETU Holdings, Inc. - Corporate Education Software - First Lien Term Loan (3M USD TERM SOFR+9.00%), 13.32% Cash, 2/18/2028

2025-08-31 0001377936

Affiliate investments - 12.9% - ETU Holdings, Inc. - Corporate Education Software - Second Lien Term Loan 15.00% PIK, 2/18/2028

2025-03-01 2025-08-31 0001377936

Affiliate investments - 12.9% - ETU Holdings, Inc. - Corporate Education Software - Second Lien Term Loan 15.00% PIK, 2/18/2028

2025-08-31 0001377936

Affiliate investments - 12.9% - ETU Holdings, Inc. - Corporate Education Software - Series A Preferred Units

2025-03-01 2025-08-31 0001377936

Affiliate investments - 12.9% - ETU Holdings, Inc. - Corporate Education Software - Series A Preferred Units

2025-08-31 0001377936

Affiliate investments - 12.9% - Corporate Education Software

2025-08-31 0001377936

Affiliate investments - 12.9% - Axero Holdings, LLC - Employee Collaboration Software - First Lien Term Loan (3M USD TERM SOFR+2.50%), 4.50% Cash, 12/31/2021

2025-03-01 2025-08-31 0001377936

Affiliate investments - 12.9% - Axero Holdings, LLC - Employee Collaboration Software - First Lien Term Loan (3M USD TERM SOFR+2.50%), 4.50% Cash, 12/31/2021

2025-08-31 0001377936

Affiliate investments - 12.9% - Axero Holdings, LLC - Employee Collaboration Software - Delayed Draw Term Loan (3M USD TERM SOFR+2.50%), 4.50% Cash, 12/31/2027

2025-03-01 2025-08-31 0001377936

Affiliate investments - 12.9% - Axero Holdings, LLC - Employee Collaboration Software - Delayed Draw Term Loan (3M USD TERM SOFR+2.50%), 4.50% Cash, 12/31/2027

2025-08-31 0001377936

Affiliate investments - 12.9% - Axero Holdings, LLC - Employee Collaboration Software - Revolving Credit Facility 4.50% Cash, (3M USD TERM SOFR + 2.50%) PIK, 12/31/2027

2025-03-01 2025-08-31 0001377936

Affiliate investments - 12.9% - Axero Holdings, LLC - Employee Collaboration Software - Revolving Credit Facility 4.50% Cash, (3M USD TERM SOFR + 2.50%) PIK, 12/31/2027

2025-08-31 0001377936

Affiliate investments - 12.9% - Axero Holdings, LLC - Employee Collaboration Software - Series A Preferred Units

2025-03-01 2025-08-31 0001377936

Affiliate investments - 12.9% - Axero Holdings, LLC - Employee Collaboration Software - Series A Preferred Units

2025-08-31 0001377936

Affiliate investments - 12.9% - Axero Holdings, LLC - Employee Collaboration Software - Series B Preferred Units

2025-03-01 2025-08-31 0001377936

Affiliate investments - 12.9% - Axero Holdings, LLC - Employee Collaboration Software - Series B Preferred Units

2025-08-31 0001377936

Affiliate investments - 12.9% - Employee Collaboration Software

2025-08-31 0001377936

Affiliate investments - 12.9% - SmartAC.com, LLC - HVAC Monitoring Devices - First Lien Term Loan (3M USD TERM SOFR+7.50%), 11.67% Cash, 4/7/2030

2025-03-01 2025-08-31 0001377936

Affiliate investments - 12.9% - SmartAC.com, LLC - HVAC Monitoring Devices - First Lien Term Loan (3M USD TERM SOFR+7.50%), 11.67% Cash, 4/7/2030

2025-08-31 0001377936

Affiliate investments - 12.9% - SmartAC.com, LLC - HVAC Monitoring Devices - Delayed Draw Term Loan (3M USD TERM SOFR+7.50%), 11.67% Cash, 4/7/2030

2025-03-01 2025-08-31 0001377936

Affiliate investments - 12.9% - SmartAC.com, LLC - HVAC Monitoring Devices - Delayed Draw Term Loan (3M USD TERM SOFR+7.50%), 11.67% Cash, 4/7/2030

2025-08-31 0001377936

Affiliate investments - 12.9% - SmartAC.com, LLC - HVAC Monitoring Devices - Series A Preferred Units

2025-03-01 2025-08-31 0001377936

Affiliate investments - 12.9% - SmartAC.com, LLC - HVAC Monitoring Devices - Series A Preferred Units

2025-08-31 0001377936

Total HVAC Monitoring Devices

2025-08-31 0001377936

Sub Total Affiliate investments

2025-08-31 0001377936

Control investments - 10.6% - Education Services - First Lien Term Loan 4.84% PIK, 8/9/2027

2025-03-01 2025-08-31 0001377936

Control investments - 10.6% - Education Services - First Lien Term Loan 4.84% PIK, 8/9/2027

2025-08-31 0001377936

Control investments - 10.6% - Education Services - Common Stock

2025-03-01 2025-08-31 0001377936

Control investments - 10.6% - Education Services - Common Stock

2025-08-31 0001377936

Control investments - 10.6% - Education Services

2025-08-31 0001377936

Control investments - 10.6% - Pepper Palace, Inc - Specialty Food Retailer - First Lien Term Loan 4.42% PIK, 12/31/2028

2025-03-01 2025-08-31 0001377936

Control investments - 10.6% - Pepper Palace, Inc - Specialty Food Retailer - First Lien Term Loan 4.42% PIK, 12/31/2028

2025-08-31 0001377936

Control investments - 10.6% - Pepper Palace, Inc - Specialty Food Retailer - Delayed Draw Term Loan 4.42% PIK, 12/31/2028

2025-03-01 2025-08-31 0001377936

Control investments - 10.6% - Pepper Palace, Inc - Specialty Food Retailer - Delayed Draw Term Loan 4.42% PIK, 12/31/2028

2025-08-31 0001377936

Control investments - 10.6% - Pepper Palace, Inc - Specialty Food Retailer - Revolving Credit Facility - Revolving Credit Facility 4.42% PIK, 12/31/2028

2025-03-01 2025-08-31 0001377936

Control investments - 10.6% - Pepper Palace, Inc - Specialty Food Retailer - Revolving Credit Facility - Revolving Credit Facility 4.42% PIK, 12/31/2028

2025-08-31 0001377936

Control investments - 10.6% - Pepper Palace, Inc. - Specialty Food Retailer -Class A Units

2025-03-01 2025-08-31 0001377936

Control investments - 10.6% - Pepper Palace, Inc. - Specialty Food Retailer -Class A Units

2025-08-31 0001377936

Control investments - 10.6% - Specialty Food Retailer

2025-08-31 0001377936

Control investments - 10.6% - Saratoga Investment Corp. CLO 2013-1, Ltd. - Structured Finance Securities - Other/Structured Finance Securities 0.00%, 4/20/2033

2025-03-01 2025-08-31 0001377936

Control investments - 10.6% - Saratoga Investment Corp. CLO 2013-1, Ltd. - Structured Finance Securities - Other/Structured Finance Securities 0.00%, 4/20/2033

2025-08-31 0001377936

Control investments - 10.6% - Saratoga Investment Corp. CLO 2013-1, Ltd. - Structured Finance Securities - Other/Structured Finance Securities (3M USD TERM SOFR+10.00%), 14.43%, 4/20/2033

2025-03-01 2025-08-31 0001377936

Control investments - 10.6% - Saratoga Investment Corp. CLO 2013-1, Ltd. - Structured Finance Securities - Other/Structured Finance Securities (3M USD TERM SOFR+10.00%), 14.43%, 4/20/2033

2025-08-31 0001377936

Control investments - 10.6% - Saratoga Investment Corp. Senior Loan Fund 2022-1, Ltd. - Structured Finance Securities - Other/Structured Finance Securities (3M USD TERM SOFR+8.55%), 12.72%, 10/20/2033

2025-03-01 2025-08-31 0001377936

2025-08-31 0001377936

Control investments - 10.2% - Saratoga Investment Corp. Senior Loan Fund 2022-1, Ltd. - Structured Finance Securities - Other/Structured Finance Securities (3M USD TERM SOFR+8.55%), 12.87%, 10/20/2033

2025-08-31 0001377936

Control investments - 10.6% - Structured Finance Securities

2025-08-31 0001377936

Control investments - 10.6% - Saratoga Senior Loan Fund I JV, LLC - Investment Fund - Unsecured Loan 10.00%, 10/20/2033

2025-03-01 2025-08-31 0001377936

Control investments - 10.6% - Saratoga Senior Loan Fund I JV, LLC - Investment Fund - Unsecured Loan 10.00%, 10/20/2033

2025-08-31 0001377936

Control investments - 10.6% - Saratoga Senior Loan Fund I JV, LLC - Investment Fund - Membership Interest

2025-03-01 2025-08-31 0001377936

Control investments - 10.6% - Saratoga Senior Loan Fund I JV, LLC - Investment Fund - Membership Interest

2025-08-31 0001377936

Control investments - 10.6% - Investment Fund

2025-08-31 0001377936

Sub Total Control investments

2025-08-31 0001377936

Non-control/Non-affiliate investments - 229.3% - Alternative Investment Management Software - First Lien Term Loan (3M USD TERM SOFR+8.50%), 12.82% Cash, 7/18/2027

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Alternative Investment Management Software - First Lien Term Loan (3M USD TERM SOFR+8.50%), 12.82% Cash, 7/18/2027

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Altvia MidCo, LLC. - Alternative Investment Management Software - Series A-1 Preferred Shares

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Altvia MidCo, LLC. - Alternative Investment Management Software - Series A-1 Preferred Shares

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Alternative Investment Management Software

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - BQE Software, Inc. - Architecture & Engineering Software - First Lien Term Loan (3M USD TERM SOFR+5.50%), 9.82% Cash, 4/13/2028

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - BQE Software, Inc. - Architecture & Engineering Software - First Lien Term Loan (3M USD TERM SOFR+5.50%), 9.82% Cash, 4/13/2028

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - BQE Software, Inc. - Architecture & Engineering Software - Delayed Draw Term Loan (3M USD TERM SOFR+5.50%), 9.82% Cash, 4/13/2028

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - BQE Software, Inc. - Architecture & Engineering Software - Delayed Draw Term Loan (3M USD TERM SOFR+5.50%), 9.82% Cash, 4/13/2028

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Architecture & Engineering Software

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - GrowthZone, LLC - Association Management Software- First Lien Term Loan (3M USD TERM SOFR+8.25%), 12.57% Cash, 5/10/2028

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - GrowthZone, LLC - Association Management Software- First Lien Term Loan (3M USD TERM SOFR+8.25%), 12.57% Cash, 5/10/2028

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Golden TopCo LP - Association Management Software - Class A-2 Common Units

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Golden TopCo LP - Association Management Software - Class A-2 Common Units

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Association Management Software

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Artemis Wax Corp. - Consumer Services - Delayed Draw Term Loan (1M USD TERM SOFR+7.50%), 11.82% Cash, 5/20/2026

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Artemis Wax Corp. - Consumer Services - Delayed Draw Term Loan (1M USD TERM SOFR+7.50%), 11.82% Cash, 5/20/2026

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Artemis Wax Corp. - Consumer Services - Series B-1 Preferred Stock

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Artemis Wax Corp. - Consumer Services - Series B-1 Preferred Stock

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Artemis Wax Corp. - Consumer Services - Series D Preferred Stock

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Artemis Wax Corp. - Consumer Services - Series D Preferred Stock

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Consumer Services

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Schoox, Inc - Corporate Education Software - Series 1 Membership Interest

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Schoox, Inc - Corporate Education Software - Series 1 Membership Interest

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Corporate Education Software - Corporate Education Software

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Innergy, Inc.- Custom Millwork Software - First Lien Term Loan (3M USD TERM SOFR+5.50%), 9.82% Cash, 1/31/2030

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Innergy, Inc.- Custom Millwork Software - First Lien Term Loan (3M USD TERM SOFR+5.50%), 9.82% Cash, 1/31/2030

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Innergy, Inc.- Custom Millwork Software - Delayed Draw Term Loan (3M USD TERM SOFR+5.50%), 9.82% Cash, 1/31/2030

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Innergy, Inc.- Custom Millwork Software - Delayed Draw Term Loan (3M USD TERM SOFR+5.50%), 9.82% Cash, 1/31/2030

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Custom Millwork Software

2025-02-28 0001377936

Non-control/Non-affiliate investments - 276.5% - GreyHeller LLC - Cyber Security - Common Stock

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 276.5% - GreyHeller LLC - Cyber Security - Common Stock

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Cyber Security

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Gen4 Dental Partners Holdings, LLC - Dental Practice Management - First Lien Term Loan (1M USD TERM SOFR+5.75%), 10.07% Cash, 5/13/2030

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Gen4 Dental Partners Holdings, LLC - Dental Practice Management - First Lien Term Loan (1M USD TERM SOFR+5.75%), 10.07% Cash, 5/13/2030

2025-02-28 0001377936

Non-control/Non-affiliate investments - 220.9% - Gen4 Dental Partners Holdings, LLC - Dental Practice Management - Delayed Draw Term Loan - (1M USD TERM SOFR+5.75%), 10.07% Cash, 5/13/2030

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 220.9% - Gen4 Dental Partners Holdings, LLC - Dental Practice Management - Delayed Draw Term Loan - (1M USD TERM SOFR+5.75%), 10.07% Cash, 5/13/2030

2025-02-28 0001377936

Non-control/Non-affiliate investments - 220.9% - Gen4 Dental Partners Holdings, LLC - Dental Practice Management - Revolving Credit Facility - (1M USD TERM SOFR+5.75%), 10.07% Cash, 5/13/2030

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 220.9% - Gen4 Dental Partners Holdings, LLC - Dental Practice Management - Revolving Credit Facility - (1M USD TERM SOFR+5.75%), 10.07% Cash, 5/13/2030

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Gen4 Dental Partners Holdings, LLC - Dental Practice Management - Series A Preferred Units

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Gen4 Dental Partners Holdings, LLC - Dental Practice Management - Series A Preferred Units

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Modis Dental Partners OpCo, LLC - Dental Practice Management - First Lien Term Loan (1M USD TERM SOFR+9.41%), 13.74% Cash, 4/18/2028

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Modis Dental Partners OpCo, LLC - Dental Practice Management - First Lien Term Loan (1M USD TERM SOFR+9.41%), 13.74% Cash, 4/18/2028

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Modis Dental Partners OpCo, LLC - Dental Practice Management - Delayed Draw Term Loan (1M USD TERM SOFR+9.41%), 13.74% Cash, 4/18/2028

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Modis Dental Partners OpCo, LLC - Dental Practice Management - Delayed Draw Term Loan (1M USD TERM SOFR+9.41%), 13.74% Cash, 4/18/2028

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Modis Dental Partners OpCo, LLC - Dental Practice Management - Class A Preferred Units

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Modis Dental Partners OpCo, LLC - Dental Practice Management - Class A Preferred Units

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - New England Dental Partners - Dental Practice Management - First Lien Term Loan (3M USD TERM SOFR+8.00%), 12.47% Cash, 11/25/2025

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - New England Dental Partners - Dental Practice Management - First Lien Term Loan (3M USD TERM SOFR+8.00%), 12.47% Cash, 11/25/2025

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Dental Practice Management - Delayed Draw Term Loan (3M USD TERM SOFR+8.00%), 12.47% Cash, 11/25/2025

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Dental Practice Management - Delayed Draw Term Loan (3M USD TERM SOFR+8.00%), 12.47% Cash, 11/25/2025

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Dental Practice Management

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Direct Selling Software - First Lien Term Loan (1M USD TERM SOFR+6.25%), 10.67% Cash, 3/16/2027

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Direct Selling Software - First Lien Term Loan (1M USD TERM SOFR+6.25%), 10.67% Cash, 3/16/2027

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Direct Selling Software - Revolving Credit Facility (1M USD TERM SOFR+6.25%), 10.67% Cash, 3/16/2027

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Direct Selling Software - Revolving Credit Facility (1M USD TERM SOFR+6.25%), 10.67% Cash, 3/16/2027

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Direct Selling Software - Common Units

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Direct Selling Software - Common Units

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Direct Selling Software

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - C2 Educational Systems, Inc. - Education Services - First Lien Term Loan (3M USD TERM SOFR+8.50%), 12.82% Cash, 5/31/2025

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - C2 Educational Systems, Inc. - Education Services - First Lien Term Loan (3M USD TERM SOFR+8.50%), 12.82% Cash, 5/31/2025

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - C2 Educational Systems, Inc. - Education Services - Delayed Draw Term Loan (3M USD TERM SOFR+8.50%), 12.82% Cash, 5/31/2025

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - C2 Educational Systems, Inc. - Education Services - Delayed Draw Term Loan (3M USD TERM SOFR+8.50%), 12.82% Cash, 5/31/2025

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - C2 Education Systems, Inc. - Education Services - Series A-1 Preferred Stock

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - C2 Education Systems, Inc. - Education Services - Series A-1 Preferred Stock

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Education Services

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - GoReact - Education Software - First Lien Term Loan (3M USD TERM SOFR+7.50%), 12.02% Cash/1.00% PIK, 4/17/2025

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - GoReact - Education Software - First Lien Term Loan (3M USD TERM SOFR+7.50%), 12.02% Cash/1.00% PIK, 4/17/2025

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - GoReact - Education Software - Delayed Draw Term Loan (3M USD TERM SOFR+7.50%), 12.02% Cash/1.00% PIK, 4/17/2025

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - GoReact - Education Software - Delayed Draw Term Loan (3M USD TERM SOFR+7.50%), 12.02% Cash/1.00% PIK, 4/17/2025

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Identity Automation Systems - Education Software - Common Stock Class A-2 Units

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Identity Automation Systems - Education Software - Common Stock Class A-2 Units

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Identity Automation Systems - Education Software - Common Stock Class A-1 Units

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Identity Automation Systems - Education Software - Common Stock Class A-1 Units

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Ready Education - Education Software - First Lien Term Loan (3M USD TERM SOFR+7.00%), 11.32% Cash, 8/5/2027

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Ready Education - Education Software - First Lien Term Loan (3M USD TERM SOFR+7.00%), 11.32% Cash, 8/5/2027

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Education Software

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - TG Pressure Washing Holdings, LLC - Facilities Maintenance - Preferred Equity

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - TG Pressure Washing Holdings, LLC - Facilities Maintenance - Preferred Equity

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Facilities Maintenance

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Davisware, LLC - Field Service Management - First Lien Term Loan (3M USD TERM SOFR+6.50%), 10.82% Cash, 11/30/2025

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Davisware, LLC - Field Service Management - First Lien Term Loan (3M USD TERM SOFR+6.50%), 10.82% Cash, 11/30/2025

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Davisware, LLC - Field Service Management - Delayed Draw Term Loan (3M USD TERM SOFR+6.50%), 10.82% Cash, 11/30/2025

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Davisware, LLC - Field Service Management - Delayed Draw Term Loan (3M USD TERM SOFR+6.50%), 10.82% Cash, 11/30/2025

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Field Service Management

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - GDS Software Holdings, LLC - Financial Services - First Lien Term Loan (3M USD TERM SOFR+7.00%), 11.32% Cash, 12/30/2026

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - GDS Software Holdings, LLC - Financial Services - First Lien Term Loan (3M USD TERM SOFR+7.00%), 11.32% Cash, 12/30/2026

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - GDS Software Holdings, LLC - Financial Services - Delayed Draw Term Loan (3M USD TERM SOFR+7.00%), 11.32% Cash, 12/30/2026

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - GDS Software Holdings, LLC - Financial Services - Delayed Draw Term Loan (3M USD TERM SOFR+7.00%), 11.32% Cash, 12/30/2026

2025-02-28 0001377936

Non-control/Non-affiliate investments - 220.9% - GDS Software Holdings, LLC - Financial Services - Common Stock Class A Units

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 220.9% - GDS Software Holdings, LLC - Financial Services - Common Stock Class A Units

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Financial Services

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Ascend Software, LLC - Financial Services Software - First Lien Term Loan (3M USD TERM SOFR+7.50%), 12.08% Cash, 12/15/2026

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Ascend Software, LLC - Financial Services Software - First Lien Term Loan (3M USD TERM SOFR+7.50%), 12.08% Cash, 12/15/2026

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Ascend Software, LLC - Financial Services Software - Delayed Draw Term Loan (3M USD TERM SOFR+7.50%), 12.08% Cash, 12/15/2026

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Ascend Software, LLC - Financial Services Software - Delayed Draw Term Loan (3M USD TERM SOFR+7.50%), 12.08% Cash, 12/15/2026

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Financial Services Software

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Inspect Point Holdings, LLC - Fire Inspection Business Software - First Lien Term Loan (1M USD TERM SOFR+6.50%), 10.82% Cash, 07/19/2028

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Inspect Point Holdings, LLC - Fire Inspection Business Software - First Lien Term Loan (1M USD TERM SOFR+6.50%), 10.82% Cash, 07/19/2028

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Inspect Point Holdings, LLC - Fire Inspection Business Software - Delayed Draw Term Loan (1M USD TERM SOFR+6.50%), 10.82% Cash, 07/19/2028

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Inspect Point Holdings, LLC - Fire Inspection Business Software - Delayed Draw Term Loan (1M USD TERM SOFR+6.50%), 10.82% Cash, 07/19/2028

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Fire Inspection Business Software

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Stretch Zone Franchising, LLC - Health/Fitness Franchisor - First Lien Term Loan (3M USD TERM SOFR+7.00%), 11.32% Cash, 3/31/2028

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Stretch Zone Franchising, LLC - Health/Fitness Franchisor - First Lien Term Loan (3M USD TERM SOFR+7.00%), 11.32% Cash, 3/31/2028

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Stretch Zone Franchising, LLC - Health/Fitness Franchisor - Delayed Draw Term Loan (3M USD TERM SOFR+7.00%), 11.32% Cash, 3/31/2028

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Stretch Zone Franchising, LLC - Health/Fitness Franchisor - Delayed Draw Term Loan (3M USD TERM SOFR+7.00%), 11.32% Cash, 3/31/2028

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Stretch Zone Franchising, LLC - Health/Fitness Franchisor - Class A Units

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Stretch Zone Franchising, LLC - Health/Fitness Franchisor - Class A Units

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Health/Fitness Franchisor

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Alpha Aesthetics Partners OpCo, LLC - Healthcare Services - First Lien Term Loan (1M USD TERM SOFR+9.92%), 14.25% Cash, 3/20/2028

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Alpha Aesthetics Partners OpCo, LLC - Healthcare Services - First Lien Term Loan (1M USD TERM SOFR+9.92%), 14.25% Cash, 3/20/2028

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Alpha Aesthetics Partners OpCo, LLC - Healthcare Services - Delayed Draw Term Loan (1M USD TERM SOFR+9.92%), 14.25% Cash, 3/20/2028

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Alpha Aesthetics Partners OpCo, LLC - Healthcare Services - Delayed Draw Term Loan (1M USD TERM SOFR+9.92%), 14.25% Cash, 3/20/2028

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Alpha Aesthetics Partners OpCo, LLC - Healthcare Services -Class A Preferred Units

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Alpha Aesthetics Partners OpCo, LLC - Healthcare Services -Class A Preferred Units

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Axiom Medical Consulting, LLC - Healthcare Services - First Lien Term Loan (3M USD TERM SOFR+6.00%), 10.32% Cash, 9/11/2028

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Axiom Medical Consulting, LLC - Healthcare Services - First Lien Term Loan (3M USD TERM SOFR+6.00%), 10.32% Cash, 9/11/2028

2025-02-28 0001377936

Non-control/Non-affiliate investments - 220.9%- Axiom Medical Consulting, LLC - Healthcare Services - Delayed Draw Term Loan (3M USD TERM SOFR+6.00%), 11.33% Cash, 9/11/2028

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 220.9%- Axiom Medical Consulting, LLC - Healthcare Services - Delayed Draw Term Loan (3M USD TERM SOFR+6.00%), 11.33% Cash, 9/11/2028

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Axiom Parent Holdings, LLC - Healthcare Services - Class A Preferred Units

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Axiom Parent Holdings, LLC - Healthcare Services - Class A Preferred Units

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - ComForCare Health Care - Healthcare Services - First Lien Term Loan ((3M USD TERM SOFR+6.25%), 10.57% Cash, 12/31/2027

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - ComForCare Health Care - Healthcare Services - First Lien Term Loan ((3M USD TERM SOFR+6.25%), 10.57% Cash, 12/31/2027

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Healthcare Services

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Procurement Partners, LLC - Healthcare Software - First Lien Term Loan (3M USD TERM SOFR+6.50%), 10.82% Cash, 5/12/2026

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Procurement Partners, LLC - Healthcare Software - First Lien Term Loan (3M USD TERM SOFR+6.50%), 10.82% Cash, 5/12/2026

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Procurement Partners, LLC - Healthcare Software - Delayed Draw Term Loan (3M USD TERM SOFR+6.50%), 10.82% Cash, 5/12/2026

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Procurement Partners, LLC - Healthcare Software - Delayed Draw Term Loan (3M USD TERM SOFR+6.50%), 10.82% Cash, 5/12/2026

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Procurement Partners Holdings LLC - Healthcare Software - Class A Units

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Procurement Partners Holdings LLC - Healthcare Software - Class A Units

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Procurement Partners Holdings LLC - Healthcare Software - Class AA Units

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Procurement Partners Holdings LLC - Healthcare Software - Class AA Units

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Healthcare Software

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Roscoe Medical, Inc. - Healthcare Supply - Common Stock

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Roscoe Medical, Inc. - Healthcare Supply - Common Stock

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Healthcare Supply

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Granite Comfort, LP - HVAC Services and Sales - First Lien Term Loan (3M USD TERM SOFR+7.41%), 11.72% Cash, 5/16/2027

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Granite Comfort, LP - HVAC Services and Sales - First Lien Term Loan (3M USD TERM SOFR+7.41%), 11.72% Cash, 5/16/2027

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Granite Comfort, LP - HVAC Services and Sales - Delayed Draw Term Loan (3M USD TERM SOFR+7.41%), 11.72% Cash, 5/16/2027

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Granite Comfort, LP - HVAC Services and Sales - Delayed Draw Term Loan (3M USD TERM SOFR+7.41%), 11.72% Cash, 5/16/2027

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - HVAC Services and Sales

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Vector Controls Holding Co., LLC - Industrial Products - Warrants to Purchase Limited Liability Company Interests, Expires 3/6/2025

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Vector Controls Holding Co., LLC - Industrial Products - Warrants to Purchase Limited Liability Company Interests, Expires 3/6/2025

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Industrial Products

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - AgencyBloc, LLC - Insurance Software - First Lien Term Loan (1M USD TERM SOFR+7.76%), 12.09% Cash, 10/1/2026

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - AgencyBloc, LLC - Insurance Software - First Lien Term Loan (1M USD TERM SOFR+7.76%), 12.09% Cash, 10/1/2026

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Panther ParentCo LLC - Insurance Software - Class A Units

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Panther ParentCo LLC - Insurance Software - Class A Units

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Insurance Software

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Avantra - IT Services - First Lien Term Loan (3M USD TERM SOFR+7.97%), 12.29% Cash, 9/20/2029

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Avantra - IT Services - First Lien Term Loan (3M USD TERM SOFR+7.97%), 12.29% Cash, 9/20/2029

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Maple Holdings Midco Limited - IT Services - Class A Common Units

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Maple Holdings Midco Limited - IT Services - Class A Common Units

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - IT Services

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - ActiveProspect, Inc. - Lead Management Software - First Lien Term Loan (3M USD TERM SOFR+6.00%), 10.52% Cash, 8/8/2027

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - ActiveProspect, Inc. - Lead Management Software - First Lien Term Loan (3M USD TERM SOFR+6.00%), 10.52% Cash, 8/8/2027

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - ActiveProspect, Inc. - Lead Management Software - Delayed Draw Term Loan (3M USD TERM SOFR+6.00%), 10.52% Cash, 8/8/2027

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - ActiveProspect, Inc. - Lead Management Software - Delayed Draw Term Loan (3M USD TERM SOFR+6.00%), 10.52% Cash, 8/8/2027

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Lead Management Software

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Madison Logic, Inc. - Marketing Orchestration Software - First Lien Term Loan (1M USD TERM SOFR+7.50%), 11.82% Cash, 12/30/2028

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Madison Logic, Inc. - Marketing Orchestration Software - First Lien Term Loan (1M USD TERM SOFR+7.50%), 11.82% Cash, 12/30/2028

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Marketing Orchestration Software

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - ARC Health OpCo LLC -Mental Healthcare Services -First Lien Term Loan (3M USD TERM SOFR+8.40%), 12.72% Cash, 8/5/2027

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - ARC Health OpCo LLC -Mental Healthcare Services -First Lien Term Loan (3M USD TERM SOFR+8.40%), 12.72% Cash, 8/5/2027

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - ARC Health OpCo LLC -Mental Healthcare Services -Delayed Draw Term Loan (3M USD TERM SOFR+8.40%), 12.72% Cash, 8/5/2027

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - ARC Health OpCo LLC -Mental Healthcare Services -Delayed Draw Term Loan (3M USD TERM SOFR+8.40%), 12.72% Cash, 8/5/2027

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - ARC Health OpCo LLC -Mental Healthcare Services - Class A Preferred Units

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - ARC Health OpCo LLC -Mental Healthcare Services - Class A Preferred Units

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Mental Healthcare Services

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Chronus LLC - Mentoring Software - First Lien Term Loan (3M USD TERM SOFR+5.25%), 9.72% Cash, 8/26/2026

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Chronus LLC - Mentoring Software - First Lien Term Loan (3M USD TERM SOFR+5.25%), 9.72% Cash, 8/26/2026

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Chronus LLC - Mentoring Software - First Lien Term Loan (3M USD TERM SOFR+6.00%), 10.47% Cash, 8/26/2026

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Chronus LLC - Mentoring Software - First Lien Term Loan (3M USD TERM SOFR+6.00%), 10.47% Cash, 8/26/2026

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Chronus LLC - Mentoring Software - Series A Preferred Stock

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Chronus LLC - Mentoring Software - Series A Preferred Stock

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Mentoring Software

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Cloudpermit - Municipal Government Software - First Lien Term Loan (3M USD TERM SOFR+5.75%), 10.07% Cash, 9/5/2029

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Cloudpermit - Municipal Government Software - First Lien Term Loan (3M USD TERM SOFR+5.75%), 10.07% Cash, 9/5/2029

2025-02-28 0001377936

Non-control/Non-affiliate investments - 220.9% - Cloudpermit - Delayed Draw Term Loan (3M USD TERM SOFR+5.75%), 10.07% Cash, 9/5/2029

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 220.9% - Cloudpermit - Delayed Draw Term Loan (3M USD TERM SOFR+5.75%), 10.07% Cash, 9/5/2029

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Cloudpermit - Municipal Government Software - Limited Partner Interests

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Cloudpermit - Municipal Government Software - Limited Partner Interests

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Municipal Government Software

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Omatic Software, LLC - Non-profit Services - First Lien Term Loan (3M USD TERM SOFR+8.00%), 12.58% Cash/1.00% PIK, 6/30/2025

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Omatic Software, LLC - Non-profit Services - First Lien Term Loan (3M USD TERM SOFR+8.00%), 12.58% Cash/1.00% PIK, 6/30/2025

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Non-profit Services

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Emily Street Enterprises, L.L.C. - Office Supplies - Senior Secured Note (3M USD TERM SOFR+6.75%), 11.07% Cash, 12/31/2028

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Emily Street Enterprises, L.L.C. - Office Supplies - Senior Secured Note (3M USD TERM SOFR+6.75%), 11.07% Cash, 12/31/2028

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Office Supplies

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Buildout, Inc. - Real Estate Services - First Lien Term Loan (3M USD TERM SOFR+7.00%), 11.42% Cash, 7/9/2025

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Buildout, Inc. - Real Estate Services - First Lien Term Loan (3M USD TERM SOFR+7.00%), 11.42% Cash, 7/9/2025

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Buildout, Inc. - Real Estate Services - Delayed Draw Term Loan (3M USD TERM SOFR+7.00%), 11.42% Cash, 7/9/2025

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Buildout, Inc. - Real Estate Services - Delayed Draw Term Loan (3M USD TERM SOFR+7.00%), 11.42% Cash, 7/9/2025

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Buildout, Inc. - Real Estate Services - Limited Partner Interests

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Buildout, Inc. - Real Estate Services - Limited Partner Interests

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Real Estate Services

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Wellspring Worldwide Inc. - Research Software - First Lien Term Loan (3M USD TERM SOFR+8.42%), 12.74% Cash, 12/22/2028

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Wellspring Worldwide Inc. - Research Software - First Lien Term Loan (3M USD TERM SOFR+8.42%), 12.74% Cash, 12/22/2028

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Wellspring Worldwide Inc. - Research Software - Delayed DrawTerm Loan (3M USD TERM SOFR+8.42%), 12.74% Cash, 12/22/2028

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Wellspring Worldwide Inc. - Research Software - Delayed DrawTerm Loan (3M USD TERM SOFR+8.42%), 12.74% Cash, 12/22/2028

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Archimedes Parent LLC - Research Software - Class A Common Units

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Archimedes Parent LLC - Research Software - Class A Common Units

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Research Software

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - LFR Chicken LLC - Restaurant - First Lien Term Loan (1M USD TERM SOFR+7.00%), 11.32% Cash, 11/19/2026

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - LFR Chicken LLC - Restaurant - First Lien Term Loan (1M USD TERM SOFR+7.00%), 11.32% Cash, 11/19/2026

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - LFR Chicken LLC - Restaurant - Delayed Draw Term Loan (1M USD TERM SOFR+7.00%), 11.32% Cash, 11/19/2026

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - LFR Chicken LLC - Restaurant - Delayed Draw Term Loan (1M USD TERM SOFR+7.00%), 11.32% Cash, 11/19/2026

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - LFR Chicken LLC - Restaurant - Series B Preferred Units

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - LFR Chicken LLC - Restaurant - Series B Preferred Units

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Restaurant

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Avionte Holdings, LLC - Staffing Services - Class A Units

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Avionte Holdings, LLC - Staffing Services - Class A Units

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Staffing Services

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - JDXpert - Talent Acquisition Software - First Lien Term Loan (3M USD TERM SOFR+8.50%), 13.08% Cash, 5/2/2027

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - JDXpert - Talent Acquisition Software - First Lien Term Loan (3M USD TERM SOFR+8.50%), 13.08% Cash, 5/2/2027

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - JDXpert - Talent Acquisition Software - Delayed Draw Term Loan (3M USD TERM SOFR+8.50%), 13.08% Cash, 5/2/2027

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - JDXpert - Talent Acquisition Software - Delayed Draw Term Loan (3M USD TERM SOFR+8.50%), 13.08% Cash, 5/2/2027

2025-02-28 0001377936

Non-control/Non-affiliate investment - 229.3% - JDXpert - Talent Acquisition Software - Delayed Draw Term Loan (3M USD TERM SOFR+8.50%), 13.08% Cash, 5/2/2027

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investment - 229.3% - JDXpert - Talent Acquisition Software - Delayed Draw Term Loan (3M USD TERM SOFR+8.50%), 13.08% Cash, 5/2/2027

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Jobvite, Inc. - Talent Acquisition Software - First Lien Term Loan (3M USD TERM SOFR+7.50%), 11.82% Cash, 8/5/2028

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Jobvite, Inc. - Talent Acquisition Software - First Lien Term Loan (3M USD TERM SOFR+7.50%), 11.82% Cash, 8/5/2028

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Talent Acquisition Software

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - VetnCare MSO, LLC - Veterinary Services - Delayed Draw Term Loan (3M USD TERM SOFR+5.75%), 10.07% Cash, 5/12/2028

2024-03-01 2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - VetnCare MSO, LLC - Veterinary Services - Delayed Draw Term Loan (3M USD TERM SOFR+5.75%), 10.07% Cash, 5/12/2028

2025-02-28 0001377936

Non-control/Non-affiliate investments - 229.3% - Veterinary Services

2025-02-28 0001377936

Sub Total Control investment

2025-02-28 0001377936

Affiliate investments - 10.3% - ETU Holdings, Inc. - Corporate Education Software - First Lien Term Loan (3M USD TERM SOFR+9.00%), 13.47% Cash, 8/18/2027

2024-03-01 2025-02-28 0001377936

Affiliate investments - 10.3% - ETU Holdings, Inc. - Corporate Education Software - First Lien Term Loan (3M USD TERM SOFR+9.00%), 13.47% Cash, 8/18/2027

2025-02-28 0001377936

Affiliate investments - 10.3% - ETU Holdings, Inc. - Corporate Education Software - Second Lien Term Loan 15.00% PIK, 2/18/2028

2024-03-01 2025-02-28 0001377936

Affiliate investments - 10.3% - ETU Holdings, Inc. - Corporate Education Software - Second Lien Term Loan 15.00% PIK, 2/18/2028

2025-02-28 0001377936

Affiliate investments - 10.3% - ETU Holdings, Inc. - Corporate Education Software - Series A Preferred Units

2024-03-01 2025-02-28 0001377936

Affiliate investments - 10.3% - ETU Holdings, Inc. - Corporate Education Software - Series A Preferred Units

2025-02-28 0001377936

Affiliate investments - 10.3% - Corporate Education Software

2025-02-28 0001377936

Affiliate investments - 10.3% - Axero Holdings, LLC - Employee Collaboration Software - 4.50% Cash, (3M USD TERM SOFR + 2.50%) PIK, 12/31/2027

2024-03-01 2025-02-28 0001377936

Affiliate investments - 10.3% - Axero Holdings, LLC - Employee Collaboration Software - 4.50% Cash, (3M USD TERM SOFR + 2.50%) PIK, 12/31/2027

2025-02-28 0001377936

Affiliate investments - 10.3% - Axero Holdings, LLC - Employee Collaboration Software - Delayed Draw Term Loan 4.50% Cash, (3M USD TERM SOFR + 2.50%) PIK, 12/31/2027

2024-03-01 2025-02-28 0001377936

Affiliate investments - 10.3% - Axero Holdings, LLC - Employee Collaboration Software - Delayed Draw Term Loan 4.50% Cash, (3M USD TERM SOFR + 2.50%) PIK, 12/31/2027

2025-02-28 0001377936

Affiliate investments - 13.1% - Axero Holdings, LLC - Employee Collaboration Software - Revolving Credit Facility (3M USD TERM SOFR+8.00%), 13.48% Cash, 6/30/2026

2024-03-01 2025-02-28 0001377936

Affiliate investments - 13.1% - Axero Holdings, LLC - Employee Collaboration Software - Revolving Credit Facility (3M USD TERM SOFR+8.00%), 13.48% Cash, 6/30/2026

2025-02-28 0001377936

Affiliate investments - 10.3% - Axero Holdings, LLC - Employee Collaboration Software - Series A Preferred Units

2024-03-01 2025-02-28 0001377936

Affiliate investments - 10.3% - Axero Holdings, LLC - Employee Collaboration Software - Series A Preferred Units

2025-02-28 0001377936

Affiliate investments - 10.3% - Axero Holdings, LLC - Employee Collaboration Software - Series B Preferred Units

2024-03-01 2025-02-28 0001377936

Affiliate investments - 10.3% - Axero Holdings, LLC - Employee Collaboration Software - Series B Preferred Units

2025-02-28 0001377936

Affiliate investments - 10.3% - Employee Collaboration Software

2025-02-28 0001377936

Sub Total Control investments

2025-02-28 0001377936

Control investments - 10.2% - Zollege PBC - Education Services - First Lien Term Loan 4.84% PIK, 8/9/2027

2024-03-01 2025-02-28 0001377936

Control investments - 10.2% - Zollege PBC - Education Services - First Lien Term Loan 4.84% PIK, 8/9/2027

2025-02-28 0001377936

Control investments - 10.2% - Zollege PBC - Education Services - Common Stock

2024-03-01 2025-02-28 0001377936

Control investments - 10.2% - Zollege PBC - Education Services - Common Stock

2025-02-28 0001377936

Control investments - 10.2% - Education Services

2025-02-28 0001377936

Control investments - 10.2% - Pepper Palace, Inc. - Specialty Food Retailer - First Lien Term Loan 4.42% PIK, 12/31/2028

2024-03-01 2025-02-28 0001377936

Control investments - 10.2% - Pepper Palace, Inc. - Specialty Food Retailer - First Lien Term Loan 4.42% PIK, 12/31/2028

2025-02-28 0001377936

Control investments - 10.2% -Pepper Palace, Inc. - Specialty Food Retailer - Delayed Draw Term Loan 4.42% PIK, 12/31/2028

2024-03-01 2025-02-28 0001377936

Control investments - 10.2% -Pepper Palace, Inc. - Specialty Food Retailer - Delayed Draw Term Loan 4.42% PIK, 12/31/2028

2025-02-28 0001377936

Control investments - 10.2% - Pepper Palace, Inc. - Specialty Food Retailer - Revolving Credit Facility 4.42% PIK, 12/31/2028

2024-03-01 2025-02-28 0001377936

Control investments - 10.2% - Pepper Palace, Inc. - Specialty Food Retailer - Revolving Credit Facility 4.42% PIK, 12/31/2028

2025-02-28 0001377936

Control investments - 10.2% - Pepper Palace, Inc. - Specialty Food Retailer - Class A Units

2024-03-01 2025-02-28 0001377936

Control investments - 10.2% - Pepper Palace, Inc. - Specialty Food Retailer - Class A Units

2025-02-28 0001377936

Control investments - 10.2% - Specialty Food Retailer

2025-02-28 0001377936

Control investments - 10.2% - Saratoga Investment Corp. CLO 2013-1, Ltd. - Structured Finance Securities - Other/Structured Finance Securities 0.00%, 4/20/2033

2024-03-01 2025-02-28 0001377936

Control investments - 10.2% - Saratoga Investment Corp. CLO 2013-1, Ltd. - Structured Finance Securities - Other/Structured Finance Securities 0.00%, 4/20/2033

2025-02-28 0001377936

Control investments - 10.2% - Saratoga Investment Corp. CLO 2013-1, Ltd. - Structured Finance Securities - Other/Structured Finance Securities (3M USD TERM SOFR+10.00%), 14.58%, 4/20/2033

2024-03-01 2025-02-28 0001377936

Control investments - 10.2% - Saratoga Investment Corp. CLO 2013-1, Ltd. - Structured Finance Securities - Other/Structured Finance Securities (3M USD TERM SOFR+10.00%), 14.58%, 4/20/2033

2025-02-28 0001377936

Control investments - 10.3% - Saratoga Investment Corp. Senior Loan Fund 2022-1, Ltd. Class E Note - Structured Finance Securities - Other/Structured Finance Securities (3M USD TERM SOFR+8.55%), 12.87%, 10/20/2033

2024-03-01 2025-02-28 0001377936

2025-02-28 0001377936

Control investments - 10.2% - Structured Finance Securities

2025-02-28 0001377936

Control investments - 10.2% - Saratoga Senior Loan Fund I JV, LLC - Investment Fund - Unsecured Loan 10.00%, 10/20/2033

2024-03-01 2025-02-28 0001377936

Control investments - 10.2% - Saratoga Senior Loan Fund I JV, LLC - Investment Fund - Unsecured Loan 10.00%, 10/20/2033

2025-02-28 0001377936

Control investments - 10.2% - Saratoga Senior Loan Fund I JV, LLC - Investment Fund - Membership Interest

2024-03-01 2025-02-28 0001377936

Control investments - 10.2% - Saratoga Senior Loan Fund I JV, LLC - Investment Fund - Membership Interest

2025-02-28 0001377936

Control investments - 10.2% - Investment Fund

2025-02-28 0001377936

Sub Total Controls investment

2025-02-28 0001377936 us-gaap:CashAndCashEquivalentsMember 2025-08-31 0001377936 us-gaap:CashAndCashEquivalentsMember 2025-02-28 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember sar:AxeroHoldingsLLCMember 2025-02-28 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember sar:AxeroHoldingsLLCMember 2025-03-01 2025-08-31 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember sar:AxeroHoldingsLLCMember 2025-08-31 0001377936 us-gaap:InvestmentAffiliatedIssuerMember sar:ETUHoldingsIncMember 2025-02-28 0001377936 us-gaap:InvestmentAffiliatedIssuerMember sar:ETUHoldingsIncMember 2025-03-01 2025-08-31 0001377936 us-gaap:InvestmentAffiliatedIssuerMember sar:ETUHoldingsIncMember 2025-08-31 0001377936 us-gaap:InvestmentAffiliatedIssuerMember sar:SmartACcomLLCMember 2025-02-28 0001377936 us-gaap:InvestmentAffiliatedIssuerMember sar:SmartACcomLLCMember 2025-03-01 2025-08-31 0001377936 us-gaap:InvestmentAffiliatedIssuerMember sar:SmartACcomLLCMember 2025-08-31 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember sar:PepperPalaceIncMember 2025-02-28 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember sar:PepperPalaceIncMember 2025-03-01 2025-08-31 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember sar:PepperPalaceIncMember 2025-08-31 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember sar:ZollegePBCMember 2025-02-28 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember sar:ZollegePBCMember 2025-03-01 2025-08-31 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember sar:ZollegePBCMember 2025-08-31 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-02-28 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-03-01 2025-08-31 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember sar:SaratogaInvestmentCorpSeniorLoanFund20221LtdClassENoteMember 2025-02-28 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember sar:SaratogaInvestmentCorpSeniorLoanFund20221LtdClassENoteMember 2025-03-01 2025-08-31 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember sar:SaratogaInvestmentCorpSeniorLoanFund20221LtdClassENoteMember 2025-08-31 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember sar:SaratogaInvestmentCorpCLO20131LtdClassF2R3NoteMember 2025-02-28 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember sar:SaratogaInvestmentCorpCLO20131LtdClassF2R3NoteMember 2025-03-01 2025-08-31 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember sar:SaratogaInvestmentCorpCLO20131LtdClassF2R3NoteMember 2025-08-31 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember sar:SaratogaSeniorLoanFundIJVLLC1Member 2025-02-28 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember sar:SaratogaSeniorLoanFundIJVLLC1Member 2025-03-01 2025-08-31 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember sar:SaratogaSeniorLoanFundIJVLLC1Member 2025-08-31 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember sar:SaratogaSeniorLoanFundIJVLLC2Member 2025-02-28 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember sar:SaratogaSeniorLoanFundIJVLLC2Member 2025-03-01 2025-08-31 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember sar:SaratogaSeniorLoanFundIJVLLC2Member 2025-08-31 0001377936 us-gaap:InvestmentAffiliatedIssuerMember sar:AxeroHoldingsLLCMember 2024-02-29 0001377936 us-gaap:InvestmentAffiliatedIssuerMember sar:AxeroHoldingsLLCMember 2024-03-01 2025-02-28 0001377936 us-gaap:InvestmentAffiliatedIssuerMember sar:AxeroHoldingsLLCMember 2025-02-28 0001377936 us-gaap:InvestmentAffiliatedIssuerMember sar:ETUHoldingsIncMember 2024-02-29 0001377936 us-gaap:InvestmentAffiliatedIssuerMember sar:ETUHoldingsIncMember 2024-03-01 2025-02-28 0001377936 us-gaap:InvestmentAffiliatedIssuerMember 2024-02-29 0001377936 us-gaap:InvestmentAffiliatedIssuerMember 2024-03-01 2025-02-28 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember sar:NetreoHoldingsLLCMember 2024-02-29 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember sar:NetreoHoldingsLLCMember 2024-03-01 2025-02-28 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember sar:NetreoHoldingsLLCMember 2025-02-28 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember sar:PepperPalaceIncMember 2024-02-29 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember sar:PepperPalaceIncMember 2024-03-01 2025-02-28 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember sar:ZollegePBCMember 2024-02-29 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember sar:ZollegePBCMember 2024-03-01 2025-02-28 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-03-01 2025-02-28 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember sar:SaratogaInvestmentCorpSeniorLoanFund20221LtdClassENoteMember 2024-02-29 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember sar:SaratogaInvestmentCorpSeniorLoanFund20221LtdClassENoteMember 2024-03-01 2025-02-28 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember sar:SaratogaInvestmentCorpCLO20131LtdClassF2R3NoteMember 2024-02-29 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember sar:SaratogaInvestmentCorpCLO20131LtdClassF2R3NoteMember 2024-03-01 2025-02-28 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember sar:SaratogaSeniorLoanFundIJVLLC1Member 2024-02-29 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember sar:SaratogaSeniorLoanFundIJVLLC1Member 2024-03-01 2025-02-28 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember sar:SaratogaSeniorLoanFundIJVLLC2Member 2024-02-29 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember sar:SaratogaSeniorLoanFundIJVLLC2Member 2024-03-01 2025-02-28 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember 2024-02-29 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember 2024-03-01 2025-02-28 0001377936 sar:SBADebenturesMember 2025-03-01 2025-08-31 0001377936 us-gaap:CollateralizedLoanObligationsMember 2022-10-28 2022-10-28 0001377936 sar:SLFJVMember 2025-08-31 0001377936 sar:CODMMember 2025-03-01 2025-08-31 0001377936 sar:CODMMember 2024-03-01 2024-08-31 0001377936 us-gaap:CashAndCashEquivalentsMember 2025-08-31 0001377936 srt:MinimumMember 2025-08-31 0001377936 srt:MaximumMember 2025-08-31 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember 2025-08-31 0001377936 srt:MinimumMember us-gaap:InvestmentAffiliatedIssuerMember 2025-08-31 0001377936 srt:MaximumMember us-gaap:InvestmentAffiliatedIssuerMember 2025-08-31 0001377936 2024-03-01 2025-02-28 0001377936 2023-03-01 2024-02-29 0001377936 2022-03-01 2023-02-28 0001377936 sar:SaratogaInvestmentCorpMember 2025-03-01 2025-08-31 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member sar:FirstLienTermLoansMember 2025-08-31 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member sar:FirstLienTermLoansMember 2025-08-31 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member sar:FirstLienTermLoansMember 2025-08-31 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember sar:FirstLienTermLoansMember 2025-08-31 0001377936 us-gaap:InvestmentsMember sar:FirstLienTermLoansMember 2025-08-31 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member sar:SecondLienTermLoansMember 2025-08-31 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member sar:SecondLienTermLoansMember 2025-08-31 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member sar:SecondLienTermLoansMember 2025-08-31 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember sar:SecondLienTermLoansMember 2025-08-31 0001377936 us-gaap:InvestmentsMember sar:SecondLienTermLoansMember 2025-08-31 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:UnsecuredDebtMember 2025-08-31 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:UnsecuredDebtMember 2025-08-31 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:UnsecuredDebtMember 2025-08-31 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:UnsecuredDebtMember 2025-08-31 0001377936 us-gaap:InvestmentsMember us-gaap:UnsecuredDebtMember 2025-08-31 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:SecuritiesFinancingTransactionFairValueMember 2025-08-31 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:SecuritiesFinancingTransactionFairValueMember 2025-08-31 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesFinancingTransactionFairValueMember 2025-08-31 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:SecuritiesFinancingTransactionFairValueMember 2025-08-31 0001377936 us-gaap:InvestmentsMember us-gaap:SecuritiesFinancingTransactionFairValueMember 2025-08-31 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:EquitySecuritiesMember 2025-08-31 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:EquitySecuritiesMember 2025-08-31 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember 2025-08-31 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:EquitySecuritiesMember 2025-08-31 0001377936 us-gaap:InvestmentsMember us-gaap:EquitySecuritiesMember 2025-08-31 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member 2025-08-31 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member 2025-08-31 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member 2025-08-31 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember 2025-08-31 0001377936 us-gaap:InvestmentsMember 2025-08-31 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member sar:FirstLienTermLoansMember 2025-02-28 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member sar:FirstLienTermLoansMember 2025-02-28 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member sar:FirstLienTermLoansMember 2025-02-28 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember sar:FirstLienTermLoansMember 2025-02-28 0001377936 us-gaap:InvestmentsMember sar:FirstLienTermLoansMember 2025-02-28 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member sar:SecondLienTermLoansMember 2025-02-28 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member sar:SecondLienTermLoansMember 2025-02-28 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member sar:SecondLienTermLoansMember 2025-02-28 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember sar:SecondLienTermLoansMember 2025-02-28 0001377936 us-gaap:InvestmentsMember sar:SecondLienTermLoansMember 2025-02-28 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:UnsecuredDebtMember 2025-02-28 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:UnsecuredDebtMember 2025-02-28 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:UnsecuredDebtMember 2025-02-28 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:UnsecuredDebtMember 2025-02-28 0001377936 us-gaap:InvestmentsMember us-gaap:UnsecuredDebtMember 2025-02-28 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:SecuritiesFinancingTransactionFairValueMember 2025-02-28 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:SecuritiesFinancingTransactionFairValueMember 2025-02-28 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesFinancingTransactionFairValueMember 2025-02-28 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:SecuritiesFinancingTransactionFairValueMember 2025-02-28 0001377936 us-gaap:InvestmentsMember us-gaap:SecuritiesFinancingTransactionFairValueMember 2025-02-28 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:EquitySecuritiesMember 2025-02-28 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:EquitySecuritiesMember 2025-02-28 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember 2025-02-28 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:EquitySecuritiesMember 2025-02-28 0001377936 us-gaap:InvestmentsMember us-gaap:EquitySecuritiesMember 2025-02-28 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member 2025-02-28 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member 2025-02-28 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member 2025-02-28 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember 2025-02-28 0001377936 us-gaap:InvestmentsMember 2025-02-28 0001377936 us-gaap:FairValueInputsLevel3Member sar:FirstLienTermLoansMember 2025-02-28 0001377936 us-gaap:FairValueInputsLevel3Member sar:SecondLienTermLoansMember 2025-02-28 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:UnsecuredDebtMember 2025-02-28 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesFinancingTransactionFairValueMember 2025-02-28 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember 2025-02-28 0001377936 us-gaap:FairValueInputsLevel3Member 2025-02-28 0001377936 us-gaap:FairValueInputsLevel3Member sar:FirstLienTermLoansMember 2025-03-01 2025-08-31 0001377936 us-gaap:FairValueInputsLevel3Member sar:SecondLienTermLoansMember 2025-03-01 2025-08-31 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:UnsecuredDebtMember 2025-03-01 2025-08-31 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesFinancingTransactionFairValueMember 2025-03-01 2025-08-31 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember 2025-03-01 2025-08-31 0001377936 us-gaap:FairValueInputsLevel3Member 2025-03-01 2025-08-31 0001377936 us-gaap:FairValueInputsLevel3Member sar:FirstLienTermLoansMember 2025-08-31 0001377936 us-gaap:FairValueInputsLevel3Member sar:SecondLienTermLoansMember 2025-08-31 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:UnsecuredDebtMember 2025-08-31 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesFinancingTransactionFairValueMember 2025-08-31 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember 2025-08-31 0001377936 us-gaap:FairValueInputsLevel3Member 2025-08-31 0001377936 us-gaap:FairValueInputsLevel3Member sar:FirstLienTermLoansMember 2024-02-29 0001377936 us-gaap:FairValueInputsLevel3Member sar:SecondLienTermLoansMember 2024-02-29 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:UnsecuredDebtMember 2024-02-29 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesFinancingTransactionFairValueMember 2024-02-29 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember 2024-02-29 0001377936 us-gaap:FairValueInputsLevel3Member 2024-02-29 0001377936 us-gaap:FairValueInputsLevel3Member sar:FirstLienTermLoansMember 2024-03-01 2024-08-31 0001377936 us-gaap:FairValueInputsLevel3Member sar:SecondLienTermLoansMember 2024-03-01 2024-08-31 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:UnsecuredDebtMember 2024-03-01 2024-08-31 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesFinancingTransactionFairValueMember 2024-03-01 2024-08-31 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember 2024-03-01 2024-08-31 0001377936 us-gaap:FairValueInputsLevel3Member 2024-03-01 2024-08-31 0001377936 us-gaap:FairValueInputsLevel3Member sar:FirstLienTermLoansMember 2024-08-31 0001377936 us-gaap:FairValueInputsLevel3Member sar:SecondLienTermLoansMember 2024-08-31 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:UnsecuredDebtMember 2024-08-31 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesFinancingTransactionFairValueMember 2024-08-31 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember 2024-08-31 0001377936 us-gaap:FairValueInputsLevel3Member 2024-08-31 0001377936 us-gaap:FairValueInputsLevel3Member sar:FirstLienTermLoansMember sar:MeasurementInputMarketYieldMember us-gaap:MarketApproachValuationTechniqueMember 2025-08-31 0001377936 srt:MinimumMember us-gaap:FairValueInputsLevel3Member sar:FirstLienTermLoansMember sar:MeasurementInputMarketYieldMember us-gaap:MarketApproachValuationTechniqueMember 2025-08-31 0001377936 srt:MaximumMember us-gaap:FairValueInputsLevel3Member sar:FirstLienTermLoansMember sar:MeasurementInputMarketYieldMember us-gaap:MarketApproachValuationTechniqueMember 2025-08-31 0001377936 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member sar:FirstLienTermLoansMember sar:MeasurementInputMarketYieldMember us-gaap:MarketApproachValuationTechniqueMember 2025-08-31 0001377936 us-gaap:FairValueInputsLevel3Member sar:SecondLienTermLoansMember sar:MeasurementInputMarketYieldMember us-gaap:MarketApproachValuationTechniqueMember 2025-08-31 0001377936 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member sar:SecondLienTermLoansMember sar:MeasurementInputMarketYieldMember us-gaap:MarketApproachValuationTechniqueMember 2025-08-31 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:UnsecuredDebtMember us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2025-08-31 0001377936 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:UnsecuredDebtMember us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2025-08-31 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesFinancingTransactionFairValueMember us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2025-08-31 0001377936 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesFinancingTransactionFairValueMember us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2025-08-31 0001377936 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesFinancingTransactionFairValueMember us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2025-08-31 0001377936 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesFinancingTransactionFairValueMember us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2025-08-31 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesFinancingTransactionFairValueMember sar:MeasurementInputRecoveryRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2025-08-31 0001377936 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesFinancingTransactionFairValueMember sar:MeasurementInputRecoveryRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2025-08-31 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesFinancingTransactionFairValueMember us-gaap:MeasurementInputPrepaymentRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2025-08-31 0001377936 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesFinancingTransactionFairValueMember us-gaap:MeasurementInputPrepaymentRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2025-08-31 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember us-gaap:MeasurementInputRevenueMultipleMember sar:EnterpriseValueWaterfallMember 2025-08-31 0001377936 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember us-gaap:MeasurementInputRevenueMultipleMember sar:EnterpriseValueWaterfallMember 2025-08-31 0001377936 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember us-gaap:MeasurementInputRevenueMultipleMember sar:EnterpriseValueWaterfallMember 2025-08-31 0001377936 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember us-gaap:MeasurementInputRevenueMultipleMember sar:EnterpriseValueWaterfallMember 2025-08-31 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember us-gaap:MeasurementInputEbitdaMultipleMember sar:EnterpriseValueWaterfallMember 2025-08-31 0001377936 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember us-gaap:MeasurementInputEbitdaMultipleMember sar:EnterpriseValueWaterfallMember 2025-08-31 0001377936 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember us-gaap:MeasurementInputEbitdaMultipleMember sar:EnterpriseValueWaterfallMember 2025-08-31 0001377936 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember us-gaap:MeasurementInputEbitdaMultipleMember sar:EnterpriseValueWaterfallMember 2025-08-31 0001377936 us-gaap:FairValueInputsLevel3Member sar:FirstLienTermLoansMember sar:MeasurementInputMarketYieldMember us-gaap:MarketApproachValuationTechniqueMember 2025-02-28 0001377936 srt:MinimumMember us-gaap:FairValueInputsLevel3Member sar:FirstLienTermLoansMember sar:MeasurementInputMarketYieldMember us-gaap:MarketApproachValuationTechniqueMember 2025-02-28 0001377936 srt:MaximumMember us-gaap:FairValueInputsLevel3Member sar:FirstLienTermLoansMember sar:MeasurementInputMarketYieldMember us-gaap:MarketApproachValuationTechniqueMember 2025-02-28 0001377936 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member sar:FirstLienTermLoansMember sar:MeasurementInputMarketYieldMember us-gaap:MarketApproachValuationTechniqueMember 2025-02-28 0001377936 us-gaap:FairValueInputsLevel3Member sar:FirstLienTermLoansMember us-gaap:MeasurementInputRevenueMultipleMember us-gaap:MarketApproachValuationTechniqueMember 2025-02-28 0001377936 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member sar:FirstLienTermLoansMember us-gaap:MeasurementInputRevenueMultipleMember us-gaap:MarketApproachValuationTechniqueMember 2025-02-28 0001377936 us-gaap:FairValueInputsLevel3Member sar:FirstLienTermLoansMember us-gaap:MeasurementInputEbitdaMultipleMember us-gaap:MarketApproachValuationTechniqueMember 2025-02-28 0001377936 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member sar:FirstLienTermLoansMember us-gaap:MeasurementInputEbitdaMultipleMember us-gaap:MarketApproachValuationTechniqueMember 2025-02-28 0001377936 us-gaap:FairValueInputsLevel3Member sar:SecondLienTermLoansMember sar:MeasurementInputMarketYieldMember us-gaap:MarketApproachValuationTechniqueMember 2025-02-28 0001377936 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member sar:SecondLienTermLoansMember sar:MeasurementInputMarketYieldMember us-gaap:MarketApproachValuationTechniqueMember 2025-02-28 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:UnsecuredDebtMember us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2025-02-28 0001377936 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:UnsecuredDebtMember us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2025-02-28 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesFinancingTransactionFairValueMember us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2025-02-28 0001377936 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesFinancingTransactionFairValueMember us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2025-02-28 0001377936 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesFinancingTransactionFairValueMember us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2025-02-28 0001377936 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesFinancingTransactionFairValueMember us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2025-02-28 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesFinancingTransactionFairValueMember sar:MeasurementInputRecoveryRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2025-02-28 0001377936 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesFinancingTransactionFairValueMember sar:MeasurementInputRecoveryRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2025-02-28 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesFinancingTransactionFairValueMember us-gaap:MeasurementInputPrepaymentRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2025-02-28 0001377936 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesFinancingTransactionFairValueMember us-gaap:MeasurementInputPrepaymentRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2025-02-28 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember us-gaap:MeasurementInputEbitdaMultipleMember sar:EnterpriseValueWaterfallMember 2025-02-28 0001377936 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember us-gaap:MeasurementInputEbitdaMultipleMember sar:EnterpriseValueWaterfallMember 2025-02-28 0001377936 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember us-gaap:MeasurementInputEbitdaMultipleMember sar:EnterpriseValueWaterfallMember 2025-02-28 0001377936 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember us-gaap:MeasurementInputEbitdaMultipleMember sar:EnterpriseValueWaterfallMember 2025-02-28 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember us-gaap:MeasurementInputRevenueMultipleMember sar:EnterpriseValueWaterfallMember 2025-02-28 0001377936 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember us-gaap:MeasurementInputRevenueMultipleMember sar:EnterpriseValueWaterfallMember 2025-02-28 0001377936 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember us-gaap:MeasurementInputRevenueMultipleMember sar:EnterpriseValueWaterfallMember 2025-02-28 0001377936 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember us-gaap:MeasurementInputRevenueMultipleMember sar:EnterpriseValueWaterfallMember 2025-02-28 0001377936 sar:FirstLienTermLoansMember 2025-08-31 0001377936 sar:SecondLienTermLoansMember 2025-08-31 0001377936 us-gaap:UnsecuredDebtMember 2025-08-31 0001377936 us-gaap:SecuritiesFinancingTransactionFairValueMember 2025-08-31 0001377936 us-gaap:EquitySecuritiesMember 2025-08-31 0001377936 sar:FirstLienTermLoansMember 2025-02-28 0001377936 sar:SecondLienTermLoansMember 2025-02-28 0001377936 us-gaap:UnsecuredDebtMember 2025-02-28 0001377936 us-gaap:SecuritiesFinancingTransactionFairValueMember 2025-02-28 0001377936 us-gaap:EquitySecuritiesMember 2025-02-28 0001377936 sar:SaratogaCLOMember 2025-03-01 2025-08-31 0001377936 2018-12-14 2018-12-14 0001377936 srt:MinimumMember 2018-12-14 2018-12-14 0001377936 srt:MaximumMember 2018-12-14 2018-12-14 0001377936 srt:MinimumMember sar:SaratogaCLOMember 2021-02-26 0001377936 srt:MaximumMember sar:SaratogaCLOMember 2021-02-26 0001377936 2021-02-26 2021-02-26 0001377936 sar:ClassFR3NotesMember 2021-02-26 2021-02-26 0001377936 sar:TheClassFR2Member 2021-02-26 2021-02-26 0001377936 sar:TheClassGR2Member 2021-02-26 2021-02-26 0001377936 sar:SaratogaInvestmentCorpCLO20131LtdMember 2021-02-26 2021-02-26 0001377936 2021-02-26 0001377936 2021-08-31 2021-08-31 0001377936 sar:ClassFR3NotesMember 2021-08-09 0001377936 sar:ClassF1R3Member 2021-08-09 0001377936 sar:ClassF2R3Member 2021-08-09 0001377936 sar:ClassF1R3Member 2021-08-11 2021-08-11 0001377936 2024-06-10 0001377936 2024-03-01 2024-11-30 0001377936 sar:SaratogaCLOMember 2025-06-01 2025-08-31 0001377936 sar:SaratogaCLOMember 2024-06-01 2024-08-31 0001377936 sar:SaratogaCLOMember 2025-03-01 2025-08-31 0001377936 sar:SaratogaCLOMember 2024-03-01 2024-08-31 0001377936 us-gaap:SubordinatedDebtMember 2025-05-31 0001377936 sar:ClassF2R3Member 2025-05-31 0001377936 sar:ClassF2R3Member 2025-05-31 2025-05-31 0001377936 us-gaap:SubordinatedDebtMember 2025-05-31 2025-05-31 0001377936 sar:SaratogaCLOMember 2025-05-31 0001377936 2025-05-31 2025-05-31 0001377936 sar:LIBORMember 2025-05-31 0001377936 2025-05-31 0001377936 2008-01-01 2008-01-31 0001377936 2008-12-31 2008-12-31 0001377936 us-gaap:SubordinatedDebtMember 2008-12-31 2008-12-31 0001377936 us-gaap:SubordinatedDebtMember 2025-02-28 2025-02-28 0001377936 2025-02-28 2025-02-28 0001377936 sar:LIBORMember 2025-02-28 0001377936 sar:SaratogaCLOMember 2025-05-31 0001377936 sar:SaratogaCLOMember 2008-01-01 2008-01-31 0001377936 sar:SaratogaCLOMember 2018-12-01 2018-12-31 0001377936 sar:SaratogaCLOMember 2021-02-28 2021-02-28 0001377936 sar:SaratogaCLOMember 2025-03-01 2025-05-31 0001377936 sar:SecuredOvernightFinancingRateMember 2025-03-01 2025-08-31 0001377936 us-gaap:PrimeRateMember 2025-03-01 2025-08-31 0001377936 sar:SecuredOvernightFinancingRateMember 2024-03-01 2025-02-28 0001377936 us-gaap:PrimeRateMember 2024-03-01 2025-02-28 0001377936 sar:SaratogaCLOMember us-gaap:DebtMember 2025-05-31 0001377936 sar:SaratogaCLOMember us-gaap:DebtMember 2025-02-28 0001377936 sar:SaratogaCLOMember us-gaap:EquitySecuritiesMember 2025-05-31 0001377936 sar:SaratogaCLOMember us-gaap:EquitySecuritiesMember 2025-02-28 0001377936 sar:SaratogaCLOMember 2025-05-31 0001377936 sar:SaratogaCLOMember 2025-02-28 0001377936 sar:ClassA1R4Member sar:SaratogaCLOMember 2025-05-31 0001377936 sar:ClassA1R4Member sar:SaratogaCLOMember 2025-02-28 0001377936 sar:ClassA2R4Member sar:SaratogaCLOMember 2025-05-31 0001377936 sar:ClassA2R4Member sar:SaratogaCLOMember 2025-02-28 0001377936 sar:ClassBFLR3Member sar:SaratogaCLOMember 2025-05-31 0001377936 sar:ClassBFLR3Member sar:SaratogaCLOMember 2025-02-28 0001377936 sar:ClassBFXDR3Member sar:SaratogaCLOMember 2025-05-31 0001377936 sar:ClassBFXDR3Member sar:SaratogaCLOMember 2025-02-28 0001377936 sar:ClassCFLR3Member sar:SaratogaCLOMember 2025-05-31 0001377936 sar:ClassCFLR3Member sar:SaratogaCLOMember 2025-02-28 0001377936 sar:ClassCFXDR3Member sar:SaratogaCLOMember 2025-05-31 0001377936 sar:ClassCFXDR3Member sar:SaratogaCLOMember 2025-02-28 0001377936 sar:ClassDR3Member sar:SaratogaCLOMember 2025-05-31 0001377936 sar:ClassDR3Member sar:SaratogaCLOMember 2025-02-28 0001377936 sar:ClassER3Member sar:SaratogaCLOMember 2025-05-31 0001377936 sar:ClassER3Member sar:SaratogaCLOMember 2025-02-28 0001377936 sar:ClassF1R3Member sar:SaratogaCLOMember 2025-05-31 0001377936 sar:ClassF1R3Member sar:SaratogaCLOMember 2025-02-28 0001377936 sar:ClassF2R3Member sar:SaratogaCLOMember 2025-05-31 0001377936 sar:ClassF2R3Member sar:SaratogaCLOMember 2025-02-28 0001377936 sar:SaratogaCLOMember 2025-06-01 2025-08-31 0001377936 sar:SaratogaCLOMember 2024-06-01 2024-08-31 0001377936 sar:SaratogaCLOMember 2025-03-01 2025-08-31 0001377936 sar:SaratogaCLOMember 2024-03-01 2024-08-31 0001377936

ALTISOURCE PORTFOLIO SOL, Banking, Finance, Insurance & Real Estate, Common Stock, Equity

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Altisource Portfolio Solutions - CS Warrant - Banking, Finance, Insurance & Real Estate - Warrants - Equity

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Altisource Portfolio Solutions - NS Warrant - Banking, Finance, Insurance & Real Estate - Warrants - Equity

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Envision Parent Inc - Healthcare & Pharmaceuticals - Common Stock - Equity

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Envision Parent Inc - Healthcare & Pharmaceuticals - Warrants - Equity

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Franchise Group Inc-Services: Consumer-Common Stock-Equity

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Instant Brands Litigation Trust - Consumer goods: Durable - Equity Interests - Equity

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Isagenix International, LLC - Beverage, Food & Tobacco - Common Stock - Equity

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Wellpath Holdings LLC - Healthcare & Pharmaceuticals - Preferred Stock - Equity

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Resolute Investment Managers (American Beacon), Inc. - Banking, Finance, Insurance & Real Estate - Common Stock - Equity

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Wellpath Holdings LLC - Healthcare & Pharmaceuticals - Common Stock - Equity

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

1011778 B.C Unltd Liability Co - Beverage, Food & Tobacco - Term Loan B6 - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

19TH HOLDINGS GOLF, LLC - Consumer goods: Durable - Term Loan - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

888 Acquisitions Limited - Hotel, Gaming & Leisure - Term Loan B - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Adtalem Global Education Inc.- Services: Business - Term Loan B (08/24) - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Agiliti Health Inc.- Healthcare & Pharmaceuticals - Term Loan B (03/23) - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

AHEAD DB Holdings, LLC - Services: Business - Term Loan B3 (07/24) - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Air Canada - Transportation: Consumer - Term Loan B (03/24) - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

AIT Worldwide Logistics Holdings, Inc. - Transportation: Cargo - Term Loan B (01/25) - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

AlixPartners, LLP - Banking, Finance, Insurance & Real Estate - Term Loan B (01/21) - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Allen Media, LLC - Media: Diversified & Production - Term Loan (7/21) - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Alliant Holdings Intermediate, LLC - Banking, Finance, Insurance & Real Estate - Term Loan B6 (09/24) - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Alterra Mountain Company (Intrawest Resort Holdings) - Hotel, Gaming & Leisure - First Lien Term Loan - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Altisource Solutions S.a r.l. - Banking, Finance, Insurance & Real Estate - Term Loan (Specified) B - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Altium Packaging LLC - Containers, Packaging & Glass - Term Loan B - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

American Axle & Manufacturing Inc. - Automotive - Term Loan (12/22) - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

American Greetings Corporation - Media: Advertising, Printing & Publishing - Term Loan B (04/24) - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

American Trailer World Corp - Automotive - Term Loan - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Mayfield Agency Borrower Inc. (FeeCo)-Banking, Finance, Insurance & Real Estate-Term Loan B (12/24)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

RV Retailer LLC-Automotive-Term Loan-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Anchor Packaging, LLC - Containers, Packaging & Glass - Term Loan (12/24) - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

AP Core Holdings II LLC - High Tech Industries - Term Loan B1 - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

AP Core Holdings II LLC - High Tech Industries - Term Loan B2 - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

APEX GROUP TREASURY LLC - Banking, Finance, Insurance & Real Estate - Term Loan (2/25) - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Aramark Services, Inc. - Services: Consumer - Term Loan B8 (03/24) - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Aramark Services, Inc. - Services: Consumer - Term Loan B7 (03/24) - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

DOTDASH MEREDITH, INC.-Media:Advertising, Printing & Publishing-Term Loan B (11/24)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

ARCIS GOLF LLC - Services: Consumer - Term Loan B (01/25) - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Assuredpartners Inc. - Banking, Finance, Insurance & Real Estate - Term Loan B5 (02/24) - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Ascensus Group Holdings, Inc - Banking, Finance, Insurance & Real Estate - Term Loan - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Aspire Bakeries Holdings, LLC - Beverage, Food & Tobacco - Term loan - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Asurion, LLC - Banking, Finance, Insurance & Real Estate - Term Loan B10 - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Asurion, LLC - Banking, Finance, Insurance & Real Estate - Term Loan B12 - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

ATHENAHEALTH GROUP INC. - Healthcare & Pharmaceuticals -Term Loan B (2/22) - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Avolon TLB Borrower 1 (US) LLC - Capital Equipment - Term Loan B6 - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Axalta Coating Systems US Holdings - Chemicals, Plastics, & Rubber - Term Loan B (11/24) - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

B&G Foods, Inc. - Beverage, Food & Tobacco - Term Loan B - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Baldwin Insurance Group Holdings, LLC - Banking, Finance, Insurance & Real Estate - Term Loan B-1 (12/24) - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Belfor Holdings Inc. - Services: Consumer - Term Loan 4/23 - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Bengal Debt Merger Sub LLC - Beverage, Food & Tobacco - Third Out Term Loan - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Franchise Group, Inc. - Services: Consumer - Term Loan B - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Blackstone Mortgage Trust, Inc. - Banking, Finance, Insurance & Real Estate - Term Loan B - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Bombardier Recreational Products, Inc. - Consumer goods: Durable - Term Loan - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Bombardier Recreational Products, Inc. - Consumer goods: Durable - Term Loan B3 - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Boost Newco Borrower, LLC (Worldpay) - Banking, Finance, Insurance & Real Estate - Term Loan B (01/25) - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Boxer Parent Company, Inc. - High Tech Industries -Term Loan - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

BroadStreet Partners, Inc. - Banking, Finance, Insurance & Real Estate - Term Loan B-4 - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Brookfield WEC Holdings Inc. - Energy: Electricity - Term Loan B - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Brookfield Property REIT Inc.-Banking, Finance, Insurance & Real Estate-Term Loan B (05/25)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

BROWN GROUP HOLDING, LLC - Aerospace & Defense - Term Loan B-2 - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Buckeye Partners, L.P. - Utilities: Oil & Gas - Term Loan B (01/25) - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Buckeye Partners, L.P. - Utilities: Oil & Gas - Term Loan B5 (09/24) - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

BW Gas & Convenience Holdings LLC - Beverage, Food & Tobacco - Term Loan B - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Callaway Golf Company - Retail-Term Loan B - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Calpine Corporation - Utilities: Electric - Term Loan B10 (01/24) - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Camping World, Inc. - Retail - Term Loan B (5/21) - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

CAPSTONE BORROWER INC - Services: Business - Term Loan B - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

CareerBuilder, LLC (c) - Services: Business - Term Loan B3 - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Castle US Holding Corporation - Media: Advertising, Printing & Publishing - Term Loan (4/25) - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Castle US Holding Corporation - Media: Advertising, Printing & Publishing - Term Loan B (USD) - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

CBL & Associates Limited Partnership - Retail-Term Loan 11/21 - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

CCC Intelligent Solutions Inc. - Services: Business - Term Loan B - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

CCRR Parent, Inc. - Healthcare & Pharmaceuticals - Term Loan - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

CCRR Parent, Inc. - Healthcare & Pharmaceuticals - Term Loan B - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

CDK GLOBAL, INC. - High Tech Industries - Term Loan B (05/24) - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Charlotte Buyer, Inc. - Services: Business - Term Loan B (01/25) - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Chemours Company, (The)-Chemicals, Plastics, & Rubber-Term Loan B3 (08/23)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Churchill Downs Incorporated-Hotel, Gaming & Leisure-Term Loan B1 (3/21)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

CIMPRESS PUBLIC LIMITED COMPANY-Media: Advertising, Printing & Publishing-Term Loan B-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

CITADEL SECURITIES LP-Banking, Finance, Insurance & Real Estate-Term Loan (10/24)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Citco Funding LLC-Banking, Finance, Insurance & Real Estate-Term Loan B (06/24)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Clarios Global LP-Automotive-Term Loan B(07/24)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

TIBCO Software Inc-High Tech Industries-Term Loan (Cov-Lite) (10/24)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

CLYDESDALE ACQUISITION HOLDINGS, INC.-Containers, Packaging & Glass-Term Loan B-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Columbus McKinnon Corporation-Capital Equipment-Term Loan (03/24)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Connect Finco SARL-Telecommunications-Term Loan B (03/24)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Corelogic, Inc.-Services:-Business-Term Loan (4/21)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Creative Artists Agency, LLC-Media: Diversified & Production-Term Loan B (09/24)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

CROCS INC-Consumer goods: Durable-Term Loan B (01/24)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Cross Financial Corp-Banking, Finance, Insurance & Real Estate-Term Loan B2 (10/24)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Crown Subsea Communications Holding, Inc.-Construction & Building-Term Loan B-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Dave & Buster's Inc. - Hotel, Gaming & Leisure - Term Loan B (1/24) - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Delek US Holdings, Inc.-Utilities: Oil & Gas-Term Loan B (11/22)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Derby Buyer LLC-Chemicals, Plastics, & Rubber-Term Loan B (12/24)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

DexKo Global, Inc. (Dragon Merger)-Automotive-Term Loan (9/21)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Diamond Sports Group, LLC-Media: Broadcasting & Subscription-1st Priority Term Loan-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

DIRECTV FINANCING, LLC-Media: Broadcasting & Subscription-Term Loan (1/24)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

DISCOVERY PURCHASER CORPORATION-Chemicals, Plastics, & Rubber-Term Loan-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Dispatch Acquisition Holdings, LLC-Environmental Industries-Term Loan B (3/21)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

DOMTAR CORPORATION-Forest Products & Paper-Term Loan 9/21-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

DRI HOLDING INC.-Media: Advertising, Printing & Publishing-Term Loan (12/21)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

DRW Holdings, LLC-Banking, Finance, Insurance & Real Estate-Term Loan B (06/24)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

DTZ U.S. Borrower, LLC - Construction & Building - Term Loan B1 (01/25) - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

DTZ U.S. Borrower, LLC - Construction & Building - 2024-3 Term Loan (09/24) - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Dye & Durham Corporation-Services: Business-Term Loan B (04/24)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

EAB Global, Inc.-Services: Business-Term Loan (08/21)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Echo Global Logistics, Inc.-Services: Business-Term Loan-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Edelman Financial Group Inc., The-Banking, Finance, Insurance & Real Estate-Term Loan (12/24)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

ELECTRON BIDCO INC.-Healthcare & Pharmaceuticals-Term Loan-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Embecta Corp-Healthcare & Pharmaceuticals-Term Loan B-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Emrld Borrower LP-Capital Equipment-Term Loan B (04/23)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Endo Finance Holdings, Inc.-Healthcare & Pharmaceuticals-Term Loan B-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Endure Digital, Inc.-High Tech Industries-Term Loan B-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Entain Holdings (Gibraltar) Limited-Hotel, Gaming & Leisure-Term Loan B3 (5/24)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

EOS U.S. FINCO LLC-Transportation: Cargo-Term Loan-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Franchise Group, Inc. - Services: Consumer - First Out Term Loan - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Evertec Group LLC-Banking, Finance, Insurance & Real Estate-Term Loan B (09/23)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Fiesta Purchaser, Inc-Beverage, Food & Tobacco Term-Loan B (12/24)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Finco I LLC-Banking, Finance, Insurance & Real Estate-Term Loan B (9/24)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

First Brands Group, LLC-Automotive-1st Lien Term Loan (3/21)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

First Student Bidco Inc.-Transportation: Consumer-Term Loan (8/25)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

GGP Inc. - Banking, Finance, Insurance & Real Estate - Term Loan B - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Franchise Group, Inc. - Services: Consumer - Term Loan DIP New Money - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Flutter Financing B.V. - Hotel, Gaming & Leisure - Term Loan - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Franklin Square Holdings, L.P. - Banking, Finance, Insurance & Real Estate - Term Loan B (04/24) - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Froneri International (R&R Ice Cream)-Beverage, Food & Tobacco-Term Loan B4 (10/24)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Fusion Buyer LLC-Services: Consumer-Term Loan (06/25)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Garrett LX III S.a r.l. - Automotive - Term Loan (1/25) - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Genesee & Wyoming, Inc. - Transportation: Cargo - Term Loan B (03/24) - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

GIP Pilot Acquisition Partners, L.P. - Energy: Oil & Gas - Term Loan B - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Global Tel*Link Corporation - Telecommunications - Term Loan (6/24) - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Go Daddy Operating Company, LLC-High Tech Industries-Term Loan B7-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

GOLDEN WEST PACKAGING GROUP LLC-Forest Products & Paper-Term Loan (11/21)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

GOTO GROUP, INC.-High Tech Industries-First Lien Term Loan-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

GOTO GROUP, INC.-High Tech Industries-Second-Out Term Loan (02/24)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Graham Packaging Co Inc-Containers, Packaging & Glass-Term Loan B (07/24)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Great Outdoors Group, LLC-Retail-Term Loan (1/25)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Griffon Corporation-Consumer goods: Durable-Term Loan B-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Grosvenor Capital Management Holdings, LLLP - Banking, Finance, Insurance & Real Estate - Term Loan B (5/24) - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Groupe Solmax Inc.-Environmental Industries-Term Loan (6/21)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

GYP HOLDINGS III CORP.-Construction & Building-Term Loan(1/24)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Hertz Corporation (The)-Transportation: Consumer-Term Loan B-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Hillman Group Inc. (The) (New)-Consumer goods: Durable-Term Loan B-1 (2/21)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Hilton Domestic Operating Company Inc.-Hotel, Gaming & Leisure-Term Loan B 4-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

HLF Financing SARL (Herbalife)-Consumer goods: Non-durable-Term Loan-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Holley Purchaser, Inc-Automotive-Term Loan (11/21)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Hudson River Trading LLC-Banking, Finance, Insurance & Real Estate-Term Loan (10/24)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Hunter Douglas Inc-Consumer goods: Durable-Term Loan B (1/25)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Hyperion Refinance S.a.r.l. - Banking, Finance, Insurance & Real Estate - Term Loan B (11/24) - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Idera, Inc. - High Tech Industries - Term Loan (06/24) - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

IMA Financial Group, Inc. - Banking, Finance, Insurance & Real Estate - Term Loan (10/21) - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

INEOS 226 Ltd. - Chemicals, Plastics, & Rubber - Term Loan 3/23 - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Ineos US Finance LLC-Chemicals, Plastics, & Rubber-Term Loan C-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

INEOS US PETROCHEM LLC-Chemicals, Plastics, & Rubber-Term Loan B-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Informatica Inc.-High Tech Industries-Term Loan B (06/24)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Ingram Micro Inc. - Wholesale - Term Loan B - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Inmar, Inc. - Services: Business - Term Loan (06/23) - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Innophos, Inc. - Chemicals, Plastics, & Rubber - Term Loan B - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Instant Brands Litigation Trust (c)-Consumer goods: Durable-Instant Brands TL-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

IRB Holding Corporation-Beverage, Food & Tobacco-Term Loan B-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Isagenix International, LLC - Beverage, Food & Tobacco - Term Loan - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Isolved Inc.-Services: Business-Term Loan B (11/24)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Jane Street Group-Banking, Finance, Insurance & Real Estate-Term Loan B-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Journey Personal Care Corp.-Consumer goods: Non-durable-Term Loan B (11/24)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

JP Intermediate B, LLC-Consumer goods: Non-durable-Term Loan 7/23-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Kleopatra Finco S.a r.l.-Containers, Packaging & Glass-Term Loan (1/21) (USD)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Koppers Inc-Chemicals, Plastics, & Rubber-Term Loan-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Lakeland Tours, LLC-Hotel, Gaming & Leisure-Holdco Fixed Term Loan-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Latham Pool Products, Inc.-Consumer goods: Durable-Term Loan 2/22-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Lealand Finance Company B.V.-Energy: Oil & Gas-Exit Term Loan-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Liquid Tech Solutions Holdings, LLC-Services: Business-Term Loan (12/24)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Lifetime Brands, Inc-Consumer goods: Non-durable-Term Loan-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

LOYALTY VENTURES INC.-Services: Business-Loyalty Ventures Claims-Term Loan B

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Lumen Technologies Inc - Telecommunications - Term Loan B2 (3/24) - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

LSF9 Atlantis Holdings, LLC (A Wireless)-Retail-Term Loan-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

MAGNITE, INC.Services: Business-Term Loan B-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Marriott Ownership Resorts, Inc.-Hotel, Gaming & Leisure-Term Loan B (3/24)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Max US Bidco Inc.-Beverage, Food & Tobacco-Term Loan B-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

McGraw-Hill Education, Inc.-Media: Advertising, Printing & Publishing-Term Loan (1/25)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Michaels Companies Inc-Retail-Term Loan B (Magic Mergeco)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

MIWD Holdco II LLC-Construction & Building-Term Loan B2 (03/24)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

MKS Instruments, Inc.-High Tech Industries-Term Loan B (01/25)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Momentive Performance Materials Inc.-Chemicals, Plastics, & Rubber-Term Loan (03/23)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Moneygram International, Inc.-Services: Business-Term Loan B-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

MPH Acquisition Holdings LLC (Multiplan) - Services: Business - First-Out Term Loan (01/25) - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

MPH Acquisition Holdings LLC (Multiplan) - Services: Business - Second-Out Term Loan (01/25) - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

NAB Holdings, LLC (North American Bancard)-Banking, Finance, Insurance & Real Estate-Term Loan B (2/25)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Napa Management Services Corp-Healthcare & Pharmaceuticals-Term Loan B (02/22)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Natgasoline LLC-Chemicals, Plastics, & Rubber-Term Loan (3/25)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

National Mentor Holdings, Inc.-Healthcare & Pharmaceuticals-Term Loan 2/21-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

National Mentor Holdings, Inc. - Healthcare & Pharmaceuticals - Term Loan C 2/21 - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Next Level Apparel, Inc.-Retail-Term Loan-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Nielsen Consumer Inc.-Services: Business-Term Loan (08/25)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

NortonLifeLock Inc.-High Tech Industries-Term Loan B (05/24)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Nouryon Finance B.V.-Chemicals, Plastics, & Rubber-Term Loan B (10/24)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Novae LLCAutomotive-Term Loan B-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Olaplex, Inc.-Consumer goods: Non-durable-Term Loan (2/22)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Open Text Corporation-High Tech Industries-Term Loan B (08/23)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Oxbow Carbon, LLC-Metals & Mining-Term Loan B (04/23)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

PACIFIC DENTAL SERVICES, LLC-Healthcare & Pharmaceuticals-Term Loan B (02//24)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Padagis LLC-Healthcare & Pharmaceuticals-Term Loan-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

PAR PETROLEUM LLC-Energy: Oil & Gas-Term Loan B-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

PATAGONIA HOLDCO LLC-Telecommunications-Term Loan B-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Pathway Partners Vet Management Company LLC-Consumer goods: Non-durable-Term Loan B (03/25)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Pathway Partners Vet Management Company LLC (c)-Consumer goods: Non-durable-Term Loan B (03/25)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

PCI Gaming Authority-Hotel, Gaming & Leisure-Term Loan-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

PEARLS (Netherlands) Bidco B.V.-Chemicals, Plastics, & Rubber-USD Term Loan (02/22)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

PEDIATRIC ASSOCIATES HOLDING COMPANY, LLC-Healthcare & Pharmaceuticals-Term Loan (12/22)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Penn National Gaming, Inc-Hotel, Gaming & Leisure-Term Loan B-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Peraton Corp.-Aerospace & Defense-Term Loan B-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Phoenix Guarantor Inc.-Healthcare & Pharmaceuticals-Term Loan B (12/24)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

PHYSICIAN PARTNERS, LLC-Healthcare & Pharmaceuticals-Term Loan-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

PHYSICIAN PARTNERS, LLC (b) (c)-Healthcare & Pharmaceuticals-Term Loan B1 (1/25)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Plastipak Holdings Inc.-Containers, Packaging & Glass -Term Loan B-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Playtika Holding Corp.-High Tech Industries-Term Loan B (3/21)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

PMHC II, INC.-Chemicals, Plastics, & Rubber-Term Loan (02/22)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

PointClickCare Technologies, Inc.-High Tech Industries-Term Loan B (10/24)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Polymer Process Holdings, Inc.-Containers, Packaging & Glass-Term Loan-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Pre-Paid Legal Services, Inc.-Services: Consumer-Term Loan (12/21)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Prime Security Services Borrower, LLC (ADT)-Services: Consumer-Term Loan B-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Primo Brands Corporation-Beverage, Food & Tobacco-Term Loan B (01/25)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

PRIORITY HOLDINGS, LLC-Services: Consumer-Term Loan B (5/24)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

PriSo Acquisition Corporation-Construction & Building-Term Loan (01/21)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Project Leopard Holdings, Inc. (NEW)-High Tech Industries-Term Loan B (06/22)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Propulsion (BC) Finco-Aerospace & Defense-Term Loan B (10/24)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

PUG LLC-Services: Consumer-Term Loan B (03/24)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Quartz AcquireCo, LLC-High Tech Industries-Term Loan (2/25)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Quikrete Holdings, Inc.-Construction & Building-Term Loan (2/25)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Rackspace Technology Global, Inc. - High Tech Industries - Term Loan(3/24) - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Rackspace Technology Global, Inc. - High Tech Industries - Super-Priority Term Loan (03/24) - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

RAND PARENT LLC-Transportation: Cargo-Term Loan B (01/25)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

RealPage, Inc.-High Tech Industries-Term Loan (04/21)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Rent-A-Center, Inc.-Retail-Term Loan B2 (9/21)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Research Now Group, Inc - Media: Advertising, Printing & Publishing -Term Loan (07/24) - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Research Now Group, Inc - Media: Advertising, Printing & Publishing - Second-Out Term Loan - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Resideo Funding Inc.-Services: Consumer-Term Loan B (12/24)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Resolute Investment Managers (American Beacon), Inc.-Banking, Finance, Insurance & Real Estate-Term Loan (12/23)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Restoration Hardware, Inc. - Retail - Term Loan (9/21) - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Reynolds Consumer Products LLC-Containers, Packaging & Glass-Term Loan B (2/25)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Russell Investments US Inst'l Holdco, Inc.-Banking, Finance, Insurance & Real Estate-Term Loan B PIK (3/24)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Ryan Specialty Group LLC-Banking, Finance, Insurance & Real Estate-Term Loan B (09/24)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

S&S HOLDINGS LLC-Services: Business-Term Loan-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Sally Holdings LLC-Retail-Term Loan B-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Schweitzer-Mauduit International, Inc.-High Tech Industries-Term Loan B-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Scientific Games Holdings LP-Hotel, Gaming & Leisure-Term Loan B-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Sedgwick Claims Management Services, Inc.-Services: Business-Term Loan B 2/23-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

SETANTA AIRCRAFT LEASING DAC-Aerospace & Defense-Term Loan B (05/24)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Sitel Worldwide Corporation-Services: Business-USD Term Loan (7/21)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

SiteOne Landscape Supply, LLC-Services: Business-Term Loan B (06/24)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Smyrna Ready Mix Concrete, LLC-Construction & Building-Term Loan B-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Sparta U.S. HoldCo LLC-Chemicals, Plastics, & Rubber-Term Loan-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Specialty Pharma III Inc.-Services: Business-Term Loan-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Spin Holdco, Inc.-Services: Consumer-Term Loan 3/21-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

SRAM, LLC-Consumer goods: Durable-Term Loan(02/25)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

STANDARD INDUSTRIES INC.-Construction & Building-Term Loan B-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Staples, Inc.-Wholesale-Term Loan B-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Star Parent, Inc.-Services: Business-Term Loan B (09/23)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Storable, Inc-High Tech Industries-Term Loan B (3/25)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Teneo Holdings LLC-Banking, Finance, Insurance & Real Estate-Term Loan B (03/24)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

SupplyOne, Inc-Wholesale-Term Loan B (03/24)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Sweetwater Borrower, LLC-Retail-Term Loan (8/21)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Syncsort Incorporated-High Tech Industries-Term Loan B (10/21)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Ta TT Buyer LLC-Media: Broadcasting & Subscription-Term Loan B (6/24)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Tenable Holdings, Inc.-Services: Business-Term Loan B (6/21)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Thor Industries, Inc.-Automotive-Term Loan B (06/24)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Torrid LLC-Wholesale-Term Loan 5/21-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

TORY BURCH LLC-Retail-Term Loan-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Tosca Services, LLC-Containers, Packaging & Glass-Term Loan A (08/24)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Trans Union LLC-Banking, Finance, Insurance & Real Estate-Term Loan B9 (11/24)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Tronox Finance LLC-Chemicals, Plastics, & Rubber-Term Loan (09/24)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Tronox Finance LLC-Chemicals, Plastics, & Rubber-Term Loan B (09/24)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

TruGreen Limited Partnership-Services: Consumer-Term Loan-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Ultra Clean Holdings, Inc.-High Tech Industries-Term Loan B (09/24)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Univision Communications Inc. - Media: Broadcasting & Subscription - Term Loan B (05/24) - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Univision Communications Inc. - Media: Broadcasting & Subscription - Term Loan B (6/22) - Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Vaco Holdings, LLC-Services: Business-Term Loan (01/22)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Vericast Corp.-Media: Advertising, Printing & Publishing-Extended Term Loan (07/24)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Verifone Systems, Inc.-Banking, Finance, Insurance & Real Estate-Term Loan (03/25)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Vertex Aerospace Services Corp-Aerospace & Defense-Term Loan (10/21)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Vertiv Group Corporation-Capital Equipment-Term Loan-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Viasat Inc-Telecommunications-Term Loan (2/22)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Virtus Investment Partners, Inc.-Banking, Finance, Insurance & Real Estate-Term Loan B (9/21)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Vistra Operations Company LLC-Energy: Electricity-2018 Incremental Term Loan-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

VM Consolidated, Inc.-Construction & Building-Term Loan B-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Warner Music Group Corp. (WMG Acquisition Corp.), Hotel, Gaming & Leisure, Term Loan J, Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Watlow Electric Manufacturing Company, High Tech Industries, Term Loan B (03/21), Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

WeddingWire, Inc, Services: Consumer, Term Loan B (12/24), Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

WEX Inc, Services: Business, Term Loan B (11/24), Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Windsor Holdings III, LLC, Chemicals, Plastics, & Rubber, Term Loan B (02/25), Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Wyndham Hotels & Resorts, Inc, Hotel, Gaming & Leisure, Term Loan (05/24), Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Xperi Corporation, High Tech Industries, Term Loan (1/25), Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Zayo Group, LLC-Telecommunications-Term Loan 4/22-Loan

2025-08-31 0001377936

ZEBRA BUYER (Allspring) LLC-Banking, Finance, Insurance & Real Estate-Term Loan B (12/24)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Zekelman Industries, Inc, Metals & Mining, Term Loan B (03/24), Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Zest Acquisition Corp, Healthcare & Pharmaceuticals, Term Loan (1/23), Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Zodiac Pool Solutions-Consumer goods: Durable-Term Loan (1/22)-Loan

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936 sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

U.S. Bank Money Market [Member]

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

Total cash and cash equivalents

sar:SaratogaInvestmentCorpCLO20131LtdMember 2025-08-31 0001377936

ALTISOURCE PORTFOLIO SOL, Banking, Finance, Insurance & Real Estate, Common Stock, Equity